Table S7A. Manually Curated List of Genes Predicted by TUSON Explorer to Have TSG-like Signatures,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,
Gene,Gene Description,TUSON_p_value_TSG,TUSON_q_value_TSG,TSG_Probability_LASSO,TSG_LASSO_Rank,qvalue_LOF/Benign,qvalue_Splicing/Benign,qvalue_MissDamaging/Benign,qvalue_Deletion_GISTIC2,Manual Confidence,Literature Status,GO Terms,KEGG Pathways,Implicated in Cancer (PMID),Potential Functional Role in Cancer (PMID),
TP53,tumor protein p53,7.14604062715782E-104,1.33480892874681E-99,0.99933520874033,3,0,1.99839697836951E-158,0,1.08850420658813E-13,4,Known TSG,"GO:0000060~protein import into nucleus, translocation,GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0001701~in utero embryonic development,GO:0001775~cell activation,GO:0001836~release of cytochrome c from mitochondria,GO:0002263~cell activation during immune response,GO:0002285~lymphocyte activation during immune response,GO:0002286~T cell activation during immune response,GO:0002309~T cell proliferation during immune response,GO:0002326~B cell lineage commitment,GO:0002347~response to tumor cell,GO:0002360~T cell lineage commitment,GO:0002366~leukocyte activation during immune response,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006259~DNA metabolic process,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006839~mitochondrial transport,GO:0006873~cellular ion homeostasis,GO:0006885~regulation of pH,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006919~activation of caspase activity,GO:0006955~immune response,GO:0006970~response to osmotic stress,GO:0006974~response to DNA damage stimulus,GO:0006983~ER overload response,GO:0006984~ER-nuclear signaling pathway,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007242~intracellular signaling cascade,GO:0007346~regulation of mitotic cell cycle,GO:0007369~gastrulation,GO:0007406~negative regulation of neuroblast proliferation,GO:0007568~aging,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008156~negative regulation of DNA replication,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0008635~activation of caspase activity by cytochrome c,GO:0008637~apoptotic mitochondrial changes,GO:0009267~cellular response to starvation,GO:0009303~rRNA transcription,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009651~response to salt stress,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010332~response to gamma radiation,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010721~negative regulation of cell development,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0017038~protein import,GO:0019725~cellular homeostasis,GO:0022402~cell cycle process,GO:0030003~cellular cation homeostasis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030641~regulation of cellular pH,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031570~DNA integrity checkpoint,GO:0031571~G1 DNA damage checkpoint,GO:0031575~G1/S transition checkpoint,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0032535~regulation of cellular component size,GO:0032583~regulation of gene-specific transcription,GO:0032774~RNA biosynthetic process,GO:0032943~mononuclear cell proliferation,GO:0033077~T cell differentiation in the thymus,GO:0033365~protein localization in organelle,GO:0033554~cellular response to stress,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0040008~regulation of growth,GO:0042098~T cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042594~response to starvation,GO:0042770~DNA damage response, signal transduction,GO:0042771~DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043193~positive regulation of gene-specific transcription,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0043933~macromolecular complex subunit organization,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045165~cell fate commitment,GO:0045184~establishment of protein localization,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045926~negative regulation of growth,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046907~intracellular transport,GO:0048145~regulation of fibroblast proliferation,GO:0048147~negative regulation of fibroblast proliferation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048598~embryonic morphogenesis,GO:0048878~chemical homeostasis,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050801~ion homeostasis,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051095~regulation of helicase activity,GO:0051097~negative regulation of helicase activity,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051262~protein tetramerization,GO:0051276~chromosome organization,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051346~negative regulation of hydrolase activity,GO:0051453~regulation of intracellular pH,GO:0051726~regulation of cell cycle,GO:0051960~regulation of nervous system development,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060284~regulation of cell development,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070661~leukocyte proliferation,GO:0070727~cellular macromolecule localization,GO:0000267~cell fraction,GO:0005626~insoluble fraction,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0016604~nuclear body,GO:0016605~PML body,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000739~DNA strand annealing activity,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity,GO:0005507~copper ion binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,","hsa04010:MAPK signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04310:Wnt signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,","Reviewed (1505019, 19776744, 22713868, 20504879, 20066118), Associated with Li-Fraumeni syndrome, Cancer gene census (14993899)","Reviewed (1505019, 19776744, 22713868, 20504879, 20066118), Cancer gene census (14993899)", 
PTEN,phosphatase and tensin homolog; phosphatase and tensin homolog pseudogene 1,3.56895457129778E-101,3.33322512186356E-97,0.99983577855974,1,1.4501698410691E-165,1.64900907401719E-38,2.2877124661146E-55,2.66975286059864E-236,4,Known TSG,"GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006020~inositol metabolic process,GO:0006470~protein amino acid dephosphorylation,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006928~cell motion,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007568~aging,GO:0007584~response to nutrient,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007613~memory,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009743~response to carbohydrate stimulus,GO:0009746~response to hexose stimulus,GO:0009749~response to glucose stimulus,GO:0009968~negative regulation of signal transduction,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010043~response to zinc ion,GO:0010608~posttranscriptional regulation of gene expression,GO:0010627~regulation of protein kinase cascade,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010810~regulation of cell-substrate adhesion,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0014070~response to organic cyclic substance,GO:0014706~striated muscle tissue development,GO:0016265~death,GO:0016311~dephosphorylation,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0019637~organophosphate metabolic process,GO:0019751~polyol metabolic process,GO:0030030~cell projection organization,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030258~lipid modification,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030384~phosphoinositide metabolic process,GO:0031175~neuron projection development,GO:0031647~regulation of protein stability,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol stimulus,GO:0033198~response to ATP,GO:0034284~response to monosaccharide stimulus,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042493~response to drug,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043542~endothelial cell migration,GO:0043549~regulation of kinase activity,GO:0043627~response to estrogen stimulus,GO:0044087~regulation of cellular component biogenesis,GO:0045471~response to ethanol,GO:0045806~negative regulation of endocytosis,GO:0045859~regulation of protein kinase activity,GO:0046486~glycerolipid metabolic process,GO:0046685~response to arsenic,GO:0046838~phosphorylated carbohydrate dephosphorylation,GO:0046839~phospholipid dephosphorylation,GO:0046855~inositol phosphate dephosphorylation,GO:0046856~phosphoinositide dephosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0048545~response to steroid hormone stimulus,GO:0048666~neuron development,GO:0048738~cardiac muscle tissue development,GO:0048870~cell motility,GO:0050764~regulation of phagocytosis,GO:0050765~negative regulation of phagocytosis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051051~negative regulation of transport,GO:0051129~negative regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051338~regulation of transferase activity,GO:0051674~localization of cell,GO:0051726~regulation of cell cycle,GO:0051893~regulation of focal adhesion formation,GO:0051895~negative regulation of focal adhesion formation,GO:0051896~regulation of protein kinase B signaling cascade,GO:0051898~negative regulation of protein kinase B signaling cascade,GO:0060537~muscle tissue development,GO:0060548~negative regulation of cell death,GO:0060627~regulation of vesicle-mediated transport,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0000287~magnesium ion binding,GO:0004437~inositol or phosphatidylinositol phosphatase activity,GO:0004438~phosphatidylinositol-3-phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005161~platelet-derived growth factor receptor binding,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0008289~lipid binding,GO:0016314~phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,GO:0016791~phosphatase activity,GO:0019904~protein domain specific binding,GO:0030165~PDZ domain binding,GO:0034593~phosphatidylinositol bisphosphate phosphatase activity,GO:0034594~phosphatidylinositol trisphosphate phosphatase activity,GO:0042577~lipid phosphatase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051717~inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,GO:0051800~phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,","hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,hsa04115:p53 signaling pathway,hsa04510:Focal adhesion,hsa04530:Tight junction,hsa05200:Pathways in cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05222:Small cell lung cancer,","Reviewed (22473468, 12928488, 10200246), Associated with Cowden's disease, breast, and gastrointestinal familial carcinomas, Cancer gene census (14993899)","Reviewed (22473468, 12928488, 10200246), Cancer gene census (14993899)", 
CDKN2A,"cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)",9.80714179038639E-96,6.10625338342091E-92,0.98874194240004,29,3.67141033600714E-97,1.38705981306796E-10,9.26819247286573E-09,0,4,Known TSG,"GO:0000075~cell cycle checkpoint,GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000737~DNA catabolic process, endonucleolytic,GO:0001558~regulation of cell growth,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0006259~DNA metabolic process,GO:0006308~DNA catabolic process,GO:0006309~DNA fragmentation involved in apoptosis,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006919~activation of caspase activity,GO:0006921~cell structure disassembly during apoptosis,GO:0006997~nucleus organization,GO:0007005~mitochondrion organization,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007162~negative regulation of cell adhesion,GO:0007346~regulation of mitotic cell cycle,GO:0007398~ectoderm development,GO:0007568~aging,GO:0007569~cell aging,GO:0008219~cell death,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008544~epidermis development,GO:0008637~apoptotic mitochondrial changes,GO:0009057~macromolecule catabolic process,GO:0009303~rRNA transcription,GO:0010149~senescence,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010564~regulation of cell cycle process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010810~regulation of cell-substrate adhesion,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016072~rRNA metabolic process,GO:0016265~death,GO:0017145~stem cell division,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022411~cellular component disassembly,GO:0022613~ribonucleoprotein complex biogenesis,GO:0030155~regulation of cell adhesion,GO:0030262~apoptotic nuclear changes,GO:0030308~negative regulation of cell growth,GO:0030888~regulation of B cell proliferation,GO:0030889~negative regulation of B cell proliferation,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031647~regulation of protein stability,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032386~regulation of intracellular transport,GO:0032535~regulation of cellular component size,GO:0032774~RNA biosynthetic process,GO:0032944~regulation of mononuclear cell proliferation,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0033081~regulation of T cell differentiation in the thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033084~regulation of immature T cell proliferation in the thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033088~negative regulation of immature T cell proliferation in the thymus,GO:0033673~negative regulation of kinase activity,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042254~ribosome biogenesis,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of transcription factor activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045580~regulation of T cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045736~negative regulation of cyclin-dependent protein kinase activity,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045926~negative regulation of growth,GO:0045936~negative regulation of phosphate metabolic process,GO:0046822~regulation of nucleocytoplasmic transport,GO:0048103~somatic stem cell division,GO:0050670~regulation of lymphocyte proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050863~regulation of T cell activation,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050869~negative regulation of B cell activation,GO:0051090~regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051101~regulation of DNA binding,GO:0051174~regulation of phosphorus metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051301~cell division,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051340~regulation of ligase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051348~negative regulation of transferase activity,GO:0051352~negative regulation of ligase activity,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051726~regulation of cell cycle,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0060341~regulation of cellular localization,GO:0070663~regulation of leukocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,GO:0001652~granular component,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044452~nucleolar part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0004857~enzyme inhibitor activity,GO:0004860~protein kinase inhibitor activity,GO:0004861~cyclin-dependent protein kinase inhibitor activity,GO:0008134~transcription factor binding,GO:0016538~cyclin-dependent protein kinase regulator activity,GO:0019207~kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019887~protein kinase regulator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,GO:0030528~transcription regulator activity,GO:0051059~NF-kappaB binding,GO:0055103~ligase regulator activity,GO:0055104~ligase inhibitor activity,GO:0055105~ubiquitin-protein ligase inhibitor activity,GO:0055106~ubiquitin-protein ligase regulator activity,","hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05223:Non-small cell lung cancer,","Reviewed (9823374, 9132280), Associated with familial melanoma, Cancer gene census (14993899)","Reviewed (9823374, 9132280), Cancer gene census (14993899)", 
ARID1A,AT rich interactive domain 1A (SWI-like),6.49209751930759E-88,3.03164723907866E-84,0.9996650061958,2,1.79010844960352E-169,0.553361731952308,0.005629812000978,1.07974690669095E-146,4,Known TSG,"GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007242~intracellular signaling cascade,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0030518~steroid hormone receptor signaling pathway,GO:0030520~estrogen receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031958~corticosteroid receptor signaling pathway,GO:0034621~cellular macromolecular complex subunit organization,GO:0034728~nucleosome organization,GO:0040029~regulation of gene expression, epigenetic,GO:0042766~nucleosome mobilization,GO:0042921~glucocorticoid receptor signaling pathway,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048096~chromatin-mediated maintenance of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0005730~nucleolus,GO:0016514~SWI/SNF complex,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0070603~SWI/SNF-type complex,GO:0003677~DNA binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None,"Reviewed (23208470, 23355908, 21900401), Cancer gene census (14993899)","Reviewed (23208470, 23355908, 21900401), Cancer gene census (14993899)", 
APC,adenomatous polyposis coli,2.97545177701564E-86,1.1115692748575E-82,0.999279454804464,5,2.91290476571211E-190,1,0.017583416010038,6.43770803132044E-40,4,Known TSG,"GO:0000075~cell cycle checkpoint,GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000281~cytokinesis after mitosis,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0000910~cytokinesis,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001775~cell activation,GO:0001822~kidney development,GO:0001942~hair follicle development,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0003002~regionalization,GO:0006461~protein complex assembly,GO:0006469~negative regulation of protein kinase activity,GO:0006928~cell motion,GO:0006974~response to DNA damage stimulus,GO:0007026~negative regulation of microtubule depolymerization,GO:0007043~cell-cell junction assembly,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007067~mitosis,GO:0007088~regulation of mitosis,GO:0007091~mitotic metaphase/anaphase transition,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic cell cycle spindle assembly checkpoint,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007166~cell surface receptor linked signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0007389~pattern specification process,GO:0007398~ectoderm development,GO:0007409~axonogenesis,GO:0007423~sensory organ development,GO:0008285~negative regulation of cell proliferation,GO:0008544~epidermis development,GO:0009798~axis specification,GO:0009894~regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0009952~anterior/posterior pattern formation,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0009968~negative regulation of signal transduction,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010638~positive regulation of organelle organization,GO:0010639~negative regulation of organelle organization,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010948~negative regulation of cell cycle process,GO:0016055~Wnt receptor signaling pathway,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0019827~stem cell maintenance,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030155~regulation of cell adhesion,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0030182~neuron differentiation,GO:0030217~T cell differentiation,GO:0030278~regulation of ossification,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030856~regulation of epithelial cell differentiation,GO:0030858~positive regulation of epithelial cell differentiation,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0031112~positive regulation of microtubule polymerization or depolymerization,GO:0031113~regulation of microtubule polymerization,GO:0031114~regulation of microtubule depolymerization,GO:0031116~positive regulation of microtubule polymerization,GO:0031175~neuron projection development,GO:0031272~regulation of pseudopodium assembly,GO:0031274~positive regulation of pseudopodium assembly,GO:0031334~positive regulation of protein complex assembly,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0031577~spindle checkpoint,GO:0032271~regulation of protein polymerization,GO:0032273~positive regulation of protein polymerization,GO:0032880~regulation of protein localization,GO:0032886~regulation of microtubule-based process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033043~regulation of organelle organization,GO:0033077~T cell differentiation in the thymus,GO:0033205~cytokinesis during cell cycle,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0035019~somatic stem cell maintenance,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0042176~regulation of protein catabolic process,GO:0042303~molting cycle,GO:0042325~regulation of phosphorylation,GO:0042481~regulation of odontogenesis,GO:0042483~negative regulation of odontogenesis,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042633~hair cycle,GO:0042981~regulation of apoptosis,GO:0043010~camera-type eye development,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043242~negative regulation of protein complex disassembly,GO:0043244~regulation of protein complex disassembly,GO:0043254~regulation of protein complex assembly,GO:0043297~apical junction assembly,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0043588~skin development,GO:0043933~macromolecular complex subunit organization,GO:0044087~regulation of cellular component biogenesis,GO:0044092~negative regulation of molecular function,GO:0045216~cell-cell junction organization,GO:0045321~leukocyte activation,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045736~negative regulation of cyclin-dependent protein kinase activity,GO:0045785~positive regulation of cell adhesion,GO:0045786~negative regulation of cell cycle,GO:0045839~negative regulation of mitosis,GO:0045841~negative regulation of mitotic metaphase/anaphase transition,GO:0045859~regulation of protein kinase activity,GO:0046649~lymphocyte activation,GO:0046716~muscle maintenance,GO:0048285~organelle fission,GO:0048534~hemopoietic or lymphoid organ development,GO:0048538~thymus development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0048870~cell motility,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051094~positive regulation of developmental process,GO:0051129~negative regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051302~regulation of cell division,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051493~regulation of cytoskeleton organization,GO:0051494~negative regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051674~localization of cell,GO:0051726~regulation of cell cycle,GO:0051781~positive regulation of cell division,GO:0051783~regulation of nuclear division,GO:0051784~negative regulation of nuclear division,GO:0051983~regulation of chromosome segregation,GO:0051988~regulation of attachment of spindle microtubules to kinetochore,GO:0060041~retina development in camera-type eye,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0060249~anatomical structure homeostasis,GO:0060341~regulation of cellular localization,GO:0060491~regulation of cell projection assembly,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0070830~tight junction assembly,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005881~cytoplasmic microtubule,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005923~tight junction,GO:0015630~microtubule cytoskeleton,GO:0016327~apicolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0030877~beta-catenin destruction complex,GO:0031253~cell projection membrane,GO:0033267~axon part,GO:0034747~Axin-APC-beta-catenin-GSK3B complex,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043296~apical junction complex,GO:0044427~chromosomal part,GO:0044430~cytoskeletal part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0070160~occluding junction,GO:0070161~anchoring junction,GO:0008013~beta-catenin binding,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,GO:0019207~kinase regulator activity,GO:0019887~protein kinase regulator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,","hsa04310:Wnt signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,","Reviewed (17881494, 10784639, 16158975, 12646874), Associated with Familial adenomatous polyposis coli, Cancer gene census (14993899)","Reviewed (17881494, 10784639, 16158975, 12646874), Cancer gene census (14993899)", 
PBRM1,polybromo 1,5.3667860351607E-67,1.67076993917945E-63,0.999195272841164,6,8.80224264885246E-69,7.95162159503104E-12,0.000781647082239,2.62984281461845E-73,4,Known TSG,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0001890~placenta development,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007507~heart development,GO:0016568~chromatin modification,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0045449~regulation of transcription,GO:0048285~organelle fission,GO:0051276~chromosome organization,GO:0000228~nuclear chromosome,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,GO:0003682~chromatin binding,",None,"Reviewed (23867514, 21248752), Cancer gene census (14993899)","Reviewed (23867514, 21248752), Cancer gene census (14993899)", 
RB1,retinoblastoma 1,2.620113873725E-66,6.99158672104419E-63,0.999302124752274,4,4.25331981775941E-73,2.98926109185599E-27,0.503116045574968,1.52030513164755E-189,4,Known TSG,"GO:0000075~cell cycle checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription of G1/S-phase of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0001558~regulation of cell growth,GO:0002520~immune system development,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007090~regulation of S phase of mitotic cell cycle,GO:0007242~intracellular signaling cascade,GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010948~negative regulation of cell cycle process,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0019216~regulation of lipid metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030308~negative regulation of cell growth,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032535~regulation of cellular component size,GO:0033261~regulation of S phase,GO:0033673~negative regulation of kinase activity,GO:0034101~erythrocyte homeostasis,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0042692~muscle cell differentiation,GO:0043086~negative regulation of catalytic activity,GO:0043353~enucleate erythrocyte differentiation,GO:0043549~regulation of kinase activity,GO:0043550~regulation of lipid kinase activity,GO:0044092~negative regulation of molecular function,GO:0045445~myoblast differentiation,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045649~regulation of macrophage differentiation,GO:0045651~positive regulation of macrophage differentiation,GO:0045749~negative regulation of S phase of mitotic cell cycle,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045926~negative regulation of growth,GO:0045930~negative regulation of mitotic cell cycle,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048534~hemopoietic or lymphoid organ development,GO:0048872~homeostasis of number of cells,GO:0051094~positive regulation of developmental process,GO:0051146~striated muscle cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051318~G1 phase,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016514~SWI/SNF complex,GO:0016585~chromatin remodeling complex,GO:0016604~nuclear body,GO:0016605~PML body,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0035189~Rb-E2F complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070603~SWI/SNF-type complex,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0030528~transcription regulator activity,GO:0031625~ubiquitin protein ligase binding,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0050681~androgen receptor binding,GO:0051219~phosphoprotein binding,GO:0051427~hormone receptor binding,","hsa04110:Cell cycle,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,","Reviewed (21295686, 23359405, 21213952), Associated with retinoblastoma and osteosarcoma, Cancer gene census (14993899)","Reviewed (21295686, 23359405, 21213952), Cancer gene census (14993899)", 
VHL,von Hippel-Lindau tumor suppressor,4.26811295444095E-62,9.96551023450031E-59,0.999155255894234,7,1.51038178142394E-55,9.68972587952552E-13,3.29190024080499E-13,7.93367228239136E-36,4,Known TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001666~response to hypoxia,GO:0001944~vasculature development,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006508~proteolysis,GO:0006916~anti-apoptosis,GO:0006928~cell motion,GO:0008285~negative regulation of cell proliferation,GO:0009057~macromolecule catabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0016477~cell migration,GO:0016481~negative regulation of transcription,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0030198~extracellular matrix organization,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031647~regulation of protein stability,GO:0032446~protein modification by small protein conjugation,GO:0032989~cellular component morphogenesis,GO:0033238~regulation of cellular amine metabolic process,GO:0042069~regulation of catecholamine metabolic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043062~extracellular structure organization,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043534~blood vessel endothelial cell migration,GO:0043542~endothelial cell migration,GO:0043632~modification-dependent macromolecule catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048514~blood vessel morphogenesis,GO:0048870~cell motility,GO:0050821~protein stabilization,GO:0051094~positive regulation of developmental process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051674~localization of cell,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070482~response to oxygen levels,GO:0070647~protein modification by small protein conjugation or removal,GO:0000151~ubiquitin ligase complex,GO:0000153~cytoplasmic ubiquitin ligase complex,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0019898~extrinsic to membrane,GO:0030891~VCB complex,GO:0008134~transcription factor binding,","hsa04120:Ubiquitin mediated proteolysis,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,","Reviewed (12507560, 18923434, 15448019), Associated with von Hippel-Lindau syndrome, Cancer gene census (14993899)","Reviewed (12507560, 18923434, 15448019), Cancer gene census (14993899)", 
NF1,neurofibromin 1,3.8133140704679E-59,7.91432150247443E-56,0.993015240803529,21,6.01420465351425E-60,4.97206455308041E-13,0.001681203562019,4.85216948744171E-25,4,Known TSG,"GO:0000165~MAPKKK cascade,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001508~regulation of action potential,GO:0001568~blood vessel development,GO:0001649~osteoblast differentiation,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001666~response to hypoxia,GO:0001822~kidney development,GO:0001889~liver development,GO:0001936~regulation of endothelial cell proliferation,GO:0001937~negative regulation of endothelial cell proliferation,GO:0001944~vasculature development,GO:0001952~regulation of cell-matrix adhesion,GO:0006140~regulation of nucleotide metabolic process,GO:0006469~negative regulation of protein kinase activity,GO:0006873~cellular ion homeostasis,GO:0007010~cytoskeleton organization,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007272~ensheathment of neurons,GO:0007406~negative regulation of neuroblast proliferation,GO:0007422~peripheral nervous system development,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007632~visual behavior,GO:0008285~negative regulation of cell proliferation,GO:0008366~axon ensheathment,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009968~negative regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010594~regulation of endothelial cell migration,GO:0010627~regulation of protein kinase cascade,GO:0010648~negative regulation of cell communication,GO:0010721~negative regulation of cell development,GO:0010741~negative regulation of protein kinase cascade,GO:0010810~regulation of cell-substrate adhesion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0014002~astrocyte development,GO:0014013~regulation of gliogenesis,GO:0014014~negative regulation of gliogenesis,GO:0014037~Schwann cell differentiation,GO:0014044~Schwann cell development,GO:0014065~phosphoinositide 3-kinase cascade,GO:0019220~regulation of phosphate metabolic process,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019725~cellular homeostasis,GO:0021510~spinal cord development,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021782~glial cell development,GO:0021896~forebrain astrocyte differentiation,GO:0021897~forebrain astrocyte development,GO:0021987~cerebral cortex development,GO:0022011~myelination in the peripheral nervous system,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030155~regulation of cell adhesion,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0030325~adrenal gland development,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0030900~forebrain development,GO:0031279~regulation of cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0032292~ensheathment of axons in the peripheral nervous system,GO:0032318~regulation of Ras GTPase activity,GO:0032320~positive regulation of Ras GTPase activity,GO:0032386~regulation of intracellular transport,GO:0032387~negative regulation of intracellular transport,GO:0032844~regulation of homeostatic process,GO:0032880~regulation of protein localization,GO:0033157~regulation of intracellular protein transport,GO:0033673~negative regulation of kinase activity,GO:0034103~regulation of tissue remodeling,GO:0035270~endocrine system development,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042060~wound healing,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042306~regulation of protein import into nucleus,GO:0042308~negative regulation of protein import into nucleus,GO:0042325~regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042552~myelination,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0042990~regulation of transcription factor import into nucleus,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0043010~camera-type eye development,GO:0043062~extracellular structure organization,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0043473~pigmentation,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0043535~regulation of blood vessel endothelial cell migration,GO:0043547~positive regulation of GTPase activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045124~regulation of bone resorption,GO:0045596~negative regulation of cell differentiation,GO:0045685~regulation of glial cell differentiation,GO:0045686~negative regulation of glial cell differentiation,GO:0045761~regulation of adenylate cyclase activity,GO:0045762~positive regulation of adenylate cyclase activity,GO:0045765~regulation of angiogenesis,GO:0045859~regulation of protein kinase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046823~negative regulation of nucleocytoplasmic transport,GO:0046850~regulation of bone remodeling,GO:0048483~autonomic nervous system development,GO:0048485~sympathetic nervous system development,GO:0048514~blood vessel morphogenesis,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048708~astrocyte differentiation,GO:0048713~regulation of oligodendrocyte differentiation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0048732~gland development,GO:0048745~smooth muscle tissue development,GO:0048844~artery morphogenesis,GO:0048853~forebrain morphogenesis,GO:0048854~brain morphogenesis,GO:0048878~chemical homeostasis,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051051~negative regulation of transport,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051174~regulation of phosphorus metabolic process,GO:0051223~regulation of protein transport,GO:0051224~negative regulation of protein transport,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051339~regulation of lyase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051348~negative regulation of transferase activity,GO:0051349~positive regulation of lyase activity,GO:0051960~regulation of nervous system development,GO:0055082~cellular chemical homeostasis,GO:0060284~regulation of cell development,GO:0060341~regulation of cellular localization,GO:0060348~bone development,GO:0060537~muscle tissue development,GO:0070201~regulation of establishment of protein localization,GO:0070482~response to oxygen levels,GO:0030424~axon,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,","Reviewed (11239415, 15715079), Associated with neurofibromatosis type 1, Cancer gene census (14993899)","Well-described (11239415, 15937108)", 
MAP3K1,mitogen-activated protein kinase kinase kinase 1,9.33923055864189E-52,1.74447487604872E-48,0.997789344302984,10,6.07221707040166E-53,0.240747627635196,0.001768241738557,5.70594452601351E-84,4,Unclear,"GO:0000165~MAPKKK cascade,GO:0000186~activation of MAPKK activity,GO:0000187~activation of MAPK activity,GO:0000209~protein polyubiquitination,GO:0001654~eye development,GO:0001932~regulation of protein amino acid phosphorylation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006970~response to osmotic stress,GO:0007005~mitochondrion organization,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007249~I-kappaB kinase/NF-kappaB cascade,GO:0007254~JNK cascade,GO:0007256~activation of JNKK activity,GO:0007257~activation of JUN kinase activity,GO:0007423~sensory organ development,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008219~cell death,GO:0008637~apoptotic mitochondrial changes,GO:0009057~macromolecule catabolic process,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010628~positive regulation of gene expression,GO:0010638~positive regulation of organelle organization,GO:0010639~negative regulation of organelle organization,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0030334~regulation of cell migration,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0031098~stress-activated protein kinase signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031334~positive regulation of protein complex assembly,GO:0031399~regulation of protein modification process,GO:0032147~activation of protein kinase activity,GO:0032231~regulation of actin filament bundle formation,GO:0032232~negative regulation of actin filament bundle formation,GO:0032268~regulation of cellular protein metabolic process,GO:0032271~regulation of protein polymerization,GO:0032273~positive regulation of protein polymerization,GO:0032446~protein modification by small protein conjugation,GO:0032535~regulation of cellular component size,GO:0032583~regulation of gene-specific transcription,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0040012~regulation of locomotion,GO:0042060~wound healing,GO:0042325~regulation of phosphorylation,GO:0042787~protein ubiquitination during ubiquitin-dependent protein catabolic process,GO:0042981~regulation of apoptosis,GO:0043010~camera-type eye development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043193~positive regulation of gene-specific transcription,GO:0043254~regulation of protein complex assembly,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043506~regulation of JUN kinase activity,GO:0043507~positive regulation of JUN kinase activity,GO:0043549~regulation of kinase activity,GO:0043632~modification-dependent macromolecule catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044087~regulation of cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046328~regulation of JNK cascade,GO:0046777~protein amino acid autophosphorylation,GO:0046782~regulation of viral transcription,GO:0048524~positive regulation of viral reproduction,GO:0050434~positive regulation of viral transcription,GO:0050792~regulation of viral reproduction,GO:0051129~negative regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051270~regulation of cell motion,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051493~regulation of cytoskeleton organization,GO:0051494~negative regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070647~protein modification by small protein conjugation or removal,GO:0080135~regulation of cellular response to stress,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004706~JUN kinase kinase kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004842~ubiquitin-protein ligase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0008432~JUN kinase binding,GO:0008545~JUN kinase kinase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0017076~purine nucleotide binding,GO:0019787~small conjugating protein ligase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030554~adenyl nucleotide binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046625~sphingolipid binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051019~mitogen-activated protein kinase binding,","hsa04010:MAPK signaling pathway,hsa04120:Ubiquitin mediated proteolysis,hsa04622:RIG-I-like receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,","Significantly mutated somatically in breast cancers (23000897), Variants associated with familial breast cancer (23225170), Depletion inhibits migration and invasion of cancer cells (19513748), Overexpressed in HCC (22110214)","Promotes apoptosis when stimulated (11756439, 21152872), Activates NFkB (9008162, 18420486), Activates JNK (21364884, 18420486), Activates TORC1 (18784253)", 
SMAD4,SMAD family member 4,1.46114248926681E-47,2.48115277791043E-44,0.99765355185226,12,4.06390822623334E-41,0.194276866008828,7.36926847464584E-21,1.54165310350852E-66,4,Known TSG,"GO:0001558~regulation of cell growth,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001666~response to hypoxia,GO:0001702~gastrulation with mouth forming second,GO:0001763~morphogenesis of a branching structure,GO:0001817~regulation of cytokine production,GO:0001822~kidney development,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0002009~morphogenesis of an epithelium,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007183~SMAD protein complex assembly,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0009967~positive regulation of signal transduction,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010647~positive regulation of cell communication,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010720~positive regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010770~positive regulation of cell morphogenesis involved in differentiation,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0016481~negative regulation of transcription,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0022604~regulation of cell morphogenesis,GO:0030182~neuron differentiation,GO:0030308~negative regulation of cell growth,GO:0030509~BMP signaling pathway,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032535~regulation of cellular component size,GO:0032880~regulation of protein localization,GO:0032909~regulation of transforming growth factor-beta2 production,GO:0033157~regulation of intracellular protein transport,GO:0033158~regulation of protein import into nucleus, translocation,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042306~regulation of protein import into nucleus,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045792~negative regulation of cell size,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045926~negative regulation of growth,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046822~regulation of nucleocytoplasmic transport,GO:0048598~embryonic morphogenesis,GO:0048663~neuron fate commitment,GO:0048729~tissue morphogenesis,GO:0048754~branching morphogenesis of a tube,GO:0051050~positive regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051130~positive regulation of cellular component organization,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051247~positive regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060021~palate development,GO:0060284~regulation of cell development,GO:0060341~regulation of cellular localization,GO:0060390~regulation of SMAD protein nuclear translocation,GO:0060391~positive regulation of SMAD protein nuclear translocation,GO:0060393~regulation of pathway-restricted SMAD protein phosphorylation,GO:0060395~SMAD protein signal transduction,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0065003~macromolecular complex assembly,GO:0070201~regulation of establishment of protein localization,GO:0070271~protein complex biogenesis,GO:0070482~response to oxygen levels,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032444~activin responsive factor complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0005072~transforming growth factor beta receptor, cytoplasmic mediator activity,GO:0005518~collagen binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0030616~transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046332~SMAD binding,GO:0046983~protein dimerization activity,GO:0070412~R-SMAD binding,","hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,","Reviewed (12821112, 20087440), Associated with juvenile polyposis ","Reviewed (12821112, 20087440)", 
KDM6A,lysine (K)-specific demethylase 6A,3.32992448765896E-46,5.18330495874847E-43,0.997670530225005,11,1.54370962583214E-44,3.62335421696069E-15,0.000949654177846,0.011586412203758,4,Known TSG,"GO:0006325~chromatin organization,GO:0016568~chromatin modification,GO:0051276~chromosome organization,GO:0055114~oxidation reduction,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0005506~iron ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Well-described (22249190, 23644518, 22722839, 23033341, 22832583), Cancer gene census (14993899)","Well-described (22249190, 23644518)", 
GATA3,GATA binding protein 3,6.01715631619523E-45,8.64572791001621E-42,0.99809207213772,9,1.24442100949867E-48,5.3114466213143E-18,0.660096042000246,1,4,Known TSG,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0032774~RNA biosynthetic process,GO:0043627~response to estrogen stimulus,GO:0045449~regulation of transcription,GO:0048545~response to steroid hormone stimulus,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Reviewed (19798694, 19059610), Cancer gene census (14993899) ","Reviewed (19798694, 19059610), Cancer gene census (14993899) ", 
ARID2,"AT rich interactive domain 2 (ARID, RFX-like)",1.531336490994E-36,2.04313102251979E-33,0.990262553020657,26,2.08884028373566E-36,1.87419928914085E-07,0.063139447956966,0.465970635275895,4,Known TSG,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Reviewed (22095441), Cancer gene census (14993899)",Reviewed (22095441), 
SETD2,SET domain containing 2,2.22863669266523E-32,2.77524698548625E-29,0.996542719163247,14,1.03188071465148E-29,0.103792469577916,0.000395232639306,3.38222917283079E-65,4,Known TSG,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0008213~protein amino acid alkylation,GO:0010033~response to organic substance,GO:0010452~histone H3-K36 methylation,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0018022~peptidyl-lysine methylation,GO:0018023~peptidyl-lysine trimethylation,GO:0018205~peptidyl-lysine modification,GO:0032259~methylation,GO:0034968~histone lysine methylation,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0051789~response to protein stimulus,GO:0055114~oxidation reduction,GO:0003677~DNA binding,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00310:Lysine degradation,","Well-described (20501857, 20944102), Cancer gene census (14993899)","Well-described (20501857, 20944102)", 
KMT2D,myeloid/lymphoid or mixed-lineage leukemia 2,2.68792766117469E-32,3.13798754894263E-29,0.993478222008074,19,1.46337956633871E-32,0.711440547260872,0.07591503469536,1,4,Putative TSG,"GO:0001701~in utero embryonic development,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009792~embryonic development ending in birth or egg hatching,GO:0016568~chromatin modification,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Knockdown decreases tumorigenicity in mice (17178841), Mutated in 32% of diffuse large B-cell lymphoma and 89% of follicular lymphoma (21796119), Reduced expression in 30 cell lines (23754336), Elevated levels associated with malignancy in breast and colon (20433758) ","Well-described (17178841, 16603732)", 
NPM1,"nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin) pseudogene 21; hypothetical LOC100131044; similar to nucleophosmin 1; nucleophosmin (nucleolar phosphoprotein B23, numatrin)",1.47523519058138E-31,1.62093636028644E-28,0.840940099788376,183,1.87236927152919E-40,1,1,0.711942235533458,4,Known TSG,"GO:0000054~ribosome export from nucleus,GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000226~microtubule cytoskeleton organization,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0006403~RNA localization,GO:0006405~RNA export from nucleus,GO:0006407~rRNA export from nucleus,GO:0006461~protein complex assembly,GO:0006884~cell volume homeostasis,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006916~anti-apoptosis,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007098~centrosome cycle,GO:0007568~aging,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009891~positive regulation of biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010638~positive regulation of organelle organization,GO:0010639~negative regulation of organelle organization,GO:0010824~regulation of centrosome duplication,GO:0010825~positive regulation of centrosome duplication,GO:0010826~negative regulation of centrosome duplication,GO:0010941~regulation of cell death,GO:0015031~protein transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016049~cell growth,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0022402~cell cycle process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0031023~microtubule organizing center organization,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031497~chromatin assembly,GO:0032535~regulation of cellular component size,GO:0032886~regulation of microtubule-based process,GO:0033043~regulation of organelle organization,GO:0033119~negative regulation of RNA splicing,GO:0033674~positive regulation of kinase activity,GO:0033750~ribosome localization,GO:0033753~establishment of ribosome localization,GO:0034613~cellular protein localization,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0040007~growth,GO:0042127~regulation of cell proliferation,GO:0042254~ribosome biogenesis,GO:0042255~ribosome assembly,GO:0042273~ribosomal large subunit biogenesis,GO:0042274~ribosomal small subunit biogenesis,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043388~positive regulation of DNA binding,GO:0043484~regulation of RNA splicing,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043549~regulation of kinase activity,GO:0043933~macromolecular complex subunit organization,GO:0044093~positive regulation of molecular function,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046605~regulation of centrosome cycle,GO:0046907~intracellular transport,GO:0048024~regulation of nuclear mRNA splicing, via spliceosome,GO:0048025~negative regulation of nuclear mRNA splicing, via spliceosome,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0050684~regulation of mRNA processing,GO:0050686~negative regulation of mRNA processing,GO:0051029~rRNA transport,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051129~negative regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051236~establishment of RNA localization,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051276~chromosome organization,GO:0051297~centrosome organization,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051493~regulation of cytoskeleton organization,GO:0051640~organelle localization,GO:0051656~establishment of organelle localization,GO:0051726~regulation of cell cycle,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0070271~protein complex biogenesis,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0070727~cellular macromolecule localization,GO:0080135~regulation of cellular response to stress,GO:0000922~spindle pole,GO:0001652~granular component,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0015934~large ribosomal subunit,GO:0015935~small ribosomal subunit,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0031616~spindle pole centrosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0033279~ribosomal subunit,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0044452~nucleolar part,GO:0070013~intracellular organelle lumen,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0019843~rRNA binding,GO:0030528~transcription regulator activity,GO:0030957~Tat protein binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043021~ribonucleoprotein binding,GO:0043023~ribosomal large subunit binding,GO:0043024~ribosomal small subunit binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051059~NF-kappaB binding,GO:0051082~unfolded protein binding,",None,"Well-described (17488663, 22053282, 19770764, 18212245)","Well-described (17488663, 22053282, 19770764, 18212245)", 
ATRX,"alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)",3.1527551797221E-30,3.27168411122384E-27,0.99124475137275,25,2.15467784517256E-29,0.438064062710815,0.028895572122701,0.532751754888998,4,Known TSG,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006304~DNA modification,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006310~DNA recombination,GO:0006355~regulation of transcription, DNA-dependent,GO:0006730~one-carbon metabolic process,GO:0006974~response to DNA damage stimulus,GO:0030900~forebrain development,GO:0032259~methylation,GO:0033554~cellular response to stress,GO:0040029~regulation of gene expression, epigenetic,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Well-described (23904111, 23583981, 23361940, 23334666, 22829774), Cancer gene census (14993899)","Well-described (23904111, 23563309, 22829774)", 
FBXW7,F-box and WD repeat domain containing 7,6.0302724828826E-29,5.92839261619811E-26,0.987725935348011,30,2.05997778535844E-21,0.152693208651414,1.38081380772004E-33,8.92401655667372E-19,4,Known TSG,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,","hsa04120:Ubiquitin mediated proteolysis,","Reviewed (18094723), Cancer gene census (14993899)",Reviewed (18094723), 
PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",3.41101628839772E-26,3.03401777385624E-23,0.996535197778794,15,2.63815894494738E-19,3.32452465140711E-16,1.06451347306049E-08,1.41111291720796E-116,4,Known TSG,"GO:0001775~cell activation,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008286~insulin receptor signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010810~regulation of cell-substrate adhesion,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010827~regulation of glucose transport,GO:0010828~positive regulation of glucose transport,GO:0014065~phosphoinositide 3-kinase cascade,GO:0016310~phosphorylation,GO:0019637~organophosphate metabolic process,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030183~B cell differentiation,GO:0030258~lipid modification,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030384~phosphoinositide metabolic process,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032880~regulation of protein localization,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042113~B cell activation,GO:0043434~response to peptide hormone stimulus,GO:0045321~leukocyte activation,GO:0046324~regulation of glucose import,GO:0046326~positive regulation of glucose import,GO:0046486~glycerolipid metabolic process,GO:0046649~lymphocyte activation,GO:0046834~lipid phosphorylation,GO:0046854~phosphoinositide phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048534~hemopoietic or lymphoid organ development,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0060396~growth hormone receptor signaling pathway,GO:0060416~response to growth hormone stimulus,GO:0070201~regulation of establishment of protein localization,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0005829~cytosol,GO:0005942~phosphoinositide 3-kinase complex,GO:0005943~1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,GO:0044445~cytosolic part,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005543~phospholipid binding,GO:0005545~phosphatidylinositol binding,GO:0008289~lipid binding,GO:0017046~peptide hormone binding,GO:0019207~kinase regulator activity,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0032403~protein complex binding,GO:0035014~phosphoinositide 3-kinase regulator activity,GO:0035091~phosphoinositide binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0043125~ErbB-3 class receptor binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,","hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04150:mTOR signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,","Well-described (23166678, 21984976, 20530665), Cancer gene census (14993899)","Well-described (23166678, 21984976, 20530665)", 
CASP8,"caspase 8, apoptosis-related cysteine peptidase",7.28746115877118E-24,6.18738577203122E-21,0.99661399972271,13,3.00855939747242E-19,0.09546493192653,8.67234541997921E-06,1.18587551454267E-06,4,Known TSG,"GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001944~vasculature development,GO:0002009~morphogenesis of an epithelium,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0006461~protein complex assembly,GO:0006508~proteolysis,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007507~heart development,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0008633~activation of pro-apoptotic gene products,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016331~morphogenesis of embryonic epithelium,GO:0021915~neural tube development,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030163~protein catabolic process,GO:0030225~macrophage differentiation,GO:0034097~response to cytokine stimulus,GO:0034612~response to tumor necrosis factor,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043933~macromolecular complex subunit organization,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048514~blood vessel morphogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0019867~outer membrane,GO:0030529~ribonucleoprotein complex,GO:0030684~preribosome,GO:0030686~90S preribosome,GO:0030687~preribosome, large subunit precursor,GO:0030689~Noc complex,GO:0030690~Noc1p-Noc2p complex,GO:0031090~organelle membrane,GO:0031264~death-inducing signaling complex,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0044452~nucleolar part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0070013~intracellular organelle lumen,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0042802~identical protein binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,hsa05200:Pathways in cancer,hsa05416:Viral myocarditis,","Downregulated in SCLC (12170765), Frequently methylated in neuroblastoma (17064406), pediatric tumors and cell lines (12384554), breast cancers (20132554) and cervical cancer (19258216)",Well-described (22343728), 
CDH1,"cadherin 1, type 1, E-cadherin (epithelial)",2.15624333353167E-23,1.75115083595818E-20,0.99407687094708,17,7.86517588087947E-22,2.24992883079417E-06,0.158762609749043,1.45605628617511E-10,4,Known TSG,"GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0006461~protein complex assembly,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007416~synaptogenesis,GO:0009636~response to toxin,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010033~response to organic substance,GO:0010941~regulation of cell death,GO:0016337~cell-cell adhesion,GO:0021536~diencephalon development,GO:0021983~pituitary gland development,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032880~regulation of protein localization,GO:0033157~regulation of intracellular protein transport,GO:0035270~endocrine system development,GO:0042306~regulation of protein import into nucleus,GO:0042307~positive regulation of protein import into nucleus,GO:0042493~response to drug,GO:0042981~regulation of apoptosis,GO:0042990~regulation of transcription factor import into nucleus,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043009~chordate embryonic development,GO:0043062~extracellular structure organization,GO:0043067~regulation of programmed cell death,GO:0043281~regulation of caspase activity,GO:0043933~macromolecular complex subunit organization,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0048666~neuron development,GO:0048732~gland development,GO:0050808~synapse organization,GO:0051050~positive regulation of transport,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051336~regulation of hydrolase activity,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0060341~regulation of cellular localization,GO:0065003~macromolecular complex assembly,GO:0070201~regulation of establishment of protein localization,GO:0070271~protein complex biogenesis,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031224~intrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0070161~anchoring junction,GO:0005509~calcium ion binding,GO:0008013~beta-catenin binding,GO:0016563~transcription activator activity,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030528~transcription regulator activity,GO:0042153~RPTP-like protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,","hsa04514:Cell adhesion molecules (CAMs),hsa04520:Adherens junction,hsa05130:Pathogenic Escherichia coli infection,hsa05200:Pathways in cancer,hsa05213:Endometrial cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,","Reviewed (15780560, 20373070), Associated with familial gastric carcinoma, Cancer gene census (14993899)","Reviewed (15780560, 20373070)", 
CTCF,CCCTC-binding factor (zinc finger protein),2.84396824062381E-23,2.21343678194218E-20,0.994066405214384,18,1.17461725862681E-19,0.086613954967869,0.000559973911613,3.54910822438145E-07,4,Putative TSG,"GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006349~genetic imprinting,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006730~one-carbon metabolic process,GO:0007059~chromosome segregation,GO:0007063~regulation of sister chromatid cohesion,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010216~maintenance of DNA methylation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016584~nucleosome positioning,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031497~chromatin assembly,GO:0032259~methylation,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0034621~cellular macromolecular complex subunit organization,GO:0034728~nucleosome organization,GO:0040029~regulation of gene expression, epigenetic,GO:0040030~regulation of molecular function, epigenetic,GO:0043414~biopolymer methylation,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0051983~regulation of chromosome segregation,GO:0070602~regulation of centromeric sister chromatid cohesion,GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0031490~chromatin DNA binding,GO:0043035~chromatin insulator sequence binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Ectopic expression inhibits clonogenicity (20038529) and growth (11507042), suppresses orthotopic breast tumor growth (23553099), Elevated in breast (15958555) and lung (21325284) cell lines, mutated in breast cancer (23000897), mutated in AML (22976956), 1/18 breast cancers (14503807), 4 missense mutations found in 100 varied samples (11782357), Reviewed (21465478)",Reviewed here (21465478), 
ATM,"similar to Serine-protein kinase ATM (Ataxia telangiectasia mutated) (A-T, mutated); ataxia telangiectasia mutated",1.94662432633014E-22,1.45443983166083E-19,0.965068541717233,53,1.06739891031024E-15,1.66454672305969E-07,2.11165585912489E-09,7.610915475494E-79,4,Known TSG,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000279~M phase,GO:0001756~somitogenesis,GO:0003002~regionalization,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007088~regulation of mitosis,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic cell cycle spindle assembly checkpoint,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007131~reciprocal meiotic recombination,GO:0007242~intracellular signaling cascade,GO:0007276~gamete generation,GO:0007292~female gamete generation,GO:0007346~regulation of mitotic cell cycle,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0008219~cell death,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009952~anterior/posterior pattern formation,GO:0010212~response to ionizing radiation,GO:0010564~regulation of cell cycle process,GO:0010639~negative regulation of organelle organization,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010948~negative regulation of cell cycle process,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0031570~DNA integrity checkpoint,GO:0031577~spindle checkpoint,GO:0032504~multicellular organism reproduction,GO:0033043~regulation of organelle organization,GO:0033554~cellular response to stress,GO:0035282~segmentation,GO:0042157~lipoprotein metabolic process,GO:0042159~lipoprotein catabolic process,GO:0042770~DNA damage response, signal transduction,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0044265~cellular macromolecule catabolic process,GO:0045786~negative regulation of cell cycle,GO:0045839~negative regulation of mitosis,GO:0045841~negative regulation of mitotic metaphase/anaphase transition,GO:0048609~reproductive process in a multicellular organism,GO:0051129~negative regulation of cellular component organization,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0051402~neuron apoptosis,GO:0051726~regulation of cell cycle,GO:0051783~regulation of nuclear division,GO:0051784~negative regulation of nuclear division,GO:0060548~negative regulation of cell death,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001727~lipid kinase activity,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0004428~inositol or phosphatidylinositol kinase activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035004~phosphoinositide 3-kinase activity,GO:0047485~protein N-terminus binding,","hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,","Reviewed (23847781, 20956556), Cancer gene census (14993899)","Reviewed (23847781, 20956556)", 
RPL22,ribosomal protein L22 pseudogene 11; ribosomal protein L22,4.26185969550072E-19,2.8431170447235E-16,0.998961336979163,8,1.59971868521519E-21,1,1,3.74969983730501E-158,4,Putative TSG,"GO:0001775~cell activation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006412~translation,GO:0006414~translational elongation,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030217~T cell differentiation,GO:0042110~T cell activation,GO:0045321~leukocyte activation,GO:0046631~alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046649~lymphocyte activation,GO:0048534~hemopoietic or lymphoid organ development,GO:0005829~cytosol,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~ribonucleoprotein complex,GO:0033279~ribosomal subunit,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044445~cytosolic part,GO:0001871~pattern binding,GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,","hsa03010:Ribosome,","Inactivation promotes cellular transformation (22976955), Downregulated in NSCLC (23797773), 5q- syndrome promotes AML, and deleted in 10% AML (22976955), Mutated in endometrial cancer (23636398), Mutated in 116/226 MSI tumors (23127973); Mutated in 64% of 134 MSI gastric tumors (23237666)",Induces Lin28B (22976955), 
STAG2,stromal antigen 2,1.46287086139236E-17,9.42240166205099E-15,0.975587255140275,44,4.97308875179152E-16,0.039276671482174,0.274474210293647,1,4,Known TSG,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0007126~meiosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0000785~chromatin,GO:0005694~chromosome,GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,","hsa04110:Cell cycle,","Loss of expression in gastric, breast, lung, and prostate cancers (22668012), Mutational inactivation in glioblastoma (21852505)","Well-described, loss leads to aneuploidy (21852505)", 
FAT1,FAT tumor suppressor homolog 1 (Drosophila),5.00192589038181E-17,3.11436579021473E-14,0.97699717516197,41,9.73425676348998E-17,1,0.621617423105817,1.15100240857824E-129,4,Known TSG,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007267~cell-cell signaling,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None,"Suppresses cancer cell growth in vitro and in vivo, and mutated in multiple cancer types (23354438), siRNA to FAT reduces invasion and migration, increases PDCD4 (22986533) (21617878), knockdown enhances DCIS progression in vivo (22751464), Expression elevated in leukemia and gliomas and associated with poor prognosis (22986533), LOH in astrocytic tumors (19126244), HD in oral cancer (17325662), Homolog of Drosophila TSG",Aberrant Wnt activation (23354438), 
MAP2K4,mitogen-activated protein kinase kinase 4,9.25897631649293E-17,5.40463808174285E-14,0.992692138785675,22,1.32271171500018E-12,2.6860191896912E-11,0.003960740667106,2.11906490082978E-21,4,Known TSG,"GO:0000165~MAPKKK cascade,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0016310~phosphorylation,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,","Well-described (21896780, 21575258), Cancer gene census (14993899)","Well-described (21896780, 21575258)", 
BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),7.84429720462246E-16,4.44010992379221E-13,0.98987725150519,28,2.72056513407565E-12,0.09546493192653,0.00486917504851,1.24753137075303E-76,4,Known TSG,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0042127~regulation of cell proliferation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0004221~ubiquitin thiolesterase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None,"Well-described (22997315, 22878500), and Cancer gene census (14993899)","Well-described (22997315, 22878500)", 
RNF43,ring finger protein 43,2.01582542162692E-15,1.10745891325204E-12,0.92527891366725,85,1.37313064997383E-17,1,1,1,4,Known TSG,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Well-described (22895187, 23096461), Cancer gene census (14993899)","Well-described (22895187, 23096461)", 
ZC3H13,zinc finger CCCH-type containing 13,3.0898438620634E-14,1.60319981943006E-11,0.971579753609386,48,4.1611208509754E-11,1,0.005114169787542,5.36910851201066E-82,4,Putative TSG,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"3.3% LOF mutations in 90 samples of gastric cancer, 15.2% LOF mutations in 93 samples of colorectal cancer (21388066), Single report of an MLL-ZC3H13 fusion in ET (21962339)",Unknown , 
RASA1,RAS p21 protein activator (GTPase activating protein) 1,1.92898912523497E-13,9.73826699196325E-11,0.990205109991617,27,1.47294761600779E-11,0.985776716444512,0.271476723733921,1.72133665806353E-79,4,Putative TSG,"GO:0000910~cytokinesis,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001944~vasculature development,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0007162~negative regulation of cell adhesion,GO:0007242~intracellular signaling cascade,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008360~regulation of cell shape,GO:0010810~regulation of cell-substrate adhesion,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010941~regulation of cell death,GO:0022604~regulation of cell morphogenesis,GO:0030155~regulation of cell adhesion,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0032271~regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043254~regulation of protein complex assembly,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0044087~regulation of cellular component biogenesis,GO:0045767~regulation of anti-apoptosis,GO:0045768~positive regulation of anti-apoptosis,GO:0048514~blood vessel morphogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051252~regulation of RNA metabolic process,GO:0051301~cell division,GO:0051493~regulation of cytoskeleton organization,GO:0060548~negative regulation of cell death,GO:0001726~ruffle,GO:0005886~plasma membrane,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0001948~glycoprotein binding,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008200~ion channel inhibitor activity,GO:0015459~potassium channel regulator activity,GO:0016247~channel regulator activity,GO:0016248~channel inhibitor activity,GO:0019870~potassium channel inhibitor activity,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,hsa04360:Axon guidance,",Mutations in RASA1 are associated with impaired angiogenesis (15917201),"Loss of RASA1 leads to Ras hyperactivation (23322774, 17120209), and may also mediate pathological angiogenesis or lymphogenesis (22232212, 20676106)", 
STK11,serine/threonine kinase 11,3.08812898413181E-13,1.51797792880521E-10,0.995866931415415,16,3.28169630248565E-10,0.000214727458341,0.074231066734267,1.30365364287623E-229,4,Known TSG,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0010565~regulation of cellular ketone metabolic process,GO:0016310~phosphorylation,GO:0019216~regulation of lipid metabolic process,GO:0019217~regulation of fatty acid metabolic process,GO:0022402~cell cycle process,GO:0042127~regulation of cell proliferation,GO:0046320~regulation of fatty acid oxidation,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04150:mTOR signaling pathway,hsa04920:Adipocytokine signaling pathway,","Conditional deletion causes oviductal adenomas and endometrial cancer (22916036), Frequently mutated in lung cancer (12097271) and lung cancer cell lines (15021901), Germline mutations associated with Peutz-Jegher syndrome, Cancer gene census (14993899)",Well-described (22916036), 
EP300,E1A binding protein p300,9.33320435789021E-13,4.35837310502578E-10,0.908485665678887,98,8.07952314007831E-07,0.077458924367798,3.41627932248727E-09,0.032747108540135,4,Known TSG,"GO:0000302~response to reactive oxygen species,GO:0001558~regulation of cell growth,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0001889~liver development,GO:0003002~regionalization,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006473~protein amino acid acetylation,GO:0006474~N-terminal protein amino acid acetylation,GO:0006915~apoptosis,GO:0006979~response to oxidative stress,GO:0007049~cell cycle,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0008219~cell death,GO:0008361~regulation of cell size,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0012501~programmed cell death,GO:0014706~striated muscle tissue development,GO:0016265~death,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0018076~N-terminal peptidyl-lysine acetylation,GO:0018205~peptidyl-lysine modification,GO:0018394~peptidyl-lysine acetylation,GO:0030162~regulation of proteolysis,GO:0030307~positive regulation of cell growth,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031365~N-terminal protein amino acid modification,GO:0031960~response to corticosteroid stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032535~regulation of cellular component size,GO:0035282~segmentation,GO:0035295~tube development,GO:0040008~regulation of growth,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0043009~chordate embryonic development,GO:0043388~positive regulation of DNA binding,GO:0043543~protein amino acid acylation,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0045471~response to ethanol,GO:0045793~positive regulation of cell size,GO:0045862~positive regulation of proteolysis,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045927~positive regulation of growth,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048545~response to steroid hormone stimulus,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051384~response to glucocorticoid stimulus,GO:0051592~response to calcium ion,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060541~respiratory system development,GO:0070482~response to oxygen levels,GO:0000123~histone acetyltransferase complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0008022~protein C-terminus binding,GO:0008080~N-acetyltransferase activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042975~peroxisome proliferator activated receptor binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04330:Notch signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa04630:Jak-STAT signaling pathway,hsa04720:Long-term potentiation,hsa04916:Melanogenesis,hsa05016:Huntington's disease,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05215:Prostate cancer,","Well-described (23759652, 12385008), Cancer gene census (14993899)","Well-described (23759652, 12385008), Cancer gene census (14993899)", 
CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1.23261493858184E-12,5.61561327750492E-10,0.992173455149174,23,1.19715304956908E-14,1,1,2.03238347931599E-07,4,Putative TSG,"GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001558~regulation of cell growth,GO:0006355~regulation of transcription, DNA-dependent,GO:0006469~negative regulation of protein kinase activity,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007423~sensory organ development,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010638~positive regulation of organelle organization,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0015672~monovalent inorganic cation transport,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030001~metal ion transport,GO:0030308~negative regulation of cell growth,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031112~positive regulation of microtubule polymerization or depolymerization,GO:0031113~regulation of microtubule polymerization,GO:0031116~positive regulation of microtubule polymerization,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031334~positive regulation of protein complex assembly,GO:0032271~regulation of protein polymerization,GO:0032273~positive regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0032886~regulation of microtubule-based process,GO:0033043~regulation of organelle organization,GO:0033673~negative regulation of kinase activity,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043254~regulation of protein complex assembly,GO:0043549~regulation of kinase activity,GO:0043583~ear development,GO:0044087~regulation of cellular component biogenesis,GO:0044092~negative regulation of molecular function,GO:0045449~regulation of transcription,GO:0045736~negative regulation of cyclin-dependent protein kinase activity,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045926~negative regulation of growth,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0048102~autophagic cell death,GO:0048839~inner ear development,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,GO:0051130~positive regulation of cellular component organization,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051726~regulation of cell cycle,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0005829~cytosol,GO:0004857~enzyme inhibitor activity,GO:0004860~protein kinase inhibitor activity,GO:0004861~cyclin-dependent protein kinase inhibitor activity,GO:0005072~transforming growth factor beta receptor, cytoplasmic mediator activity,GO:0016538~cyclin-dependent protein kinase regulator activity,GO:0019207~kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019887~protein kinase regulator activity,GO:0030291~protein serine/threonine kinase inhibitor activity,","hsa04012:ErbB signaling pathway,hsa04110:Cell cycle,hsa05200:Pathways in cancer,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,",Reviewed (18354415),Reviewed (18354415), 
ARID1B,AT rich interactive domain 1B (SWI1-like),2.74208496334479E-12,1.21950964357898E-09,0.94365009755992,67,8.59206430666007E-11,1,0.271476723733921,9.21012656168534E-52,4,Known TSG,"GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0031328~positive regulation of cellular biosynthetic process,GO:0040029~regulation of gene expression, epigenetic,GO:0045449~regulation of transcription,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048096~chromatin-mediated maintenance of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0005730~nucleolus,GO:0016514~SWI/SNF complex,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0070603~SWI/SNF-type complex,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None,"Well-described (23660946, 23202128, 16230384)","Well-described (23660946, 23202128, 16230384)", 
B2M,beta-2-microglobulin,2.11826561775821E-11,9.20164731955943E-09,0.98688218380414,31,1.06770729688019E-09,9.36102128183724E-05,0.745415986888831,1.35923464846016E-45,4,Known TSG,"GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001914~regulation of T cell mediated cytotoxicity,GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002237~response to molecule of bacterial origin,GO:0002428~antigen processing and presentation of peptide antigen via MHC class Ib,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002475~antigen processing and presentation via MHC class Ib,GO:0002477~antigen processing and presentation of exogenous peptide antigen via MHC class Ib,GO:0002478~antigen processing and presentation of exogenous peptide antigen,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002684~positive regulation of immune system process,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002703~regulation of leukocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002709~regulation of T cell mediated immunity,GO:0002711~positive regulation of T cell mediated immunity,GO:0002819~regulation of adaptive immune response,GO:0002821~positive regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002824~positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0006955~immune response,GO:0009617~response to bacterium,GO:0010033~response to organic substance,GO:0019882~antigen processing and presentation,GO:0019884~antigen processing and presentation of exogenous antigen,GO:0031341~regulation of cell killing,GO:0031343~positive regulation of cell killing,GO:0048002~antigen processing and presentation of peptide antigen,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0012505~endomembrane system,GO:0031090~organelle membrane,GO:0031901~early endosome membrane,GO:0042611~MHC protein complex,GO:0042612~MHC class I protein complex,GO:0044431~Golgi apparatus part,GO:0044440~endosomal part,GO:0044459~plasma membrane part,","hsa04612:Antigen processing and presentation,",Reviewed (22833104),Reviewed (22833104), 
KDM5C,lysine (K)-specific demethylase 5C,5.22068541005829E-11,2.21629960851088E-08,0.970761471961462,49,1.76251626575785E-08,1,0.131320291423494,1,4,Known TSG,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0055114~oxidation reduction,GO:0003677~DNA binding,GO:0005506~iron ion binding,GO:0008270~zinc ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Frequently mutated in RCC (21248752, 23036577), Cancer gene census (14993899)",Well-described (21725364), 
FUBP1,far upstream element (FUSE) binding protein 1,7.54872076248286E-11,3.06527293744385E-08,0.97864178421455,38,4.1117075338719E-11,0.240747627635196,1,2.87227445091463E-47,4,Known TSG,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003723~RNA binding,GO:0030528~transcription regulator activity,GO:0043566~structure-specific DNA binding,",None,"Reviewed (22913971, 21817013), Cancer gene census (14993899)","Reviewed (22913971, 21817013), Cancer gene census (14993899)", 
TGFBR2,"transforming growth factor, beta receptor II (70/80kDa)",1.90261834667107E-10,7.56149108456786E-08,0.983672588088332,33,2.53162359089851E-06,0.846204308491937,0.000385508175565,1.03512239184412E-31,4,Known TSG,"GO:0001501~skeletal system development,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001570~vasculogenesis,GO:0001763~morphogenesis of a branching structure,GO:0001773~myeloid dendritic cell activation,GO:0001775~cell activation,GO:0001944~vasculature development,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002274~myeloid leukocyte activation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0002643~regulation of tolerance induction,GO:0002645~positive regulation of tolerance induction,GO:0002649~regulation of tolerance induction to self antigen,GO:0002651~positive regulation of tolerance induction to self antigen,GO:0002661~regulation of B cell tolerance induction,GO:0002663~positive regulation of B cell tolerance induction,GO:0002664~regulation of T cell tolerance induction,GO:0002666~positive regulation of T cell tolerance induction,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0007565~female pregnancy,GO:0007566~embryo implantation,GO:0007584~response to nutrient,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009743~response to carbohydrate stimulus,GO:0009746~response to hexose stimulus,GO:0009749~response to glucose stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010324~membrane invagination,GO:0010464~regulation of mesenchymal cell proliferation,GO:0014070~response to organic cyclic substance,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016202~regulation of striated muscle tissue development,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0018210~peptidyl-threonine modification,GO:0019220~regulation of phosphate metabolic process,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0031667~response to nutrient levels,GO:0032101~regulation of response to external stimulus,GO:0032147~activation of protein kinase activity,GO:0033674~positive regulation of kinase activity,GO:0033993~response to lipid,GO:0034284~response to monosaccharide stimulus,GO:0035162~embryonic hemopoiesis,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040008~regulation of growth,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042493~response to drug,GO:0043009~chordate embryonic development,GO:0043011~myeloid dendritic cell differentiation,GO:0043085~positive regulation of catalytic activity,GO:0043415~positive regulation of skeletal muscle regeneration,GO:0043416~regulation of skeletal muscle regeneration,GO:0043549~regulation of kinase activity,GO:0043627~response to estrogen stimulus,GO:0044093~positive regulation of molecular function,GO:0045321~leukocyte activation,GO:0045580~regulation of T cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045927~positive regulation of growth,GO:0046620~regulation of organ growth,GO:0046634~regulation of alpha-beta T cell activation,GO:0046635~positive regulation of alpha-beta T cell activation,GO:0046637~regulation of alpha-beta T cell differentiation,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0048514~blood vessel morphogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048545~response to steroid hormone stimulus,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048634~regulation of muscle development,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048754~branching morphogenesis of a tube,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050870~positive regulation of T cell activation,GO:0051094~positive regulation of developmental process,GO:0051136~regulation of NK T cell differentiation,GO:0051138~positive regulation of NK T cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0055021~regulation of cardiac muscle growth,GO:0055024~regulation of cardiac muscle tissue development,GO:0060021~palate development,GO:0060043~regulation of cardiac muscle cell proliferation,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060420~regulation of heart growth,GO:0060541~respiratory system development,GO:0070723~response to cholesterol,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005901~caveola,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043235~receptor complex,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0070022~transforming growth factor beta receptor complex,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001871~pattern binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0005024~transforming growth factor beta receptor activity,GO:0005026~transforming growth factor beta receptor activity, type II,GO:0005160~transforming growth factor beta receptor binding,GO:0005524~ATP binding,GO:0005539~glycosaminoglycan binding,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019955~cytokine binding,GO:0030145~manganese ion binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0030554~adenyl nucleotide binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0034714~type III transforming growth factor beta receptor binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0050431~transforming growth factor beta binding,","hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,","Decreased expression in lung carcinomas especiall large cell carcinoma (17566598), Methylated in non-small cell lung cancer (15073112), Mutated or downregulated in oral squamous cell carcinoma (23913824)",Well-described (23604118), 
BCOR,BCL6 co-repressor,7.16640624702688E-10,2.73186331200439E-07,0.89803050366864,111,3.41481919061059E-08,1,0.524342468927875,1,4,Known TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0009798~axis specification,GO:0009890~negative regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0042476~odontogenesis,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0060021~palate development,GO:0065001~specification of axis polarity,GO:0031519~PcG protein complex,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0004842~ubiquitin-protein ligase activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0031072~heat shock protein binding,GO:0042826~histone deacetylase binding,",None,"Reviewed (22210327), Frequently mutated in medulloblastomas (22820256) and AML (22012066), Fusion constructs found in bone sarcomas (22387997) and endometrial stromal sarcomas (23580382), Cancer gene census (14993899)",Reviewed (22210327), 
SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",3.8314911824676E-09,1.40330242739828E-06,0.828966039680004,192,0.003288001885165,0.694596125122932,1.71841601412893E-13,0.005291322217929,4,Known TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001824~blastocyst development,GO:0001832~blastocyst growth,GO:0001835~blastocyst hatching,GO:0001944~vasculature development,GO:0003007~heart morphogenesis,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006342~chromatin silencing,GO:0006346~methylation-dependent chromatin silencing,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007090~regulation of S phase of mitotic cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0007398~ectoderm development,GO:0007403~glial cell fate determination,GO:0007507~heart development,GO:0008544~epidermis development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009913~epidermal cell differentiation,GO:0010001~glial cell differentiation,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010948~negative regulation of cell cycle process,GO:0016458~gene silencing,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0021781~glial cell fate commitment,GO:0030198~extracellular matrix organization,GO:0030216~keratinocyte differentiation,GO:0030326~embryonic limb morphogenesis,GO:0030855~epithelial cell differentiation,GO:0030900~forebrain development,GO:0030902~hindbrain development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0033261~regulation of S phase,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0035188~hatching,GO:0040007~growth,GO:0040029~regulation of gene expression, epigenetic,GO:0042063~gliogenesis,GO:0043009~chordate embryonic development,GO:0043062~extracellular structure organization,GO:0043193~positive regulation of gene-specific transcription,GO:0043388~positive regulation of DNA binding,GO:0044093~positive regulation of molecular function,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045749~negative regulation of S phase of mitotic cell cycle,GO:0045786~negative regulation of cell cycle,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045930~negative regulation of mitotic cell cycle,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048514~blood vessel morphogenesis,GO:0048589~developmental growth,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0048736~appendage development,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0060173~limb development,GO:0060343~trabecula formation,GO:0060347~heart trabecula formation,GO:0060429~epithelium development,GO:0000785~chromatin,GO:0000792~heterochromatin,GO:0005694~chromosome,GO:0016514~SWI/SNF complex,GO:0016585~chromatin remodeling complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0070603~SWI/SNF-type complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042393~histone binding,GO:0042623~ATPase activity, coupled,GO:0042802~identical protein binding,GO:0047485~protein N-terminus binding,GO:0070577~histone acetyl-lysine binding,",None,"Well-described (21317927, 18386774, 21280140, 19176640), Cancer gene census (14993899)","Well-described (21317927, 18386774, 21280140, 19176640), Cancer gene census (14993899)", 
CREBBP,CREB binding protein,2.01298418946231E-08,6.5965845043801E-06,0.936810641352835,75,0.000124642052459,1,0.000653148890191,1.90039028086134E-09,4,Known TSG,"GO:0001666~response to hypoxia,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006473~protein amino acid acetylation,GO:0006474~N-terminal protein amino acid acetylation,GO:0008283~cell proliferation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0018076~N-terminal peptidyl-lysine acetylation,GO:0018205~peptidyl-lysine modification,GO:0018394~peptidyl-lysine acetylation,GO:0019827~stem cell maintenance,GO:0030718~germ-line stem cell maintenance,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031365~N-terminal protein amino acid modification,GO:0042592~homeostatic process,GO:0043543~protein amino acid acylation,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070482~response to oxygen levels,GO:0000123~histone acetyltransferase complex,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0000940~outer kinetochore of condensed chromosome,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042975~peroxisome proliferator activated receptor binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043425~bHLH transcription factor binding,GO:0043426~MRF binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051577~MyoD binding,","hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04330:Notch signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa04630:Jak-STAT signaling pathway,hsa04720:Long-term potentiation,hsa04916:Melanogenesis,hsa05016:Huntington's disease,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05215:Prostate cancer,","Reviewed (11358491, 11467739, 22150306)","Reviewed (11358491, 11467739, 22150306)", 
ACVR1B,"activin A receptor, type IB",2.64386167559709E-08,8.37028682008101E-06,0.952246766724768,61,0.000631725392942,1,1.32633163785E-05,1,4,Known TSG,"GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001558~regulation of cell growth,GO:0001701~in utero embryonic development,GO:0001942~hair follicle development,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007398~ectoderm development,GO:0008361~regulation of cell size,GO:0008544~epidermis development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009967~positive regulation of signal transduction,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016310~phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018210~peptidyl-threonine modification,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0030308~negative regulation of cell growth,GO:0032535~regulation of cellular component size,GO:0032844~regulation of homeostatic process,GO:0032925~regulation of activin receptor signaling pathway,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0040008~regulation of growth,GO:0042303~molting cycle,GO:0042633~hair cycle,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045646~regulation of erythrocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045792~negative regulation of cell size,GO:0045926~negative regulation of growth,GO:0046777~protein amino acid autophosphorylation,GO:0051094~positive regulation of developmental process,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043235~receptor complex,GO:0044459~plasma membrane part,GO:0048179~activin receptor complex,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0005024~transforming growth factor beta receptor activity,GO:0005025~transforming growth factor beta receptor activity, type I,GO:0005524~ATP binding,GO:0016361~activin receptor activity, type I,GO:0017002~activin receptor activity,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0019899~enzyme binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048185~activin binding,","hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05220:Chronic myeloid leukemia,","Somatic mutations found in pancreatic cancer (11248065), truncated form expressed in pituitary tumors, restoration of wild-type expression suppresses proliferation (12364468), downregulated in papillary thryoid cancers (11272093)","Reviewed (11272093), Can promote prostate cancer cell migration and metastasis (23159635, 21998723)", 
ACVR2A,"activin A receptor, type IIA",2.98457543303918E-08,9.1391613956949E-06,0.993333100959327,20,5.20910515697436E-07,1,0.932145335372239,0.031650599625113,4,Putative TSG,"GO:0001501~skeletal system development,GO:0001702~gastrulation with mouth forming second,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0003002~regionalization,GO:0003006~reproductive developmental process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007320~insemination,GO:0007368~determination of left/right symmetry,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0007498~mesoderm development,GO:0007548~sex differentiation,GO:0007618~mating,GO:0007620~copulation,GO:0008283~cell proliferation,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009799~determination of symmetry,GO:0009855~determination of bilateral symmetry,GO:0009952~anterior/posterior pattern formation,GO:0009967~positive regulation of signal transduction,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010647~positive regulation of cell communication,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019953~sexual reproduction,GO:0030278~regulation of ossification,GO:0030500~regulation of bone mineralization,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032504~multicellular organism reproduction,GO:0032768~regulation of monooxygenase activity,GO:0032844~regulation of homeostatic process,GO:0032924~activin receptor signaling pathway,GO:0032925~regulation of activin receptor signaling pathway,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042713~sperm ejaculation,GO:0043009~chordate embryonic development,GO:0043084~penile erection,GO:0045137~development of primary sexual characteristics,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045646~regulation of erythrocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045778~positive regulation of ossification,GO:0045937~positive regulation of phosphate metabolic process,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048232~male gamete generation,GO:0048598~embryonic morphogenesis,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048706~embryonic skeletal system development,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051094~positive regulation of developmental process,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051341~regulation of oxidoreductase activity,GO:0060011~Sertoli cell proliferation,GO:0070167~regulation of biomineral formation,GO:0070169~positive regulation of biomineral formation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034673~inhibin-betaglycan-ActRII complex,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0005024~transforming growth factor beta receptor activity,GO:0005026~transforming growth factor beta receptor activity, type II,GO:0005524~ATP binding,GO:0015026~coreceptor activity,GO:0016362~activin receptor activity, type II,GO:0017002~activin receptor activity,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032403~protein complex binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0034711~inhibin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043621~protein self-association,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048185~activin binding,GO:0048186~inhibin beta-A binding,GO:0048187~inhibin beta-B binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,","Recurrently mutated in MSI colorectal cancer (21544814), MSI gastric cancer (23237666, 12615714) and pancreatic cancer (22421440), Restoration in MSI colon cancer cell lines leads suppresses growth and enhances migration (17258738, 15520171), Frequent promoter methylation in MSI colon cancers (20011542), Downregulated in papillary thyroid cancer (22848350)","Transmits growth suppressive signals from activin (17258738, 16337854) and stimulates TGFBR2 effector pathways (15520171)", 
RERE,arginine-glutamic acid dipeptide (RE) repeats,3.10897488130088E-08,9.36653900126116E-06,0.947945624168067,64,0.002059276162079,1,8.00731060577319E-08,4.21804633282764E-156,4,Novel,"GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing substrate import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016568~chromatin modification,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0070727~cellular macromolecule localization,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008267~poly-glutamine tract binding,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Downregulated in neuroblastoma cell lines (11331249), In deletion peak with no other known TSGs (11331249), Expression decreased in neuroblastoma (17044048), somatic mutation in 1/25 melanomas (22622578), Somatic mutation in 3/276 colon cancers (22810696)",Overexpression enhances caspase-dependent apoptosis (11331249), 
ASXL1,additional sex combs like 1 (Drosophila),3.27096453806261E-08,9.69815025499548E-06,0.861275785763324,155,8.85935459302447E-09,1,1,1,4,Known TSG,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Reviewed (23736028, 23147254, 23009937), Cancer gene census (14993899)",Well-described (22897849), 
USP28,ubiquitin specific peptidase 28,5.60534741154783E-08,1.6108043738508E-05,0.94326739884511,69,0.00012890330495,0.893571396845862,0.014638549156905,2.60855661228101E-87,4,Unclear,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0004221~ubiquitin thiolesterase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None,"High expression found in breast and colon carcinomas (17558397), Knockdown inhibits growth and clonogenicity of cancer cell lines (17558397), Upregulated in 9/10 colon carcinomas (17558397)","Stabilizes Chk2 and 53BP1 in response to DNA damage (16901786), Stabilizes Myc and leads to its accumulation (17558397)", 
MEN1,multiple endocrine neoplasia I,6.86804928366881E-08,1.91475063536791E-05,0.982550123062612,34,1.62862937837674E-06,1,0.886481428527679,1,4,Known TSG,"GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPKKK cascade,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001776~leukocyte homeostasis,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0002051~osteoblast fate commitment,GO:0002076~osteoblast development,GO:0002520~immune system development,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007565~female pregnancy,GO:0008213~protein amino acid alkylation,GO:0008285~negative regulation of cell proliferation,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010212~response to ionizing radiation,GO:0010332~response to gamma radiation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010638~positive regulation of organelle organization,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0030097~hemopoiesis,GO:0030278~regulation of ossification,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0031056~regulation of histone modification,GO:0031058~positive regulation of histone modification,GO:0031060~regulation of histone methylation,GO:0031062~positive regulation of histone methylation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032259~methylation,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032504~multicellular organism reproduction,GO:0032925~regulation of activin receptor signaling pathway,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043392~negative regulation of DNA binding,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0043414~biopolymer methylation,GO:0043433~negative regulation of transcription factor activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045736~negative regulation of cyclin-dependent protein kinase activity,GO:0045786~negative regulation of cell cycle,GO:0045859~regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045926~negative regulation of growth,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0046620~regulation of organ growth,GO:0046621~negative regulation of organ growth,GO:0048534~hemopoietic or lymphoid organ development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048585~negative regulation of response to stimulus,GO:0048598~embryonic morphogenesis,GO:0048609~reproductive process in a multicellular organism,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048872~homeostasis of number of cells,GO:0051090~regulation of transcription factor activity,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051101~regulation of DNA binding,GO:0051130~positive regulation of cellular component organization,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051302~regulation of cell division,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051348~negative regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0051781~positive regulation of cell division,GO:0051972~regulation of telomerase activity,GO:0051974~negative regulation of telomerase activity,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0060021~palate development,GO:0060135~maternal process involved in female pregnancy,GO:0060348~bone development,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070303~negative regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0000267~cell fraction,GO:0000785~chromatin,GO:0005625~soluble fraction,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032153~cell division site,GO:0032154~cleavage furrow,GO:0032155~cell division site part,GO:0034399~nuclear periphery,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000217~DNA secondary structure binding,GO:0000400~four-way junction DNA binding,GO:0000403~Y-form DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0043566~structure-specific DNA binding,GO:0046332~SMAD binding,GO:0047485~protein N-terminus binding,GO:0070412~R-SMAD binding,",None,"Well-described (9354421,  22723327), Cancer gene census (14993899)","Well-described (19596783, 23648481)", 
ID3,"inhibitor of DNA binding 3, dominant negative helix-loop-helix protein",1.41589714009262E-07,3.77822038282716E-05,0.951831704264758,62,0.00027309309673,0.571473810679365,0.025485718920263,1.28428911494383E-112,4,Unclear,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006275~regulation of DNA replication,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0009611~response to wounding,GO:0009890~negative regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0016481~negative regulation of transcription,GO:0030182~neuron differentiation,GO:0030855~epithelial cell differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of transcription factor activity,GO:0044092~negative regulation of molecular function,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051052~regulation of DNA metabolic process,GO:0051090~regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051101~regulation of DNA binding,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051726~regulation of cell cycle,GO:0051789~response to protein stimulus,GO:0060429~epithelium development,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,","hsa04350:TGF-beta signaling pathway,","Knockdown decreases proliferation, increases apoptosis, and suppresses migration, and inhibits growth of medulloblastoma cells in vitro (23768125), Increased expression in medulloblastoma (23768125), Mutated in 34% Burkitt's lymphoma (23143597), ID3 mutations promote proliferation and cell cycle progression; restoration of wild-type ID3 decreases proliferation rate (23143597)",ID3 mutations promote proliferation and cell cycle progression (23143597), 
SMAD2,SMAD family member 2,2.60851918398834E-07,6.86260983629834E-05,0.981921990960579,36,6.95789117614438E-05,1,0.14157858166002,0.000658093333157,4,Known TSG,"GO:0000578~embryonic axis specification,GO:0001701~in utero embryonic development,GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0002790~peptide secretion,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007183~SMAD protein complex assembly,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007352~zygotic determination of dorsal/ventral axis,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0007498~mesoderm development,GO:0007507~heart development,GO:0008285~negative regulation of cell proliferation,GO:0009743~response to carbohydrate stimulus,GO:0009746~response to hexose stimulus,GO:0009749~response to glucose stimulus,GO:0009791~post-embryonic development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009798~axis specification,GO:0009880~embryonic pattern specification,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009914~hormone transport,GO:0009950~dorsal/ventral axis specification,GO:0009952~anterior/posterior pattern formation,GO:0009953~dorsal/ventral pattern formation,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010720~positive regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010770~positive regulation of cell morphogenesis involved in differentiation,GO:0010817~regulation of hormone levels,GO:0015833~peptide transport,GO:0016310~phosphorylation,GO:0016441~posttranscriptional gene silencing,GO:0016458~gene silencing,GO:0016481~negative regulation of transcription,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0022604~regulation of cell morphogenesis,GO:0030072~peptide hormone secretion,GO:0030073~insulin secretion,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0031016~pancreas development,GO:0031047~gene silencing by RNA,GO:0031050~dsRNA fragmentation,GO:0031053~primary microRNA processing,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0032940~secretion by cell,GO:0033993~response to lipid,GO:0034284~response to monosaccharide stimulus,GO:0034470~ncRNA processing,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035195~gene silencing by miRNA,GO:0035196~gene silencing by miRNA, production of miRNAs,GO:0035265~organ growth,GO:0035295~tube development,GO:0040007~growth,GO:0040029~regulation of gene expression, epigenetic,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0043193~positive regulation of gene-specific transcription,GO:0043331~response to dsRNA,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046879~hormone secretion,GO:0046903~secretion,GO:0048332~mesoderm morphogenesis,GO:0048339~paraxial mesoderm development,GO:0048340~paraxial mesoderm morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051130~positive regulation of cellular component organization,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060021~palate development,GO:0060284~regulation of cell development,GO:0060541~respiratory system development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070723~response to cholesterol,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032444~activin responsive factor complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0005072~transforming growth factor beta receptor, cytoplasmic mediator activity,GO:0005160~transforming growth factor beta receptor binding,GO:0008134~transcription factor binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0030618~transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,GO:0031625~ubiquitin protein ligase binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046332~SMAD binding,GO:0070410~co-SMAD binding,GO:0070412~R-SMAD binding,","hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,","Well-described (19276350, 10438456, 19610047)","Well-described (19276350, 10438456, 19610047)", 
NOTCH2,Notch homolog 2 (Drosophila),2.76487148832025E-07,7.17292146254639E-05,0.827342455452622,195,0.00010389532227,1,0.191185446314387,1.09941515636655E-12,4,Known TSG/context-dependent,"GO:0001709~cell fate determination,GO:0002009~morphogenesis of an epithelium,GO:0002011~morphogenesis of an epithelial sheet,GO:0002520~immune system development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006916~anti-apoptosis,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0007368~determination of left/right symmetry,GO:0007389~pattern specification process,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009611~response to wounding,GO:0009799~determination of symmetry,GO:0009855~determination of bilateral symmetry,GO:0009967~positive regulation of signal transduction,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016049~cell growth,GO:0019827~stem cell maintenance,GO:0022402~cell cycle process,GO:0030097~hemopoiesis,GO:0030326~embryonic limb morphogenesis,GO:0031099~regeneration,GO:0032535~regulation of cellular component size,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0040007~growth,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042246~tissue regeneration,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048534~hemopoietic or lymphoid organ development,GO:0048589~developmental growth,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048736~appendage development,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051252~regulation of RNA metabolic process,GO:0060173~limb development,GO:0060429~epithelium development,GO:0060548~negative regulation of cell death,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0003702~RNA polymerase II transcription factor activity,GO:0003704~specific RNA polymerase II transcription factor activity,GO:0005509~calcium ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa04320:Dorso-ventral axis formation,hsa04330:Notch signaling pathway,","Reviewed (21948802, 22128846)","Reviewed (21948802, 22128846)", 
ZFP36L1,"zinc finger protein 36, C3H type-like 1",3.23674623328954E-07,8.14505861130571E-05,0.933714778286299,78,1.73762034455033E-06,1,1,6.58291914975423E-10,4,Putative TSG,"GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001944~vasculature development,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006417~regulation of translation,GO:0009057~macromolecule catabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0016071~mRNA metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0043487~regulation of RNA stability,GO:0043488~regulation of mRNA stability,GO:0044265~cellular macromolecule catabolic process,GO:0048514~blood vessel morphogenesis,GO:0051252~regulation of RNA metabolic process,GO:0005829~cytosol,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008270~zinc ion binding,GO:0017091~AU-rich element binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Conditional knockout in T cells leads to T-ALL (20622884), Intratumoral injection of ZFP36L1 reduces tumor growth and decreases angiogenesis (20802528), Overexpressed in LN+ breast cancers (17855657)","Induces post-transcriptional destruction of cancer-relevant mRNAs (21278925) including VEGF (20802528) and Stat5b (20702587), ", 
SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",3.27040738716167E-07,8.14505861130571E-05,0.972244111993125,47,0.000437561888063,1,0.023464581367934,1,4,Known TSG,"GO:0006259~DNA metabolic process,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0015074~DNA integration,GO:0016032~viral reproduction,GO:0016568~chromatin modification,GO:0019058~viral infectious cycle,GO:0019079~viral genome replication,GO:0022415~viral reproductive process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0043193~positive regulation of gene-specific transcription,GO:0043388~positive regulation of DNA binding,GO:0044093~positive regulation of molecular function,GO:0045090~retroviral genome replication,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016514~SWI/SNF complex,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0070603~SWI/SNF-type complex,GO:0002039~p53 binding,",None,"Well-described (15899790, 19480937, 22160322), associated with rhabdoid predisposition syndrome, Cancer gene census (14993899)","Well-described (15899790, 19480937, 22160322)", 
TET2,tet oncogene family member 2,4.67499419470413E-07,0.000111954123799,0.908375333988482,99,3.04330873587656E-07,1,1,0.000144884816993,4,Known TSG,"GO:0007049~cell cycle,GO:0055114~oxidation reduction,GO:0005506~iron ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Reviewed (22240200), Cancer gene census (14993899)",Reviewed (22240200), 
NF2,neurofibromin 2 (merlin),8.60957320284419E-07,0.00018919790336,0.98638883440777,32,6.51856430412635E-06,0.09546493192653,1,1,4,Known TSG,"GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0001952~regulation of cell-matrix adhesion,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006275~regulation of DNA replication,GO:0006469~negative regulation of protein kinase activity,GO:0007010~cytoskeleton organization,GO:0007162~negative regulation of cell adhesion,GO:0007369~gastrulation,GO:0007398~ectoderm development,GO:0007498~mesoderm development,GO:0008156~negative regulation of DNA replication,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010638~positive regulation of organelle organization,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010810~regulation of cell-substrate adhesion,GO:0010812~negative regulation of cell-substrate adhesion,GO:0014009~glial cell proliferation,GO:0014010~Schwann cell proliferation,GO:0019220~regulation of phosphate metabolic process,GO:0022407~regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0032231~regulation of actin filament bundle formation,GO:0032233~positive regulation of actin filament bundle formation,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0033673~negative regulation of kinase activity,GO:0034330~cell junction organization,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042475~odontogenesis of dentine-containing tooth,GO:0042476~odontogenesis,GO:0042509~regulation of tyrosine phosphorylation of STAT protein,GO:0042516~regulation of tyrosine phosphorylation of Stat3 protein,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0042522~regulation of tyrosine phosphorylation of Stat5 protein,GO:0042524~negative regulation of tyrosine phosphorylation of Stat5 protein,GO:0042532~negative regulation of tyrosine phosphorylation of STAT protein,GO:0043086~negative regulation of catalytic activity,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0044087~regulation of cellular component biogenesis,GO:0044092~negative regulation of molecular function,GO:0045216~cell-cell junction organization,GO:0045859~regulation of protein kinase activity,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0046425~regulation of JAK-STAT cascade,GO:0046426~negative regulation of JAK-STAT cascade,GO:0048332~mesoderm morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051492~regulation of stress fiber formation,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051496~positive regulation of stress fiber formation,GO:0001726~ruffle,GO:0005730~nucleolus,GO:0005768~endosome,GO:0005769~early endosome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0009898~internal side of plasma membrane,GO:0019898~extrinsic to membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030175~filopodium,GO:0031252~cell leading edge,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032153~cell division site,GO:0032154~cleavage furrow,GO:0032155~cell division site part,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044459~plasma membrane part,GO:0048471~perinuclear region of cytoplasm,GO:0070013~intracellular organelle lumen,GO:0070161~anchoring junction,GO:0008092~cytoskeletal protein binding,",None,"Reviewed (23267122), and well-described (14580336, 20643348, 15743831), associated with Neurofibroma-predisposition syndrome, Cancer gene census (14993899)","Reviewed (23267122), and well-described (14580336, 20643348, 15743831)", 
CHD8,chromodomain helicase DNA binding protein 8,9.71326860310884E-07,0.000208544993376,0.846365163301401,176,0.000810531197333,0.271266544308466,0.115596765889253,0.029077460294522,4,Putative TSG,"GO:0001701~in utero embryonic development,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0016055~Wnt receptor signaling pathway,GO:0016568~chromatin modification,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043044~ATP-dependent chromatin remodeling,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0060548~negative regulation of cell death,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008013~beta-catenin binding,GO:0008094~DNA-dependent ATPase activity,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035064~methylated histone residue binding,GO:0042393~histone binding,GO:0042623~ATPase activity, coupled,","hsa04310:Wnt signaling pathway,","Downregulated in GCs (23835524), Loss of expression by IHC in 35.7% of GCs and 28.6% of CRCs (21447119), knockdown in gastric cancer cell lines promotes proliferation (23835524), facilitates androgen-stimulated proliferation of a prostate cancer cell line (20308527)","GSEA highly enriched for Wnt pathway and cell cycle control (23835524), important coactivator of androgen-responsive transcription (20308527)", 
TRIP12,thyroid hormone receptor interactor 12,4.64213656529577E-06,0.000910672615879,0.890771580976707,124,0.00147762107325,1,0.271476723733921,4.84469372100017E-70,4,Putative TSG,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,GO:0000502~proteasome complex,GO:0004842~ubiquitin-protein ligase activity,GO:0008134~transcription factor binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0035257~nuclear hormone receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0051427~hormone receptor binding,","hsa04120:Ubiquitin mediated proteolysis,","Frameshift mutations in gastric and colon cancer with MSI (22124266), Knockdown stabilizes ARF and reactivates p53 in AML cells (20699639)","Ub ligase for ARF - knockdown stabilizes ARF and reactivates p53 in AML cells (20699639), Ub ligase for RNF168 which initiates histone ubiquitination (22884692)", 
MLLT4,"similar to Afadin (Protein AF-6); myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4",7.783540958237E-06,0.00146857334908,0.784668377250938,248,0.008860958514633,1,0.018651724385232,6.97926046460417E-70,4,Putative TSG,"GO:0007155~cell adhesion,GO:0007267~cell-cell signaling,GO:0022610~biological adhesion,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0008022~protein C-terminus binding,","hsa04520:Adherens junction,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,","Knockdown induces tumor growth, invasiveness, and cell migration (21478912), Deleted in 14.5% breast cancers and correlated with poor prognosis (16819513)","Regulates lymphangiogenesis by modulating RhoA activity (23840823), Maintains barrier function and homeostasis of intestinal epithelial tissue through interactions with nectin-2 and nectin-3 (21652626)", 
DNER,delta/notch-like EGF repeat containing,1.38788332912273E-05,0.002516919680066,0.790306239220258,239,0.008729718508796,1,0.086833240644954,1.59204635411385E-60,4,Putative TSG,"GO:0001764~neuron migration,GO:0006508~proteolysis,GO:0006897~endocytosis,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0007220~Notch receptor processing,GO:0007416~synaptogenesis,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0010001~glial cell differentiation,GO:0010324~membrane invagination,GO:0014706~striated muscle tissue development,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0016485~protein processing,GO:0042063~gliogenesis,GO:0042692~muscle cell differentiation,GO:0043062~extracellular structure organization,GO:0048741~skeletal muscle fiber development,GO:0048747~muscle fiber development,GO:0048870~cell motility,GO:0050808~synapse organization,GO:0051146~striated muscle cell differentiation,GO:0051604~protein maturation,GO:0051605~protein maturation by peptide bond cleavage,GO:0051674~localization of cell,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0005112~Notch binding,GO:0005509~calcium ion binding,GO:0030276~clathrin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None,Inhibits growth of GBM-derived neurospheres in vitro and in vivo (19544453,Canonical Notch ligand (19544453), 
MGA,MAX gene associated,1.5219850608936E-05,0.002733572976195,0.927772115510847,82,9.72723709574989E-05,1,1,1.91795864788171E-64,4,Novel,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None,"Deleted in 4% CLL patients (23047824), Mutated in 1/59 CLL patients (23047824), 5/149 esophageal cancer samples (23525077), and 2/60 ACC samples (23685749), ","Myc antagonist of the Mad family (10601024, 16620026)", 
CYLD,cylindromatosis (turban tumor syndrome),1.54446858969636E-05,0.002747536074947,0.914887658020121,92,0.004599797029865,1,0.271476723733921,1,4,Known TSG,"GO:0006412~translation,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0005840~ribosome,GO:0005856~cytoskeleton,GO:0030529~ribonucleoprotein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0003735~structural constituent of ribosome,GO:0004221~ubiquitin thiolesterase activity,GO:0005198~structural molecule activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04622:RIG-I-like receptor signaling pathway,","Reviewed (21345146, 19373246), Cancer gene census (14993899), mutated in the skin appendage tumors cylindromas, trichoepitheliomas, and spiradenomas","Reviewed (21345146, 20347313, 19373246)", 
ZNRF3,zinc and ring finger 3,6.13377424395789E-05,0.009547730758574,0.905468823534989,106,0.010592767698501,1,0.399243341661191,1,4,Known TSG,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Well-described (2350420, 22575959)","Well-described (2350420, 22575959)", 
BRCA1,"breast cancer 1, early onset",6.27002509488498E-05,0.009679156921269,0.790358463883625,238,0.00147762107325,0.893571396845862,1,2.50807743481328E-05,4,Known TSG,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000226~microtubule cytoskeleton organization,GO:0000724~double-strand break repair via homologous recombination,GO:0000725~recombinational repair,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0006508~proteolysis,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006974~response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007098~centrosome cycle,GO:0007242~intracellular signaling cascade,GO:0007549~dosage compensation,GO:0008219~cell death,GO:0008610~lipid biosynthetic process,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0009048~dosage compensation, by inactivation of X chromosome,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010212~response to ionizing radiation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010565~regulation of cellular ketone metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010639~negative regulation of organelle organization,GO:0010824~regulation of centrosome duplication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010948~negative regulation of cell cycle process,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016053~organic acid biosynthetic process,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0016567~protein ubiquitination,GO:0019216~regulation of lipid metabolic process,GO:0019217~regulation of fatty acid metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0030163~protein catabolic process,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031023~microtubule organizing center organization,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031570~DNA integrity checkpoint,GO:0031572~G2/M transition DNA damage checkpoint,GO:0031576~G2/M transition checkpoint,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032446~protein modification by small protein conjugation,GO:0032886~regulation of microtubule-based process,GO:0033043~regulation of organelle organization,GO:0033554~cellular response to stress,GO:0040029~regulation of gene expression, epigenetic,GO:0042127~regulation of cell proliferation,GO:0042304~regulation of fatty acid biosynthetic process,GO:0042770~DNA damage response, signal transduction,GO:0042772~DNA damage response, signal transduction resulting in transcription,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043627~response to estrogen stimulus,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045833~negative regulation of lipid metabolic process,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045922~negative regulation of fatty acid metabolic process,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0046394~carboxylic acid biosynthetic process,GO:0046599~regulation of centriole replication,GO:0046600~negative regulation of centriole replication,GO:0046605~regulation of centrosome cycle,GO:0046606~negative regulation of centrosome cycle,GO:0046890~regulation of lipid biosynthetic process,GO:0048545~response to steroid hormone stimulus,GO:0048584~positive regulation of response to stimulus,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051055~negative regulation of lipid biosynthetic process,GO:0051129~negative regulation of cellular component organization,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051297~centrosome organization,GO:0051493~regulation of cytoskeleton organization,GO:0051494~negative regulation of cytoskeleton organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051726~regulation of cell cycle,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0070647~protein modification by small protein conjugation or removal,GO:0080135~regulation of cellular response to stress,GO:0000151~ubiquitin ligase complex,GO:0000152~nuclear ubiquitin ligase complex,GO:0000793~condensed chromosome,GO:0000930~gamma-tubulin complex,GO:0000931~gamma-tubulin large complex,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0008274~gamma-tubulin ring complex,GO:0015630~microtubule cytoskeleton,GO:0030529~ribonucleoprotein complex,GO:0031436~BRCA1-BARD1 complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044450~microtubule organizing center part,GO:0070013~intracellular organelle lumen,GO:0070531~BRCA1-A complex,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004842~ubiquitin-protein ligase activity,GO:0008092~cytoskeletal protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0015631~tubulin binding,GO:0016563~transcription activator activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0050681~androgen receptor binding,GO:0051427~hormone receptor binding,","hsa04120:Ubiquitin mediated proteolysis,","Reviewed (22843421, 19119312, 23620175)","Reviewed (22843421, 19119312, 23620175)", 
TRAF3,TNF receptor-associated factor 3,8.52848549659601E-05,0.012445592233665,0.901293249809583,109,0.000893699091714,1,1,4.85198814974058E-08,4,Known TSG,"GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04620:Toll-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,","Deletion in mouse B lymphocytes leads to B cell lymphoma (22033491), Homozygous inactivation reported in ~13% multiple myeloma (17692804, 17692805)","Well-described role in noncanonical NFkB pathway (22435551, 9916988)", 
FAS,"Fas (TNF receptor superfamily, member 6)",0.00011561501245,0.015536495090336,0.868311267660877,149,0.02327437466064,0.720097705280436,0.416621938814839,8.67364233008314E-62,4,Known TSG,"GO:0001775~cell activation,GO:0001776~leukocyte homeostasis,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002260~lymphocyte homeostasis,GO:0002377~immunoglobulin production,GO:0002440~production of molecular mediator of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0003014~renal system process,GO:0006461~protein complex assembly,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0006917~induction of apoptosis,GO:0006924~activation-induced cell death of T cells,GO:0006925~inflammatory cell apoptosis,GO:0006927~transformed cell apoptosis,GO:0006955~immune response,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0008633~activation of pro-apoptotic gene products,GO:0009636~response to toxin,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010939~regulation of necrotic cell death,GO:0010940~positive regulation of necrotic cell death,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0019724~B cell mediated immunity,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030217~T cell differentiation,GO:0031960~response to corticosteroid stimulus,GO:0033077~T cell differentiation in the thymus,GO:0042110~T cell activation,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043383~negative T cell selection,GO:0043933~macromolecular complex subunit organization,GO:0045058~T cell selection,GO:0045060~negative thymic T cell selection,GO:0045061~thymic T cell selection,GO:0045321~leukocyte activation,GO:0045619~regulation of lymphocyte differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0046649~lymphocyte activation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048545~response to steroid hormone stimulus,GO:0048872~homeostasis of number of cells,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050869~negative regulation of B cell activation,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051384~response to glucocorticoid stimulus,GO:0051789~response to protein stimulus,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070227~lymphocyte apoptosis,GO:0070231~T cell apoptosis,GO:0070271~protein complex biogenesis,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005625~soluble fraction,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031264~death-inducing signaling complex,GO:0044459~plasma membrane part,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0042802~identical protein binding,","hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa04940:Type I diabetes mellitus,hsa05010:Alzheimer's disease,hsa05200:Pathways in cancer,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,","Well-descibred (20505730, 22669972)","Well-descibred (20505730, 22669972)", 
EPHA2,EPH receptor A2,0.000121516277445,0.016097890399984,0.850820618310245,169,0.014278261879055,1,0.660096042000246,7.15980118645894E-113,4,Context-dependent,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016310~phosphorylation,GO:0030182~neuron differentiation,GO:0048013~ephrin receptor signaling pathway,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04360:Axon guidance,",Reviewed (19074825),Reviewed (19074825), 
PTCH1,patched homolog 1 (Drosophila),0.000141167345085,0.018311561380903,0.844911324268146,177,0.011114935270523,1,0.848879761867496,1,4,Known TSG,"GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0003002~regionalization,GO:0003007~heart morphogenesis,GO:0007166~cell surface receptor linked signal transduction,GO:0007224~smoothened signaling pathway,GO:0007389~pattern specification process,GO:0007398~ectoderm development,GO:0007507~heart development,GO:0007584~response to nutrient,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008544~epidermis development,GO:0008589~regulation of smoothened signaling pathway,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009953~dorsal/ventral pattern formation,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0014020~primary neural tube formation,GO:0014070~response to organic cyclic substance,GO:0016331~morphogenesis of embryonic epithelium,GO:0016485~protein processing,GO:0021532~neural tube patterning,GO:0021904~dorsal/ventral neural tube patterning,GO:0021915~neural tube development,GO:0030326~embryonic limb morphogenesis,GO:0030879~mammary gland development,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol stimulus,GO:0032526~response to retinoic acid,GO:0033189~response to vitamin A,GO:0033273~response to vitamin,GO:0033500~carbohydrate homeostasis,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040008~regulation of growth,GO:0040014~regulation of multicellular organism growth,GO:0040015~negative regulation of multicellular organism growth,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0043009~chordate embryonic development,GO:0043616~keratinocyte proliferation,GO:0043627~response to estrogen stimulus,GO:0045926~negative regulation of growth,GO:0048545~response to steroid hormone stimulus,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048732~gland development,GO:0048736~appendage development,GO:0048878~chemical homeostasis,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051241~negative regulation of multicellular organismal process,GO:0051604~protein maturation,GO:0060173~limb development,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0001871~pattern binding,GO:0005113~patched binding,GO:0005539~glycosaminoglycan binding,GO:0008158~hedgehog receptor activity,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,","hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,","Reviewed (16419085, 16258256, 20024066)","Reviewed (16419085, 16258256, 20024066)", 
SPRED1,"sprouty-related, EVH1 domain containing 1",0.000170767287663,0.021265081108332,0.8701967690629,147,0.00669509242468,1,1,5.2497064035729E-57,4,Putative TSG,"GO:0000165~MAPKKK cascade,GO:0000188~inactivation of MAPK activity,GO:0006469~negative regulation of protein kinase activity,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0019220~regulation of phosphate metabolic process,GO:0033673~negative regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0005173~stem cell factor receptor binding,","hsa04630:Jak-STAT signaling pathway,","Overexpression inhibits prostate cancer cell proliferation and migration in rponse to growth factor stimulation (23169297), Germline mutations result in Legius syndrome, a neurofibromatosis-like syndrome displaying altered pigmentation without tumorigenesis (20179001, 17704776), rare cases of Legius syndrome present with neurofibromas (19966658), Overexpression inhibits cell migration by suppressing RhoA-induced stress fiber formation (15184877), Expression level frequently decreased in HCC (16652141), Inhibits growth-factor mediated HCC cell motility (16652141)","Inhibits Ras-dependent ERK signaling induced by growth factors (15184877): Recruits neurofibromin to the membrane, which dampens growth factor-induced Ras activity (22802525, 22751498), Overexpression reduces ERK phosphorylation (23169297), Reduces secretion of MMP-9 and MMP-2 (16652141)", 
HNF1A,HNF1 homeobox A,0.000293800139572,0.034086290727066,0.960228379781457,56,0.020731291482554,1,0.771592454005998,3.26049560498667E-24,4,Known TSG,"GO:0001701~in utero embryonic development,GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0001824~blastocyst development,GO:0001889~liver development,GO:0001890~placenta development,GO:0001894~tissue homeostasis,GO:0002790~peptide secretion,GO:0002791~regulation of peptide secretion,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0003006~reproductive developmental process,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006694~steroid biosynthetic process,GO:0006699~bile acid biosynthetic process,GO:0006778~porphyrin metabolic process,GO:0006779~porphyrin biosynthetic process,GO:0006783~heme biosynthetic process,GO:0006869~lipid transport,GO:0006979~response to oxidative stress,GO:0007267~cell-cell signaling,GO:0007369~gastrulation,GO:0007498~mesoderm development,GO:0008104~protein localization,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0008206~bile acid metabolic process,GO:0008610~lipid biosynthetic process,GO:0009743~response to carbohydrate stimulus,GO:0009746~response to hexose stimulus,GO:0009749~response to glucose stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009914~hormone transport,GO:0010033~response to organic substance,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010817~regulation of hormone levels,GO:0010876~lipid localization,GO:0015718~monocarboxylic acid transport,GO:0015721~bile acid and bile salt transport,GO:0015833~peptide transport,GO:0015849~organic acid transport,GO:0015908~fatty acid transport,GO:0015918~sterol transport,GO:0016053~organic acid biosynthetic process,GO:0016125~sterol metabolic process,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0018130~heterocycle biosynthetic process,GO:0030072~peptide hormone secretion,GO:0030073~insulin secretion,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030301~cholesterol transport,GO:0030326~embryonic limb morphogenesis,GO:0031016~pancreas development,GO:0031018~endocrine pancreas development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0032940~secretion by cell,GO:0033013~tetrapyrrole metabolic process,GO:0033014~tetrapyrrole biosynthetic process,GO:0033500~carbohydrate homeostasis,GO:0034284~response to monosaccharide stimulus,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035270~endocrine system development,GO:0042168~heme metabolic process,GO:0042440~pigment metabolic process,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0043009~chordate embryonic development,GO:0043691~reverse cholesterol transport,GO:0044271~nitrogen compound biosynthetic process,GO:0045449~regulation of transcription,GO:0045453~bone resorption,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046148~pigment biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046849~bone remodeling,GO:0046879~hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046903~secretion,GO:0046942~carboxylic acid transport,GO:0048332~mesoderm morphogenesis,GO:0048339~paraxial mesoderm development,GO:0048340~paraxial mesoderm morphogenesis,GO:0048341~paraxial mesoderm formation,GO:0048598~embryonic morphogenesis,GO:0048608~reproductive structure development,GO:0048729~tissue morphogenesis,GO:0048736~appendage development,GO:0048771~tissue remodeling,GO:0048871~multicellular organismal homeostasis,GO:0048878~chemical homeostasis,GO:0050796~regulation of insulin secretion,GO:0051046~regulation of secretion,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0060173~limb development,GO:0060249~anatomical structure homeostasis,GO:0060341~regulation of cellular localization,GO:0001750~photoreceptor outer segment,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005929~cilium,GO:0031513~nonmotile primary cilium,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0042995~cell projection,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0045120~pronucleus,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003704~specific RNA polymerase II transcription factor activity,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa04950:Maturity onset diabetes of the young,","Biallelic inactivating mutations associated with hepatocellular adenomas (23707370), Recapitulation in HCC lines decreases proliferation, clonogenic growth, and tumorigenicity (21898499)","Induces differentation and G2/M arrest of hepatocytes (21898499), Knockdown induces EMT (21975049)", 
THUMPD3,THUMP domain containing 3,0.000342616481057,0.038093650295626,0.812123366207177,214,0.028937801866185,1,0.505087244311173,5.00959360010641E-58,4,Novel,"GO:0003723~RNA binding,",None,None,Unknown, 
PHACTR4,phosphatase and actin regulator 4,0.000369986231528,0.040360971334841,0.912538437116286,94,0.020483263385881,1,0.970645685897825,9.85896856139436E-97,4,Known TSG,"GO:0003779~actin binding,GO:0004857~enzyme inhibitor activity,GO:0004864~phosphoprotein phosphatase inhibitor activity,GO:0008092~cytoskeletal protein binding,GO:0019208~phosphatase regulator activity,GO:0019212~phosphatase inhibitor activity,GO:0019888~protein phosphatase regulator activity,",None,"Well-described (23319639), validated STOP gene (22628553)",Well-described (23319639), 
INO80,INO80 homolog (S. cerevisiae),0.000513781271101,0.050777356417429,0.780260250695347,253,0.131933408525821,1,0.08825557681226,7.56043162304672E-56,4,Known TSG,"GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0016568~chromatin modification,GO:0051276~chromosome organization,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None,"Reviewed (22749148, 22749148, 19424290, 17316710)","Reviewed (22749148, 22749148, 19424290, 17316710)", 
HLA-DRB1,"major histocompatibility complex, class II, DR beta 4; major histocompatibility complex, class II, DR beta 1",0.000611922156046,0.057150469763906,0.902096952775714,108,0.003032938724433,1,1,1.16761695228888E-189,4,Novel,"GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0006955~immune response,GO:0009405~pathogenesis,GO:0019882~antigen processing and presentation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042611~MHC protein complex,GO:0042613~MHC class II protein complex,GO:0044459~plasma membrane part,GO:0032395~MHC class II receptor activity,","hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,","Polymorphisms associated with altered risk many cancers including follicular lymphoma and breast cancer (23791106, 24000898, 23894725, 21720852, 21133715), esophageal cancer (22588649), ALL (22868506), lung carcinoma (20449807), HCC (22499074, 21172035), and sometimes cervical carcinoma (23992015, 23590002, 23482656, 22863772, 21692064, 18451182)",Unknown, 
PTPRK,"protein tyrosine phosphatase, receptor type, K",0.00066042299643,0.06047078995257,0.893827200355455,118,0.130381293471046,1,0.196420711694315,3.53243194471268E-07,4,Known TSG,"GO:0000302~response to reactive oxygen species,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0006979~response to oxidative stress,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0010035~response to inorganic substance,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010837~regulation of keratinocyte proliferation,GO:0010839~negative regulation of keratinocyte proliferation,GO:0016311~dephosphorylation,GO:0016477~cell migration,GO:0016481~negative regulation of transcription,GO:0022610~biological adhesion,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031589~cell-substrate adhesion,GO:0033554~cellular response to stress,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0034394~protein localization at cell surface,GO:0034599~cellular response to oxidative stress,GO:0034613~cellular protein localization,GO:0034614~cellular response to reactive oxygen species,GO:0034644~cellular response to UV,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0045786~negative regulation of cell cycle,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048041~focal adhesion formation,GO:0048870~cell motility,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051674~localization of cell,GO:0051726~regulation of cell cycle,GO:0070727~cellular macromolecule localization,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031252~cell leading edge,GO:0031256~leading edge membrane,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008013~beta-catenin binding,GO:0016791~phosphatase activity,GO:0019198~transmembrane receptor protein phosphatase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0045295~gamma-catenin binding,",None,"Negative regulator of breast cancer cell invasion, migration, and proliferation (23552869), Low levels associated with poor prognosis in breast cancer (23552869), validated STOP gene (22628553), expression level significantly downregulated in NSCLC (22245727), Re-expression of PTPRK in melanoma cells reduces proliferation and migration (18276111), Identified as putuative TSG in transposon-based genetic screen in CRC cells (19251594)",Negatively regulates beta-catenin transcriptional activity (18276111) , 
BCL10,B-cell CLL/lymphoma 10; hypothetical LOC646626,0.000861404933278,0.072478300669834,0.914968324525618,91,0.019020134381306,1,1,3.80854617361279E-09,4,Known TSG,"GO:0001816~cytokine production,GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0002218~activation of innate immune response,GO:0002221~pattern recognition receptor signaling pathway,GO:0002224~toll-like receptor signaling pathway,GO:0002237~response to molecule of bacterial origin,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002700~regulation of production of molecular mediator of immune response,GO:0002702~positive regulation of production of molecular mediator of immune response,GO:0002718~regulation of cytokine production during immune response,GO:0002720~positive regulation of cytokine production during immune response,GO:0002757~immune response-activating signal transduction,GO:0002758~innate immune response-activating signal transduction,GO:0002764~immune response-regulating signal transduction,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002902~regulation of B cell apoptosis,GO:0002903~negative regulation of B cell apoptosis,GO:0002905~regulation of mature B cell apoptosis,GO:0002906~negative regulation of mature B cell apoptosis,GO:0006355~regulation of transcription, DNA-dependent,GO:0006461~protein complex assembly,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006952~defense response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007249~I-kappaB kinase/NF-kappaB cascade,GO:0008219~cell death,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010628~positive regulation of gene expression,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0014020~primary neural tube formation,GO:0016064~immunoglobulin mediated immune response,GO:0016265~death,GO:0016331~morphogenesis of embryonic epithelium,GO:0019220~regulation of phosphate metabolic process,GO:0019724~B cell mediated immunity,GO:0021915~neural tube development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031349~positive regulation of defense response,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032635~interleukin-6 production,GO:0032641~lymphotoxin A production,GO:0032677~regulation of interleukin-8 production,GO:0032763~regulation of mast cell cytokine production,GO:0032765~positive regulation of mast cell cytokine production,GO:0032844~regulation of homeostatic process,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042035~regulation of cytokine biosynthetic process,GO:0042089~cytokine biosynthetic process,GO:0042107~cytokine metabolic process,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042109~lymphotoxin A biosynthetic process,GO:0042226~interleukin-6 biosynthetic process,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043388~positive regulation of DNA binding,GO:0043933~macromolecular complex subunit organization,GO:0044093~positive regulation of molecular function,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045414~regulation of interleukin-8 biosynthetic process,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045941~positive regulation of transcription,GO:0048584~positive regulation of response to stimulus,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0050778~positive regulation of immune response,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0050854~regulation of antigen receptor-mediated signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050870~positive regulation of T cell activation,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051291~protein heterooligomerization,GO:0060429~epithelium development,GO:0060548~negative regulation of cell death,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0065003~macromolecular complex assembly,GO:0070228~regulation of lymphocyte apoptosis,GO:0070229~negative regulation of lymphocyte apoptosis,GO:0070271~protein complex biogenesis,GO:0000323~lytic vacuole,GO:0001772~immunological synapse,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0032449~CBM complex,GO:0042101~T cell receptor complex,GO:0043235~receptor complex,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0046696~lipopolysaccharide receptor complex,GO:0048471~perinuclear region of cytoplasm,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008022~protein C-terminus binding,GO:0008047~enzyme activator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030528~transcription regulator activity,GO:0031625~ubiquitin protein ligase binding,GO:0032182~small conjugating protein binding,GO:0043130~ubiquitin binding,GO:0043422~protein kinase B binding,GO:0043621~protein self-association,GO:0051059~NF-kappaB binding,","hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,","Reviewed (17073595, 10845924)","Reviewed (17073595, 10845924)", 
WWC2,WW and C2 domain containing 2,0.002647479679871,0.168779088533507,0.841662187292569,181,0.174737163665832,1,0.621617423105817,2.34619807529479E-117,4,Novel,None,None,None,Involvedi n FAT-Hippo signaling cascade (23076869), 
ING1,"inhibitor of growth family, member 1",0.003477416450915,0.200477351501953,0.86928064945064,148,0.177214745363094,1,0.621617423105817,1,4,Known TSG,"GO:0001558~regulation of cell growth,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030308~negative regulation of cell growth,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032535~regulation of cellular component size,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0045792~negative regulation of cell size,GO:0045926~negative regulation of growth,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Reviewed (23412501, 23445221, 19442118)","Reviewed (23412501, 15743678)", 
MLH1,"mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)",0.00712987456563,0.309540216112558,0.876929987718983,138,0.174737163665832,1,1,1.22194776668285E-34,4,Known TSG,"GO:0000018~regulation of DNA recombination,GO:0000019~regulation of mitotic recombination,GO:0000226~microtubule cytoskeleton organization,GO:0000239~pachytene,GO:0000279~M phase,GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0000712~resolution of meiotic joint molecules as recombinants,GO:0000726~non-recombinational repair,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0001775~cell activation,GO:0002200~somatic diversification of immune receptors,GO:0002204~somatic recombination of immunoglobulin genes during immune response,GO:0002208~somatic diversification of immunoglobulins during immune response,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002377~immunoglobulin production,GO:0002381~immunoglobulin production during immune response,GO:0002440~production of molecular mediator of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002520~immune system development,GO:0002562~somatic diversification of immune receptors via germline recombination within a single locus,GO:0002566~somatic diversification of immune receptors via somatic mutation,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006461~protein complex assembly,GO:0006917~induction of apoptosis,GO:0006955~immune response,GO:0006974~response to DNA damage stimulus,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007059~chromosome segregation,GO:0007060~male meiosis chromosome segregation,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007128~meiotic prophase I,GO:0007131~reciprocal meiotic recombination,GO:0007140~male meiosis,GO:0007242~intracellular signaling cascade,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007292~female gamete generation,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0009057~macromolecule catabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016064~immunoglobulin mediated immune response,GO:0016071~mRNA metabolic process,GO:0016444~somatic cell DNA recombination,GO:0016445~somatic diversification of immunoglobulins,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031123~RNA 3'-end processing,GO:0031124~mRNA 3'-end processing,GO:0032504~multicellular organism reproduction,GO:0033554~cellular response to stress,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042113~B cell activation,GO:0042770~DNA damage response, signal transduction,GO:0042981~regulation of apoptosis,GO:0043060~meiotic metaphase I plate congression,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044265~cellular macromolecule catabolic process,GO:0045132~meiotic chromosome segregation,GO:0045143~homologous chromosome segregation,GO:0045190~isotype switching,GO:0045321~leukocyte activation,GO:0045910~negative regulation of DNA recombination,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045950~negative regulation of mitotic recombination,GO:0046649~lymphocyte activation,GO:0048232~male gamete generation,GO:0048477~oogenesis,GO:0048609~reproductive process in a multicellular organism,GO:0050000~chromosome localization,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051225~spindle assembly,GO:0051255~spindle midzone assembly,GO:0051257~spindle midzone assembly involved in meiosis,GO:0051303~establishment of chromosome localization,GO:0051304~chromosome separation,GO:0051307~meiotic chromosome separation,GO:0051310~metaphase plate congression,GO:0051311~meiotic metaphase plate congression,GO:0051321~meiotic cell cycle,GO:0051324~prophase,GO:0051327~M phase of meiotic cell cycle,GO:0051640~organelle localization,GO:0051656~establishment of organelle localization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000795~synaptonemal complex,GO:0001673~male germ cell nucleus,GO:0005694~chromosome,GO:0005712~chiasma,GO:0032300~mismatch repair complex,GO:0032389~MutLalpha complex,GO:0043073~germ cell nucleus,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030983~mismatched DNA binding,GO:0032134~mispaired DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032403~protein complex binding,GO:0032404~mismatch repair complex binding,GO:0032407~MutSalpha complex binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043566~structure-specific DNA binding,","hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,","Cancer gene census (14993899), validated STOP gene (22628553), Reviewed (21651356, 21114775, 20420947, 20142816, 19793569, 19564652)","Reviewed (21651356, 21114775, 20420947, 20142816, 19793569, 19564652)", 
PRDM5,PR domain containing 5,0.008757810206423,0.348057737969743,0.796725395373438,229,0.394092838066716,1,0.463044273101743,0.143361976130108,4,Known TSG,"GO:0000278~mitotic cell cycle,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006476~protein amino acid deacetylation,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0007049~cell cycle,GO:0008213~protein amino acid alkylation,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0016575~histone deacetylation,GO:0032259~methylation,GO:0034968~histone lysine methylation,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0051567~histone H3-K9 methylation,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070491~transcription repressor binding,",None,"Knockout mice in an APC(min) background develop more intestinal adenomas (23873026), Downregulated in colon cancer (23873026), Downregulated in multiple carcinoma cell lines by CpG methylation (22087297), Ectopic PRDM5 expression inhibits tumor cell clonogenicity (22087297), Knockdown of PRDM5 increases cell proliferation (22087297), Expression is reduced or lost by DNA methylation in cervical cancer (22087297)","Regulates proteins involved in metabolic processes (23873026), Inhibits TCF/beta-catenin-dependent transcription and downregulates CDK4, TWIST1, and MDM2 by binding to target gene promoters (22087297)", 
DNAJC11,"DnaJ (Hsp40) homolog, subfamily C, member 11",0.010114102028401,0.381512350865222,0.893535664507069,120,0.079846922014139,1,1,1.93687698643497E-145,4,Putative TSG,"GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0031072~heat shock protein binding,",None,"Deletions and somatic mutations found in neuroblastoma (17222547, 12964007)",Unknown, 
PRKCD,"protein kinase C, delta",0.012082641097187,0.412620634646191,0.83883207849108,187,0.312009080922827,1,1,4.73732616036608E-66,4,Context-dependent,"GO:0001775~cell activation,GO:0001816~cytokine production,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006955~immune response,GO:0007242~intracellular signaling cascade,GO:0007568~aging,GO:0008283~cell proliferation,GO:0009968~negative regulation of signal transduction,GO:0010149~senescence,GO:0010469~regulation of receptor activity,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0016064~immunoglobulin mediated immune response,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019724~B cell mediated immunity,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031647~regulation of protein stability,GO:0032091~negative regulation of protein binding,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032613~interleukin-10 production,GO:0032615~interleukin-12 production,GO:0032943~mononuclear cell proliferation,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0043393~regulation of protein binding,GO:0044092~negative regulation of molecular function,GO:0045321~leukocyte activation,GO:0045936~negative regulation of phosphate metabolic process,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0048585~negative regulation of response to stimulus,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0050821~protein stabilization,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051174~regulation of phosphorus metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0070661~leukocyte proliferation,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0004699~calcium-independent protein kinase C activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019992~diacylglycerol binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043560~insulin receptor substrate binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04062:Chemokine signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04530:Tight junction,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa04930:Type II diabetes mellitus,","Reviewed (14754503, 15054085, 8585964)","Reviewed (14754503, 15054085, 8585964)", 
MCPH1,microcephalin 1,0.01246963100047,0.41986238230345,0.806325314464148,218,0.391188549851751,0.64404871523565,0.991617699290978,3.26293763281552E-60,4,Known TSG,"GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",None,"Reviewed (20376879, 21698754, 19829069)","Reviewed (20376879, 21698754, 19829069)", 
KMT2C,myeloid/lymphoid or mixed-lineage leukemia 3,1.99205458659433E-27,1.86047938114977E-24,0.969505435994923,52,1.62721817693948E-25,0.602606327394993,0.007331356689805,1.92928364957E-31,3,Putative TSG,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007242~intracellular signaling cascade,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0003677~DNA binding,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Frequently mutated in MSI colon cancer (21853109), Dowregulated in breast cancer (23754336), Germline mutation found in colon and AML pedigree (23429989), Deleted in leukemia (11891048) and colon cancers (17614854)",Well-described (19433796), 
CIC,capicua homolog (Drosophila),7.66675008429754E-21,5.5079701855613E-18,0.975286939055025,45,1.12932024108951E-17,0.631152535913834,0.002151459620514,1.18475394398954E-06,3,Known TSG,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,",None,"Well-described (21817013, 23527265), Cancer gene census (14993899)","Well-described (21817013, 23527265)", 
RUNX1,runt-related transcription factor 1,1.46501651069486E-19,1.01352012604701E-16,0.991319539303605,24,1.48406390038932E-18,0.059380025258737,0.342096927505986,1,3,Known TSG,"GO:0002520~immune system development,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030852~regulation of granulocyte differentiation,GO:0030853~negative regulation of granulocyte differentiation,GO:0030854~positive regulation of granulocyte differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048534~hemopoietic or lymphoid organ development,GO:0051094~positive regulation of developmental process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0031404~chloride ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0050824~water binding,","hsa05200:Pathways in cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,","Well-described (22366949, 22171576, 23148227), Associated with familial platelet disorder","Well-described (22366949, 22171576, 23148227)", 
NOTCH1,"Notch homolog 1, translocation-associated (Drosophila)",6.3223364096564E-17,3.80951360632167E-14,0.978529544776727,39,9.01507369509486E-13,0.069513498549928,0.000463940849582,0.273393467499571,3,Known TSG/context-dependent,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001708~cell fate specification,GO:0001763~morphogenesis of a branching structure,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0001942~hair follicle development,GO:0001944~vasculature development,GO:0002040~sprouting angiogenesis,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0007221~positive regulation of transcription of Notch receptor target,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007368~determination of left/right symmetry,GO:0007386~compartment specification,GO:0007389~pattern specification process,GO:0007398~ectoderm development,GO:0007409~axonogenesis,GO:0007439~ectodermal gut development,GO:0007440~foregut morphogenesis,GO:0007492~endoderm development,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0008544~epidermis development,GO:0009611~response to wounding,GO:0009799~determination of symmetry,GO:0009855~determination of bilateral symmetry,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0010001~glial cell differentiation,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010720~positive regulation of cell development,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0014013~regulation of gliogenesis,GO:0014015~positive regulation of gliogenesis,GO:0014031~mesenchymal cell development,GO:0016202~regulation of striated muscle tissue development,GO:0017145~stem cell division,GO:0019953~sexual reproduction,GO:0021700~developmental maturation,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030326~embryonic limb morphogenesis,GO:0030856~regulation of epithelial cell differentiation,GO:0030858~positive regulation of epithelial cell differentiation,GO:0030900~forebrain development,GO:0031069~hair follicle morphogenesis,GO:0031099~regeneration,GO:0031175~neuron projection development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032504~multicellular organism reproduction,GO:0032583~regulation of gene-specific transcription,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040007~growth,GO:0042060~wound healing,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042246~tissue regeneration,GO:0042303~molting cycle,GO:0042633~hair cycle,GO:0042640~anagen,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043193~positive regulation of gene-specific transcription,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045604~regulation of epidermal cell differentiation,GO:0045606~positive regulation of epidermal cell differentiation,GO:0045616~regulation of keratinocyte differentiation,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045661~regulation of myoblast differentiation,GO:0045662~negative regulation of myoblast differentiation,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045682~regulation of epidermis development,GO:0045684~positive regulation of epidermis development,GO:0045685~regulation of glial cell differentiation,GO:0045687~positive regulation of glial cell differentiation,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046532~regulation of photoreceptor cell differentiation,GO:0046533~negative regulation of photoreceptor cell differentiation,GO:0048103~somatic stem cell division,GO:0048232~male gamete generation,GO:0048514~blood vessel morphogenesis,GO:0048546~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048565~gut development,GO:0048567~ectodermal gut morphogenesis,GO:0048589~developmental growth,GO:0048598~embryonic morphogenesis,GO:0048609~reproductive process in a multicellular organism,GO:0048634~regulation of muscle development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048663~neuron fate commitment,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048709~oligodendrocyte differentiation,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0048736~appendage development,GO:0048742~regulation of skeletal muscle fiber development,GO:0048754~branching morphogenesis of a tube,GO:0048762~mesenchymal cell differentiation,GO:0048812~neuron projection morphogenesis,GO:0048820~hair follicle maturation,GO:0048858~cell projection morphogenesis,GO:0050678~regulation of epithelial cell proliferation,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0051094~positive regulation of developmental process,GO:0051147~regulation of muscle cell differentiation,GO:0051148~negative regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051301~cell division,GO:0051960~regulation of nervous system development,GO:0055123~digestive system development,GO:0060173~limb development,GO:0060284~regulation of cell development,GO:0060485~mesenchyme development,GO:0060541~respiratory system development,GO:0060548~negative regulation of cell death,GO:0001669~acrosomal vesicle,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0005509~calcium ion binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0031490~chromatin DNA binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,","hsa04320:Dorso-ventral axis formation,hsa04330:Notch signaling pathway,hsa05020:Prion diseases,","Reviewed (21948802, 18758480)","Reviewed (21948802, 18758480)", 
ARHGAP35,Rho GTPase Activating Protein 35,2.23177887059624E-14,1.19106850068192E-11,0.97661690399984,42,1.78126578649119E-12,1,0.122408621449127,1.23428784403613E-25,3,Putative TSG,"GO:0001654~eye development,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0006350~transcription,GO:0007423~sensory organ development,GO:0008360~regulation of cell shape,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0014020~primary neural tube formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016481~negative regulation of transcription,GO:0021915~neural tube development,GO:0022604~regulation of cell morphogenesis,GO:0030900~forebrain development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0043009~chordate embryonic development,GO:0043010~camera-type eye development,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04510:Focal adhesion,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,","Reduces pancreatic cancer cell invasiveness and metastasis (16776779), Deleted in some gliomas (11054565)","Required for polarized cell migration (18502760, 11553710), Role in mammary epithelial cell differentiation (21945077), Negative regulation of RhoA (21118992, 17129786)", 
IL32,interleukin 32,6.4093485733131E-11,2.66044937779812E-08,0.98131600397381,37,8.55793596231622E-13,1,1,0.012238842219857,3,Unclear,"GO:0006952~defense response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0005125~cytokine activity,",None,"Decreased expression in CMML but increased expression in MDS (18287021), higher expression predicts poor survivial in HNSCC (23359495), Overexpressed in HCC (22198481), Downregulated in response to all-trans retinoic acid treatment in tongue cancer cells (21725974)","Inhibits cancer cell growth through inhibition of NFkB and STAT3 (21423208), in some cases increases NFkB, p38MAPK, and Bcl-2 (22198481), enhances cytotoxic effect of NK cells toward cancer cells ( 22043900)", 
KANSL1,KAT8 Regulatory NSL Complex Subunit 1,3.66077230331179E-10,1.42457428861585E-07,0.949939319353814,63,1.40204599659029E-09,1,1,0.137544801454382,3,Novel,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0051301~cell division,GO:0000444~MIS12/MIND type complex,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,",None,"1 mutation found in 240 neuroblastoma samples (23334666), Haploinsufficiency causes the 17q21.31 microdeletion syndrome (22544367)",Component of MLL complex and NSL1 complex (16227571), 
GPS2,G protein pathway suppressor 2,3.01658038709246E-09,1.12693410101E-06,0.98202201981831,35,4.39676204860449E-08,0.000104878921767,1,0.001021734640885,3,Putative TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPKKK cascade,GO:0000188~inactivation of MAPK activity,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0007049~cell cycle,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0009890~negative regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0016481~negative regulation of transcription,GO:0019220~regulation of phosphate metabolic process,GO:0031098~stress-activated protein kinase signaling pathway,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0048585~negative regulation of response to stimulus,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070303~negative regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0004857~enzyme inhibitor activity,GO:0005095~GTPase inhibitor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None,"Frequently mutated in medulloblastoma (22820256), Depletion promotes proliferation of MCF7 cells (19858209)",Potentiates SMRT-mediated repression activity (19858209), 
LARP4B,"La ribonucleoprotein domain family, member 4B",5.92245455240268E-09,2.12741401123711E-06,0.937429868337496,73,3.69702188390195E-07,1,0.525159447973644,0.00021740551315,3,Novel,"GO:0030529~ribonucleoprotein complex,GO:0003723~RNA binding,",None,"1 mutation found in whole exome sequencing of 22 GBM samples (18772396), Germline mutations in closely related LARP4 cause MPD and ET (15572213, 16682284)","Involved in mRNA metabolism - overexpression of LARP4B stimulates protein synthesis, while knockdown impairs translation (20573744)", 
NSD1,nuclear receptor binding SET domain protein 1,8.35303361790845E-09,2.94389273488513E-06,0.905528660159233,105,3.86253271197494E-07,1,0.666701143072617,0.011490982176158,3,Putative TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001702~gastrulation with mouth forming second,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0007369~gastrulation,GO:0008213~protein amino acid alkylation,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032259~methylation,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048598~embryonic morphogenesis,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016564~transcription repressor activity,GO:0016922~ligand-dependent nuclear receptor binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030331~estrogen receptor binding,GO:0030528~transcription regulator activity,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0042054~histone methyltransferase activity,GO:0042799~histone methyltransferase activity (H4-K20 specific),GO:0042974~retinoic acid receptor binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0046975~histone methyltransferase activity (H3-K36 specific),GO:0050681~androgen receptor binding,GO:0051427~hormone receptor binding,","hsa00310:Lysine degradation,","Hypermethylated in neuroblastoma and glioma cell lines, and this hypermethylation predicts poor outcome, restoration inhibits cellular growth and decreases colony formation (20018718), Mutated in 2/50 AML samples (22976956), mutated in 7/92 head and neck squamous cancer, fusion with NUP98 found in 6/124 pediatric AML patients (23630019)",Unknown, 
HLA-A,"major histocompatibility complex, class I, A",1.1228511561305E-08,3.8840253232151E-06,0.973643384232798,46,9.32760576233988E-08,0.194276866008828,1,1,3,Putative TSG,"GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006955~immune response,GO:0019882~antigen processing and presentation,GO:0048002~antigen processing and presentation of peptide antigen,GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0010008~endosome membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031901~early endosome membrane,GO:0042611~MHC protein complex,GO:0042612~MHC class I protein complex,GO:0044431~Golgi apparatus part,GO:0044440~endosomal part,GO:0044459~plasma membrane part,GO:0032393~MHC class I receptor activity,","hsa04144:Endocytosis,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04650:Natural killer cell mediated cytotoxicity,hsa04940:Type I diabetes mellitus,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,","Frequently mutated in lung cancer (22960745), mutated in colon cancers (16101834)",Immune evasion (1423320), 
CRIPAK,cysteine-rich PAK1 inhibitor,1.44282034117946E-08,4.90008020961656E-06,0.924266797609053,87,1.19661119872034E-09,1,1,0.074843536965913,3,Novel,"GO:0006469~negative regulation of protein kinase activity,GO:0006984~ER-nuclear signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0019220~regulation of phosphate metabolic process,GO:0033043~regulation of organelle organization,GO:0033673~negative regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0043627~response to estrogen stimulus,GO:0044092~negative regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0048545~response to steroid hormone stimulus,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051493~regulation of cytoskeleton organization,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,",None,Knockdown increases invasiveness of MCF7 cells (16278681),PAK1 inhibitor (16278681), 
AOAH,acyloxyacyl hydrolase (neutrophil),1.49843298147458E-08,4.99807672517208E-06,0.954678003704656,60,5.748935930358E-08,1,1,1,3,Novel,"GO:0005976~polysaccharide metabolic process,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0008653~lipopolysaccharide metabolic process,GO:0009611~response to wounding,GO:0031348~negative regulation of defense response,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0044264~cellular polysaccharide metabolic process,GO:0048585~negative regulation of response to stimulus,GO:0050727~regulation of inflammatory response,GO:0050728~negative regulation of inflammatory response,GO:0004091~carboxylesterase activity,GO:0004465~lipoprotein lipase activity,GO:0016298~lipase activity,GO:0050528~acyloxyacyl hydrolase activity,",None,"Amplified in gastric cancer (17611641), mutated in 4/112 prostate cancers (22610119), mutated in 1/87 neuroblastoma samples (22367537)","Unknown, but has phospholipase, lysophospholipase, diacylglycerollipase, and acyltransferase activities in vitro (1577781)", 
TNRC6B,trinucleotide repeat containing 6B,2.33754629359205E-08,7.5281081410355E-06,0.871573560531107,145,5.49576063322347E-05,1,0.010677704780833,1,3,Putative TSG,"GO:0006417~regulation of translation,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016458~gene silencing,GO:0031047~gene silencing by RNA,GO:0032268~regulation of cellular protein metabolic process,GO:0000932~cytoplasmic mRNA processing body,GO:0030529~ribonucleoprotein complex,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None,"Downregulation promotes proliferation of hepatoma cell lines and loss of cell adhesion (23496901), Validated STOP gene (22628553), Genomic region contains SNPs associated with risk of prostate cancer (19117981)",Plays a role in RNA-mediated gene silencing by miRNAs and siRNAS (19838187), 
DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,2.97087005050847E-08,9.1391613956949E-06,0.643231194943416,457,1.62073906459841E-06,1,0.73524777513296,1,3,Known TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006325~chromatin organization,GO:0006342~chromatin silencing,GO:0006346~methylation-dependent chromatin silencing,GO:0006349~genetic imprinting,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006730~one-carbon metabolic process,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016458~gene silencing,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0019953~sexual reproduction,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032259~methylation,GO:0032504~multicellular organism reproduction,GO:0040029~regulation of gene expression, epigenetic,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0016363~nuclear matrix,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0008270~zinc ion binding,GO:0009008~DNA-methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00270:Cysteine and methionine metabolism,","Deletion promotes tumor growth and progression, with increased angiogenesis, invasiveness, and aggressiveness (22011581), Mutated in leukemias (23284304), Deficiency leads to changes in methylation patterns and gene deregulation (23284304), Cancer gene census (14993899)","Required to maintain normal DNA methylation patterns (23284304, 22011581)", 
NCOR1,nuclear receptor co-repressor 1,3.95615816876042E-08,1.15464185053556E-05,0.93340160451748,79,3.24706933006677E-06,0.117527903718632,0.745415986888831,0.000840312321322,3,Unclear,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000226~microtubule cytoskeleton organization,GO:0000279~M phase,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0009890~negative regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0032774~RNA biosynthetic process,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0048585~negative regulation of response to stimulus,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051225~spindle assembly,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070303~negative regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0015630~microtubule cytoskeleton,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,",None,"Elevated NCOR1 associated with better prognosis in breast cancer (16019133), LOF NCOR1 reduces growth of spontaneous thryoid tumors in mice (23840792), Loss of NCOR1 due to misfolding contributes to malignant growth in AML (22514634), validated STOP gene (22628553)","NCOR1 knockdown elevates expression of CDKN1A (23840792, 20466759)", 
TBX3,T-box 3,7.70055936055781E-08,2.11527571023323E-05,0.920461353517513,88,8.20262101515055E-06,1,0.426177263688485,0.000516756422903,3,Unclear/Putative OG,"GO:0000578~embryonic axis specification,GO:0001501~skeletal system development,GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001763~morphogenesis of a branching structure,GO:0001944~vasculature development,GO:0001947~heart looping,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0003002~regionalization,GO:0003006~reproductive developmental process,GO:0003007~heart morphogenesis,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006916~anti-apoptosis,GO:0007267~cell-cell signaling,GO:0007350~blastoderm segmentation,GO:0007351~tripartite regional subdivision,GO:0007389~pattern specification process,GO:0007498~mesoderm development,GO:0007507~heart development,GO:0007548~sex differentiation,GO:0007568~aging,GO:0007569~cell aging,GO:0008284~positive regulation of cell proliferation,GO:0008595~determination of anterior/posterior axis, embryo,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009798~axis specification,GO:0009880~embryonic pattern specification,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009914~hormone transport,GO:0009948~anterior/posterior axis specification,GO:0009952~anterior/posterior pattern formation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010817~regulation of hormone levels,GO:0010941~regulation of cell death,GO:0016202~regulation of striated muscle tissue development,GO:0016481~negative regulation of transcription,GO:0021761~limbic system development,GO:0030326~embryonic limb morphogenesis,GO:0030539~male genitalia development,GO:0030540~female genitalia development,GO:0030879~mammary gland development,GO:0030900~forebrain development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032274~gonadotropin secretion,GO:0032275~luteinizing hormone secretion,GO:0032940~secretion by cell,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035117~embryonic arm morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035140~arm morphogenesis,GO:0035239~tube morphogenesis,GO:0035282~segmentation,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045661~regulation of myoblast differentiation,GO:0045662~negative regulation of myoblast differentiation,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0046545~development of primary female sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046660~female sex differentiation,GO:0046661~male sex differentiation,GO:0046879~hormone secretion,GO:0046884~follicle-stimulating hormone secretion,GO:0046903~secretion,GO:0048332~mesoderm morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048634~regulation of muscle development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048729~tissue morphogenesis,GO:0048732~gland development,GO:0048736~appendage development,GO:0048742~regulation of skeletal muscle fiber development,GO:0048754~branching morphogenesis of a tube,GO:0048806~genitalia development,GO:0050886~endocrine process,GO:0051147~regulation of muscle cell differentiation,GO:0051148~negative regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051726~regulation of cell cycle,GO:0060173~limb development,GO:0060284~regulation of cell development,GO:0060548~negative regulation of cell death,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0016564~transcription repressor activity,GO:0016565~general transcriptional repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None,"Overexpressed in breast cancer, specifically ER positive and advanced stage disease (18245468, 23624936), in HNSCC (23082988), and in melanoma, breast, liver, lung, pancreas, ovarian, and cervical cancers (20624445), Overexpression in conditional transgenic setting causes mammary gland hyperplasia (22039763), methylation predicts progression of bladder cancer (22284968)","Represses p14Arf, promotes senescence bypass through inactivation of p53 pathway (18245468, 12000749), also inhibits NFkB pathway (22039763) and represses PTEN transcription (23082988)", 
ZFP36L2,"zinc finger protein 36, C3H type-like 2",8.7236100249624E-08,2.36156973414888E-05,0.80831772780715,216,1.08805673176636E-05,1,0.271476723733921,1,3,Putative TSG,"GO:0000288~nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0008283~cell proliferation,GO:0009057~macromolecule catabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0016071~mRNA metabolic process,GO:0043487~regulation of RNA stability,GO:0043488~regulation of mRNA stability,GO:0044265~cellular macromolecule catabolic process,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Induction of expression inhibits proliferation and apoptosis (17172869), Mice lacking ZFP36L2 develop T-ALL (20622884), Heterozygous frameshift mutations found in AML, and hemizygous frameshift mutation found in a Burkitt's lymphoma cell line (21109922), Translocation found in Fanconia amenia (21325596)","Induced by p53, leading to inhibition of cellular proliferation and apoptosis (17172869), Regulates ARE-containing mRNAs (21278925)", 
RBMX,"similar to RNA binding motif protein, X-linked; similar to hCG2011544; RNA binding motif protein, X-linked",4.56853324007507E-07,0.000111394742755,0.963873092242707,55,2.08036925836691E-06,1,1,1,3,Putative TSG,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0005681~spliceosome,GO:0030529~ribonucleoprotein complex,GO:0030530~heterogeneous nuclear ribonucleoprotein complex,GO:0000166~nucleotide binding,GO:0003723~RNA binding,","hsa03040:Spliceosome,","Downregulated in OSCC and ectopic expression reduces proliferation, colonogenicitiy, anchorage-independent growth, and tumorigenicity (16707624), Expression correlates with BAX in 122 breast cancers (16552754), upregulated in immortalized cells and cancer cell lines (19160420), 1 mutation found in 112 prostate tumors (22610119), 1 mutation in 8 AML samples (22237025)","Promotes HR by facilitating proper BRCA2 expression (22344029), upregulates cell cycles inhibitory gene TXNIP and downregulates pro-proliferative genes EGR1, JUND, JUNB, FOS, FOSL1, ROS, and KIT (16707624), induced by p53 to facilitate DSB repair (17387044)", 
AJUBA,Ajuba LIM Protein,4.59199913919766E-07,0.000111394742755,0.977188238183395,40,5.44021392901473E-06,1,1,0.306221348619516,3,Novel,"GO:0006928~cell motion,GO:0007044~cell-substrate junction assembly,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0009611~response to wounding,GO:0016477~cell migration,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030032~lamellipodium assembly,GO:0030334~regulation of cell migration,GO:0031589~cell-substrate adhesion,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0035313~wound healing, spreading of epidermal cells,GO:0040012~regulation of locomotion,GO:0042060~wound healing,GO:0043087~regulation of GTPase activity,GO:0048041~focal adhesion formation,GO:0048870~cell motility,GO:0051270~regulation of cell motion,GO:0051336~regulation of hydrolase activity,GO:0051674~localization of cell,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0015630~microtubule cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Transcriptionally repressed in SCLC cell lines, restoration leads to growth inhibition (23714854), Overexpressed in testicular germ cell tumors (19041365), Accumulation in nucleus of P19 embryonal cells results in growth inhibition (11029037)","Negatively regulates proliferation (11029037), stimulates MAPK pathway activity (10330178), important for E-cadherin mediated adhesion (22105346), negatively regulates the Hippo pathway (20303269)", 
CDK12,"Cdc2-related kinase, arginine/serine-rich",4.83869581996704E-07,0.000114407593951,0.626764919025056,488,0.000183126614909,1,0.177749549869629,1,3,Putative TSG,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0046777~protein amino acid autophosphorylation,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None,"Frequent somatic mutations found in diverse cancer sample types (22544022), Cancer gene census (14993899), Involved in translocation fusion events in gastric cancer (21097718)","Maintenance of genomic stability through upregulation of critical DNA damage response factors (22988298, 22012619), Negative regulator of MAPK pathway (19651820)", 
ELF3,"E74-like factor 3 (ets domain transcription factor, epithelial-specific )",4.9820535041913E-07,0.000116324721756,0.852910077571696,166,1.92189427258125E-05,1,0.910322520092466,1,3,Unclear/context-dependent,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007398~ectoderm development,GO:0008544~epidermis development,GO:0009611~response to wounding,GO:0022612~gland morphogenesis,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0030879~mammary gland development,GO:0032774~RNA biosynthetic process,GO:0043062~extracellular structure organization,GO:0045449~regulation of transcription,GO:0048732~gland development,GO:0048771~tissue remodeling,GO:0051252~regulation of RNA metabolic process,GO:0060056~mammary gland involution,GO:0060429~epithelium development,GO:0060443~mammary gland morphogenesis,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None,"Overexpression increases proliferation and permits anchorage-independent growth of MCF-12A cells, and promotes motility, invasion, adhesion, and EMT (14767472, 15169914), Induced by IL-1beta in prostate cancers, and upregulation in prostate cancer associated with adverse prognosis (23687337), Overexpressed during early breast tumorigenesis (9129154), Upregulated in endometrial cancers (20973258), Pathologically expressed in breast tissue and breast cancer cell lines (14997048), Increased expression in lung adenocarcinoma (9395241), Expressed in squamous anal cancer (10891534), Negatively regulates invasion of oral SCC by transcriptional repression of MMP-9 (18302674), Amplified in breast cancer (23329352), Expression correlated with advanced stage of colorectal cancer (22993316)","Antagonizes androgen receptor signaling in prostate cancer (23435425), Upregulates TGFbeta receptor II in the breast cancer cell line Hs578t (10644990), Upregulates ErbB2 in breast cancer (11175365), Promotes differentiation of squamous epithelial cells (10773884), SAR domain and cytoplasmic expression is required for transformation of MCF-12A cells (15169914)", 
KEAP1,kelch-like ECH-associated protein 1,5.93105413245093E-07,0.000135105073342,0.682518472612095,392,0.011114935270523,1,8.68323539537761E-08,0.062899794517744,3,Putative TSG,"GO:0001701~in utero embryonic development,GO:0006350~transcription,GO:0009792~embryonic development ending in birth or egg hatching,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0045604~regulation of epidermal cell differentiation,GO:0045682~regulation of epidermis development,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0015630~microtubule cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044459~plasma membrane part,GO:0070013~intracellular organelle lumen,GO:0070161~anchoring junction,GO:0030528~transcription regulator activity,","hsa04120:Ubiquitin mediated proteolysis,","Highly mutated (60%) in lung papillary adenocarcinomas (21248763), mutation and allelic loss found in a wide variety of solid tumors (22348534), hypermethylation of promoter is common in colorectal cancer (22325485), biallelic inactivation found in NSCLC (17020408)","Part of complex that degrades IKKbeta, Bcl-2, and Nrf2 (22743616)", 
HLA-B,"Major Histocompatibility Complex, Class I, B",7.59800623382659E-07,0.000168956141002,0.969580353536859,51,4.16314941918471E-05,0.001778610187611,1,1,3,Putative TSG,"GO:0005102~receptor binding, GO:0032393~MHC class I receptor activity, GO:0002474~antigen processing and presentation of peptide antigen via MHC class I, GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent, GO:0002667~regulation of T cell anergy, GO:0006952~defense response, GO:0000139~Golgi membrane, GO:0005886~plasma membrane, GO:0005887~integral to plasma membrane, GO:0012507~ER to Golgi transport vesicle membrane, GO:0016020~membrane, GO:0016021~integral to membrane, GO:0030670~phagocytic vesicle membrane, GO:0031901~early endosome membrane, GO:0042612~MHC class I protein complex, GO:0071556~integral to lumenal side of endoplasmic reticulum membrane,","hsa04144: Endocytosis,hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04650:Natural killer cell mediated cytotoxicity,hsa04930:Type I diabetes mellitus,hsa05320:Autoimmune thyroid disease,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis","Promoter hypermethylation observed in esophageal cancers (11577000), downregulated by c-Myc (8206526, 9839551) and p-53 (9839551)",Immune evasion (1423320), 
RBM10,RNA binding motif protein 10,9.21830730907289E-07,0.000200219490961,0.97037501293537,50,3.49570469642635E-05,1,0.927073995450158,1,3,Putative TSG,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0016585~chromatin remodeling complex,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Truncating mutations found in lung cancer (22980975), mutated in pancreatic cancer (22355676), structurally related to TSG RBM5 (20186023)",Expression correlates with BAX and VEGF in breast cancer (16552754), 
ZC3H18,zinc finger CCCH-type containing 18,1.9702550280192E-06,0.000418209018959,0.976463304875281,43,0.000555784701544,0.468960239540674,0.382789390978339,1.39700912386945E-35,3,Novel,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"2 mutations in lymphoma (21796119), 1 mutation in ICGC SCLC (22941189), Mutation present early in an SCN patient who progressed to AML (22371884)",Critical for IKK activation (22308454), 
DDX3X,"DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked",2.62625097883215E-06,0.000545063800373,0.784335969174339,249,0.145761173724383,0.202641274030266,1.90948479511576E-11,1,3,Putative TSG/Unclear,"GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008186~RNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,","hsa04622:RIG-I-like receptor signaling pathway,","Associated with advanced stage of gallbladder cancer (23330003), frequently somatically mutated in medulloblastoma (22820256, 22832583), mRNA levels decreased by endometrial cancer-associated miRNAs (22492871), Downregulated in colon cancer cell line (22150006), Frequently somatically mutated in CLL (22150006), Overexpression in MCF10A cells increases soft agar colony formation, motility, and invasion (18264132)","Increases p53 accumulation and promotes apoptosis (23470959), Upregulates p21 (16818630)", 
MYO6,myosin VI,2.85257222578485E-06,0.000585529633027,0.939673042863593,72,0.003403081876561,1,0.031386027151152,0.136488683400242,3,Unclear/Putative OG,"GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006605~protein targeting,GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007416~synaptogenesis,GO:0007423~sensory organ development,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008104~protein localization,GO:0009891~positive regulation of biosynthetic process,GO:0010324~membrane invagination,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0014047~glutamate secretion,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016358~dendrite development,GO:0019226~transmission of nerve impulse,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030048~actin filament-based movement,GO:0030182~neuron differentiation,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0031175~neuron projection development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031644~regulation of neurological system process,GO:0032940~secretion by cell,GO:0033554~cellular response to stress,GO:0034613~cellular protein localization,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0042490~mechanoreceptor differentiation,GO:0042491~auditory receptor cell differentiation,GO:0042770~DNA damage response, signal transduction,GO:0043062~extracellular structure organization,GO:0043583~ear development,GO:0044057~regulation of system process,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048167~regulation of synaptic plasticity,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048666~neuron development,GO:0048839~inner ear development,GO:0050804~regulation of synaptic transmission,GO:0050808~synapse organization,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,GO:0051046~regulation of secretion,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051969~regulation of transmission of nerve impulse,GO:0060113~inner ear receptor cell differentiation,GO:0070727~cellular macromolecule localization,GO:0001726~ruffle,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005905~coated pit,GO:0005938~cell cortex,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0015629~actin cytoskeleton,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016459~myosin complex,GO:0016461~unconventional myosin complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0019898~extrinsic to membrane,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030139~endocytic vesicle,GO:0030424~axon,GO:0030659~cytoplasmic vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0031090~organelle membrane,GO:0031252~cell leading edge,GO:0031253~cell projection membrane,GO:0031256~leading edge membrane,GO:0031410~cytoplasmic vesicle,GO:0031941~filamentous actin,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031981~nuclear lumen,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0032587~ruffle membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044433~cytoplasmic vesicle part,GO:0044451~nucleoplasm part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045334~clathrin-coated endocytic vesicle,GO:0048471~perinuclear region of cytoplasm,GO:0070013~intracellular organelle lumen,GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043531~ADP binding,GO:0051015~actin filament binding,GO:0060001~minus-end directed microfilament motor activity,",None,"Amplified in HNSCC (18314910), upregulated in prostate cancer, highest in middle-grade prostate cancer (18543251, 18543251, 17071605), 1 mutation found in 99 PDAC samples (23103869), mutations found in 11/276 colorectal cancer samples (22810696), knockdown attenuates activation of p53 (20576604), knockdown decreases migration and soft agar colony formation in prostate cancer cell line (17071605)","Induced by p53 and DNA damage (20576604), knockdown attenuates activation of p53 (20576604), knockdown decreases migration of prostate cancer cells (17071605), knockdown decreases secretion of VEGF and PSA (19855435)", 
ZNF318,zinc finger protein 318,3.53563676408416E-06,0.000717849555612,0.875348360853648,140,9.98346621468353E-05,1,1,1,3,Novel,"GO:0000279~M phase,GO:0006350~transcription,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0045449~regulation of transcription,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,None ,Two spliced isoforms of ZNF318 act as a coactivator and corepressor of AR (16446156), 
MBD6,methyl-CpG binding domain protein 6,3.86798128122595E-06,0.000776881960774,0.926017681395504,84,1.14613852428987E-05,1,1,1,3,Novel,"GO:0003677~DNA binding,",None,Knockdown attenuates cell proliferation and induces cell death in human adipose tissue-derived stem cells (23052207),"Regulated by Ago2, functions downstream of Oct4 to regulate proliferation, self-renewal and survival of human adipose stem cells (23052207), Binds to heterochromatin but not methylated DNA (20700456)", 
KMT2B,myeloid/lymphoid or mixed-lineage leukemia 4,4.68036678218261E-06,0.000910672615879,0.78679814309271,243,0.000412717317133,0.694596125122932,0.806088806440884,1,3,Putative TSG,"GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0031328~positive regulation of cellular biosynthetic process,GO:0040029~regulation of gene expression, epigenetic,GO:0045449~regulation of transcription,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048096~chromatin-mediated maintenance of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Downregulated in 8 breast cancer samples (23754336), Knockdown reduces cell viability and induces apoptosis, Depletion suppresses growth of xenograft colon cancer tumors (22713656), Mutations found in parathyroid carcinoma (23616356), Frameshift mutations found in MSI tumors (23259788), Frequently mutated in B-cell lymphomas (23015417)","Regulates expression of cell-cycle regulatory genes including cyclin D, cyclin E, p27, HOXA5 and HOXB7 via histone H3K4 trimethylation (22713656)", 
CCAR1,cell division cycle and apoptosis regulator 1,6.38766424658905E-06,0.001230053406825,0.958335257245734,58,0.002243491490089,0.985776716444512,0.271476723733921,1,3,Unclear,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006350~transcription,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006915~apoptosis,GO:0007049~cell cycle,GO:0008219~cell death,GO:0008380~RNA splicing,GO:0012501~programmed cell death,GO:0016071~mRNA metabolic process,GO:0016265~death,GO:0045449~regulation of transcription,GO:0005794~Golgi apparatus,GO:0048471~perinuclear region of cytoplasm,",None,"CCAR1 depletion inhibits growth, invasion, migration, and tumorigenicity of prostate cancer cells (23887938), Tat-tagged CCAR1 inhibits growth of breast cancer xenografts (17513614), CCAR1 expression decrased in worse prognosis breast cancers due partly to promoter methylation (17513614)","Promotes chromatin loading of AR transcriptional complex (23887938), Coactivator of APC (21903591), p53 coactivator (18722177)", 
NAA25,chromosome 12 open reading frame 30,7.18508018827638E-06,0.001369490947314,0.907436318177536,100,0.000395439062106,1,0.886481428527679,0.004946237205841,3,Novel,None,None,"Knockdown disrupts normal cell-cycle progression, and inhibits growth of HeLa cells and a thyroid cancer cell line (18570629)","Component of the NatB complex, which is essential for normal proliferation (18570629)", 
PHF6,PHD finger protein 6,1.15004176015236E-05,0.002148163003789,0.687107478396144,382,0.005283523447347,0.218890589494935,0.227591325759547,1,3,Known TSG,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Knockdown impairs cell proliferation and causes growth arrest (23229552), Mutated in 38% of adult T-ALL and 3% adult AML (23229552), Known frequently mutated T-ALL driver (22675565), Cancer gene census (14993899), Mutated in a CML patient in blast crisis (22928734)","Regulates ribosomal RNA synthesis, and deficiency leads to accumulation of DNA damage at the ribosomal DNA locus (23229552)", 
TCF12,transcription factor 12,1.17850743163126E-05,0.0021788013127,0.929031240738192,80,0.001716199506841,1,0.58177193050653,5.71835589171327E-13,3,Unclear,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0007517~muscle organ development,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None,"Overexpression correlates with metastasis of colorectal cancer (22130667), Fusion constructs with disrupted TCF12 found in CLL (22137486), Expression upregulated in colorectal cancer and associated with progression free survival (21999571)","Transcriptional repressor of E-cadherin (22130667, 23386606)", 
KMT2A,myeloid/lymphoid or mixed-lineage leukemia 1,1.18977318858282E-05,0.0021788013127,0.63871000481074,465,0.000749052675701,1,0.86861908420637,1.38537483767605E-66,3,Unclear,"GO:0002520~immune system development,GO:0003002~regionalization,GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006730~one-carbon metabolic process,GO:0006915~apoptosis,GO:0007049~cell cycle,GO:0007389~pattern specification process,GO:0008219~cell death,GO:0008285~negative regulation of cell proliferation,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0012501~programmed cell death,GO:0016265~death,GO:0016568~chromatin modification,GO:0030097~hemopoiesis,GO:0031056~regulation of histone modification,GO:0031060~regulation of histone methylation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0032259~methylation,GO:0032268~regulation of cellular protein metabolic process,GO:0032774~RNA biosynthetic process,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0035162~embryonic hemopoiesis,GO:0040029~regulation of gene expression, epigenetic,GO:0042127~regulation of cell proliferation,GO:0043414~biopolymer methylation,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048534~hemopoietic or lymphoid organ development,GO:0048568~embryonic organ development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051569~regulation of histone H3-K4 methylation,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0005525~GTP binding,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0017076~purine nucleotide binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0019001~guanyl nucleotide binding,GO:0030528~transcription regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0042054~histone methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,",None,"Rearrangements are common in childhood acute leukemias, fusing KMT2A to any of >50 partner genes or itself, and the fusions result in KMT2A gain-of-function (14970849), Recurrently mutated in SCLC (22941188)","Critical in hematopoietic differentiation (15663355), Stabilizes telomeric chromatin in cooperation with p53 (22941188)", 
TMCO2,transmembrane and coiled-coil domains 2,1.93170099443339E-05,0.003403985176889,0.909498198759828,96,0.001789860552945,1,0.745415986888831,1,3,Novel,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None,None,Unknown, 
GIGYF2,GRB10 interacting GYF protein 2,2.49329422499537E-05,0.004304062697487,0.769878956812087,278,0.001255644359758,1,0.979134174282624,3.85060261944435E-91,3,Novel/Unclear,None,None,Knockdown results in significant reduction of Akt phosphorylation at Serine 473 in breast cancer cell lines (19724902),Involved in regulation of Akt activation (19724902), 
TP53BP1,tumor protein p53 binding protein 1,2.53407520443771E-05,0.004304062697487,0.828868692349134,193,0.011937913796588,1,0.10931505751462,4.85765741051531E-47,3,Known TSG,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006974~response to DNA damage stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0033554~cellular response to stress,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042162~telomeric DNA binding,GO:0043565~sequence-specific DNA binding,",None,Reviewed (21868291),Reviewed (21868291), 
CCDC88A,coiled-coil domain containing 88A,2.53464798288731E-05,0.004304062697487,0.847253570229305,174,0.048180391464084,1,0.001323765619315,8.00827640022711E-11,3,Unclear,"GO:0001932~regulation of protein amino acid phosphorylation,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006275~regulation of DNA replication,GO:0006928~cell motion,GO:0016044~membrane organization,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030032~lamellipodium assembly,GO:0031399~regulation of protein modification process,GO:0032147~activation of protein kinase activity,GO:0032148~activation of protein kinase B activity,GO:0032268~regulation of cellular protein metabolic process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0033674~positive regulation of kinase activity,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048870~cell motility,GO:0051052~regulation of DNA metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051493~regulation of cytoskeleton organization,GO:0051674~localization of cell,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042995~cell projection,GO:0003779~actin binding,GO:0005543~phospholipid binding,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0008289~lipid binding,GO:0015631~tubulin binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0035091~phosphoinositide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043422~protein kinase B binding,GO:0046983~protein dimerization activity,",None,"Expression correlated with TNM stage but not overall survival in cancer patients (23222280), Expression correlated with stage and found most frequently in TNBC subtype breast cancer (22780975), Depletion prolongs EGFR signaling, delays EGFR downregulation after stimulation, and enhances cell proliferation (23051738)","Enhances PI3K-Akt signaling downstream of both GPCRs and RTKs (23509302), Crucial for cellular motility in cancer cell lines and for metastasis in a mouse model (23222280)", 
USP9X,"ubiquitin specific peptidase 9, X-linked",3.48295645325657E-05,0.00580876282057,0.858806359967128,156,0.001136543868282,0.17048923469897,1,1,3,Unclear,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007276~gamete generation,GO:0007292~female gamete generation,GO:0009057~macromolecule catabolic process,GO:0016579~protein deubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0030509~BMP signaling pathway,GO:0032504~multicellular organism reproduction,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048285~organelle fission,GO:0048609~reproductive process in a multicellular organism,GO:0051301~cell division,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070646~protein modification by small protein removal,GO:0070647~protein modification by small protein conjugation or removal,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004221~ubiquitin thiolesterase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0046332~SMAD binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0070410~co-SMAD binding,",None,"Knockdown impairs growth of medulloblastoma cells (23667531), Knockdown impairs migration of breast cancer cells (23184937), Chemical inhibition of USP9X sensitizes cells to chemotherapy (23171055), Promotes clonogenic survival in response to 5-FU, and decreases apoptotic pathway activation (22895071), Low expression level in PDAC correlates with poor survival (22699621), Loss of expression enhances transformation of pancreatic cells (22699621), Chemical inhibition in CML cells promotes apoptosis (21248063), Overexpression in MM correlates with poor prognosis (20023629), Knockdown enhances apoptosis of lymphoma cell lines (20023629)","Stabilizes MCL1 and thereby promotes survival (20023629), Stabilizes SMURF1, which is required for cellular motility (23184937)", 
GSE1,Gse1 Coiled-Coil Protein,4.12273417945992E-05,0.006814916083021,0.908939548344898,97,0.00257467498582,1,0.707289184858051,1.93506203935026E-27,3,Novel,"GO:0005515~protein binding, ",None,None,Unknown, 
CBFB,"core-binding factor, beta subunit",4.68024947386435E-05,0.007601946080201,0.867773914773251,150,0.013790277559456,1,0.239978199885825,1.46460239281359E-07,3,Putative TSG,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001775~cell activation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0021700~developmental maturation,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030099~myeloid cell differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046649~lymphocyte activation,GO:0048469~cell maturation,GO:0048534~hemopoietic or lymphoid organ development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060216~definitive hemopoiesis,GO:0060348~bone development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None,"Fusions to MYH11 frequently found in AML with bone marrow eosinophilia (8142642, 7919348), Dual loss of CBFB and RUNX1 inhibits leukemia development induced by MLL-AF9 in a mouse genetic model (23979164), Frequently mutated in breast cancer (23000897), High expression levels correlates with better overall survival in colorectal cancer (19156145)","Reviewed (15156186, 8585960)", 
IWS1,IWS1 homolog (S. cerevisiae),4.98074956157394E-05,0.007951745389798,0.93681720135281,74,0.028447680448183,1,0.070801567544737,1,3,Novel,None,None,Knockdown reduces cellular viability (17184735),"Interacts with PRMT5, which methylates transcriptional elongation factor Spt5 and regulates its interaction with RNA Pol II (17184735), Yeast homolog is required for heterochromatic gene silencing (21844224)", 
TCF7L2,"transcription factor 7-like 2 (T-cell specific, HMG-box)",6.45958846188826E-05,0.009837519816883,0.934542220167738,77,0.002836151765406,1,0.970645685897825,5.00998818278436E-23,3,Unclear,"GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0002791~regulation of peptide secretion,GO:0002793~positive regulation of peptide secretion,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006916~anti-apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007166~cell surface receptor linked signal transduction,GO:0007439~ectodermal gut development,GO:0007442~hindgut morphogenesis,GO:0007548~sex differentiation,GO:0008283~cell proliferation,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010908~regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010941~regulation of cell death,GO:0016055~Wnt receptor signaling pathway,GO:0019827~stem cell maintenance,GO:0021915~neural tube development,GO:0022402~cell cycle process,GO:0030538~embryonic genitalia morphogenesis,GO:0031016~pancreas development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032024~positive regulation of insulin secretion,GO:0032350~regulation of hormone metabolic process,GO:0032583~regulation of gene-specific transcription,GO:0033500~carbohydrate homeostasis,GO:0035019~somatic stem cell maintenance,GO:0035112~genitalia morphogenesis,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0042692~muscle cell differentiation,GO:0042762~regulation of sulfur metabolic process,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043193~positive regulation of gene-specific transcription,GO:0045165~cell fate commitment,GO:0045444~fat cell differentiation,GO:0045445~myoblast differentiation,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046883~regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,GO:0048546~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048557~embryonic digestive tract morphogenesis,GO:0048562~embryonic organ morphogenesis,GO:0048565~gut development,GO:0048567~ectodermal gut morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048619~embryonic hindgut morphogenesis,GO:0048625~myoblast cell fate commitment,GO:0048806~genitalia development,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0048878~chemical homeostasis,GO:0050796~regulation of insulin secretion,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051176~positive regulation of sulfur metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0055123~digestive system development,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0060341~regulation of cellular localization,GO:0060548~negative regulation of cell death,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044445~cytosolic part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070369~beta-catenin-TCF7L2 complex,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030528~transcription regulator activity,","hsa04310:Wnt signaling pathway,hsa04520:Adherens junction,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),","Well-described (12633551, 21383188)","Well-described (12633551, 21383188)", 
CHD2,chromodomain helicase DNA binding protein 2,6.4791357323557E-05,0.009837519816883,0.850802658301534,170,0.020070154139954,0.212926211249287,0.315741488517384,1,3,Putative TSG,"GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,",None,"Heterozygous mice exhibit increased susceptibility to lymphomas (19137022), Expression downregulated in more advanced or relapsed colon cancer (17390049), Deleted in HDLM2 Hodgkin's lymphoma cell line ( 17606441)",Involved in DNA damage response and maintenance of genome stability (19137022), 
SOX9,SRY (sex determining region Y)-box 9,6.53060901168963E-05,0.009837519816883,0.798961185952272,227,0.004738432236175,1,0.621617423105817,1,3,Unclear/Tissue-specific,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0001708~cell fate specification,GO:0001837~epithelial to mesenchymal transition,GO:0001942~hair follicle development,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007398~ectoderm development,GO:0007507~heart development,GO:0007530~sex determination,GO:0007542~primary sex determination, germ-line,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008544~epidermis development,GO:0008584~male gonad development,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0014031~mesenchymal cell development,GO:0014032~neural crest cell development,GO:0014033~neural crest cell differentiation,GO:0016337~cell-cell adhesion,GO:0016481~negative regulation of transcription,GO:0018992~germ-line sex determination,GO:0019100~male germ-line sex determination,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0022610~biological adhesion,GO:0030238~male sex determination,GO:0030278~regulation of ossification,GO:0030279~negative regulation of ossification,GO:0030500~regulation of bone mineralization,GO:0030502~negative regulation of bone mineralization,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032330~regulation of chondrocyte differentiation,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032989~cellular component morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042303~molting cycle,GO:0042633~hair cycle,GO:0042981~regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0045137~development of primary sexual characteristics,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048608~reproductive structure development,GO:0048705~skeletal system morphogenesis,GO:0048762~mesenchymal cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051241~negative regulation of multicellular organismal process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060348~bone development,GO:0060349~bone morphogenesis,GO:0060350~endochondral bone morphogenesis,GO:0060485~mesenchyme development,GO:0070167~regulation of biomineral formation,GO:0070168~negative regulation of biomineral formation,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003704~specific RNA polymerase II transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None,"Overexpressed in a wide range of human cancers, and its expression is correlated with stage and aggressiveness (22246670), Amplified in colorectal cancer (22246670), Promotes proliferation, inhibits senescence, and increases tumorigenicity, while its inactivation reduces tumorigenicity (22246670), Overexpression decreases proliferation of prostate tumor cell lines, decreases cell cycle arrest, and increases sensitivity to apoptosis (15077158), Decreased expression in bile duct cancer (23933788)","Directly binds and activates the promoter of Bmi1, which represses Arf (22246670), Regulated either directly or indirectly by WT1 (16877546)", 
WDR33,WD repeat domain 33,6.93443257695003E-05,0.010362261288388,0.883363391799239,130,0.003150424062994,1,0.995601060411906,1,3,Novel,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006974~response to DNA damage stimulus,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0033554~cellular response to stress,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,",None,None,Unknown, 
CCDC144NL,"coiled-coil domain containing 144 family, N-terminal like",9.6635957279092E-05,0.013674720045577,0.928621438924,81,0.005283523447347,1,0.745415986888831,1,3,Novel,None,None,None,Unknown, 
LUC7L3,cisplatin resistance-associated overexpressed protein,0.000100029827182,0.01404854993936,0.876415039179284,139,0.025842768992215,1,0.111721095746119,1,3,Novel,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006915~apoptosis,GO:0008219~cell death,GO:0008380~RNA splicing,GO:0012501~programmed cell death,GO:0016071~mRNA metabolic process,GO:0016265~death,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,",None,"Expression elevated 2-3x in cisplatin-resistant cell lines (10631324), Cisplatin affects the subnuclear distribution of the protein (12565863), Blood levels of the protein elevated in NPC and HNSCC patients, can be used as part of a blood-based detection signature (22986368)","Involved in RNA splicing (12565863), May cooperate with RBM25 to affect splicing of Bcl-xS (18663000)", 
RPL5,ribosomal protein L5 pseudogene 34; ribosomal protein L5 pseudogene 1; ribosomal protein L5,0.000103513130169,0.014429266853982,0.94335319603308,68,0.009954604898577,0.368547672816551,0.84978015877207,4.42591564459382E-18,3,Putative TSG,"GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0006412~translation,GO:0006414~translational elongation,GO:0016072~rRNA metabolic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0033279~ribosomal subunit,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044445~cytosolic part,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,GO:0008097~5S rRNA binding,GO:0019843~rRNA binding,","hsa03010:Ribosome,","Mutations found in 12/122 pediatric T-ALLs (23263491), Commonly mutated in Diamond-Blackfan anemia which predisposes to leukemia (20116044)","Yeast and lymphoid cells expressing the a mutant form of the related ribosomal protein RPL10 show a ribosome biogenesis defect (23263491), Required for activation of p53 in response to inhibition of ribosomal biogenesis (21406728, 22284678)", 
AMBRA1,autophagy/beclin-1 regulator 1,0.000108232802536,0.014975411248719,0.786739290637521,244,0.022188031223104,1,0.355506890692437,1,3,Novel,"GO:0006914~autophagy,GO:0005773~vacuole,GO:0005776~autophagic vacuole,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,",None,"Functional deciency of Ambra1 in mouse embryos leads to uncontrolled cell proliferation, excessive apoptosis, and autophagy impairment (17589504)",Promotes autophagy through competition with Bcl-2 for Beclin 1 binding (23069654), 
ZMYM4,"zinc finger, MYM-type 4",0.000111686230007,0.015227642994874,0.890145164144094,125,0.006962965589332,0.64404871523565,0.971784231743341,0.001239009513558,3,Novel,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Fusion gene ZMYM4-OPRD1 found in the breast cancer cell line ZR-75-30 (23260012), candidate for involvement in translocations such as t(1;11)(p32;q23) in ALL (10449923)",Unknown, 
CTDNEP1,CTD Nuclear Envelope Phosphatase 1,0.000143896429388,0.018409872633826,0.92483216989478,86,0.002477840646123,0.638569690742653,1,0.00243277944745,3,Putative TSG,"GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006997~nucleus organization,GO:0006998~nuclear envelope organization,GO:0010256~endomembrane organization,GO:0016044~membrane organization,GO:0016311~dephosphorylation,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,",None,Recurrent truncating mutations identified in 3% medulloblastoma (22832583),"Encodes a nuclear envelope phosphatase; involved in lipin activation pathway, and may regulate nuclear membrane biogenesis and DA production (22832583)", 
AMOT,angiomotin,0.000174077837919,0.021392104832144,0.906597623673079,101,0.003032938724433,1,1,0.000885539471751,3,Unclear/Tissue-specific,"GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001667~ameboidal cell migration,GO:0001701~in utero embryonic development,GO:0001702~gastrulation with mouth forming second,GO:0001944~vasculature development,GO:0003013~circulatory system process,GO:0003018~vascular process in circulatory system,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0007010~cytoskeleton organization,GO:0007043~cell-cell junction assembly,GO:0007369~gastrulation,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008015~blood circulation,GO:0008361~regulation of cell size,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010594~regulation of endothelial cell migration,GO:0010595~positive regulation of endothelial cell migration,GO:0010638~positive regulation of organelle organization,GO:0016477~cell migration,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0032231~regulation of actin filament bundle formation,GO:0032233~positive regulation of actin filament bundle formation,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0040019~positive regulation of embryonic development,GO:0042074~cell migration involved in gastrulation,GO:0042330~taxis,GO:0043009~chordate embryonic development,GO:0043114~regulation of vascular permeability,GO:0043116~negative regulation of vascular permeability,GO:0043535~regulation of blood vessel endothelial cell migration,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0044087~regulation of cellular component biogenesis,GO:0045216~cell-cell junction organization,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0045793~positive regulation of cell size,GO:0045995~regulation of embryonic development,GO:0048514~blood vessel morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048870~cell motility,GO:0051094~positive regulation of developmental process,GO:0051130~positive regulation of cellular component organization,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051492~regulation of stress fiber formation,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051496~positive regulation of stress fiber formation,GO:0051674~localization of cell,GO:0001725~stress fiber,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0009986~cell surface,GO:0015629~actin cytoskeleton,GO:0016021~integral to membrane,GO:0016327~apicolateral plasma membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031252~cell leading edge,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0032432~actin filament bundle,GO:0042641~actomyosin,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043296~apical junction complex,GO:0044430~cytoskeletal part,GO:0044459~plasma membrane part,GO:0070160~occluding junction,GO:0043532~angiostatin binding,",None,"Liver-specific knockout leads to tumorigenesis in response to toxic injury (24003254), Increases proliferation of biliary epithelial cells and liver tumorigenesis in response to toxic injury (24003254), Depletion in Schwann cells lacking Merlin decreases proliferation and tumorigenicity (21481793), Promotes anchorage-independent growth of mammary epithelial cells, and is required for proliferation of mammary epithelial cells in some contexts (21285250)","Antagonizes YAP signaling by preventing phosphorylation of Yap, preventing its nuclear translocation (24003254, 21224387), May act as transcripational cofactor for YAP (24003254), Antagnoizes Ras-MAPK pathway (21481793)", 
RUFY2,RUN and FYVE domain containing 2,0.000197881118159,0.023846589716668,0.851408765982328,168,0.040281356329577,1,0.271476723733921,1,3,Putative TSG,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Frequently mutated, in 50% MSI-H cell lines, often by frameshift mutations (20824714)",Unknown, 
MED23,mediator complex subunit 23,0.000213310193832,0.025378478411355,0.874495548531224,142,0.003571230977982,0.846204308491937,1,8.71945153823605E-10,3,Putative TSG,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None,"Expression downregulated in ESCC samples (23625751), Overexpression inhibits cell growth, while knockdown promotes in vitro and in vivo tumorigenicity of ESCC cells (23625751), Key feature of Ras-addicted lung cancer: RNAi specifically inhibits proliferation and tumorigenecity of Ras-active lung cancer cells (22988093), Upregulated by Ras transformation (22988093), Mutated in sporadic gastric cancer (23208944)","Component of Mediator complex (23625751), Knockdown inhibits cell apoptosis by downregulation of Bax, Cas9, Casp9 and upregulation of cyclin D1 and Bcl2 (23625751)", 
LIMCH1,LIM and calponin homology domains 1,0.000305109778797,0.035179910852825,0.941986924606088,70,0.09986559706465,1,0.08825557681226,1,3,Unclear,"GO:0007010~cytoskeleton organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0031032~actomyosin structure organization,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Upregulated in PIK3CA mutated cancers (21209903), rare mutation in colon cancer (22810696)",Facilitates cell migration (18553215), 
CTNND1,"catenin (cadherin-associated protein), delta 1",0.000319296974829,0.036589866213677,0.801251487350058,225,0.011161612971399,1,1,1,3,Context-dependent,"GO:0006350~transcription,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0045449~regulation of transcription,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0042153~RPTP-like protein binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,","hsa04520:Adherens junction,hsa04670:Leukocyte transendothelial migration,","Reviewed (23216611, 23950111, 21481789)","Reviewed (23216611, 23950111, 21481789)", 
MBD1,methyl-CpG binding domain protein 1,0.000338354906216,0.038073080079566,0.833888651942317,190,0.162811867918105,0.059380025258737,0.053281993127228,3.715062157293E-18,3,Unclear,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0008327~methyl-CpG binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Undergoes frequent loss of heterozygosity in several cancers (12776203), Contributes to chemotherapeutic resistance of pancreatic cancer cell lines (23588667), Overexpression contributes to invasiveness and EMT of pancreatic cells (23331011)",Binds to methylated CpG islands and represses transcription (22945648), 
EPB41L4A,erythrocyte membrane protein band 4.1 like 4A,0.000440636276509,0.045981257032992,0.244638080361689,916,0.160176446289636,1,0.038129880226435,1.51654498395578E-64,3,Novel,"GO:0005856~cytoskeleton,GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0008092~cytoskeletal protein binding,",None,"Loss of heterozygosity found at D18Mit34 in some mouse intestinal adenomas (21219111), Expressed in mouse teratocarcinoma F9 cells and mouse brain tissue (7983158)",Component of beta-catenin/Tcf pathway (10874211), 
RBBP6,retinoblastoma binding protein 6,0.000466431096541,0.047626569752597,0.808261339598896,217,0.033475836114919,1,0.848879761867496,1,3,Context-dependent,"GO:0016567~protein ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0070647~protein modification by small protein conjugation or removal,GO:0000151~ubiquitin ligase complex,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Overexpressed in lung adenocarcinomas and lung squamous cell carcinomas (21676486), Overexpression predicts poor prognosis of colon cancer (23799110), Isoform 3 is downregulated in some human cancers (22139301), Overexpression of isoform 3 results in increased G2/M cell cycle arrest (22139301)","E3 ligase that promotes degradation of p53, thereby increasing cell proliferation (21676486), Isoform 3 regulates cell cycle progression, and its overexpression leads to G2/M arrest (22139301)", 
PNISR,PNN-Interacting Serine/Arginine-Rich Protein,0.000496478746109,0.049858744615932,0.910887477182397,95,0.022318292355759,1,1,2.67627092353334E-14,3,Novel,"GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None,Contained with in an 4.8Mb deletion region  observed in leukemia (15205317),Unknown, 
WAC,WW domain containing adaptor with coiled-coil,0.000504960225878,0.050439315824498,0.867223052140467,152,0.034066824179813,0.631768750281355,0.910322520092466,1,3,Putative TSG,"GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None,Recurrently mutated in AML (22237025),Required for autophagosome formation (22354037), 
CUL3,cullin 3,0.000518198322773,0.050944349847813,0.85645418859283,159,0.312150786515571,0.117527903718632,0.005629812000978,8.63850617568084E-65,3,Context-dependent,"GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0001831~trophectodermal cellular morphogenesis,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007369~gastrulation,GO:0008054~cyclin catabolic process,GO:0008284~positive regulation of cell proliferation,GO:0008629~induction of apoptosis by intracellular signals,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010498~proteasomal protein catabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0032989~cellular component morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048598~embryonic morphogenesis,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000151~ubiquitin ligase complex,GO:0005794~Golgi apparatus,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0019899~enzyme binding,GO:0030332~cyclin binding,GO:0031625~ubiquitin protein ligase binding,","hsa04120:Ubiquitin mediated proteolysis,","Increasingly expressed during progression of DCIS to invasive breast carcinoma (22825334), Loss of Cul3 expression found in some human liver cancers (20978349)","Component of 3-member E3 ligase complexes which degrade a variety of substrates, reviewed (24024173, 23661552, 22743616)", 
DUSP16,dual specificity phosphatase 16,0.000564343891314,0.05461854686975,0.786831260812868,242,0.006940230464711,1,1,1.34867694988794E-15,3,Putative TSG,"GO:0000165~MAPKKK cascade,GO:0000188~inactivation of MAPK activity,GO:0006469~negative regulation of protein kinase activity,GO:0006470~protein amino acid dephosphorylation,GO:0006605~protein targeting,GO:0006611~protein export from nucleus,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016311~dephosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0033673~negative regulation of kinase activity,GO:0034613~cellular protein localization,GO:0042325~regulation of phosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045184~establishment of protein localization,GO:0045204~MAPK export from nucleus,GO:0045208~MAPK phosphatase export from nucleus,GO:0045209~MAPK phosphatase export from nucleus, leptomycin B sensitive,GO:0045859~regulation of protein kinase activity,GO:0046907~intracellular transport,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0070727~cellular macromolecule localization,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0033549~MAP kinase phosphatase activity,","hsa04010:MAPK signaling pathway,","Frequently deleted through 12p chromosom arm deletions or focal deletions in multiple tumor types (11896457), Overexpression in BCR-Abl-transformed rat fibroblasts decreases tumorigenicity in vitro and in vivo (14586399), Downregulated in prostate carcinoma (14999772)","Encodes a JNK-specific MAPK phosphatase (14586399), also blocks nuclear accumulation of phospho-ERK (20122898)", 
UPF3B,UPF3 regulator of nonsense transcripts homolog B (yeast),0.000570644720477,0.054943673885491,0.92723433183117,83,0.048597330136744,1,0.724507651291874,1,3,Novel,"GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006403~RNA localization,GO:0008380~RNA splicing,GO:0009057~macromolecule catabolic process,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016071~mRNA metabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051236~establishment of RNA localization,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005487~nucleocytoplasmic transporter activity,",None,Germline truncating mutations cause mental retardation phenotype (17704778),"Alternative nonsense-mediated mRNA decay factor that degrades aberrant mRNAs and regulates normal mRNAs (15734573, 17363904)", 
ZNF319,zinc finger protein 319,0.000655142386128,0.060282781430947,0.857631106743053,157,0.071653253124773,1,0.342096927505986,1,3,Novel,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,None,Unknown, 
RPL18,ribosomal protein L18,0.000692207518627,0.062765748739962,0.935461304718444,76,0.008698238474137,1,1,1.50521715670512E-22,3,Putative TSG,"GO:0006412~translation,GO:0006414~translational elongation,GO:0005829~cytosol,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~ribonucleoprotein complex,GO:0033279~ribosomal subunit,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044445~cytosolic part,GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,","hsa03010:Ribosome,",Deleted in oligodendrogliomas (16550607),Unknown, 
PPM1D,"protein phosphatase 1D magnesium-dependent, delta isoform",0.000724227526996,0.065351912931196,0.821438138597685,202,0.008017573161201,1,1,1,3,Known OG,"GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0009314~response to radiation,GO:0009617~response to bacterium,GO:0009628~response to abiotic stimulus,GO:0016311~dephosphorylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0042127~regulation of cell proliferation,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0008287~protein serine/threonine phosphatase complex,GO:0000287~magnesium ion binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04115:p53 signaling pathway,","Amplified in breast cancer and expression is correlated with aggressivenes (12021784, 16254685), Overexpression reduces starvation-induced apoptosis and enhances cellular transformation (12021784), Overexpression enhances tumorigenicity in vivo (12021785), Amplified in human breast tumor cell lines and 11% primary breast tumors (12021785), Downregulation by RNAi suppresses growth of neuroblastoma cell lines (12702577), Amplified in neuroblastoma (12702577), Amplified in ovarian clear cell adenocarcinoma and associated with poor prognosis (12796361), PPM1D null mice are resistant to spontaneous tumors throughout their lifespan (16652371), Silencing by RNAi reduces proliferation and invasion of glioma cells (21336731), Knockdown by RNAi inhibits colorectal carcinoma cell proliferation (23745790)",Reduces phosphorylation of p53 by negatively regulating p38MAPK (12021785), 
TMPO,thymopoietin,0.00075630258443,0.066952492770449,0.802836473400528,223,0.059666322445333,1,0.505087244311173,0.08018158278728,3,Putative OG,"GO:0045449~regulation of transcription,GO:0000785~chromatin,GO:0005635~nuclear envelope,GO:0005694~chromosome,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,GO:0005521~lamin binding,",None,"Upregulated in murine medulloblastoma (15064731), Possible growth inhibitory function in nasopharyngeal carcinoma cells (16038265), Abundantly expressed in lung cancer-derived endothelial cells and cancerous lung cells (18220333), Widely overexpressed in diverse digestive tract cancers (22745766), Overexpressed in rapidly replicating cells of various hematological malignancies (17364180)",Plays a role in nuclear envelope organization and cell cycle control (10430029), 
TMEM30A,transmembrane protein 30A,0.000772369265355,0.067416287418497,0.9467495150821,65,0.015399458093631,1,1,0.66505102460377,3,Novel,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None,Increased expression levels in primary prostate cancer patients who later developed drug resistance (19893039),Unknown, 
GNPTAB,"N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits",0.000867598249095,0.072672052443243,0.840763255926445,184,0.079237091276073,1,0.6394955370665,0.276743165525358,3,Novel,"GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0008104~protein localization,GO:0009306~protein secretion,GO:0015031~protein transport,GO:0016310~phosphorylation,GO:0032940~secretion by cell,GO:0045184~establishment of protein localization,GO:0046835~carbohydrate phosphorylation,GO:0046903~secretion,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0003976~UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,GO:0005509~calcium ion binding,GO:0008134~transcription factor binding,GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04142:Lysosome,",None,Unknown, 
PLEKHM3,"pleckstrin homology domain containing, family M, member 3",0.000891073488636,0.074305186134968,0.848467927454937,172,0.038081395895301,1,0.876560862545503,3.91544357430084E-20,3,Novel,"GO:0007242~intracellular signaling cascade,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019992~diacylglycerol binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,None,Unknown, 
TTC18,tetratricopeptide repeat domain 18,0.000924215523004,0.075386121197326,0.919228414922703,89,0.097018469422695,1,0.329352821947289,1,3,Novel,None,None,None,Unknown, 
CERK,ceramide kinase,0.000939767606952,0.076321387522857,0.878584352024182,135,0.053217006038047,1,0.742087095988098,4.97839222165934E-52,3,Putative OG,"GO:0006643~membrane lipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006672~ceramide metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007205~activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0032147~activation of protein kinase activity,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046519~sphingoid metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0000267~cell fraction,GO:0000299~integral to membrane of membrane fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0019898~extrinsic to membrane,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001727~lipid kinase activity,GO:0001729~ceramide kinase activity,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004143~diacylglycerol kinase activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa00600:Sphingolipid metabolism,","Expression and enzyme activity decreased during differentiation of the leukemia cell line HL-60 (17957442), High expression associated with poor pathohistological grade in breast cancer, and higher expression found in ER- breast cancer tumors (19125296), Knockdown by RNAi sensitizes tumor cells to apoptosis induction (19545154), Inhibits growth arrest of a neuroblastoma cell line (19903244)","Ceramide kinase involved in eicosanoid biosynthesis, IL6 secretion mast cell degranulation, and neutrophil phagocytosis (16394251, 21111813", 
PRKRA,"protein kinase, interferon-inducible double stranded RNA dependent activator",0.001147256272777,0.090803389488113,0.94151949619612,71,0.059408666154239,0.319328035851206,1,1,3,Context-dependent,"GO:0001501~skeletal system development,GO:0006396~RNA processing,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006917~induction of apoptosis,GO:0006955~immune response,GO:0007423~sensory organ development,GO:0008285~negative regulation of cell proliferation,GO:0009615~response to virus,GO:0010033~response to organic substance,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016246~RNA interference,GO:0016310~phosphorylation,GO:0016441~posttranscriptional gene silencing,GO:0016458~gene silencing,GO:0030422~RNA interference, production of siRNA,GO:0031047~gene silencing by RNA,GO:0031050~dsRNA fragmentation,GO:0035194~posttranscriptional gene silencing by RNA,GO:0040029~regulation of gene expression, epigenetic,GO:0042127~regulation of cell proliferation,GO:0042471~ear morphogenesis,GO:0042473~outer ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043331~response to dsRNA,GO:0043583~ear development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048471~perinuclear region of cytoplasm,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0008047~enzyme activator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,",None,"Upregulated in bronchioloalveolar carcinoma and adenocarcinoma (17332367), Mutated in 50% of Carney Complex (18990538), expression levels increased in basal cell carcinoma, actinic keratosis, and squamous cell carcinoma samples (22025453)","Protein kinase activated by double-stranded RNA, component of Dicer complex (17332367)", 
PRPF40A,PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae),0.001277929179935,0.098923131410398,0.886799898724103,128,0.053217006038047,1,1,1,3,Novel,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,","hsa03040:Spliceosome,",None,Candidate p53 target (23817466), 
RNF111,ring finger protein 111,0.001523465819558,0.112923881125109,0.796062754621697,230,0.055126224185143,1,1,1.84320338485343E-27,3,Putative TSG,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Validated STOP gene (22628553), Re-expression in lung carcinoma cells restores TGFbeta signaling and significantly decreases growth in soft agar (2346761)","Amplifies TGFbeta signaling pathway by Smad7 degradation (14657019, 17591695)", 
TCEB3,"transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A)",0.001721216430706,0.125099617545343,0.783070165413745,251,0.135084878467865,0.694596125122932,0.745415986888831,1.60995471225063E-113,3,Putative TSG,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006354~RNA elongation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003711~transcription elongation regulator activity,GO:0016944~RNA polymerase II transcription elongation factor activity,GO:0030528~transcription regulator activity,",None,"Contained in consensus deletion sequence in neuroblastoma (9516832), Mutated in 28% MSI-CRC samples (21544814)","Stimulates rate of transcription elongation (10692460), Potential tumor cell antigen in peripheral T-cell lymphoma (21887344)", 
ZNF234,zinc finger protein 234,0.001775543690968,0.128095676658372,0.828278716199827,194,0.08829450653022,1,0.886481428527679,1.61980409284122E-10,3,Novel,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,None,Binds to p53 and preferentially transactivates proarrest p53 target genes over proapoptotic target genes (17719541), 
GLTSCR1,glioma tumor suppressor candidate region gene 1,0.001776153983325,0.128095676658372,0.79108869781713,237,0.038081395895301,1,1,9.37377254237815E-24,3,Putative TSG,None,None,"Contained in minimal deletion region in glioma (10708517), Allelic variants associated with increased risk of basal cell carcinoma (12117772), Polymorphisms associated with increased risk and progression of oligodendroglioma (15834925)",Unknown, 
KBTBD7,kelch repeat and BTB (POZ) domain containing 7,0.001904461208697,0.134239361951924,0.475473986268273,699,0.116386400651727,1,0.621617423105817,4.51854360859483E-75,3,Novel,None,None,None,May act as transcriptional activator in MAPK signaling (20132730), 
CLGN,calmegin,0.002034303911349,0.139701333676818,0.786073780018131,245,0.122976203557728,1,0.613513232463045,0.236520395342042,3,Novel,"GO:0006457~protein folding,GO:0007338~single fertilization,GO:0009566~fertilization,GO:0019953~sexual reproduction,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051082~unfolded protein binding,",None,Expressed in spermatocytic seminomas (16397242),Testis-specific molecular chaperone which plays a key role in spermatogenesis (21057513), 
HAUS8,"HAUS augmin-like complex, subunit 8",0.002335118491566,0.156335764530354,0.892357314236599,123,0.033618927856919,1,1,1,3,Novel,"GO:0000087~M phase of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031023~microtubule organizing center organization,GO:0048285~organelle fission,GO:0051225~spindle assembly,GO:0051297~centrosome organization,GO:0051301~cell division,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0070652~HAUS complex,",None,None,Unknown, 
SIK3,serine/threonine-protein kinase QSK,0.002402711993396,0.159971745809814,0.578750917175395,567,0.32956975240756,1,0.142038435823367,1.69993842745467E-84,3,Novel,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None,"Identified as a tumor-associated antigen in ovarian cancer (21399663), Expression increased in ovarian cancer relative to normal ovary tissue by IHC (21399663), Overexpression promotes G1/S cell cycle progression in ovarian cancer cells (21399663)","Negative regulator if Hippo signaling (23263283), Induces nuclear export of HDACs (23393134), Influence PI3K and c-Src signaling (21399663)", 
TEX11,testis expressed 11,0.002434173047328,0.159971745809814,0.878592359123985,134,0.015722758385579,1,1,1,3,Novel,"GO:0000279~M phase,GO:0000712~resolution of meiotic joint molecules as recombinants,GO:0003006~reproductive developmental process,GO:0006259~DNA metabolic process,GO:0006310~DNA recombination,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007060~male meiosis chromosome segregation,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007129~synapsis,GO:0007130~synaptonemal complex assembly,GO:0007131~reciprocal meiotic recombination,GO:0007140~male meiosis,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009566~fertilization,GO:0010941~regulation of cell death,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045132~meiotic chromosome segregation,GO:0045137~development of primary sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048608~reproductive structure development,GO:0051026~chiasma formation,GO:0051276~chromosome organization,GO:0051304~chromosome separation,GO:0051307~meiotic chromosome separation,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0060548~negative regulation of cell death,GO:0070192~chromosome organization involved in meiosis,GO:0070193~synaptonemal complex organization,GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000795~synaptonemal complex,GO:0000801~central element,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,",None,Validated STOP gene (22628553),"Unknown, expressed only in male germ cells and modulates germ cell proliferation (22383461)", 
ERRFI1,ERBB receptor feedback inhibitor 1,0.002765966084695,0.172533294023919,0.767555487838083,284,0.044704400659365,1,1,1.85291422719341E-163,3,Putative TSG,"GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None,"Deletion results in overproliferation and impaired differentiation of epidermal keratinocytes (16648858), Donwregulated in various human cancers (16648858), In glioblastoma with focal deletion of ERRFI1 locus, restoration of ERRFI1 slows cell migration (21113414), Validated STOP gene (22628553)",Negative regulation of EGFR and MAPK pathways (16648858), 
MORC4,MORC family CW-type zinc finger 4,0.002771025654862,0.172533294023919,0.895858522837931,113,0.366733093576785,0.631768750281355,0.179340642005228,1,3,Novel/Unclear,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Highly expressed in a subset of DLBCL and Hodgkin lymphoma cell lines (17608765), Validated STOP gene (22628553)",Unknown, 
SPEN,"spen homolog, transcriptional regulator (Drosophila)",0.002904993230951,0.17967671708916,0.686299258128856,384,0.071653253124773,1,1,2.80106614461077E-105,3,Putative TSG,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043566~structure-specific DNA binding,",None,Reviewed (14991875),Reviewed (18380007), 
MGAT2,"mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase",0.003175433725566,0.188298179555057,0.913835894812523,93,0.039876711490802,1,1,1,3,Novel,"GO:0006486~protein amino acid glycosylation,GO:0006487~protein amino acid N-linked glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0016051~carbohydrate biosynthetic process,GO:0018196~peptidyl-asparagine modification,GO:0018279~protein amino acid N-linked glycosylation via asparagine,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0044431~Golgi apparatus part,GO:0005529~sugar binding,GO:0008375~acetylglucosaminyltransferase activity,GO:0008455~alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,GO:0030246~carbohydrate binding,","hsa00510:N-Glycan biosynthesis,",None,Downregulated in ESCC in respose to IR (15226608), 
MLF1,myeloid leukemia factor 1,0.003293123185226,0.19297086451594,0.814662412395626,210,0.107155541229646,1,0.943222637657724,1,3,Putative TSG,"GO:0002244~hemopoietic progenitor cell differentiation,GO:0002318~myeloid progenitor cell differentiation,GO:0002520~immune system development,GO:0006350~transcription,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0022402~cell cycle process,GO:0030097~hemopoiesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0003677~DNA binding,GO:0019904~protein domain specific binding,",None,"Frequently mutated in small intestine neuroendocrine tumors (23676460), Loss-of-function translocations found in AML (20471513, 18090933, 16341033), frequently methylated in gastric cancer (19375421, 16367923)",Stabilizes activity of p53 by inhibiting its E3 ligase COP1 (17967869), 
SENP6,SUMO1/sentrin specific peptidase 6,0.00330588771589,0.19297086451594,0.824135153599729,200,0.071653253124773,1,1,0.591153187093397,3,Context-dependent,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None,"Overexpressed in hepatocellular carcinoma tumor samples (23461386), Knockdown by RNAi reduces grwoth and sensitizes cells to radiation (23461386), Reduced SENP6 mRNA levels found in breast cancer tissue arrays (21152235)","Regulates PML nuclear bodies (21148299), Required for activation of NFkB in response to radiation (23461386)", 
ARPP21,"cyclic AMP-regulated phosphoprotein, 21 kD",0.005245369259453,0.25852775530704,0.80549453140275,219,0.509049012414356,1,0.124048480937491,6.56219400718681E-36,3,Novel,None,None,Contains miR-128-2 in one of its introns (22193543),Unknown, 
FTSJD1,FtsJ methyltransferase domain containing 1,0.005613363628202,0.27050697313092,0.893884189225733,117,0.089487894971588,1,1,2.2789006416609E-09,3,Novel,"GO:0006730~one-carbon metabolic process,GO:0032259~methylation,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None,Frequently mutated in AAC (23685749),Unknown, 
RC3H2,ring finger and CCCH-type zinc finger domains 2,0.00607545733198,0.284581321636196,0.811282590886655,215,0.295055376807704,1,0.73524777513296,1,3,Novel,"GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0009986~cell surface,GO:0012505~endomembrane system,GO:0048471~perinuclear region of cytoplasm,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,None,Unknown, 
NAA15,NMDA receptor regulated 1,0.006270845564876,0.290929557355978,0.854419979105677,162,0.130381293471046,0.891183396549264,1,0.034658992781849,3,Novel/Unclear,"GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006473~protein amino acid acetylation,GO:0006474~N-terminal protein amino acid acetylation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031365~N-terminal protein amino acid modification,GO:0043543~protein amino acid acylation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048514~blood vessel morphogenesis,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0008080~N-acetyltransferase activity,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0043021~ribonucleoprotein binding,GO:0043022~ribosome binding,",None,"Overexpressed in papillary thyroid carcinomas (16279846), Increased expression in Burkitt lymphoma cell line (12140756)",Unknown, 
TTK,TTK protein kinase,0.006635986982043,0.300858254460157,0.847196253050621,175,0.228552499927778,0.09546493192653,1,2.03265975382247E-05,3,Putative OG,"GO:0000075~cell cycle checkpoint,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007088~regulation of mitosis,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic cell cycle spindle assembly checkpoint,GO:0007346~regulation of mitotic cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0009967~positive regulation of signal transduction,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010564~regulation of cell cycle process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010639~negative regulation of organelle organization,GO:0010647~positive regulation of cell communication,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0010948~negative regulation of cell cycle process,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031577~spindle checkpoint,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0033043~regulation of organelle organization,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0045786~negative regulation of cell cycle,GO:0045839~negative regulation of mitosis,GO:0045841~negative regulation of mitotic metaphase/anaphase transition,GO:0045937~positive regulation of phosphate metabolic process,GO:0051129~negative regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051726~regulation of cell cycle,GO:0051783~regulation of nuclear division,GO:0051784~negative regulation of nuclear division,GO:0060393~regulation of pathway-restricted SMAD protein phosphorylation,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04110:Cell cycle,","RNAI-mediated depletion in TNBC cell lines compromises cell viability and anchorage-independent growth, and increases apoptosis (23700430), Overexpressed in TNBC (23700430)",Mitotic checkpoint protein for accurate chromosome segregation during mitosis - its degradation produces excess centrosomes resulting in aberrant mitotic spindles (23700430), 
ELF1,E74-like factor 1 (ets domain transcription factor),0.006718064773807,0.302377667252847,0.697183518005127,370,0.281167290532872,1,0.886481428527679,6.82671158624814E-75,3,Putative TSG,"GO:0001817~regulation of cytokine production,GO:0002683~negative regulation of immune system process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009891~positive regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050854~regulation of antigen receptor-mediated signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050858~negative regulation of antigen receptor-mediated signaling pathway,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None,"Deleted in prostate cancer, correlated with tumor progression (23813660), Expression in breast cancer negatively correlated with histological grade (21811762), Upregulated in ~70% NSCLC, overexpression correlated with poor prognosis (20346215, 19624906)","Transcription factor, positive regulator of the hematopoietic Hox cofactor MEIS1 (20600580)", 
LARP7,"La ribonucleoprotein domain family, member 7",0.007142343441539,0.309540216112558,0.847343128549564,173,0.056166926372309,1,1,0.005183750261646,3,Putative TSG,"GO:0006396~RNA processing,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None,"Downregulated late stage cervicl cancer with lymph node metastasis (18191186), Truncating mutations found in MSI gastric cancers (22488152), Downregulated in gastric cancers (22488152), RNAi-mediated knockdown increases cell proliferation and migration (22488152)",Component of 7SK snRNP complex which controls the nuclear level of active P-TEFb (23471002), 
RBM46,RNA binding motif protein 46,0.008376943605304,0.33942067159105,0.815702872304957,208,0.325638335415723,1,0.621617423105817,6.72881698810982E-13,3,Novel,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None,None,Unknown, 
HERC4,hect domain and RLD 4,0.008610605707601,0.344405790176185,0.802979920589265,222,0.44336934738674,1,0.494743979854933,1,3,Novel,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0005829~cytosol,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,","hsa04120:Ubiquitin mediated proteolysis,",None,E3 ligase imporatnt in spermatogenesis (17967448 ), 
MFRP,membrane frizzled-related protein,0.009121868103009,0.356458942042077,0.709475744166154,357,0.19144231863822,1,1,1.86577541387258E-75,3,Novel,"GO:0007600~sensory perception,GO:0007601~visual perception,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0005576~extracellular region,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None,"Mutated in a primary myelofibrosis patient (23872309), MFRP mRNA not detectable in several cancer cell lines (11263980), Located within a frequently deleted region in neuroblastoma (12964007)",Homology suggests a role in WNT signaling pathway (11263980), 
PRPF38B,PRP38 pre-mRNA processing factor 38 (yeast) domain containing B,0.009711519109455,0.374023640093843,0.906158386939477,103,0.337520807549262,1,0.876560862545503,6.75245606351546E-24,3,Novel,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0005681~spliceosome,GO:0030529~ribonucleoprotein complex,","hsa03040:Spliceosome,",None,Unknown, 
TNPO1,transportin 1,0.009997257988921,0.379550369867998,0.643903706233307,455,0.34151371666018,1,0.724507651291874,1.48883877482367E-97,3,Novel,"GO:0000059~protein import into nucleus, docking,GO:0000060~protein import into nucleus, translocation,GO:0006461~protein complex assembly,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070727~cellular macromolecule localization,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0046930~pore complex,GO:0005048~signal sequence binding,GO:0008139~nuclear localization sequence binding,GO:0008565~protein transporter activity,GO:0042277~peptide binding,",None,None,Part of karyopherin receptor complex which interacts wit NLS to import nuclear proteins (9687515), 
CEL,carboxyl ester lipase (bile salt-stimulated lipase),0.011310121426523,0.403361741905996,0.881062673905567,133,0.338162824922626,1,0.990178279265157,1,3,Novel,"GO:0006631~fatty acid metabolic process,GO:0006638~neutral lipid metabolic process,GO:0006639~acylglycerol metabolic process,GO:0006641~triglyceride metabolic process,GO:0006643~membrane lipid metabolic process,GO:0006662~glycerol ether metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006672~ceramide metabolic process,GO:0006706~steroid catabolic process,GO:0006707~cholesterol catabolic process,GO:0006869~lipid transport,GO:0007586~digestion,GO:0007589~body fluid secretion,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0009062~fatty acid catabolic process,GO:0010876~lipid localization,GO:0015918~sterol transport,GO:0016042~lipid catabolic process,GO:0016054~organic acid catabolic process,GO:0016125~sterol metabolic process,GO:0016127~sterol catabolic process,GO:0018350~protein amino acid esterification,GO:0018904~organic ether metabolic process,GO:0022600~digestive system process,GO:0030149~sphingolipid catabolic process,GO:0030157~pancreatic juice secretion,GO:0030299~intestinal cholesterol absorption,GO:0030301~cholesterol transport,GO:0044236~multicellular organismal metabolic process,GO:0044240~multicellular organismal lipid catabolic process,GO:0044241~lipid digestion,GO:0044242~cellular lipid catabolic process,GO:0044243~multicellular organismal catabolic process,GO:0044258~intestinal lipid catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0046466~membrane lipid catabolic process,GO:0046486~glycerolipid metabolic process,GO:0046514~ceramide catabolic process,GO:0046519~sphingoid metabolic process,GO:0046521~sphingoid catabolic process,GO:0046903~secretion,GO:0050878~regulation of body fluid levels,GO:0050892~intestinal absorption,GO:0005576~extracellular region,GO:0001871~pattern binding,GO:0004091~carboxylesterase activity,GO:0004771~sterol esterase activity,GO:0004806~triacylglycerol lipase activity,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0016298~lipase activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0047372~acylglycerol lipase activity,","hsa00100:Steroid biosynthesis,hsa00561:Glycerolipid metabolism,",None,Unknown, 
ADAM23,ADAM metallopeptidase domain 23,0.011897677284149,0.410769905032683,0.890121331023742,126,0.191764109541618,1,1,7.07701423568503E-21,3,Putative TSG,"GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0022610~biological adhesion,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0032403~protein complex binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None,"Epigenetically downregulated in breast cancers, and downregulation is associated with cancer progression (14661055), Epigenetically silenced by aberrant methylation in pancreatic cancer (15467763), Methylation not observed in brain tumors (15862898), RNAi-mediated knockdown enhances meigration and metastasis (19549921), Downregulated in NSCLC, and expression level decreases with NSCLC progression (21429053), Frequently silenced by promoter methylation or deleted in gastric cancers (16103878), Hypermethylatd in HNSCC, methylation correlated with progression (17284367), Hypermethylated in colorectal cancer samples and cell lines (19089928), Silenced by promoter hypermethylation in breast invasive lobular carcinoma (1926792)",Negatively modulates integrin alpha(5)beta(3) activation during metastasis (19549921), 
MANEA,"mannosidase, endo-alpha",0.013175113335662,0.432509564142055,0.84115903743633,182,0.469828181510526,1,0.775559138960562,3.83193975783922E-13,3,Novel,"GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004559~alpha-mannosidase activity,GO:0004569~glycoprotein endo-alpha-1,2-mannosidase activity,GO:0015923~mannosidase activity,",None,None,Unknown, 
AADACL3,arylacetamide deacetylase-like 3,0.01372427721235,0.441758011053217,0.443147393574613,739,0.237711021508806,1,1,5.98568000903327E-97,3,Novel,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None,None,Unknown, 
DNAJC1,"DnaJ (Hsp40) homolog, subfamily C, member 1",0.016120540280638,0.483331576086745,0.854214515612719,163,0.298041973041423,1,1,1,3,Unclear,"GO:0006417~regulation of translation,GO:0006457~protein folding,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0030162~regulation of proteolysis,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032880~regulation of protein localization,GO:0045861~negative regulation of proteolysis,GO:0050708~regulation of protein secretion,GO:0051046~regulation of secretion,GO:0051223~regulation of protein transport,GO:0051248~negative regulation of protein metabolic process,GO:0060341~regulation of cellular localization,GO:0070201~regulation of establishment of protein localization,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005792~microsome,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0042598~vesicular fraction,GO:0001671~ATPase activator activity,GO:0003677~DNA binding,GO:0008047~enzyme activator activity,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0060590~ATPase regulator activity,",None,"Epigenetically silenced in malignant pediatric brain tumors (16049974), Weak expression level associated with decreased survival in primary cutaneous malignant melanoma (19838160), Upregulated in CALM/AF10+ leukemias (22064352)","Modulates GRP78 activity as a chaperone, indirectly altering proliferation (15699139), Also associates in a complex with TFII-I and GRP78 (21503958)", 
PPP1R21,"Protein Phosphatase 1, Regulatory Subunit 21",0.017778207029606,0.509323817647268,0.903555492460773,107,0.269194387967839,1,1,0.018718518090138,3,Novel,None,None,None,Unknown, 
TGIF1,TGFB-induced factor homeobox 1,0.01890807883838,0.531005819241157,0.824871837903785,198,0.120751955062333,1,1,1,3,Unclear/context-dependent,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001654~eye development,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007368~determination of left/right symmetry,GO:0007389~pattern specification process,GO:0007423~sensory organ development,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009799~determination of symmetry,GO:0009855~determination of bilateral symmetry,GO:0009890~negative regulation of biosynthetic process,GO:0009953~dorsal/ventral pattern formation,GO:0009968~negative regulation of signal transduction,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0014020~primary neural tube formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016481~negative regulation of transcription,GO:0021915~neural tube development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0043010~camera-type eye development,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048145~regulation of fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048385~regulation of retinoic acid receptor signaling pathway,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0050767~regulation of neurogenesis,GO:0051094~positive regulation of developmental process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051960~regulation of nervous system development,GO:0060041~retina development in camera-type eye,GO:0060284~regulation of cell development,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None,"Overexpression associated with poor prognosis in upper urinary tract urothelial carcinoma (22771156), Overexpression in urothelial carcinoma cells increases migration and invasion (22728270), Decreased expression observed in malignant pheochromocytoma (20534969), Expression increased in leiomyoma (19524896 )","Transcriptional corepressor of TGFbeta signaling (20622901, 22567107), inhibits p21, upregulates cyclin D1, and phosphorylates Rb to promote G1-S and proliferation (22771156), TGIF-induced superoxide production stimulates PI3K/AKT signaling to promote migration/invasion (22728270), Deficiency of TGIF1 sensitizes mice to radiation-induced intestinal damage (22567107), Downregulation sensitizes hepatocellular carcinoma cells to arsenic trioxide-induced apoptosis (21649584), Associated with intact 1p/19q status oligodendrogliomas (21625997), Expression found in well-differentiated regions of OSCC (21237437)", 
RECK,reversion-inducing-cysteine-rich protein with kazal motifs,0.019251770689508,0.532227764784555,0.800176717562813,226,0.482375155704615,1,0.990178279265157,1,3,Novel,"GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0001955~blood vessel maturation,GO:0021700~developmental maturation,GO:0030198~extracellular matrix organization,GO:0043062~extracellular structure organization,GO:0000267~cell fraction,GO:0000300~peripheral to membrane of membrane fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0008191~metalloendopeptidase inhibitor activity,GO:0010576~metalloenzyme regulator activity,GO:0030414~peptidase inhibitor activity,GO:0048551~metalloenzyme inhibitor activity,",None,None,Unknown, 
CASZ1,castor zinc finger 1,0.019973987917863,0.53682607239966,0.465273654778798,714,0.803605490639911,1,0.239978199885825,1.9071395190496E-108,3,Putative TSG,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Expression frequently lost in neuroectodermal tumors (16631614), Low expression correlated with poor survival in neuroblastoma, and ectopic restoration inhibited migration, proliferation, and tumorigenicity (21252912, 17044048), Expression induced by HDAC inhibitors in neuroblastoma cells (17940511)",Regulates expression of a number of genes involved in cell growth and developmental processes (21252912) Inhibits cell cycle progression by restoring pRb activity (23892435), 
EBF2,early B-cell factor 2,0.020386106608868,0.540897848504315,0.431761796320847,755,0.699428465752458,1,0.505087244311173,4.91989701924076E-62,3,Unclear,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Upregulation in osteosarcoma contributes to resistance to TRAIL-induced apoptosis (19671856), Frequently methylated in CML, ALL, and epithelial cancers (20184741), Validated STOP gene (22628553)",Knockdown increases sensitivity to TRAIL-induced apoptosis (19671856), 
PAPD4,PAP associated domain containing 4,0.022724437756805,0.574638994586616,0.53347461396284,617,0.250885268901272,1,1,1.76400470933224E-82,3,Novel,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0016071~mRNA metabolic process,GO:0031123~RNA 3'-end processing,GO:0043631~RNA polyadenylation,GO:0030880~RNA polymerase complex,GO:0031379~RNA-directed RNA polymerase complex,GO:0031380~nuclear RNA-directed RNA polymerase complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004652~polynucleotide adenylyltransferase activity,GO:0005524~ATP binding,GO:0016779~nucleotidyltransferase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0070566~adenylyltransferase activity,",None,None,Modulates 3' miRNA modification (21813625), 
MYB,v-myb myeloblastosis viral oncogene homolog (avian),0.026317222312494,0.621406461934897,0.835397083778611,189,0.593487475771254,1,0.745415986888831,2.18260898093275E-11,3,Context-dependent,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0016363~nuclear matrix,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None,"Validated STOP gene (22628553), Reviewed (22874877, 21196221, 20647765)","Reviewed (22874877, 21196221, 20647765)", 
ZNF142,zinc finger protein 142,0.029823167357934,0.665551903320003,0.492408825238499,676,0.541115784841023,1,0.943222637657724,2.31002723198825E-80,3,Novel,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,None,Unknown, 
CCDC15,coiled-coil domain containing 15,0.030043116084469,0.667039645519082,0.462325321300125,716,0.224360486545284,1,1,1.10692114467154E-79,3,Novel,None,None,None,Unknown, 
C15orf52,chromosome 15 open reading frame 52,0.030823078122172,0.674963981528789,0.558590551408662,588,0.382078818022627,1,1,3.50525278193072E-58,3,Novel,None,None,None,Unknown, 
IFNGR1,interferon gamma receptor 1,0.031143366867646,0.676678436753783,0.792759301366416,234,0.254987251860364,1,1,7.13128708716283E-15,3,Putative TSG,"GO:0009615~response to virus,GO:0005783~endoplasmic reticulum,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031982~vesicle,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0004896~cytokine receptor activity,GO:0004904~interferon receptor activity,GO:0004906~interferon-gamma receptor activity,GO:0019955~cytokine binding,GO:0019961~interferon binding,GO:0019964~interferon-gamma binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,","A patient with homozygous IFNGR1 deletion developed B-cell lymphoma (23800860), Contained in minimal deletion region in gastric carcinoma (10441002), Polymorphic variants associated with CLL, colorectal cancer, and gastric cancer (23647060, 21859832, 18593809)","IFN-gamma elevates caspase-8, thereby sensitizing breast cancer cells to apoptosis  -- this may be preventable by IFN-gamma receptor 1 downregulation (11059759), Functions as a cotranscription factor with activated JAKs (22924155)", 
CCDC30,hypothetical protein LOC728621,0.03116543031366,0.676678436753783,0.814134349564561,212,0.370584617691407,1,1,1,3,Novel,None,None,None,Unknown, 
RBM27,RNA binding motif protein 27,0.032357936948837,0.692341242001517,0.821509412547352,201,0.724261534730691,1,0.858711823250435,0.003603559592418,3,Novel,"GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,None,Unknown, 
SLC9A1,"solute carrier family 9 (sodium/hydrogen exchanger), member 1",0.036416803017709,0.729077667275226,0.712607945997538,352,0.439297804856376,1,1,3.34014995551411E-130,3,Putative OG,"GO:0001101~response to acid,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006885~regulation of pH,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008361~regulation of cell size,GO:0009268~response to pH,GO:0009628~response to abiotic stimulus,GO:0010033~response to organic substance,GO:0010447~response to acidity,GO:0014070~response to organic cyclic substance,GO:0015672~monovalent inorganic cation transport,GO:0016049~cell growth,GO:0030001~metal ion transport,GO:0032535~regulation of cellular component size,GO:0040007~growth,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0045767~regulation of anti-apoptosis,GO:0045768~positive regulation of anti-apoptosis,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055085~transmembrane transport,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0005451~monovalent cation:hydrogen antiporter activity,GO:0008134~transcription factor binding,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015297~antiporter activity,GO:0015298~solute:cation antiporter activity,GO:0015299~solute:hydrogen antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015385~sodium:hydrogen antiporter activity,GO:0015491~cation:cation antiporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04260:Cardiac muscle contraction,hsa04810:Regulation of actin cytoskeleton,","Reviewed (16175178, 23393197, 23253131, 22738122, 22360552, 22204338)","Reviewed (17218973, 23393197, 23253131, 22738122, 22360552, 22204338)", 
ERBB2IP,erbb2 interacting protein,0.041369383090161,0.761099633644786,0.526596322047134,625,0.978888608669698,1,0.318629720376967,2.44094276716272E-91,3,Putative TSG,"GO:0000902~cell morphogenesis,GO:0006605~protein targeting,GO:0006886~intracellular protein transport,GO:0007010~cytoskeleton organization,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0008104~protein localization,GO:0008105~asymmetric protein localization,GO:0008361~regulation of cell size,GO:0015031~protein transport,GO:0016049~cell growth,GO:0022610~biological adhesion,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0034613~cellular protein localization,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0040007~growth,GO:0045103~intermediate filament-based process,GO:0045104~intermediate filament cytoskeleton organization,GO:0045175~basal protein localization,GO:0045184~establishment of protein localization,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0030056~hemidesmosome,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0045178~basal part of cell,GO:0005176~ErbB-2 class receptor binding,GO:0005178~integrin binding,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0032403~protein complex binding,","hsa04621:NOD-like receptor signaling pathway,","Downregulated in HER2+ breast cancers (23711387), Knockdown promotes cell migration, invasion, and proliferation of breast cancer cells (23711387), Colocalized with HER2 in SCC and keratoacanthoma (15948989)",Reviewed (12966186), 
CDKN1A,"cyclin-dependent kinase inhibitor 1A (p21, Cip1)",4.90184449561006E-13,2.34773213675642E-10,0.629486130392514,486,3.74006198869233E-14,1,1,1,2,Context-dependent,"GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001558~regulation of cell growth,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0006469~negative regulation of protein kinase activity,GO:0006917~induction of apoptosis,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008629~induction of apoptosis by intracellular signals,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009636~response to toxin,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010243~response to organic nitrogen,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0014070~response to organic cyclic substance,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030308~negative regulation of cell growth,GO:0030888~regulation of B cell proliferation,GO:0030890~positive regulation of B cell proliferation,GO:0031099~regeneration,GO:0031100~organ regeneration,GO:0031668~cellular response to extracellular stimulus,GO:0031960~response to corticosteroid stimulus,GO:0032535~regulation of cellular component size,GO:0032944~regulation of mononuclear cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042493~response to drug,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045736~negative regulation of cyclin-dependent protein kinase activity,GO:0045767~regulation of anti-apoptosis,GO:0045768~positive regulation of anti-apoptosis,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045926~negative regulation of growth,GO:0045936~negative regulation of phosphate metabolic process,GO:0046685~response to arsenic,GO:0048145~regulation of fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048545~response to steroid hormone stimulus,GO:0050670~regulation of lymphocyte proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050871~positive regulation of B cell activation,GO:0051174~regulation of phosphorus metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051384~response to glucocorticoid stimulus,GO:0051385~response to mineralocorticoid stimulus,GO:0051412~response to corticosterone stimulus,GO:0051726~regulation of cell cycle,GO:0055093~response to hyperoxia,GO:0060548~negative regulation of cell death,GO:0070482~response to oxygen levels,GO:0070663~regulation of leukocyte proliferation,GO:0070665~positive regulation of leukocyte proliferation,GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0004857~enzyme inhibitor activity,GO:0004860~protein kinase inhibitor activity,GO:0004861~cyclin-dependent protein kinase inhibitor activity,GO:0008270~zinc ion binding,GO:0016538~cyclin-dependent protein kinase regulator activity,GO:0019207~kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019887~protein kinase regulator activity,GO:0030291~protein serine/threonine kinase inhibitor activity,GO:0030332~cyclin binding,GO:0032403~protein complex binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04012:ErbB signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05200:Pathways in cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,","Reviewed (23159848, 22817456)","Reviewed (23159848, 22817456)", 
THRAP3,thyroid hormone receptor associated protein 3,5.85938609853158E-08,1.65829504446169E-05,0.756096784731856,300,8.66980552589109E-05,1,0.006543937923482,1.97331641916556E-17,2,Putative TSG,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007242~intracellular signaling cascade,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000119~mediator complex,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016592~Srb-mediator complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0016251~general RNA polymerase II transcription factor activity,GO:0016455~RNA polymerase II transcription mediator activity,GO:0016563~transcription activator activity,GO:0017076~purine nucleotide binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035257~nuclear hormone receptor binding,GO:0042809~vitamin D receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0051427~hormone receptor binding,",None,"Truncating mutations found in sporatic parathyroid carcinoma (23616356), freuqently deleted in OSCC (21334929)","Depletion causes hypersensitivity to DNA damaging agents (22424773), plays a critical role in cotranscriptional or posttranscriptional Cyclin D1 mRNA stability (18794151)", 
TBL1XR1,transducin (beta)-like 1 X-linked receptor 1,2.80935914365319E-07,7.18849581428738E-05,0.67711351526863,403,0.000532668435014,0.17048923469897,0.032909800411802,1,2,Unclear,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0009057~macromolecule catabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010498~proteasomal protein catabolic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016055~Wnt receptor signaling pathway,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0015630~microtubule cytoskeleton,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0042393~histone binding,GO:0043565~sequence-specific DNA binding,GO:0047485~protein N-terminus binding,","hsa04310:Wnt signaling pathway,","Knockdown results in suppressed tumorigenesis in mouse xenografts, reduced migration and invasion (19706770), Amplified in breast cancer (19706770), Frequently mutated in primary CNS lymphomas (22837180), Recurrently fused by translocation to TP63 in DLBCL (22496164), Recurrent mutations found in high-risk childhood ALL (21680795), Recurrently deleted in primary CNS lymphomas (21562036), Recurrently deleted in ALL (18767146), Elevated expression in lung adenocarcinoma (17316888)","Recruitment to promoters of Wnt target genes required for Wnt-beta-catenin signaling (18193033, 21777810)", 
WT1,Wilms tumor 1,5.76114783425836E-07,0.000132854914069,0.604356750395989,517,0.000749052675701,0.140103389040846,0.066343878305903,1,2,Context-dependent,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0001944~vasculature development,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007423~sensory organ development,GO:0007530~sex determination,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0019953~sexual reproduction,GO:0030855~epithelial cell differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032504~multicellular organism reproduction,GO:0043010~camera-type eye development,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048514~blood vessel morphogenesis,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060429~epithelium development,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Reviewed (17361230), Cancer gene census (14993899)",Reviewed (17361230), 
PLEKHA6,"pleckstrin homology domain containing, family A member 6",6.38526889900048E-07,0.000143699322608,0.490440036333237,682,0.000365762748519,1,0.088159875375492,1,2,Novel,None,None,Methylated in HNSCC (22430805),Unknown, 
COL4A2,"collagen, type IV, alpha 2",3.94262264344365E-06,0.000783449450605,0.758245256303221,298,0.033618927856919,0.846204308491937,1.59029976521782E-05,1,2,Putative TSG,"GO:0016525~negative regulation of angiogenesis,GO:0030198~extracellular matrix organization,GO:0043062~extracellular structure organization,GO:0045765~regulation of angiogenesis,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005587~collagen type IV,GO:0005604~basement membrane,GO:0030935~sheet-forming collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,","Frequently mutated in NHL (21796119), Degradation of COL4A2 by miRNA increases invasion ability of MCF-7 cells (22864815), Increases G1 arrest and apoptosis, and decreases mobility of colon cancer cells (22320979), recombinant COL4A2 fragment inhibits angiogenesis in clinical treatment (17075979)","Binds directly to VHL, necessary for VHL assembly into ECM (17700531), Cantastin, a fragment of COL4A2, inhibits angiogenesis and tumor growth (10625665)", 
EIF2AK3,eukaryotic translation initiation factor 2-alpha kinase 3,2.86693524980168E-05,0.00482445797577,0.44694390052605,734,0.022318292355759,1,0.009176683951197,1,2,Putative OG,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0002062~chondrocyte differentiation,GO:0002063~chondrocyte development,GO:0002790~peptide secretion,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006446~regulation of translational initiation,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006919~activation of caspase activity,GO:0006926~virus-infected cell apoptosis,GO:0006983~ER overload response,GO:0006984~ER-nuclear signaling pathway,GO:0006986~response to unfolded protein,GO:0007029~endoplasmic reticulum organization,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0008219~cell death,GO:0009890~negative regulation of biosynthetic process,GO:0009914~hormone transport,GO:0010033~response to organic substance,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010817~regulation of hormone levels,GO:0010941~regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0015833~peptide transport,GO:0016265~death,GO:0016310~phosphorylation,GO:0017148~negative regulation of translation,GO:0019722~calcium-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0030072~peptide hormone secretion,GO:0030073~insulin secretion,GO:0030282~bone mineralization,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031016~pancreas development,GO:0031018~endocrine pancreas development,GO:0031214~biomineral formation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031641~regulation of myelination,GO:0031642~negative regulation of myelination,GO:0031644~regulation of neurological system process,GO:0031645~negative regulation of neurological system process,GO:0032055~negative regulation of translation in response to stress,GO:0032057~negative regulation of translational initiation in response to stress,GO:0032092~positive regulation of protein binding,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032844~regulation of homeostatic process,GO:0032940~secretion by cell,GO:0033554~cellular response to stress,GO:0034620~cellular response to unfolded protein,GO:0034976~response to endoplasmic reticulum stress,GO:0035270~endocrine system development,GO:0042981~regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043393~regulation of protein binding,GO:0043555~regulation of translation in response to stress,GO:0043558~regulation of translational initiation in response to stress,GO:0043933~macromolecular complex subunit organization,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045947~negative regulation of translational initiation,GO:0046777~protein amino acid autophosphorylation,GO:0046879~hormone secretion,GO:0046903~secretion,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051216~cartilage development,GO:0051241~negative regulation of multicellular organismal process,GO:0051248~negative regulation of protein metabolic process,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051789~response to protein stimulus,GO:0051960~regulation of nervous system development,GO:0051969~regulation of transmission of nerve impulse,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0060348~bone development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003743~translation initiation factor activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity,GO:0005524~ATP binding,GO:0008135~translation factor activity, nucleic acid binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,","hsa05010:Alzheimer's disease,","Truncating germline mutations result in osteopenia, epiphyseal dysplasia, and permanent neonatal insulin-dependent diabetes (16813601), Expression linked to chemotherapeutic resistance of cancer cells (22253692), Promotes tumorigenesis by activating autophagy and enhancing tumor formation (23328692), Chemical inhibition results in inhibition of xenograft growth in mice (23333938)","ER stress sensor (15684420), regulates ATF4 and CHOP (20038797), phosphorylates EIF2A which blocks protein translation and restriction point transit in G1 (22253692), Activates autophagy in response to Myc-induced transformation (23328692)", 
JMJD1C,jumonji domain containing 1C,4.32769415206155E-05,0.007090964830382,0.431301749801029,756,0.020070154139954,1,0.104977053308268,1,2,Putative TSG,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0055114~oxidation reduction,GO:0005506~iron ion binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0035257~nuclear hormone receptor binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046966~thyroid hormone receptor binding,GO:0051427~hormone receptor binding,",None,"Expression is reduced in breast cancer tumors (17353003), Expressed in diffuse-type gastric cancer, and may reactivate silenced genes (17549425)","AR coactivator (17353003), Histone demethylase implicated in reactivation of silenced genes (17549425)", 
FANCM,"Fanconi anemia, complementation group M",4.7565838327693E-05,0.00765933012175,0.588625801579406,543,0.004738432236175,1,0.6394955370665,1,2,,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,",None, , , 
FOXA1,forkhead box A1,5.39287685900811E-05,0.008536741258425,0.62565908325994,492,0.024909454916867,1,0.032522195571966,1,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001655~urogenital system development,GO:0001708~cell fate specification,GO:0001763~morphogenesis of a branching structure,GO:0002064~epithelial cell development,GO:0002070~epithelial cell maturation,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010817~regulation of hormone levels,GO:0016481~negative regulation of transcription,GO:0021700~developmental maturation,GO:0030182~neuron differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030850~prostate gland development,GO:0030855~epithelial cell differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0033500~carbohydrate homeostasis,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042445~hormone metabolic process,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048608~reproductive structure development,GO:0048663~neuron fate commitment,GO:0048665~neuron fate specification,GO:0048732~gland development,GO:0048754~branching morphogenesis of a tube,GO:0048878~chemical homeostasis,GO:0050767~regulation of neurogenesis,GO:0051094~positive regulation of developmental process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060429~epithelium development,GO:0060541~respiratory system development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
ZNF292,zinc finger protein 292,6.07966466886726E-05,0.009543029945359,0.770675359887445,275,0.001047433880252,1,1,1.16585742211035E-21,2,Novel,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Downregulated in response to knockdown of Gfi-1B in K562 cells (18224412), putative tumor antigen in MGUS (19587378)",Unknown, 
AMER1,APC Membrane Recruitment Protein 1,8.85015549274433E-05,0.012770510219886,0.770240940174725,276,0.000169684854885,1,1,1,2,,None,None, , , 
SIN3A,"SIN3 homolog A, transcription regulator (yeast)",8.95114964460571E-05,0.012770510219886,0.778596911413371,259,0.020681427386047,1,0.229491204019952,1,2,Putative TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0000118~histone deacetylase complex,GO:0000228~nuclear chromosome,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016580~Sin3 complex,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0070822~Sin3-type complex,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,","hsa05016:Huntington's disease,","Downregulated in NSCLC (17854949), Downregulated in a variety of tumors (22890320), Reducing SIN3A increased invasiveness of lung adenocarcinoma cells (22890320)",Causes deacetylation of c-Myc protein to directly repress c-Myc activity (22101514), 
AXIN1,axin 1,0.00011502882071,0.015536495090336,0.620988621757485,497,0.003211161523434,1,1,1,2,,"GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0003006~reproductive developmental process,GO:0006915~apoptosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007292~female gamete generation,GO:0007308~oocyte construction,GO:0007309~oocyte axis specification,GO:0007389~pattern specification process,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0008219~cell death,GO:0009057~macromolecule catabolic process,GO:0009798~axis specification,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0009994~oocyte differentiation,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010799~regulation of peptidyl-threonine phosphorylation,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0012501~programmed cell death,GO:0016055~Wnt receptor signaling pathway,GO:0016265~death,GO:0019220~regulation of phosphate metabolic process,GO:0019953~sexual reproduction,GO:0021700~developmental maturation,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030163~protein catabolic process,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032504~multicellular organism reproduction,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,GO:0045937~positive regulation of phosphate metabolic process,GO:0046328~regulation of JNK cascade,GO:0046330~positive regulation of JNK cascade,GO:0048469~cell maturation,GO:0048477~oogenesis,GO:0048584~positive regulation of response to stimulus,GO:0048599~oocyte development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070304~positive regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016328~lateral plasma membrane,GO:0030877~beta-catenin destruction complex,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044459~plasma membrane part,GO:0008013~beta-catenin binding,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046332~SMAD binding,GO:0046983~protein dimerization activity,GO:0070016~armadillo repeat domain binding,GO:0070411~I-SMAD binding,","hsa04310:Wnt signaling pathway,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05217:Basal cell carcinoma,","Cancer gene census (14993899), homozygously inactivated gene (Cosmic), validated STOP gene (22628553)",0, 
INPPL1,inositol polyphosphate phosphatase-like 1,0.000120067551279,0.016019584216684,0.769100458555536,281,0.012124623174594,0.401319580699535,0.806613549597766,1,2,Unclear,"GO:0006020~inositol metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0019751~polyol metabolic process,GO:0022610~biological adhesion,GO:0032957~inositol trisphosphate metabolic process,GO:0043647~inositol phosphate metabolic process,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0019898~extrinsic to membrane,GO:0030479~actin cortical patch,GO:0030863~cortical cytoskeleton,GO:0030864~cortical actin cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044448~cell cortex part,GO:0003779~actin binding,GO:0004437~inositol or phosphatidylinositol phosphatase activity,GO:0004445~inositol-polyphosphate 5-phosphatase activity,GO:0005543~phospholipid binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008092~cytoskeletal protein binding,GO:0008289~lipid binding,GO:0016791~phosphatase activity,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0035091~phosphoinositide binding,GO:0046030~inositol trisphosphate phosphatase activity,","hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,","Expression elevated in 44% breast cancer (17893231), expression correlated with poor breast cancer survival (19065064), RNAi to SHIP2 leads to EGFR recycling and suppression of pathway (17893231), RNAi to SHIP2 leads to cell cycle arrest associated with p27 in GBM cells (10958682)","Enhances PI3K induction of invadopodia (22969158), potentiates Akt activity in serum-stimulated cells (15885100), causes cell cycle arrest associated with p27 in GBM (10958682), RNAi to SHIP2 leads to EGFR recycling and suppression of pathway (17893231)", 
HERC1,hect (homologous to the E6-AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1,0.000128312487972,0.01687851382269,0.690826837935511,377,0.071653253124773,0.846204308491937,0.053125090503257,1,2,Unclear,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0019898~extrinsic to membrane,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005086~ARF guanyl-nucleotide exchange factor activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04120:Ubiquitin mediated proteolysis,","Mutated in 2/14 TNBC samples (16464865), Deleted in 4 of 7 with MSH2-Low ALL compared to 2 of 62 with MSH2-High ALL (21946537), 1/21 cases of HERC1-PML fusion found in APML (20155840), Recessive mutation in mice causes Purkinje cell degeneration and extensive autophagy (20041218)","Degrades TSC2 in absence of TSC1 through its E3 ligase activity (16464865, 18291711), Deletion decreases MSH2 stability (21946537), Loss of HERC1 in mice leads to extensive autophagy in Purkinje cells (20041218)", 
DACH1,dachshund homolog 1 (Drosophila),0.000138145741576,0.018044925223103,0.664909945685994,425,0.063102379690016,1,0.021488554525693,3.39005982821315E-23,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
CNOT3,"CCR4-NOT transcription complex, subunit 3",0.000143588662421,0.018409872633826,0.60618288647975,513,0.23662190227951,0.631768750281355,0.000157694043043,2.84852625862028E-16,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0030528~transcription regulator activity,","hsa03018:RNA degradation,", , , 
ATAD2,"ATPase family, AAA domain containing 2",0.000164006715985,0.020699198972127,0.34604741756476,840,0.005087741288335,1,1,1,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042624~ATPase activity, uncoupled,",None, , , 
RGS12,regulator of G-protein signaling 12,0.000165804675206,0.020785674685786,0.365639506774581,828,0.013790277559456,1,0.574713924958474,1,2,,"GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
ARHGAP5,Rho GTPase activating protein 5,0.000191282711398,0.023352743569931,0.697538319208109,367,0.002705656221368,1,1,1,2,,"GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0007155~cell adhesion,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0010464~regulation of mesenchymal cell proliferation,GO:0022610~biological adhesion,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0032535~regulation of cellular component size,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0019898~extrinsic to membrane,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0005525~GTP binding,GO:0008047~enzyme activator activity,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0019904~protein domain specific binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0042169~SH2 domain binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04510:Focal adhesion,hsa04670:Leukocyte transendothelial migration,", , , 
ZMYM3,"zinc finger, MYM-type 3",0.000208513494116,0.024966817670467,0.49071102031801,681,0.009954604898577,1,0.903454196052047,1,2,,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ASXL2,additional sex combs like 2 (Drosophila),0.000241100327863,0.02850324698834,0.776761806291034,261,0.007047213734446,1,1,1,2,Putative TSG,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,"Mutations found in prostate, breast, and pancreatic cancer (23736028), Fusion with EPC1 found in T-ALL (23736028), High degree of homology to ASXL1, frequently mutated in CMML (22878500)",Transcriptional repression through chromatin remodeling (12888926), 
RAD21,RAD21 homolog (S. pombe),0.000252902685078,0.029710498456444,0.287650284466131,884,0.048840768244247,1,0.271476723733921,1,2,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006915~apoptosis,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007131~reciprocal meiotic recombination,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0033554~cellular response to stress,GO:0048285~organelle fission,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0000228~nuclear chromosome,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,","hsa04110:Cell cycle,", , , 
RBM26,RNA binding motif protein 26,0.000322936225698,0.03678125463303,0.709248725732808,358,0.135629695169034,1,0.043039943659203,6.99072461665383E-09,2,,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
MYO1B,myosin IB,0.000365918695779,0.040205854814405,0.780064556097372,255,0.035010623022671,1,0.73524777513296,1,2,,"GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
TBC1D10C,"TBC1 domain family, member 10C",0.000382988212971,0.041325319639807,0.676323363317184,404,0.004338538908467,1,1,1,2,,"GO:0032313~regulation of Rab GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032483~regulation of Rab protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005097~Rab GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
BRCA2,"breast cancer 2, early onset",0.000384956668843,0.041325319639807,0.774253000525666,269,0.001531997604458,1,1,6.47922864314523E-29,2,,"GO:0000226~microtubule cytoskeleton organization,GO:0000279~M phase,GO:0000724~double-strand break repair via homologous recombination,GO:0000725~recombinational repair,GO:0000910~cytokinesis,GO:0001556~oocyte maturation,GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0001832~blastocyst growth,GO:0001833~inner cell mass cell proliferation,GO:0002520~immune system development,GO:0003006~reproductive developmental process,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006355~regulation of transcription, DNA-dependent,GO:0006917~induction of apoptosis,GO:0006974~response to DNA damage stimulus,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007090~regulation of S phase of mitotic cell cycle,GO:0007098~centrosome cycle,GO:0007126~meiosis,GO:0007140~male meiosis,GO:0007141~male meiosis I,GO:0007242~intracellular signaling cascade,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007292~female gamete generation,GO:0007346~regulation of mitotic cell cycle,GO:0007548~sex differentiation,GO:0007568~aging,GO:0007569~cell aging,GO:0007584~response to nutrient,GO:0008156~negative regulation of DNA replication,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008406~gonad development,GO:0008585~female gonad development,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0009994~oocyte differentiation,GO:0010033~response to organic substance,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010225~response to UV-C,GO:0010332~response to gamma radiation,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010564~regulation of cell cycle process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0014070~response to organic cyclic substance,GO:0019953~sexual reproduction,GO:0021700~developmental maturation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030097~hemopoiesis,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030879~mammary gland development,GO:0031023~microtubule organizing center organization,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031667~response to nutrient levels,GO:0032504~multicellular organism reproduction,GO:0033205~cytokinesis during cell cycle,GO:0033261~regulation of S phase,GO:0033554~cellular response to stress,GO:0033595~response to genistein,GO:0033599~regulation of mammary gland epithelial cell proliferation,GO:0033600~negative regulation of mammary gland epithelial cell proliferation,GO:0035172~hemocyte proliferation,GO:0035264~multicellular organism growth,GO:0040007~growth,GO:0042127~regulation of cell proliferation,GO:0042770~DNA damage response, signal transduction,GO:0042771~DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,GO:0042772~DNA damage response, signal transduction resulting in transcription,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043627~response to estrogen stimulus,GO:0045005~maintenance of fidelity during DNA-dependent DNA replication,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0045787~positive regulation of cell cycle,GO:0045931~positive regulation of mitotic cell cycle,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046545~development of primary female sexual characteristics,GO:0046660~female sex differentiation,GO:0048232~male gamete generation,GO:0048469~cell maturation,GO:0048477~oogenesis,GO:0048478~replication fork protection,GO:0048534~hemopoietic or lymphoid organ development,GO:0048545~response to steroid hormone stimulus,GO:0048589~developmental growth,GO:0048599~oocyte development,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048732~gland development,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051297~centrosome organization,GO:0051298~centrosome duplication,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0051726~regulation of cell cycle,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0033593~BRCA2-MAGE-D1 complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043015~gamma-tubulin binding,GO:0043566~structure-specific DNA binding,","hsa03440:Homologous recombination,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,","Cancer gene census (14993899), validated STOP gene (22628553)",0, 
NUP98,nucleoporin 98kDa,0.000404371215115,0.043161428155005,0.51203287897197,649,0.183395805588652,1,0.003965093034976,1.3893825206581E-41,2,,"GO:0000059~protein import into nucleus, docking,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006403~RNA localization,GO:0006461~protein complex assembly,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006997~nucleus organization,GO:0006999~nuclear pore organization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051236~establishment of RNA localization,GO:0055085~transmembrane transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070727~cellular macromolecule localization,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031080~Nup107-160 complex,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0046930~pore complex,GO:0070013~intracellular organelle lumen,GO:0005198~structural molecule activity,GO:0017056~structural constituent of nuclear pore,",None, , , 
AFF4,"AF4/FMR2 family, member 4",0.000423473781587,0.044689642747202,0.224104711351747,931,0.144716457527672,1,0.040031182705034,4.12372017174471E-09,2,,"GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0048232~male gamete generation,GO:0048515~spermatid differentiation,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
ANO3,anoctamin 3,0.000449605735075,0.046398815057813,0.590612633877194,538,0.183935540193634,1,0.024044410070431,1,2,,"GO:0006811~ion transport,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0005216~ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0005509~calcium ion binding,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
NEK9,NIMA (never in mitosis gene a)- related kinase 9,0.000466602187736,0.047626569752597,0.724323483985246,332,0.071653253124773,1,0.342096927505986,1.49661336195831E-07,2,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0016310~phosphorylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0051301~cell division,GO:0005739~mitochondrion,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
SMARCA1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1",0.000471112398878,0.047803094171586,0.520119469643744,637,0.065637035199396,1,0.505087244311173,1,2,,"GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0030182~neuron differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0043044~ATP-dependent chromatin remodeling,GO:0043193~positive regulation of gene-specific transcription,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0016585~chromatin remodeling complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0031491~nucleosome binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,",None, , , 
C2CD5,C2 Calcium-Dependent Domain Containing 5,0.000513675570573,0.050777356417429,0.499714318075442,665,0.006085473821636,1,1,1,2,,None,None, , , 
PSIP1,PC4 and SFRS1 interacting protein 1,0.000557157829101,0.054203911925915,0.769570785333677,279,0.048597330136744,0.000753111942367,0.953842715951356,8.16427742879372E-37,2,,"GO:0006259~DNA metabolic process,GO:0006310~DNA recombination,GO:0006350~transcription,GO:0015074~DNA integration,GO:0016032~viral reproduction,GO:0019047~provirus integration,GO:0019058~viral infectious cycle,GO:0019059~initiation of viral infection,GO:0022415~viral reproductive process,GO:0030069~lysogeny,GO:0045449~regulation of transcription,GO:0005829~cytosol,GO:0003677~DNA binding,",None, , , 
CSDE1,"cold shock domain containing E1, RNA-binding",0.000593579249626,0.05599730708968,0.728473948322071,326,0.105888928450367,1,0.271476723733921,7.65843024924823E-30,2,,"GO:0003006~reproductive developmental process,GO:0006355~regulation of transcription, DNA-dependent,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048608~reproductive structure development,GO:0051252~regulation of RNA metabolic process,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0003677~DNA binding,GO:0003723~RNA binding,",None, , , 
PRRC2C,BAT2 domain containing 1,0.000598462438749,0.056174270821093,0.579258729840705,565,0.161034363867777,1,0.031386027151152,1,2,,"GO:0008022~protein C-terminus binding,",None, , , 
SESTD1,SEC14 and spectrin domains 1,0.000618626053485,0.057489134592253,0.655179810811154,442,0.198446075225,1,0.032909800411802,1,2,,None,None, , , 
CHD3,chromodomain helicase DNA binding protein 3,0.000683064353284,0.062238824658454,0.546993328712705,604,0.239073768387664,1,0.023582225435969,0.030651119389589,2,,"GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016581~NuRD complex,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0008270~zinc ion binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070035~purine NTP-dependent helicase activity,",None, , , 
ZNF750,zinc finger protein 750,0.000768566371829,0.06739930168731,0.663548641077716,427,0.026471254632193,1,0.959957487005618,1.31158592882058E-05,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
SPRED2,"sprouty-related, EVH1 domain containing 2",0.000778242546175,0.067612988465104,0.657058614532788,438,0.074046248904267,1,0.418017694810837,1,2,,"GO:0000165~MAPKKK cascade,GO:0000188~inactivation of MAPK activity,GO:0006469~negative regulation of protein kinase activity,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0019220~regulation of phosphate metabolic process,GO:0033673~negative regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0044459~plasma membrane part,GO:0005173~stem cell factor receptor binding,","hsa04630:Jak-STAT signaling pathway,", , , 
PCDH7,protocadherin 7,0.00081034080626,0.069432825321667,0.626465837241957,489,0.229708502455236,1,0.01395172132005,1,2,,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
ZBTB18,Zinc Finger And BTB Domain Containing 18,0.000819188044765,0.069870381224532,0.720160262602946,341,0.055126224185143,1,0.621617423105817,0.052502742463161,2,Putative TSG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0000228~nuclear chromosome,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None,Antagonizes MB and GBM xenograft tumor growth (20103640),Downregulates cyclin D1 while increasing p27 (20103640), 
DEPDC5,DEP domain containing 5,0.000831315316181,0.070582449049737,0.679129881902106,396,0.046290759690447,1,0.886481428527679,1,2,,"GO:0007242~intracellular signaling cascade,",None, , , 
BTBD7,BTB (POZ) domain containing 7,0.000857321799182,0.072461148809577,0.366211567594245,827,0.122976203557728,1,0.177749549869629,5.25701748039053E-05,2,,None,None, , , 
TAOK1,TAO kinase 1,0.000895800516163,0.074367368184078,0.726652759440857,329,0.130381293471046,1,0.337793531458596,1,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008047~enzyme activator activity,GO:0017076~purine nucleotide binding,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0019887~protein kinase regulator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030295~protein kinase activator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04010:MAPK signaling pathway,", , , 
DIP2C,DIP2 disco-interacting protein 2 homolog C (Drosophila),0.000907682543206,0.075020363825406,0.588474234500461,545,0.161034363867777,1,0.211818247318378,2.36996425315283E-12,2,,"GO:0008134~transcription factor binding,",None, , , 
NFATC4,"nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4",0.000920633030422,0.075386121197326,0.582245288722762,556,0.174737163665832,1,0.066428757066903,0.6432859874304,2,,"GO:0006091~generation of precursor metabolites and energy,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007507~heart development,GO:0009611~response to wounding,GO:0015980~energy derivation by oxidation of organic compounds,GO:0032774~RNA biosynthetic process,GO:0045333~cellular respiration,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,","hsa04010:MAPK signaling pathway,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,", , , 
ADAMTS19,"ADAM metallopeptidase with thrombospondin type 1 motif, 19",0.000922008400485,0.075386121197326,0.603680834835533,518,0.312009080922827,1,0.0032032688137,1.6030218456685E-07,2,,"GO:0006508~proteolysis,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
IFNGR2,interferon gamma receptor 2 (interferon gamma transducer 1),0.000983035353745,0.07948968559565,0.481971529772714,689,0.021279639282321,1,1,1,2,,"GO:0007166~cell surface receptor linked signal transduction,GO:0009615~response to virus,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0004896~cytokine receptor activity,GO:0004904~interferon receptor activity,GO:0004906~interferon-gamma receptor activity,GO:0019955~cytokine binding,GO:0019961~interferon binding,GO:0019964~interferon-gamma binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,", , , 
MKRN1,makorin ring finger protein pseudogene 6; makorin ring finger protein 1,0.001021094067554,0.081858438145211,0.774105125127653,270,0.046083612748274,1,0.858711823250435,2.69672488922469E-06,2,,"GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
TYRP1,tyrosinase-related protein 1,0.001036372172975,0.08272818726066,0.776814709504835,260,0.054321413565637,1,0.745415986888831,1.27405255781401E-38,2,,"GO:0006582~melanin metabolic process,GO:0006631~fatty acid metabolic process,GO:0016050~vesicle organization,GO:0019748~secondary metabolic process,GO:0030318~melanocyte differentiation,GO:0032438~melanosome organization,GO:0033059~cellular pigmentation,GO:0042438~melanin biosynthetic process,GO:0042440~pigment metabolic process,GO:0043437~butanoic acid metabolic process,GO:0043438~acetoacetic acid metabolic process,GO:0043473~pigmentation,GO:0046148~pigment biosynthetic process,GO:0046459~short-chain fatty acid metabolic process,GO:0048066~pigmentation during development,GO:0048753~pigment granule organization,GO:0050931~pigment cell differentiation,GO:0055114~oxidation reduction,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0033162~melanosome membrane,GO:0042470~melanosome,GO:0044433~cytoplasmic vesicle part,GO:0045009~chitosome,GO:0048770~pigment granule,GO:0005507~copper ion binding,GO:0016716~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa00350:Tyrosine metabolism,hsa04916:Melanogenesis,", , , 
VPS13A,vacuolar protein sorting 13 homolog A (S. cerevisiae),0.001132905437806,0.09004910924584,0.630483135610588,484,0.049607780939676,1,1,1,2,,"GO:0006892~post-Golgi vesicle-mediated transport,GO:0006895~Golgi to endosome transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,",None, , , 
NCOR2,nuclear receptor co-repressor 2,0.001180029581638,0.093003259727528,0.728257852806492,328,0.025059893954293,1,1,1.27498127945139E-06,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016604~nuclear body,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0005112~Notch binding,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0047485~protein N-terminus binding,GO:0070491~transcription repressor binding,","hsa04330:Notch signaling pathway,", , , 
PUS7,pseudouridylate synthase 7 homolog (S. cerevisiae),0.001263556233124,0.098752999491718,0.68312473472546,391,0.120751955062333,1,0.342096927505986,1,2,,"GO:0001522~pseudouridine synthesis,GO:0006396~RNA processing,GO:0006399~tRNA metabolic process,GO:0008033~tRNA processing,GO:0009451~RNA modification,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0003723~RNA binding,GO:0009982~pseudouridine synthase activity,GO:0016866~intramolecular transferase activity,",None, , , 
NIPBL,Nipped-B homolog (Drosophila),0.001281620954083,0.098923131410398,0.641306751315325,463,0.026499612786958,0.893571396845862,1,1,2,,"GO:0000070~mitotic sister chromatid segregation,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000819~sister chromatid segregation,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0034086~maintenance of sister chromatid cohesion,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0048285~organelle fission,GO:0051276~chromosome organization,GO:0032116~cohesin loading complex,GO:0008022~protein C-terminus binding,",None, , , 
SLC23A2,"solute carrier family 23 (nucleobase transporters), member 2",0.001294886141353,0.099535712898462,0.349974797413346,838,0.239690810977654,1,0.043039943659203,1,2,,"GO:0006766~vitamin metabolic process,GO:0006767~water-soluble vitamin metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006818~hydrogen transport,GO:0006979~response to oxidative stress,GO:0015672~monovalent inorganic cation transport,GO:0015849~organic acid transport,GO:0015851~nucleobase transport,GO:0015882~L-ascorbic acid transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0015993~molecular hydrogen transport,GO:0019852~L-ascorbic acid metabolic process,GO:0030001~metal ion transport,GO:0046942~carboxylic acid transport,GO:0051180~vitamin transport,GO:0055085~transmembrane transport,GO:0070633~transepithelial transport,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0008520~L-ascorbate:sodium symporter activity,GO:0008523~sodium-dependent multivitamin transmembrane transporter activity,GO:0015205~nucleobase transmembrane transporter activity,GO:0015229~L-ascorbic acid transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015370~solute:sodium symporter activity,GO:0015932~nucleobase, nucleoside, nucleotide and nucleic acid transmembrane transporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051183~vitamin transporter activity,",None, , , 
CDC27,cell division cycle 27 homolog (S. cerevisiae),0.001310736290018,0.100341160496918,0.591675202842209,536,0.005997399714248,1,1,0.75007955665158,2,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007091~mitotic metaphase/anaphase transition,GO:0008283~cell proliferation,GO:0009057~macromolecule catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048285~organelle fission,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0015630~microtubule cytoskeleton,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04914:Progesterone-mediated oocyte maturation,", , , 
KCNT2,"potassium channel, subfamily T, member 2",0.001325389823807,0.10104880211792,0.636900817137765,469,0.11670567902345,1,0.621617423105817,1,2,Novel,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005216~ion channel activity,GO:0005227~calcium activated cation channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0005524~ATP binding,GO:0015267~channel activity,GO:0015269~calcium-activated potassium channel activity,GO:0017076~purine nucleotide binding,GO:0022803~passive transmembrane transporter activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022839~ion gated channel activity,GO:0030554~adenyl nucleotide binding,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",None, , , 
GAPVD1,GTPase activating protein and VPS9 domains 1,0.001366215244252,0.103317953633139,0.768644009910008,282,0.357753590349385,1,0.015220087519245,1,2,,"GO:0006897~endocytosis,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0032880~regulation of protein localization,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051223~regulation of protein transport,GO:0070201~regulation of establishment of protein localization,GO:0005768~endosome,GO:0005829~cytosol,GO:0019898~extrinsic to membrane,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0032794~GTPase activating protein binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
RBM15,RNA binding motif protein 15,0.001375025909995,0.103564955535437,0.598124821549975,525,0.019056576285951,1,1,2.97962555952866E-25,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0007221~positive regulation of transcription of Notch receptor target,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0043193~positive regulation of gene-specific transcription,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
SMC4,structural maintenance of chromosomes 4,0.001384555166341,0.103863879325634,0.316376749231081,857,0.305857556518427,1,0.053125090503257,1,2,,"GO:0000070~mitotic sister chromatid segregation,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000819~sister chromatid segregation,GO:0006323~DNA packaging,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0007076~mitotic chromosome condensation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030261~chromosome condensation,GO:0048285~organelle fission,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0000793~condensed chromosome,GO:0000796~condensin complex,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,",None, , , 
WDR47,WD repeat domain 47,0.001564786998986,0.115528285984429,0.711733735590306,354,0.169281950799227,1,0.227591325759547,1.16259844082009E-22,2,,None,None, , , 
DOPEY1,dopey family member 1,0.001589686663811,0.116904555879199,0.585230579814247,551,0.180232923212735,1,0.399243341661191,1.7222884070701E-10,2,,"GO:0006892~post-Golgi vesicle-mediated transport,GO:0006895~Golgi to endosome transport,GO:0007029~endoplasmic reticulum organization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0031090~organelle membrane,GO:0044431~Golgi apparatus part,",None, , , 
MAGED1,"melanoma antigen family D, 1",0.00171805293826,0.125099617545343,0.636080738115902,471,0.130381293471046,1,0.621617423105817,1,2,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0008219~cell death,GO:0008285~negative regulation of cell proliferation,GO:0008624~induction of apoptosis by extracellular signals,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051252~regulation of RNA metabolic process,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,","hsa04722:Neurotrophin signaling pathway,", , , 
KIAA0907,KIAA0907,0.001836244389921,0.131414593713912,0.077888246543173,995,0.177214745363094,1,0.420265180899895,1,2,,None,None, , , 
BRD7,bromodomain containing 7; bromodomain containing 7 pseudogene 2,0.001848325439177,0.131774316329708,0.289923230406164,882,0.087507400804918,1,0.932145335372239,1,2,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0008134~transcription factor binding,GO:0042393~histone binding,",None, , , 
FOSL2,FOS-like antigen 2,0.001894957128448,0.134075394705579,0.649358112135227,447,0.175141656716559,1,0.271476723733921,1,2,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0016265~death,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0048145~regulation of fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0051252~regulation of RNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,",None, , , 
MAP3K4,mitogen-activated protein kinase kinase kinase 4,0.001964232836576,0.136393699458725,0.456532957543676,723,0.246598617607199,1,0.116981176010963,1.12129779034593E-51,2,,"GO:0000165~MAPKKK cascade,GO:0000186~activation of MAPKK activity,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0031098~stress-activated protein kinase signaling pathway,GO:0032147~activation of protein kinase activity,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04010:MAPK signaling pathway,hsa04912:GnRH signaling pathway,", , , 
SNRPN,small nuclear ribonucleoprotein polypeptide N; SNRPN upstream reading frame,0.002050727006537,0.140313295806257,0.680100467720116,395,0.155999549513132,1,0.420265180899895,1.45636163140458E-32,2,,"GO:0006396~RNA processing,GO:0008380~RNA splicing,GO:0005681~spliceosome,GO:0030529~ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0003723~RNA binding,GO:0042802~identical protein binding,",None, , , 
BMPR2,"bone morphogenetic protein receptor, type II (serine/threonine kinase)",0.002250098507673,0.15283487281755,0.771196539993865,274,0.089048777919289,1,0.876560862545503,1.50795514089963E-06,2,,"GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0003002~regionalization,GO:0003013~circulatory system process,GO:0003073~regulation of systemic arterial blood pressure,GO:0003085~negative regulation of systemic arterial blood pressure,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0007498~mesoderm development,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0009267~cellular response to starvation,GO:0009952~anterior/posterior pattern formation,GO:0009991~response to extracellular stimulus,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0014916~regulation of lung blood pressure,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019229~regulation of vasoconstriction,GO:0030278~regulation of ossification,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030500~regulation of bone mineralization,GO:0030501~positive regulation of bone mineralization,GO:0030509~BMP signaling pathway,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032774~RNA biosynthetic process,GO:0033554~cellular response to stress,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042594~response to starvation,GO:0044057~regulation of system process,GO:0045597~positive regulation of cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045776~negative regulation of blood pressure,GO:0045778~positive regulation of ossification,GO:0045906~negative regulation of vasoconstriction,GO:0045937~positive regulation of phosphate metabolic process,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048286~lung alveolus development,GO:0048332~mesoderm morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051094~positive regulation of developmental process,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051241~negative regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0060541~respiratory system development,GO:0070167~regulation of biomineral formation,GO:0070169~positive regulation of biomineral formation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005901~caveola,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004675~transmembrane receptor protein serine/threonine kinase activity,GO:0005024~transforming growth factor beta receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,", , , 
YLPM1,YLP motif containing 1,0.002284232385658,0.153990343715805,0.72844955514978,327,0.13793999673794,0.803736226720888,0.873980185331087,1.12959725013647E-08,2,,"GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None, , , 
ATR,ataxia telangiectasia and Rad3 related; similar to ataxia telangiectasia and Rad3 related protein,0.00229163390709,0.153990343715805,0.494199785799278,672,0.145761173724383,1,0.745415986888831,1,2,,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007242~intracellular signaling cascade,GO:0008156~negative regulation of DNA replication,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016310~phosphorylation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031570~DNA integrity checkpoint,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0043393~regulation of protein binding,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051098~regulation of binding,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051726~regulation of cell cycle,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0000803~sex chromosome,GO:0001739~sex chromatin,GO:0001741~XY body,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032403~protein complex binding,GO:0032404~mismatch repair complex binding,GO:0032405~MutLalpha complex binding,GO:0032407~MutSalpha complex binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04110:Cell cycle,hsa04115:p53 signaling pathway,", , , 
BIRC6,baculoviral IAP repeat-containing 6,0.00229184193763,0.153990343715805,0.426410279330899,761,0.425422271462593,1,0.017865975146768,1,2,,"GO:0006508~proteolysis,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0009057~macromolecule catabolic process,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060548~negative regulation of cell death,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0004842~ubiquitin-protein ligase activity,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0030414~peptidase inhibitor activity,","hsa04120:Ubiquitin mediated proteolysis,", , , 
KDM3B,lysine (K)-specific demethylase 3B,0.002420342459295,0.159971745809814,0.168217048097862,963,0.21192215077881,1,0.271476723733921,0.004339660257983,2,,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0055114~oxidation reduction,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0005506~iron ion binding,GO:0008270~zinc ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
DYRK1A,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,0.0024548125886,0.160326728470153,0.573445651789612,572,0.359769466207178,1,0.086227261596822,1,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0046777~protein amino acid autophosphorylation,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043621~protein self-association,",None, , , 
PABPC3,"poly(A) binding protein, cytoplasmic 3",0.002511878570221,0.162610714374275,0.494981146130172,671,0.079237091276073,1,0.995601060411906,6.24080279738281E-23,2,,"GO:0016071~mRNA metabolic process,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0008143~poly(A) RNA binding,GO:0070717~poly-purine tract binding,",None, , , 
GPR174,G protein-coupled receptor 174,0.002515900018961,0.162610714374275,0.577911468623598,570,0.044704400659365,1,1,2.42817711931182E-22,2,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0001608~nucleotide receptor activity, G-protein coupled,GO:0001614~purinergic nucleotide receptor activity,GO:0016502~nucleotide receptor activity,GO:0045028~purinergic nucleotide receptor activity, G-protein coupled,",None, , , 
CCDC38,coiled-coil domain containing 38,0.002565992572108,0.165276466394523,0.718467259606763,344,0.153982353328314,1,0.745415986888831,0.317696696421422,2,,None,None, , , 
RAPGEF6,Rap guanine nucleotide exchange factor (GEF) 6,0.00259356229294,0.166478178934126,0.646782716472925,451,0.120751955062333,1,0.885242164881095,1.46896225237658E-10,2,,"GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005886~plasma membrane,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0017016~Ras GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0030742~GTP-dependent protein binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
SUZ12,suppressor of zeste 12 homolog (Drosophila),0.002621742151358,0.167710690565837,0.774350592513348,268,0.168817629068277,1,0.693453523010957,0.187139382230896,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0008213~protein amino acid alkylation,GO:0008284~positive regulation of cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016567~protein ubiquitination,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0016574~histone ubiquitination,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032259~methylation,GO:0032446~protein modification by small protein conjugation,GO:0042127~regulation of cell proliferation,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0070647~protein modification by small protein conjugation or removal,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0000803~sex chromosome,GO:0001739~sex chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0031519~PcG protein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0035098~ESC/E(Z) complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
GGNBP2,gametogenetin binding protein 2,0.002659699209131,0.168981365739284,0.634121934937255,475,0.177605070258454,1,0.621617423105817,0.008060281318908,2,,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,",None, , , 
TNIK,TRAF2 and NCK interacting kinase,0.002686283918135,0.170091855277411,0.312245791441945,862,0.512535884928564,1,0.024044410070431,0.086748277565797,2,,"GO:0000165~MAPKKK cascade,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0016310~phosphorylation,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
ABCA10,"ATP-binding cassette, sub-family A (ABC1), member 10",0.002709037330485,0.170377469010548,0.633285373487827,477,0.097770001488037,1,1,1,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa02010:ABC transporters,", , , 
BCL9,B-cell CLL/lymphoma 9,0.002922002043391,0.180132264582502,0.384884529252603,809,0.162811867918105,1,0.615410746633911,1.09941515636655E-12,2,,"GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway,",None, , , 
WWP1,WW domain containing E3 ubiquitin protein ligase 1,0.002941023550849,0.180708483244464,0.445378699929169,738,0.174737163665832,1,0.75656219934849,1,2,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016032~viral reproduction,GO:0016481~negative regulation of transcription,GO:0016567~protein ubiquitination,GO:0019058~viral infectious cycle,GO:0019059~initiation of viral infection,GO:0019941~modification-dependent protein catabolic process,GO:0022415~viral reproductive process,GO:0030163~protein catabolic process,GO:0030260~entry into host cell,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044409~entry into host,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046718~entry of virus into host cell,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051806~entry into cell of other organism during symbiotic interaction,GO:0051828~entry into other organism during symbiotic interaction,GO:0052126~movement in host environment,GO:0052192~movement in environment of other organism during symbiotic interaction,GO:0070647~protein modification by small protein conjugation or removal,GO:0000151~ubiquitin ligase complex,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,","hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,", , , 
UNC13C,unc-13 homolog C (C. elegans),0.003023870342768,0.183385954975843,0.678504181935535,400,0.106883065574235,1,0.990178279265157,0.004280647212346,2,,"GO:0006887~exocytosis,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0016192~vesicle-mediated transport,GO:0019226~transmission of nerve impulse,GO:0032940~secretion by cell,GO:0046903~secretion,GO:0050877~neurological system process,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019992~diacylglycerol binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
NEUROD6,neurogenic differentiation 6,0.003043524068683,0.183891627263178,0.712097933771092,353,0.105888928450367,1,0.904617443377186,1,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0030528~transcription regulator activity,",None, , , 
BCORL1,BCL6 co-repressor-like 1,0.003132529178036,0.187540104219689,0.631329287704383,482,0.087507400804918,1,1,1,2,,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,",None, , , 
PHF20L1,PHD finger protein 20-like 1,0.003145974977538,0.187660260846385,0.16367012723898,964,0.337520807549262,0.893571396845862,0.271476723733921,1,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CLSPN,claspin homolog (Xenopus laevis),0.003237827025538,0.190786659337607,0.779934699142552,256,0.107155541229646,1,1,0.0553823267197,2,,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0033554~cellular response to stress,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,",None, , , 
USP26,ubiquitin specific peptidase 26,0.003335797343152,0.194110151316926,0.606036651091924,514,0.055398111628506,1,1,1,2,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0004221~ubiquitin thiolesterase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
ATF7IP,activating transcription factor 7 interacting protein,0.003361146706757,0.194977824023346,0.774457967228908,266,0.174737163665832,1,0.858711823250435,2.71353255802183E-10,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006730~one-carbon metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032259~methylation,GO:0040029~regulation of gene expression, epigenetic,GO:0043254~regulation of protein complex assembly,GO:0043414~biopolymer methylation,GO:0044087~regulation of cellular component biogenesis,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045898~regulation of transcriptional preinitiation complex assembly,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060260~regulation of transcription initiation from RNA polymerase II promoter,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0016887~ATPase activity,GO:0030528~transcription regulator activity,",None, , , 
CEP290,centrosomal protein 290kDa,0.003503578249717,0.201364117312207,0.612188430512668,507,0.167851103687091,1,0.780284580214678,0.750247655945318,2,,"GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001754~eye photoreceptor cell differentiation,GO:0001822~kidney development,GO:0007423~sensory organ development,GO:0008104~protein localization,GO:0015031~protein transport,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030902~hindbrain development,GO:0030916~otic vesicle formation,GO:0042461~photoreceptor cell development,GO:0042462~eye photoreceptor cell development,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043583~ear development,GO:0045184~establishment of protein localization,GO:0046530~photoreceptor cell differentiation,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048592~eye morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048666~neuron development,GO:0048793~pronephros development,GO:0048839~inner ear development,GO:0000930~gamma-tubulin complex,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0009986~cell surface,GO:0015630~microtubule cytoskeleton,GO:0031513~nonmotile primary cilium,GO:0032391~photoreceptor connecting cilium,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044450~microtubule organizing center part,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0051011~microtubule minus-end binding,",None, , , 
NOTCH3,Notch homolog 3 (Drosophila),0.003567003396608,0.202251355983671,0.178746501287765,958,0.417456662157889,1,0.08825557681226,1,2,,"GO:0006350~transcription,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0009611~response to wounding,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031099~regeneration,GO:0040007~growth,GO:0042060~wound healing,GO:0042246~tissue regeneration,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0048589~developmental growth,GO:0048663~neuron fate commitment,GO:0050767~regulation of neurogenesis,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04320:Dorso-ventral axis formation,hsa04330:Notch signaling pathway,", , , 
MBNL1,muscleblind-like (Drosophila),0.003570157839176,0.202251355983671,0.501256447032116,662,0.182558735089103,1,0.793026157219052,1,2,,"GO:0000245~spliceosome assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000381~regulation of alternative nuclear mRNA splicing, via spliceosome,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,GO:0006376~mRNA splice site selection,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0008380~RNA splicing,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014706~striated muscle tissue development,GO:0016071~mRNA metabolic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0030326~embryonic limb morphogenesis,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0042692~muscle cell differentiation,GO:0043009~chordate embryonic development,GO:0043484~regulation of RNA splicing,GO:0043933~macromolecular complex subunit organization,GO:0045445~myoblast differentiation,GO:0048024~regulation of nuclear mRNA splicing, via spliceosome,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0050684~regulation of mRNA processing,GO:0051252~regulation of RNA metabolic process,GO:0060173~limb development,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0065003~macromolecular complex assembly,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
JAK1,Janus kinase 1,0.003605637429336,0.202251355983671,0.525340547575546,626,0.174737163665832,1,0.86861908420637,0.00294968261306,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0019221~cytokine-mediated signaling pathway,GO:0046677~response to antibiotic,GO:0005856~cytoskeleton,GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005131~growth hormone receptor binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0051427~hormone receptor binding,","hsa04630:Jak-STAT signaling pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,", , , 
DHX15,DEAH (Asp-Glu-Ala-His) box polypeptide 15,0.003618116186983,0.202343689391173,0.683140660365472,390,0.253978746572756,1,0.342096927505986,1,2,,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0005681~spliceosome,GO:0005689~U12-dependent spliceosome,GO:0030529~ribonucleoprotein complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,","hsa03040:Spliceosome,", , , 
ARID5B,AT rich interactive domain 5B (MRF1-like),0.003758831677944,0.208341889947505,0.765199578107394,286,0.030639687096075,1,1,1,2,,"GO:0001501~skeletal system development,GO:0001655~urogenital system development,GO:0001667~ameboidal cell migration,GO:0001822~kidney development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007517~muscle organ development,GO:0009791~post-embryonic development,GO:0009890~negative regulation of biosynthetic process,GO:0010171~body morphogenesis,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010761~fibroblast migration,GO:0016477~cell migration,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0035264~multicellular organism growth,GO:0040007~growth,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048644~muscle organ morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048870~cell motility,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051674~localization of cell,GO:0060021~palate development,GO:0060322~head development,GO:0060323~head morphogenesis,GO:0060324~face development,GO:0060325~face morphogenesis,GO:0003677~DNA binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,",None, , , 
TCF4,transcription factor 4,0.003835614938362,0.211343514553602,0.691459365355615,376,0.301799987891845,0.985776716444512,0.505087244311173,2.6091391904053E-30,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,",None, , , 
IRF6,interferon regulatory factor 6,0.003859139358399,0.212014306104502,0.557946130105608,589,0.486796451653496,0.803233148882281,0.111721095746119,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007398~ectoderm development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008544~epidermis development,GO:0009891~positive regulation of biosynthetic process,GO:0009913~epidermal cell differentiation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0022402~cell cycle process,GO:0030216~keratinocyte differentiation,GO:0030855~epithelial cell differentiation,GO:0030879~mammary gland development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0043588~skin development,GO:0043616~keratinocyte proliferation,GO:0045449~regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048732~gland development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0060429~epithelium development,GO:0060644~mammary gland epithelial cell differentiation,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
TMEM131,transmembrane protein 131,0.003910119116091,0.212989846890806,0.606315996051592,512,0.050288326939349,1,1,1,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
RLTPR,"RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing",0.003911104314125,0.212989846890806,0.569165530960589,575,0.165392144348526,1,0.886481428527679,8.04497152977909E-08,2,,None,None, , , 
ITSN1,intersectin 1 (SH3 domain protein),0.004006410230644,0.216915178835364,0.5343219289526,615,0.423930576077157,1,0.177749549869629,1,2,,"GO:0006897~endocytosis,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0009967~positive regulation of signal transduction,GO:0010324~membrane invagination,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0035023~regulation of Rho protein signal transduction,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0046578~regulation of Ras protein signal transduction,GO:0048488~synaptic vesicle endocytosis,GO:0048489~synaptic vesicle transport,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051896~regulation of protein kinase B signaling cascade,GO:0051897~positive regulation of protein kinase B signaling cascade,GO:0060548~negative regulation of cell death,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019717~synaptosome,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030139~endocytic vesicle,GO:0031252~cell leading edge,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005509~calcium ion binding,GO:0008047~enzyme activator activity,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
ZFHX3,zinc finger homeobox 3; hypothetical LOC100132068,0.004029269526706,0.21752232800388,0.764432223222261,287,0.138169031741598,1,0.886481428527679,5.06819514956786E-16,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016202~regulation of striated muscle tissue development,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045661~regulation of myoblast differentiation,GO:0045662~negative regulation of myoblast differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048634~regulation of muscle development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048742~regulation of skeletal muscle fiber development,GO:0051094~positive regulation of developmental process,GO:0051147~regulation of muscle cell differentiation,GO:0051148~negative regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0060284~regulation of cell development,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005739~mitochondrion,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003705~RNA polymerase II transcription factor activity, enhancer binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0016564~transcription repressor activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
TACR1,tachykinin receptor 1,0.004112349069411,0.219470195050082,0.760881219369987,291,0.135733266886633,1,0.910322520092466,1,2,,"GO:0001508~regulation of action potential,GO:0002118~aggressive behavior,GO:0002526~acute inflammatory response,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0003012~muscle system process,GO:0003013~circulatory system process,GO:0003014~renal system process,GO:0003078~regulation of natriuresis,GO:0003079~positive regulation of natriuresis,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006936~muscle contraction,GO:0006937~regulation of muscle contraction,GO:0006939~smooth muscle contraction,GO:0006940~regulation of smooth muscle contraction,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007217~tachykinin receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007320~insemination,GO:0007588~excretion,GO:0007600~sensory perception,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007613~memory,GO:0007616~long-term memory,GO:0007618~mating,GO:0007620~copulation,GO:0007631~feeding behavior,GO:0007638~mechanosensory behavior,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0008284~positive regulation of cell proliferation,GO:0008306~associative learning,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0009582~detection of abiotic stimulus,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010193~response to ozone,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010632~regulation of epithelial cell migration,GO:0010634~positive regulation of epithelial cell migration,GO:0010638~positive regulation of organelle organization,GO:0010647~positive regulation of cell communication,GO:0010863~positive regulation of phospholipase C activity,GO:0014070~response to organic cyclic substance,GO:0014072~response to isoquinoline alkaloid,GO:0014832~urinary bladder smooth muscle contraction,GO:0014848~urinary tract smooth muscle contraction,GO:0019229~regulation of vasoconstriction,GO:0019233~sensory perception of pain,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0032222~regulation of synaptic transmission, cholinergic,GO:0032224~positive regulation of synaptic transmission, cholinergic,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0032230~positive regulation of synaptic transmission, GABAergic,GO:0032231~regulation of actin filament bundle formation,GO:0032233~positive regulation of actin filament bundle formation,GO:0032504~multicellular organism reproduction,GO:0032844~regulation of homeostatic process,GO:0032846~positive regulation of homeostatic process,GO:0032944~regulation of mononuclear cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0033555~multicellular organismal response to stress,GO:0035094~response to nicotine,GO:0035106~operant conditioning,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0042713~sperm ejaculation,GO:0042755~eating behavior,GO:0043085~positive regulation of catalytic activity,GO:0043278~response to morphine,GO:0043279~response to alkaloid,GO:0044057~regulation of system process,GO:0044062~regulation of excretion,GO:0044087~regulation of cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0045471~response to ethanol,GO:0045760~positive regulation of action potential,GO:0045777~positive regulation of blood pressure,GO:0045907~positive regulation of vasoconstriction,GO:0045933~positive regulation of muscle contraction,GO:0045987~positive regulation of smooth muscle contraction,GO:0046903~secretion,GO:0048015~phosphoinositide-mediated signaling,GO:0048265~response to pain,GO:0048266~behavioral response to pain,GO:0048609~reproductive process in a multicellular organism,GO:0048878~chemical homeostasis,GO:0050670~regulation of lymphocyte proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050801~ion homeostasis,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0051492~regulation of stress fiber formation,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051496~positive regulation of stress fiber formation,GO:0051606~detection of stimulus,GO:0051705~behavioral interaction between organisms,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060073~micturition,GO:0060083~smooth muscle contraction involved in micturition,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0070472~regulation of uterine smooth muscle contraction,GO:0070474~positive regulation of uterine smooth muscle contraction,GO:0070663~regulation of leukocyte proliferation,GO:0070665~positive regulation of leukocyte proliferation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044459~plasma membrane part,GO:0001653~peptide receptor activity,GO:0004995~tachykinin receptor activity,GO:0008188~neuropeptide receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0016496~substance P receptor activity,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,GO:0042277~peptide binding,GO:0042923~neuropeptide binding,","hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,", , , 
HECTD1,HECT domain containing 1,0.004325639764413,0.228891289403586,0.215117373353775,936,0.60360720344515,1,0.01395172132005,1,2,,"GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014020~primary neural tube formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0021915~neural tube development,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0043009~chordate embryonic development,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0070647~protein modification by small protein conjugation or removal,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
PPFIA4,"protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4",0.004424683778414,0.232849234141138,0.445571215060332,737,0.297499369774666,1,0.511640754947858,1,2,,"GO:0009986~cell surface,",None, , , 
CHD9,chromodomain helicase DNA binding protein 9,0.004425369565828,0.232849234141138,0.254588772176221,912,0.55657847925564,1,0.01395172132005,1,2,,"GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
MSH2,"mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)",0.004457398381636,0.233875686434207,0.744426627271321,308,0.102747334710875,1,1,1,2,,"GO:0000018~regulation of DNA recombination,GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0001101~response to acid,GO:0001701~in utero embryonic development,GO:0001775~cell activation,GO:0002200~somatic diversification of immune receptors,GO:0002204~somatic recombination of immunoglobulin genes during immune response,GO:0002208~somatic diversification of immunoglobulins during immune response,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002377~immunoglobulin production,GO:0002381~immunoglobulin production during immune response,GO:0002440~production of molecular mediator of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002562~somatic diversification of immune receptors via germline recombination within a single locus,GO:0002566~somatic diversification of immune receptors via somatic mutation,GO:0003006~reproductive developmental process,GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006928~cell motion,GO:0006955~immune response,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007242~intracellular signaling cascade,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007548~sex differentiation,GO:0007568~aging,GO:0008219~cell death,GO:0008340~determination of adult life span,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009165~nucleotide biosynthetic process,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010033~response to organic substance,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010224~response to UV-B,GO:0010243~response to organic nitrogen,GO:0010259~multicellular organismal aging,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0014070~response to organic cyclic substance,GO:0014075~response to amine stimulus,GO:0016064~immunoglobulin mediated immune response,GO:0016265~death,GO:0016310~phosphorylation,GO:0016444~somatic cell DNA recombination,GO:0016445~somatic diversification of immunoglobulins,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030183~B cell differentiation,GO:0031570~DNA integrity checkpoint,GO:0031573~intra-S DNA damage checkpoint,GO:0032504~multicellular organism reproduction,GO:0033554~cellular response to stress,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042113~B cell activation,GO:0042493~response to drug,GO:0042770~DNA damage response, signal transduction,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043200~response to amino acid stimulus,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043570~maintenance of DNA repeat elements,GO:0044093~positive regulation of molecular function,GO:0044271~nitrogen compound biosynthetic process,GO:0045137~development of primary sexual characteristics,GO:0045190~isotype switching,GO:0045321~leukocyte activation,GO:0045910~negative regulation of DNA recombination,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046546~development of primary male sexual characteristics,GO:0046649~lymphocyte activation,GO:0046661~male sex differentiation,GO:0048232~male gamete generation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051095~regulation of helicase activity,GO:0051096~positive regulation of helicase activity,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051726~regulation of cell cycle,GO:0060548~negative regulation of cell death,GO:0032300~mismatch repair complex,GO:0032301~MutSalpha complex,GO:0032302~MutSbeta complex,GO:0000166~nucleotide binding,GO:0000217~DNA secondary structure binding,GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004422~hypoxanthine phosphoribosyltransferase activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016763~transferase activity, transferring pentosyl groups,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019237~centromeric DNA binding,GO:0030554~adenyl nucleotide binding,GO:0030983~mismatched DNA binding,GO:0032134~mispaired DNA binding,GO:0032135~DNA insertion or deletion binding,GO:0032137~guanine/thymine mispair binding,GO:0032138~single base insertion or deletion binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032181~dinucleotide repeat insertion binding,GO:0032356~oxidized DNA binding,GO:0032357~oxidized purine DNA binding,GO:0032403~protein complex binding,GO:0032404~mismatch repair complex binding,GO:0032405~MutLalpha complex binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043531~ADP binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,","hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,",Cancer gene census (14993899),0, 
SHANK1,SH3 and multiple ankyrin repeat domains 1,0.004598043010448,0.239476844746496,0.585912605634922,550,0.305857556518427,1,0.503116045574968,5.05310170646388E-21,2,,"GO:0007010~cytoskeleton organization,GO:0007016~cytoskeletal anchoring at plasma membrane,GO:0008104~protein localization,GO:0032507~maintenance of protein location in cell,GO:0045185~maintenance of protein location,GO:0051235~maintenance of location,GO:0051651~maintenance of location in cell,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,",None, , , 
MAP4K4,mitogen-activated protein kinase kinase kinase kinase 4,0.00480442114266,0.246888468440076,0.580529956955733,561,0.646696693936275,1,0.024938613744621,1,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,", , , 
TMEM63A,transmembrane protein 63A,0.004811146341463,0.246888468440076,0.416990205892016,774,0.093354163157057,1,1,1,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
SCAF8,SR-Related CTD-Associated Factor 8,0.004880846737262,0.249779003302223,0.513911936016944,647,0.58944092900803,1,0.033422181864404,2.71698813489224E-38,2,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0016071~mRNA metabolic process,GO:0032774~RNA biosynthetic process,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0019904~protein domain specific binding,",None, , , 
ZNF225,zinc finger protein 225,0.004961809235158,0.252756047521885,0.665012581905964,424,0.266260812542937,1,0.710053497962842,6.36089800846893E-10,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
MAP4K3,mitogen-activated protein kinase kinase kinase kinase 3,0.004974184534665,0.252756047521885,0.657067756910012,437,0.420672500018157,1,0.227591325759547,1,2,,"GO:0000165~MAPKKK cascade,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0016310~phosphorylation,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,", , , 
CCPG1,cell cycle progression 1,0.005034949490926,0.25487214509759,0.6991168081983,365,0.093354163157057,1,1,9.69498478203268E-05,2,,"GO:0007049~cell cycle,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
LARP1,"La ribonucleoprotein domain family, member 1",0.005052532892715,0.254916232891559,0.663199923765314,429,0.160176446289636,0.319328035851206,1,0.008023793519646,2,,"GO:0003723~RNA binding,",None, , , 
TOP2B,topoisomerase (DNA) II beta 180kDa,0.005090409276115,0.254916232891559,0.642042111653937,460,0.305857556518427,1,0.621617423105817,5.56806730625968E-29,2,,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001764~neuron migration,GO:0006259~DNA metabolic process,GO:0006265~DNA topological change,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0016477~cell migration,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0000785~chromatin,GO:0000792~heterochromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003916~DNA topoisomerase activity,GO:0003918~DNA topoisomerase (ATP-hydrolyzing) activity,GO:0005080~protein kinase C binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042826~histone deacetylase binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,",None, , , 
FSIP2,fibrous sheath interacting protein 2,0.005169212076759,0.256882317916771,0.297723324830528,873,0.056901825188845,1,1,1,2,,"GO:0030529~ribonucleoprotein complex,",None, , , 
FXR1,"fragile X mental retardation, autosomal homolog 1",0.005170927326768,0.256882317916771,0.590096178429939,539,0.232970444914403,1,0.876560862545503,1,2,,"GO:0006915~apoptosis,GO:0007517~muscle organ development,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0005730~nucleolus,GO:0005844~polysome,GO:0030016~myofibril,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043034~costamere,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0043292~contractile fiber,GO:0044449~contractile fiber part,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,",None, , , 
ZMYM2,"zinc finger, MYM-type 2",0.005245570922499,0.25852775530704,0.700406488603168,364,0.145761173724383,1,1,9.58751786732146E-39,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016605~PML body,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CUX1,cut-like homeobox 1,0.00542182380057,0.26581167131458,0.479991689894242,691,0.305857556518427,0.774598070770008,0.742087095988098,1,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0007423~sensory organ development,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016192~vesicle-mediated transport,GO:0016481~negative regulation of transcription,GO:0030182~neuron differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0035295~tube development,GO:0042490~mechanoreceptor differentiation,GO:0042491~auditory receptor cell differentiation,GO:0043583~ear development,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0048839~inner ear development,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0060113~inner ear receptor cell differentiation,GO:0060541~respiratory system development,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0030173~integral to Golgi membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031228~intrinsic to Golgi membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0044431~Golgi apparatus part,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
IVNS1ABP,influenza virus NS1A binding protein,0.005460414024133,0.266366099728939,0.296749752573306,876,0.237324390669666,1,0.649072210399093,1,2,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006383~transcription from RNA polymerase III promoter,GO:0006396~RNA processing,GO:0008380~RNA splicing,GO:0009615~response to virus,GO:0032774~RNA biosynthetic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005681~spliceosome,GO:0005856~cytoskeleton,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None, , , 
KIAA0430,KIAA0430,0.005497119869882,0.267397661587326,0.588523446936756,544,0.307960290412395,0.481191066842005,0.745415986888831,1,2,,"GO:0005777~peroxisome,GO:0042579~microbody,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
SLC4A4,"solute carrier family 4, sodium bicarbonate cotransporter, member 4",0.005534130685706,0.268498771631977,0.461839254820197,720,0.517940367697009,1,0.122408621449127,1,2,,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006820~anion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0008509~anion transmembrane transporter activity,GO:0008510~sodium:bicarbonate symporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015296~anion:cation symporter activity,GO:0015297~antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015301~anion:anion antiporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
BIN2,bridging integrator 2,0.005651382882354,0.270672258614058,0.553538409734726,592,0.361916757647146,0.7340956733644,0.571300529550603,1,2,,None,None, , , 
INPP4B,"inositol polyphosphate-4-phosphatase, type II, 105kDa",0.005742638641113,0.272943377041617,0.759469842944897,294,0.34645920598726,1,0.514558837116276,0.268947350766013,2,,"GO:0004437~inositol or phosphatidylinositol phosphatase activity,GO:0016316~phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,GO:0016791~phosphatase activity,GO:0034593~phosphatidylinositol bisphosphate phosphatase activity,GO:0034596~phosphoinositide 4-phosphatase activity,GO:0034597~phosphatidyl-inositol-4,5-bisphosphate 4-phosphatase activity,GO:0042577~lipid phosphatase activity,","hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,", , , 
CNTLN,"centlein, centrosomal protein",0.005897153675396,0.278868186082849,0.636561929052857,470,0.161034363867777,1,1,3.49872198570028E-45,2,,"GO:0005813~centrosome,GO:0005814~centriole,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044450~microtubule organizing center part,GO:0000155~two-component sensor activity,GO:0004672~protein kinase activity,GO:0004673~protein histidine kinase activity,GO:0016775~phosphotransferase activity, nitrogenous group as acceptor,",None, , , 
MAP4K5,mitogen-activated protein kinase kinase kinase kinase 5,0.006233534465842,0.290364564307893,0.75888403710206,296,0.093354163157057,1,1,1,2,,"GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0001932~regulation of protein amino acid phosphorylation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0007257~activation of JUN kinase activity,GO:0010627~regulation of protein kinase cascade,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0031098~stress-activated protein kinase signaling pathway,GO:0031399~regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043506~regulation of JUN kinase activity,GO:0043507~positive regulation of JUN kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046328~regulation of JNK cascade,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
PCNX,pecanex homolog (Drosophila),0.006376259209152,0.294079372266046,0.581549843198904,557,0.724261534730691,1,0.023691065120671,1.30905203136123E-07,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
RASAL2,RAS protein activator like 2,0.00645491669278,0.295163246703645,0.542679781264088,608,0.281031984091124,1,0.86861908420637,1,2,,"GO:0051056~regulation of small GTPase mediated signal transduction,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
LRIG3,leucine-rich repeats and immunoglobulin-like domains 3,0.006849770656687,0.303847066467257,0.575494672034679,571,0.368191685376496,0.817879873922511,0.656276216627911,1,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
GCC2,GRIP and coiled-coil domain containing 2,0.006895863690675,0.303847066467257,0.656419449342911,440,0.183395805588652,1,1,1,2,,"GO:0005794~Golgi apparatus,GO:0019898~extrinsic to membrane,GO:0042802~identical protein binding,",None, , , 
MKI67,antigen identified by monoclonal antibody Ki-67,0.007012026632103,0.307459261645681,0.691736313043208,375,0.128251416750461,1,1,4.38141718798511E-14,2,,"GO:0000279~M phase,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0008283~cell proliferation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
TSPYL2,TSPY-like 2,0.007184182196435,0.310632729738911,0.665776880354439,421,0.186178157603384,0.468960239540674,1,1,2,,"GO:0001558~regulation of cell growth,GO:0006275~regulation of DNA replication,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0006350~transcription,GO:0007049~cell cycle,GO:0008156~negative regulation of DNA replication,GO:0008361~regulation of cell size,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016568~chromatin modification,GO:0019220~regulation of phosphate metabolic process,GO:0030308~negative regulation of cell growth,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031497~chromatin assembly,GO:0032535~regulation of cellular component size,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0040008~regulation of growth,GO:0042325~regulation of phosphorylation,GO:0043549~regulation of kinase activity,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045926~negative regulation of growth,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051276~chromosome organization,GO:0051338~regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000182~rDNA binding,GO:0003677~DNA binding,GO:0043565~sequence-specific DNA binding,",None, , , 
ZNF608,zinc finger protein 608,0.007301356580804,0.314970068297556,0.589970298298889,540,0.512094081736782,1,0.131320291423494,1.17137398369423E-12,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ADAM33,ADAM metallopeptidase domain 33,0.007347181621564,0.316216602555765,0.678605215522869,399,0.307346459704176,1,0.775559138960562,1,2,,"GO:0006508~proteolysis,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
CFHR4,complement factor H-related 4,0.007599382284192,0.323220617193737,0.691817559290772,374,0.533557881661922,1,0.11371447328757,0.039668679427406,2,,"GO:0005576~extracellular region,GO:0005319~lipid transporter activity,",None, , , 
OBSL1,obscurin-like 1,0.007716015433485,0.324611379013684,0.514679910053753,646,0.232970444914403,1,0.886481428527679,8.31438658126394E-50,2,,"GO:0007010~cytoskeleton organization,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0010927~cellular component assembly involved in morphogenesis,GO:0014706~striated muscle tissue development,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030239~myofibril assembly,GO:0031032~actomyosin structure organization,GO:0032989~cellular component morphogenesis,GO:0035051~cardiac cell differentiation,GO:0042692~muscle cell differentiation,GO:0048738~cardiac muscle tissue development,GO:0051146~striated muscle cell differentiation,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055003~cardiac myofibril assembly,GO:0055006~cardiac cell development,GO:0055007~cardiac muscle cell differentiation,GO:0055013~cardiac muscle cell development,GO:0060537~muscle tissue development,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0014704~intercalated disc,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0030054~cell junction,GO:0031430~M band,GO:0031672~A band,GO:0031674~I band,GO:0043292~contractile fiber,GO:0044449~contractile fiber part,GO:0044459~plasma membrane part,GO:0048471~perinuclear region of cytoplasm,GO:0008092~cytoskeletal protein binding,GO:0008093~cytoskeletal adaptor activity,GO:0060090~molecular adaptor activity,",None, , , 
ASUN,"Asunder, Spermatogenesis Regulator",0.007920226297918,0.327305104023908,0.275579460786661,894,0.385298958388893,1,0.420265180899895,1,2,,"GO:0007346~regulation of mitotic cell cycle,GO:0051726~regulation of cell cycle,",None, , , 
ST8SIA6,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6",0.007951245861808,0.32786163676095,0.506572758582535,655,0.280244211721961,1,0.75656219934849,1,2,,"GO:0006486~protein amino acid glycosylation,GO:0006493~protein amino acid O-linked glycosylation,GO:0006643~membrane lipid metabolic process,GO:0006664~glycolipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009247~glycolipid biosynthetic process,GO:0016051~carbohydrate biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0046467~membrane lipid biosynthetic process,GO:0070085~glycosylation,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0030173~integral to Golgi membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031228~intrinsic to Golgi membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0044431~Golgi apparatus part,GO:0008373~sialyltransferase activity,",None, , , 
NRXN2,neurexin 2,0.008088142514186,0.331720749101039,0.68319013058454,389,0.773989645351894,0.893571396845862,0.039525310152689,1,2,,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04514:Cell adhesion molecules (CAMs),", , , 
ARID4B,AT rich interactive domain 4B (RBP1-like),0.008098113474494,0.331720749101039,0.510209320180705,651,0.163504701136778,1,1,0.739075834582236,2,,"GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,GO:0003682~chromatin binding,",None, , , 
ARHGEF25,Rho Guanine Nucleotide Exchange Factor (GEF) 25,0.00822181905735,0.335317375921918,0.70149219066524,362,0.185909373910715,1,1,1,2,,"GO:0035023~regulation of Rho protein signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0055085~transmembrane transport,GO:0005829~cytosol,GO:0016021~integral to membrane,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0031224~intrinsic to membrane,GO:0043292~contractile fiber,GO:0044449~contractile fiber part,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0015297~antiporter activity,GO:0030695~GTPase regulator activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
CLCN5,chloride channel 5,0.008484674842503,0.341911421057768,0.614974543339413,505,0.301799987891845,1,0.745415986888831,1,2,,"GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0006897~endocytosis,GO:0007588~excretion,GO:0010324~membrane invagination,GO:0015698~inorganic anion transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0046903~secretion,GO:0055085~transmembrane transport,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005247~voltage-gated chloride channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0005524~ATP binding,GO:0008308~voltage-gated anion channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015297~antiporter activity,GO:0017076~purine nucleotide binding,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030554~adenyl nucleotide binding,GO:0031404~chloride ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043168~anion binding,",None, , , 
ACIN1,apoptotic chromatin condensation inducer 1,0.00859669696422,0.344405790176185,0.559089065386664,587,0.283501531305966,1,0.806613549597766,0.268757118535646,2,,"GO:0002520~immune system development,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0006323~DNA packaging,GO:0006915~apoptosis,GO:0006997~nucleus organization,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030261~chromosome condensation,GO:0030262~apoptotic nuclear changes,GO:0030263~apoptotic chromosome condensation,GO:0034101~erythrocyte homeostasis,GO:0042592~homeostatic process,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045655~regulation of monocyte differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048872~homeostasis of number of cells,GO:0051094~positive regulation of developmental process,GO:0051276~chromosome organization,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0016887~ATPase activity,GO:0019899~enzyme binding,","hsa03040:Spliceosome,", , , 
CR1,complement component (3b/4b) receptor 1 (Knops blood group),0.008654792811985,0.345433493451014,0.53653934187494,612,0.561253735900602,1,0.165988437655367,1,2,,"GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002526~acute inflammatory response,GO:0002541~activation of plasma proteins involved in acute inflammatory response,GO:0002684~positive regulation of immune system process,GO:0006508~proteolysis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0006959~humoral immune response,GO:0009611~response to wounding,GO:0016064~immunoglobulin mediated immune response,GO:0016485~protein processing,GO:0019724~B cell mediated immunity,GO:0045087~innate immune response,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0051604~protein maturation,GO:0051605~protein maturation by peptide bond cleavage,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0001848~complement binding,GO:0004875~complement receptor activity,","hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,", , , 
TNRC18,trinucleotide repeat containing 18,0.008796823855929,0.348865971984918,0.468676026326922,712,0.382078818022627,1,0.621617423105817,1.33678691807053E-10,2,,"GO:0003677~DNA binding,",None, , , 
EML5,echinoderm microtubule associated protein like 5,0.008939017489558,0.350045928065926,0.387979246223914,805,0.568662887694174,1,0.121054347379931,6.75200371468162E-05,2,,"GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",None, , , 
NFE2L3,nuclear factor (erythroid-derived 2)-like 3,0.009142702368924,0.356527218265417,0.697206699736161,369,0.065496806417895,1,1,1,2,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,",None, , , 
KMT2E,"Myeloid/Lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog,
Drosophila)",0.009294686026783,0.361698833946424,0.215083932176874,937,0.434004138197617,1,0.654173945238299,1,2,,"GO:0001775~cell activation,GO:0002252~immune effector process,GO:0002274~myeloid leukocyte activation,GO:0002443~leukocyte mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002446~neutrophil mediated immunity,GO:0002520~immune system development,GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0006955~immune response,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007242~intracellular signaling cascade,GO:0007584~response to nutrient,GO:0008213~protein amino acid alkylation,GO:0009891~positive regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0022402~cell cycle process,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031667~response to nutrient levels,GO:0032259~methylation,GO:0032526~response to retinoic acid,GO:0033189~response to vitamin A,GO:0033273~response to vitamin,GO:0034101~erythrocyte homeostasis,GO:0040029~regulation of gene expression, epigenetic,GO:0042119~neutrophil activation,GO:0042592~homeostatic process,GO:0043414~biopolymer methylation,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048384~retinoic acid receptor signaling pathway,GO:0048534~hemopoietic or lymphoid organ development,GO:0048872~homeostasis of number of cells,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070688~MLL5-L complex,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004308~exo-alpha-sialidase activity,GO:0008134~transcription factor binding,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016563~transcription activator activity,GO:0016997~alpha-sialidase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
MYBL1,v-myb myeloblastosis viral oncogene homolog (avian)-like 1,0.009458004525135,0.367289119594603,0.374694569160213,818,0.34715108213451,1,0.886481428527679,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None, , , 
CCDC18,coiled-coil domain containing 18,0.009587161776391,0.371532354400846,0.400910719492625,790,0.484383830794475,1,0.43858482390646,5.94745975572164E-18,2,,None,None, , , 
YTHDC1,YTH domain containing 1,0.009797600673626,0.376562516425244,0.672437430268385,409,0.314586261877537,1,0.771592454005998,5.86400471552389E-11,2,,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None, , , 
HEPACAM2,HEPACAM family member 2,0.009818726481208,0.376599572777158,0.493387837297424,674,0.122171974120509,1,1,1,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
ADNP,activity-dependent neuroprotector homeobox,0.010033289567098,0.380145671042255,0.607533526346964,510,0.168077503702506,1,1,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006497~protein amino acid lipidation,GO:0006505~GPI anchor metabolic process,GO:0006506~GPI anchor biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006720~isoprenoid metabolic process,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0010941~regulation of cell death,GO:0016090~prenol metabolic process,GO:0016093~polyprenol metabolic process,GO:0019348~dolichol metabolic process,GO:0019637~organophosphate metabolic process,GO:0030384~phosphoinositide metabolic process,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0045017~glycerolipid biosynthetic process,GO:0045449~regulation of transcription,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046489~phosphoinositide biosynthetic process,GO:0051252~regulation of RNA metabolic process,GO:0060548~negative regulation of cell death,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044421~extracellular region part,GO:0070013~intracellular organelle lumen,GO:0000030~mannosyltransferase activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0004582~dolichyl-phosphate beta-D-mannosyltransferase activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ZMAT1,"zinc finger, matrin type 1",0.010129067552611,0.381512350865222,0.710371088174594,356,0.118298231334768,1,1,1,2,,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
PRB3,proline-rich protein BstNI subfamily 3,0.010232566650102,0.382968403595269,0.770072254181814,277,0.332850778320811,0.301595591766452,1,1.02334161515626E-07,2,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005576~extracellular region,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008368~Gram-negative bacterial binding,",None, , , 
LAMA2,"laminin, alpha 2",0.010234035232482,0.382968403595269,0.637007513934839,468,0.528895408824436,0.694596125122932,0.505087244311173,1.40521441820014E-05,2,,"GO:0007155~cell adhesion,GO:0007517~muscle organ development,GO:0010647~positive regulation of cell communication,GO:0022610~biological adhesion,GO:0030155~regulation of cell adhesion,GO:0030334~regulation of cell migration,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0032222~regulation of synaptic transmission, cholinergic,GO:0032224~positive regulation of synaptic transmission, cholinergic,GO:0040012~regulation of locomotion,GO:0044057~regulation of system process,GO:0045995~regulation of embryonic development,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0051240~positive regulation of multicellular organismal process,GO:0051270~regulation of cell motion,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005605~basal lamina,GO:0005606~laminin-1 complex,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0042383~sarcolemma,GO:0043256~laminin complex,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,hsa05416:Viral myocarditis,", , , 
TAF3,"TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa",0.010352883091754,0.383693458870761,0.596620106883561,528,0.085639594557864,1,1,1,2,,"GO:0006350~transcription,GO:0008104~protein localization,GO:0032507~maintenance of protein location in cell,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0045185~maintenance of protein location,GO:0045449~regulation of transcription,GO:0051235~maintenance of location,GO:0051457~maintenance of protein location in nucleus,GO:0051651~maintenance of location in cell,GO:0070727~cellular macromolecule localization,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
RNF103,vacuolar protein sorting 24 homolog (S. cerevisiae); ring finger protein 103,0.010432502510654,0.383963854200602,0.694256107287612,373,0.213992920596624,1,1,8.92326176533384E-25,2,,"GO:0007049~cell cycle,GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,GO:0051301~cell division,GO:0005768~endosome,GO:0005770~late endosome,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031902~late endosome membrane,GO:0044440~endosomal part,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04144:Endocytosis,", , , 
ASH1L,"ash1 (absent, small, or homeotic)-like (Drosophila)",0.010713884314003,0.39086844746339,0.174556382902605,961,0.60360720344515,1,0.227591325759547,1,2,,"GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0016568~chromatin modification,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,GO:0003677~DNA binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00310:Lysine degradation,hsa04530:Tight junction,", , , 
ANKRD12,ankyrin repeat domain 12,0.011035608508709,0.398977641748406,0.523737309320048,631,0.172064157629323,1,1,1,2,,None,None, , , 
SLC35F1,"solute carrier family 35, member F1",0.011042959515174,0.398977641748406,0.719076087012543,342,0.191223495871416,1,1,1.66887519129455E-15,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
SCAF11,SR-Related CTD-Associated Factor 11,0.011073731536296,0.399317048970032,0.67773821614031,401,0.237324390669666,1,1,3.73338971372177E-05,2,,"GO:0000245~spliceosome assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000387~spliceosomal snRNP biogenesis,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0016604~nuclear body,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0031202~RNA splicing factor activity, transesterification mechanism,",None, , , 
ATP11C,"ATPase, class VI, type 11C",0.01140832566318,0.404256274984353,0.729719844852467,323,0.569637091490794,1,0.432815726606201,1,2,,"GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006869~lipid transport,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010876~lipid localization,GO:0015914~phospholipid transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,",None, , , 
MED1,mediator complex subunit 1,0.011427742291759,0.404256274984353,0.273961054081143,895,0.63576307171284,1,0.136598382188982,1,2,,"GO:0001654~eye development,GO:0001701~in utero embryonic development,GO:0001889~liver development,GO:0001890~placenta development,GO:0001892~embryonic placenta development,GO:0002520~immune system development,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006590~thyroid hormone generation,GO:0007242~intracellular signaling cascade,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010817~regulation of hormone levels,GO:0030097~hemopoiesis,GO:0030326~embryonic limb morphogenesis,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0035050~embryonic heart tube development,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0035162~embryonic hemopoiesis,GO:0035295~tube development,GO:0042403~thyroid hormone metabolic process,GO:0042445~hormone metabolic process,GO:0043009~chordate embryonic development,GO:0043010~camera-type eye development,GO:0043933~macromolecular complex subunit organization,GO:0045444~fat cell differentiation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048534~hemopoietic or lymphoid organ development,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060173~limb development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005654~nucleoplasm,GO:0016592~Srb-mediator complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016251~general RNA polymerase II transcription factor activity,GO:0016455~RNA polymerase II transcription mediator activity,GO:0016563~transcription activator activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0030528~transcription regulator activity,GO:0035257~nuclear hormone receptor binding,GO:0042809~vitamin D receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0051427~hormone receptor binding,",None, , , 
DOCK6,dedicator of cytokinesis 6,0.011604042388012,0.407428398055771,0.60509312168638,516,0.13793999673794,1,1,0.988075864406575,2,,"GO:0000166~nucleotide binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
DENND4A,DENN/MADD domain containing 4A,0.011674274760083,0.409079976268785,0.361101940053325,834,0.593487475771254,1,0.28575379652392,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,",None, , , 
ZNF492,zinc finger protein 98 (F7175); keratin associated protein 1-1; zinc finger protein 492; zinc finger protein 849 pseudogene,0.011785684464989,0.409897409894367,0.763853160230154,288,0.430452988864468,1,0.825011387083431,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005576~extracellular region,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,GO:0003677~DNA binding,GO:0005198~structural molecule activity,GO:0008270~zinc ion binding,GO:0030280~structural constituent of epidermis,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
GPRASP1,G protein-coupled receptor associated sorting protein 1,0.011829870686459,0.409897409894367,0.441763205159909,742,0.423593134230533,1,0.613513232463045,1,2,,None,None, , , 
C8orf34,chromosome 8 open reading frame 34,0.011844753869974,0.409897409894367,0.625798540032813,491,0.414150439101681,1,0.876560862545503,1,2,,None,None, , , 
INTS4,integrator complex subunit 4,0.011849917091009,0.409897409894367,0.262298366016921,904,0.413872572219158,1,0.787415323919243,1,2,,"GO:0006396~RNA processing,GO:0016073~snRNA metabolic process,GO:0016180~snRNA processing,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0005654~nucleoplasm,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032039~integrator complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None, , , 
CHDC2,Calponin Homology Domain Containing 2,0.012028896752692,0.412620634646191,0.6623898036266,430,0.197688956277573,1,1,1,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
RFX7,"regulatory factor X, 7",0.012049367609574,0.412620634646191,0.695285400991707,372,0.162479295310623,1,1,2.2829134083201E-05,2,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,",None, , , 
GPATCH8,G patch domain containing 8,0.012388726823102,0.418706533206518,0.486018095725205,685,0.46255728259106,1,0.723017377182072,9.38311702894985E-07,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
TSC2,tuberous sclerosis 2,0.012525651298273,0.420047828726094,0.426092378848172,764,0.789796866194414,1,0.116981176010963,0.39843294178636,2,,"GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0001952~regulation of cell-matrix adhesion,GO:0002009~morphogenesis of an epithelium,GO:0002526~acute inflammatory response,GO:0006461~protein complex assembly,GO:0006469~negative regulation of protein kinase activity,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0006913~nucleocytoplasmic transport,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007507~heart development,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009611~response to wounding,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009968~negative regulation of signal transduction,GO:0010324~membrane invagination,GO:0010627~regulation of protein kinase cascade,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010810~regulation of cell-substrate adhesion,GO:0014020~primary neural tube formation,GO:0014066~regulation of phosphoinositide 3-kinase cascade,GO:0014067~negative regulation of phosphoinositide 3-kinase cascade,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016331~morphogenesis of embryonic epithelium,GO:0017038~protein import,GO:0019220~regulation of phosphate metabolic process,GO:0021915~neural tube development,GO:0030030~cell projection organization,GO:0030100~regulation of endocytosis,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030155~regulation of cell adhesion,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0032006~regulation of TOR signaling pathway,GO:0032007~negative regulation of TOR signaling pathway,GO:0032231~regulation of actin filament bundle formation,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0033365~protein localization in organelle,GO:0033673~negative regulation of kinase activity,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042330~taxis,GO:0043009~chordate embryonic development,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043491~protein kinase B signaling cascade,GO:0043547~positive regulation of GTPase activity,GO:0043549~regulation of kinase activity,GO:0043933~macromolecular complex subunit organization,GO:0044087~regulation of cellular component biogenesis,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045184~establishment of protein localization,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046907~intracellular transport,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0050678~regulation of epithelial cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050918~positive chemotaxis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051174~regulation of phosphorus metabolic process,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051291~protein heterooligomerization,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051348~negative regulation of transferase activity,GO:0051492~regulation of stress fiber formation,GO:0051493~regulation of cytoskeleton organization,GO:0051726~regulation of cell cycle,GO:0051893~regulation of focal adhesion formation,GO:0051896~regulation of protein kinase B signaling cascade,GO:0051898~negative regulation of protein kinase B signaling cascade,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0060627~regulation of vesicle-mediated transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070727~cellular macromolecule localization,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005792~microsome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0019898~extrinsic to membrane,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0033596~TSC1-TSC2 complex,GO:0042598~vesicular fraction,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044445~cytosolic part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04115:p53 signaling pathway,hsa04150:mTOR signaling pathway,hsa04910:Insulin signaling pathway,", , , 
AMOTL1,angiomotin like 1,0.012762392097473,0.425694146408383,0.245323159563892,914,0.32121398057926,1,0.904617443377186,7.2179532054477E-12,2,,"GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,GO:0042802~identical protein binding,","hsa04530:Tight junction,", , , 
ZSWIM8,"Zinc Finger, SWIM-Type Containing 8",0.012883887058004,0.427702144814018,0.447769465483887,731,0.469828181510526,1,0.511640754947858,1,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ZFYVE9,"zinc finger, FYVE domain containing 9",0.012980299709068,0.428372823790962,0.590713147641516,537,0.163765601375643,1,1,1,2,,"GO:0000060~protein import into nucleus, translocation,GO:0006461~protein complex assembly,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006897~endocytosis,GO:0006913~nucleocytoplasmic transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007181~transforming growth factor beta receptor complex assembly,GO:0007183~SMAD protein complex assembly,GO:0007184~SMAD protein nuclear translocation,GO:0008104~protein localization,GO:0010324~membrane invagination,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070727~cellular macromolecule localization,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0031090~organelle membrane,GO:0031901~early endosome membrane,GO:0044440~endosomal part,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0008270~zinc ion binding,GO:0017171~serine hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04350:TGF-beta signaling pathway,", , , 
LRPPRC,leucine-rich PPR-motif containing,0.013015027217965,0.42876136402887,0.659072605625252,433,0.255405911006925,0.638569690742653,1,1,2,,"GO:0006350~transcription,GO:0006403~RNA localization,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0010970~microtubule-based transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0034643~mitochondrion localization, microtubule-mediated,GO:0045449~regulation of transcription,GO:0046907~intracellular transport,GO:0047497~mitochondrion transport along microtubule,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051236~establishment of RNA localization,GO:0051640~organelle localization,GO:0051646~mitochondrion localization,GO:0051654~establishment of mitochondrion localization,GO:0051656~establishment of organelle localization,GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005856~cytoskeleton,GO:0009295~nucleoid,GO:0012505~endomembrane system,GO:0019866~organelle inner membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031980~mitochondrial lumen,GO:0031981~nuclear lumen,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042645~mitochondrial nucleoid,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0048471~perinuclear region of cytoplasm,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003779~actin binding,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,GO:0043566~structure-specific DNA binding,GO:0048487~beta-tubulin binding,GO:0051015~actin filament binding,",None, , , 
ZNF395,zinc finger protein 395,0.01309084798114,0.430499910985398,0.430005500406137,758,0.231402678858472,1,1,1.33234762749519E-37,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CERS3,"LAG1 homolog, ceramide synthase 3",0.013396486830357,0.43670676702311,0.301978909767326,868,0.414150439101681,1,0.876560862545503,1,2,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0006643~membrane lipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0030148~sphingolipid biosynthetic process,GO:0045449~regulation of transcription,GO:0046467~membrane lipid biosynthetic process,GO:0051252~regulation of RNA metabolic process,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016410~N-acyltransferase activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0050291~sphingosine N-acyltransferase activity,",None, , , 
TCERG1,transcription elongation regulator 1,0.013740639457247,0.441758011053217,0.666733236782649,416,0.305857556518427,1,1,0.003281915314719,2,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,","hsa03040:Spliceosome,", , , 
CNOT1,"CCR4-NOT transcription complex, subunit 1",0.013952060036587,0.444727865910237,0.374174734411442,819,0.579299243471596,1,0.516028845538254,1,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,","hsa03018:RNA degradation,", , , 
NELL2,NEL-like 2 (chicken),0.014445599857573,0.458748050711736,0.441385002069448,743,0.724261534730691,1,0.227591325759547,1,2,,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0040008~regulation of growth,GO:0005576~extracellular region,GO:0005198~structural molecule activity,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
SP3,Sp3 transcription factor,0.014525054287909,0.458748050711736,0.47331479238773,703,0.382078818022627,1,0.858711823250435,1,2,,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001654~eye development,GO:0001701~in utero embryonic development,GO:0001775~cell activation,GO:0001779~natural killer cell differentiation,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0001889~liver development,GO:0001890~placenta development,GO:0001892~embryonic placenta development,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007423~sensory organ development,GO:0007565~female pregnancy,GO:0009792~embryonic development ending in birth or egg hatching,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030099~myeloid cell differentiation,GO:0030101~natural killer cell activation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030219~megakaryocyte differentiation,GO:0030224~monocyte differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0031076~embryonic camera-type eye development,GO:0032504~multicellular organism reproduction,GO:0034101~erythrocyte homeostasis,GO:0035295~tube development,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042592~homeostatic process,GO:0043009~chordate embryonic development,GO:0043010~camera-type eye development,GO:0043353~enucleate erythrocyte differentiation,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0046649~lymphocyte activation,GO:0048048~embryonic eye morphogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048609~reproductive process in a multicellular organism,GO:0048706~embryonic skeletal system development,GO:0048872~homeostasis of number of cells,GO:0051252~regulation of RNA metabolic process,GO:0060136~embryonic process involved in female pregnancy,GO:0060216~definitive hemopoiesis,GO:0060348~bone development,GO:0060541~respiratory system development,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
PKN2,protein kinase N2,0.01464588245145,0.458748050711736,0.344486043164071,841,0.332850778320811,1,1,5.76306211492799E-10,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
ABCB6,"ATP-binding cassette, sub-family B (MDR/TAP), member 6",0.01478012102585,0.459364194079622,0.605200506760737,515,0.450323987036203,1,0.688115590211361,9.94216320501126E-48,2,,"GO:0006873~cellular ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055072~iron ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0016021~integral to membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0044429~mitochondrial part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043492~ATPase activity, coupled to movement of substances,","hsa02010:ABC transporters,", , , 
DMXL2,Dmx-like 2,0.014919927858479,0.462411548693388,0.361271324421916,833,0.951632204089476,0.338959006976913,0.031388909731573,7.31392724587808E-06,2,,"GO:0006412~translation,GO:0006413~translational initiation,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0003743~translation initiation factor activity,GO:0005083~small GTPase regulator activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
MTL5,"metallothionein-like 5, testis-specific (tesmin)",0.015251189815322,0.470094017426411,0.424903458927592,768,0.166012479682229,1,1,1,2,,"GO:0006873~cellular ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0019725~cellular homeostasis,GO:0019953~sexual reproduction,GO:0030003~cellular cation homeostasis,GO:0032504~multicellular organism reproduction,GO:0042592~homeostatic process,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
MAP7D2,MAP7 domain containing 2,0.015557267231049,0.473661857402489,0.77513784576017,264,0.512324400227688,1,0.745415986888831,0.739075834582236,2,,None,None, , , 
MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10",0.015740023243709,0.475580207380498,0.476859855679188,694,0.461256174225305,1,0.858711823250435,0.839382389123923,2,,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
RGPD4,RANBP2-like and GRIP domain containing 5; RANBP2-like and GRIP domain containing 4; RANBP2-like and GRIP domain containing 3; RANBP2-like and GRIP domain containing 8; RANBP2-like and GRIP domain containing 7; RANBP2-like and GRIP domain containing 6,0.015865571945521,0.477988739307082,0.504680465232206,657,0.663281493957934,1,0.239978199885825,1,2,,"GO:0006403~RNA localization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051236~establishment of RNA localization,GO:0055085~transmembrane transport,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0046930~pore complex,GO:0008536~Ran GTPase binding,GO:0017016~Ras GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,",None, , , 
RPTN,repetin,0.0160907861415,0.483215103435816,0.550713901922561,598,0.095640578382285,1,1,1,2,,"GO:0001533~cornified envelope,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005856~cytoskeleton,GO:0031012~extracellular matrix,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044421~extracellular region part,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
LRBA,"LPS-responsive vesicle trafficking, beach and anchor containing",0.016376360995851,0.489286990790518,0.492209529659134,677,0.793725342439585,1,0.142038435823367,3.62695756087991E-15,2,,"GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
RXRG,"retinoid X receptor, gamma",0.016423948992219,0.489286990790518,0.233154237325745,923,0.6978049397017,1,0.327281109873899,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0014706~striated muscle tissue development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003707~steroid hormone receptor activity,GO:0003708~retinoic acid receptor activity,GO:0004879~ligand-dependent nuclear receptor activity,GO:0004886~retinoid-X receptor activity,GO:0005496~steroid binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa03320:PPAR signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,", , , 
SCAF1,SR-related CTD-associated factor 1,0.016679265971491,0.494526998542039,0.461457267460799,721,0.425422271462593,1,0.964584671744861,1.58641610217269E-22,2,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0032774~RNA biosynthetic process,GO:0003723~RNA binding,GO:0019904~protein domain specific binding,",None, , , 
KANSL1L,KAT8 Regulatory NSL Complex Subunit 1-Like,0.016894652428424,0.498923241409998,0.723493246102078,336,0.705626595285194,1,0.395685362190299,1.23294685336498E-37,2,,None,None, , , 
ARHGAP33,sorting nexin 26,0.016907672349298,0.498923241409998,0.102578658406309,990,0.423593134230533,1,0.858711823250435,1,2,,"GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,GO:0005886~plasma membrane,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0005543~phospholipid binding,GO:0008047~enzyme activator activity,GO:0008289~lipid binding,GO:0030675~Rac GTPase activator activity,GO:0030695~GTPase regulator activity,GO:0035091~phosphoinositide binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
SLC4A7,"solute carrier family 4, sodium bicarbonate cotransporter, member 7",0.017109041226271,0.500458477384162,0.65758414658189,435,0.616319820598673,1,0.505087244311173,5.54812510827446E-27,2,,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006820~anion transport,GO:0015672~monovalent inorganic cation transport,GO:0015698~inorganic anion transport,GO:0015701~bicarbonate transport,GO:0015711~organic anion transport,GO:0030001~metal ion transport,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0032420~stereocilium,GO:0032421~stereocilium bundle,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0008509~anion transmembrane transporter activity,GO:0008510~sodium:bicarbonate symporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015296~anion:cation symporter activity,GO:0015297~antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015301~anion:anion antiporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
BTAF1,"BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)",0.017124986993191,0.500458477384162,0.732650007260446,317,0.882830666753747,1,0.067877849760584,1.98508145947833E-24,2,,"GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
RALGAPA1,GTPase activating Rap/RanGAP domain-like 1,0.017334906562997,0.503574991742174,0.354515693070542,837,0.81684409150897,1,0.183205221865321,1,2,,"GO:0051056~regulation of small GTPase mediated signal transduction,GO:0005739~mitochondrion,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
PEX1,peroxisomal biogenesis factor 1,0.017423351329903,0.505082086961644,0.617130824740841,501,0.154088577738309,0.978493926431691,1,1,2,,"GO:0006605~protein targeting,GO:0006625~protein targeting to peroxisome,GO:0006886~intracellular protein transport,GO:0007017~microtubule-based process,GO:0007031~peroxisome organization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016558~protein import into peroxisome matrix,GO:0017038~protein import,GO:0034613~cellular protein localization,GO:0043574~peroxisomal transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051640~organelle localization,GO:0060151~peroxisome localization,GO:0060152~microtubule-based peroxisome localization,GO:0070727~cellular macromolecule localization,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005829~cytosol,GO:0031090~organelle membrane,GO:0031903~microbody membrane,GO:0042579~microbody,GO:0044438~microbody part,GO:0044439~peroxisomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032403~protein complex binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,",None, , , 
UHRF1BP1L,UHRF1 binding protein 1-like,0.017467906642605,0.505082086961644,0.758700810929927,297,0.255405911006925,1,1,1.17208431523196E-07,2,,None,None, , , 
NCOA2,nuclear receptor coactivator 2,0.017523142420201,0.505896100876249,0.259606614928603,907,0.318597611243841,1,1,1,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007242~intracellular signaling cascade,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0021549~cerebellum development,GO:0022037~metencephalon development,GO:0030518~steroid hormone receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0030902~hindbrain development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0010861~thyroid hormone receptor activator activity,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0030375~thyroid hormone receptor coactivator activity,GO:0030528~transcription regulator activity,GO:0030545~receptor regulator activity,GO:0030546~receptor activator activity,GO:0035257~nuclear hormone receptor binding,GO:0051427~hormone receptor binding,",None, , , 
MAP3K13,mitogen-activated protein kinase kinase kinase 13,0.017946075243138,0.512560763710357,0.256289372484055,911,0.563874298022813,1,0.734856399896732,1,2,,"GO:0000165~MAPKKK cascade,GO:0000186~activation of MAPKK activity,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0031098~stress-activated protein kinase signaling pathway,GO:0032147~activation of protein kinase activity,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043388~positive regulation of DNA binding,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046777~protein amino acid autophosphorylation,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0008385~IkappaB kinase complex,GO:0019898~extrinsic to membrane,GO:0044445~cytosolic part,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,","hsa04010:MAPK signaling pathway,", , , 
HPSE2,heparanase 2,0.0180392943269,0.513652406603922,0.446366709972294,735,0.540323431128064,1,0.822515305370682,1.04427858192369E-22,2,,"GO:0019898~extrinsic to membrane,GO:0030305~heparanase activity,","hsa00531:Glycosaminoglycan degradation,", , , 
TKTL1,transketolase-like 1,0.018459524570477,0.522916794460867,0.496640139826057,669,0.277920451896678,1,1,1,2,,"GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006766~vitamin metabolic process,GO:0006767~water-soluble vitamin metabolic process,GO:0006772~thiamin metabolic process,GO:0006790~sulfur metabolic process,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0042723~thiamin and derivative metabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0004802~transketolase activity,GO:0005509~calcium ion binding,GO:0016744~transferase activity, transferring aldehyde or ketonic groups,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa00030:Pentose phosphate pathway,", , , 
BAG6,HLA-B associated transcript 3,0.018591357456491,0.524573966661322,0.13946272825903,977,0.373161536660661,1,1,1,2,,None,None, , , 
ALDOB,"aldolase B, fructose-bisphosphate",0.018791887124402,0.528635029513096,0.745905782840977,307,0.541638604480542,1,0.775559138960562,1,2,,"GO:0005996~monosaccharide metabolic process,GO:0006000~fructose metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006090~pyruvate metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006094~gluconeogenesis,GO:0006096~glycolysis,GO:0006116~NADH oxidation,GO:0006461~protein complex assembly,GO:0006732~coenzyme metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006734~NADH metabolic process,GO:0006769~nicotinamide metabolic process,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009743~response to carbohydrate stimulus,GO:0009820~alkaloid metabolic process,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010043~response to zinc ion,GO:0016051~carbohydrate biosynthetic process,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019319~hexose biosynthetic process,GO:0019320~hexose catabolic process,GO:0019362~pyridine nucleotide metabolic process,GO:0019674~NAD metabolic process,GO:0019748~secondary metabolic process,GO:0030388~fructose 1,6-bisphosphate metabolic process,GO:0031667~response to nutrient levels,GO:0031960~response to corticosteroid stimulus,GO:0032781~positive regulation of ATPase activity,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034637~cellular carbohydrate biosynthetic process,GO:0042594~response to starvation,GO:0043085~positive regulation of catalytic activity,GO:0043434~response to peptide hormone stimulus,GO:0043462~regulation of ATPase activity,GO:0043603~cellular amide metabolic process,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044093~positive regulation of molecular function,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046165~alcohol biosynthetic process,GO:0046364~monosaccharide biosynthetic process,GO:0046365~monosaccharide catabolic process,GO:0046496~nicotinamide nucleotide metabolic process,GO:0046688~response to copper ion,GO:0048545~response to steroid hormone stimulus,GO:0051186~cofactor metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051384~response to glucocorticoid stimulus,GO:0065003~macromolecular complex assembly,GO:0070070~proton-transporting V-type ATPase complex assembly,GO:0070071~proton-transporting two-sector ATPase complex assembly,GO:0070072~vacuolar proton-transporting V-type ATPase complex assembly,GO:0070271~protein complex biogenesis,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0034451~centriolar satellite,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044450~microtubule organizing center part,GO:0048471~perinuclear region of cytoplasm,GO:0004332~fructose-bisphosphate aldolase activity,GO:0005529~sugar binding,GO:0008092~cytoskeletal protein binding,GO:0016832~aldehyde-lyase activity,GO:0019899~enzyme binding,GO:0030246~carbohydrate binding,GO:0042802~identical protein binding,GO:0048029~monosaccharide binding,GO:0051117~ATPase binding,GO:0070061~fructose binding,","hsa00010:Glycolysis / Gluconeogenesis,hsa00030:Pentose phosphate pathway,hsa00051:Fructose and mannose metabolism,", , , 
SLK,STE20-like kinase (yeast),0.018933019734173,0.531005819241157,0.599989009325703,522,0.810516722993232,0.893571396845862,0.271476723733921,2.89909938404746E-23,2,,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006974~response to DNA damage stimulus,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0033554~cellular response to stress,GO:0005886~plasma membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04114:Oocyte meiosis,", , , 
ZBTB20,zinc finger and BTB domain containing 20,0.019034752660091,0.531397676693458,0.23293106766409,924,0.420672500018157,1,0.920948634037278,1,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
KAT6B,K(Lysine) Acetyltransferase 6B,0.019070644459721,0.531397676693458,0.398875152552087,792,0.46255728259106,1,0.886481428527679,1,2,,"GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006473~protein amino acid acetylation,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031497~chromatin assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0043543~protein amino acid acylation,GO:0043933~macromolecular complex subunit organization,GO:0043966~histone H3 acetylation,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0000123~histone acetyltransferase complex,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070775~H3 histone acetyltransferase complex,GO:0070776~MOZ/MORF histone acetyltransferase complex,GO:0003677~DNA binding,GO:0004402~histone acetyltransferase activity,GO:0004406~H3/H4 histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ALB,albumin,0.019087828354858,0.531397676693458,0.282569324633056,886,0.281121517321128,1,1,1,2,,"GO:0001897~cytolysis by symbiont of host cells,GO:0001906~cell killing,GO:0001907~killing by symbiont of host cells,GO:0009267~cellular response to starvation,GO:0009991~response to extracellular stimulus,GO:0010941~regulation of cell death,GO:0019836~hemolysis by symbiont of host erythrocytes,GO:0031640~killing of cells of another organism,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0033554~cellular response to stress,GO:0042594~response to starvation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0044003~modification by symbiont of host morphology or physiology,GO:0044004~disruption by symbiont of host cells,GO:0051235~maintenance of location,GO:0051640~organelle localization,GO:0051646~mitochondrion localization,GO:0051651~maintenance of location in cell,GO:0051657~maintenance of organelle location,GO:0051659~maintenance of mitochondrion location,GO:0051702~interaction with symbiont,GO:0051715~cytolysis of cells of another organism,GO:0051801~cytolysis of cells in other organism during symbiotic interaction,GO:0051818~disruption of cells of other organism during symbiotic interaction,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051883~killing of cells in other organism during symbiotic interaction,GO:0052025~modification by symbiont of host cell membrane,GO:0052043~modification by symbiont of host cellular component,GO:0052111~modification by symbiont of host structure,GO:0052185~modification of structure of other organism during symbiotic interaction,GO:0052188~modification of cellular component in other organism during symbiotic interaction,GO:0052331~hemolysis by organism of erythrocytes in other organism during symbiotic interaction,GO:0052332~modification by organism of cell membrane in other organism during symbiotic interaction,GO:0060548~negative regulation of cell death,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0003677~DNA binding,GO:0005504~fatty acid binding,GO:0005507~copper ion binding,GO:0008144~drug binding,GO:0008289~lipid binding,GO:0015643~toxin binding,GO:0016209~antioxidant activity,GO:0019825~oxygen binding,GO:0019842~vitamin binding,GO:0030170~pyridoxal phosphate binding,GO:0031406~carboxylic acid binding,GO:0033293~monocarboxylic acid binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048037~cofactor binding,GO:0070279~vitamin B6 binding,",None, , , 
CD1D,CD1d molecule,0.019089236097292,0.531397676693458,0.226074059925139,929,0.512094081736782,0.891183396549264,0.964584671744861,1,2,,"GO:0001775~cell activation,GO:0002475~antigen processing and presentation via MHC class Ib,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002684~positive regulation of immune system process,GO:0006952~defense response,GO:0006955~immune response,GO:0009581~detection of external stimulus,GO:0009595~detection of biotic stimulus,GO:0009617~response to bacterium,GO:0016045~detection of bacterium,GO:0019882~antigen processing and presentation,GO:0019883~antigen processing and presentation of endogenous antigen,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030217~T cell differentiation,GO:0031349~positive regulation of defense response,GO:0042110~T cell activation,GO:0045058~T cell selection,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0048003~antigen processing and presentation of lipid antigen via MHC class Ib,GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib,GO:0048534~hemopoietic or lymphoid organ development,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0051606~detection of stimulus,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042611~MHC protein complex,GO:0042612~MHC class I protein complex,GO:0044437~vacuolar part,GO:0044440~endosomal part,GO:0044459~plasma membrane part,GO:0003823~antigen binding,GO:0008289~lipid binding,GO:0030881~beta-2-microglobulin binding,GO:0030882~lipid antigen binding,GO:0030884~exogenous lipid antigen binding,","hsa04640:Hematopoietic cell lineage,", , , 
ZFX,"zinc finger protein, X-linked",0.019205035686017,0.532227764784555,0.141024736544421,976,0.267201558484155,1,1,1,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
NEXN,nexilin (F actin binding protein),0.019307612263283,0.53271327838383,0.47662593297297,696,0.776961865429334,1,0.342096927505986,7.39819109897293E-08,2,,"GO:0030334~regulation of cell migration,GO:0033043~regulation of organelle organization,GO:0040012~regulation of locomotion,GO:0051270~regulation of cell motion,GO:0051493~regulation of cytoskeleton organization,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0051015~actin filament binding,",None, , , 
PDS5B,"PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae)",0.019367317013364,0.533572440254604,0.656887429358597,439,0.508762855496194,1,0.745415986888831,1.21534810353575E-29,2,,"GO:0000070~mitotic sister chromatid segregation,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000819~sister chromatid segregation,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitosis,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0042127~regulation of cell proliferation,GO:0048285~organelle fission,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,",None, , , 
CTCFL,CCCTC-binding factor (zinc finger protein)-like,0.019561170055798,0.533866892964951,0.273467926742121,896,0.425620619628491,1,1,1,2,,"GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0006305~DNA alkylation,GO:0006306~DNA methylation,GO:0006325~chromatin organization,GO:0006349~genetic imprinting,GO:0006350~transcription,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0007049~cell cycle,GO:0007276~gamete generation,GO:0008213~protein amino acid alkylation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0019953~sexual reproduction,GO:0031056~regulation of histone modification,GO:0031060~regulation of histone methylation,GO:0031399~regulation of protein modification process,GO:0032259~methylation,GO:0032268~regulation of cellular protein metabolic process,GO:0032504~multicellular organism reproduction,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0040029~regulation of gene expression, epigenetic,GO:0043046~DNA methylation during gametogenesis,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0051276~chromosome organization,GO:0051569~regulation of histone H3-K4 methylation,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042393~histone binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
SCAF4,SR-Related CTD-Associated Factor 4,0.019797775425473,0.535945865467253,0.722687166494993,337,0.451763036267207,1,1,1,2,,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0016071~mRNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008022~protein C-terminus binding,",None, , , 
SLC26A7,"solute carrier family 26, member 7",0.019862592029951,0.536146468970301,0.258907438965687,909,0.312009080922827,1,1,1,2,,"GO:0001696~gastric acid secretion,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0006835~dicarboxylic acid transport,GO:0007586~digestion,GO:0008272~sulfate transport,GO:0015698~inorganic anion transport,GO:0015701~bicarbonate transport,GO:0015711~organic anion transport,GO:0015849~organic acid transport,GO:0019532~oxalate transport,GO:0022600~digestive system process,GO:0046717~acid secretion,GO:0046903~secretion,GO:0046942~carboxylic acid transport,GO:0055085~transmembrane transport,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0005310~dicarboxylic acid transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015267~channel activity,GO:0015297~antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015301~anion:anion antiporter activity,GO:0019531~oxalate transmembrane transporter activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,",None, , , 
USP29,ubiquitin specific peptidase 29,0.020038152331155,0.53777679223224,0.389540378779023,804,0.508762855496194,1,0.758241787629174,2.29733395782824E-21,2,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0004221~ubiquitin thiolesterase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
SPTY2D1,"SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)",0.020198659419069,0.539783246282068,0.535473086122977,613,0.169281950799227,1,1,0.997250017768032,2,,None,None, , , 
ABL2,"v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)",0.020311546968516,0.540415500931147,0.230764160601593,925,0.635318185644003,1,0.600962306999824,1,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0051017~actin filament bundle formation,GO:0051341~regulation of oxidoreductase activity,GO:0051353~positive regulation of oxidoreductase activity,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04012:ErbB signaling pathway,hsa05416:Viral myocarditis,", , , 
ZNF658,zinc finger protein 658,0.020338995511248,0.540415500931147,0.391950986280755,803,0.406297742708815,1,1,3.94092365968932E-25,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CASK,calcium/calmodulin-dependent serine protein kinase (MAGUK family),0.020511200738658,0.543444990918276,0.714256099272673,349,0.255405911006925,1,1,1,2,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007155~cell adhesion,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016310~phosphorylation,GO:0022610~biological adhesion,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0019717~synaptosome,GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004385~guanylate kinase activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016776~phosphotransferase activity, phosphate group as acceptor,GO:0017076~purine nucleotide binding,GO:0019201~nucleotide kinase activity,GO:0019205~nucleobase, nucleoside, nucleotide kinase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04530:Tight junction,", , , 
PHF14,PHD finger protein 14,0.020640036382806,0.545311512863424,0.413914777119473,775,0.625472564317623,1,0.494743979854933,5.01740601522976E-05,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
NRK,Nik related kinase,0.021026009488184,0.551175521925926,0.293026113578644,878,0.329724506875734,1,1,1,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0045449~regulation of transcription,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
PRKCE,"protein kinase C, epsilon",0.021116762190427,0.552436976127426,0.616673038395779,502,0.617460903123271,1,0.688115590211361,1,2,,"GO:0001932~regulation of protein amino acid phosphorylation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006917~induction of apoptosis,GO:0007242~intracellular signaling cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0031399~regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0042325~regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0051174~regulation of phosphorus metabolic process,GO:0005886~plasma membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0004699~calcium-independent protein kinase C activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019992~diacylglycerol binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04270:Vascular smooth muscle contraction,hsa04530:Tight junction,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04930:Type II diabetes mellitus,", , , 
INTS8,integrator complex subunit 8,0.02132892418734,0.55615369033203,0.29299882940437,879,0.429933700635118,1,1,1,2,,"GO:0006396~RNA processing,GO:0016073~snRNA metabolic process,GO:0016180~snRNA processing,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0005654~nucleoplasm,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032039~integrator complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None, , , 
MICAL1,"microtubule associated monoxygenase, calponin and LIM domain containing 1",0.021521867072018,0.558240805878618,0.531874812294845,618,0.597589807832722,1,0.589980756912926,1.5359771748389E-22,2,,"GO:0007010~cytoskeleton organization,GO:0055114~oxidation reduction,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,GO:0008270~zinc ion binding,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
SUPT6H,suppressor of Ty 6 homolog (S. cerevisiae),0.021610782693894,0.558503170751193,0.097148699532744,993,0.895608464248601,1,0.08825557681226,1,2,,"GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003711~transcription elongation regulator activity,GO:0003723~RNA binding,GO:0030528~transcription regulator activity,",None, , , 
GOLIM4,golgi integral membrane protein 4,0.021760582906675,0.560642659467292,0.602847655190969,519,0.621807327439166,1,0.75656219934849,1,2,,"GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0005801~cis-Golgi network,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030139~endocytic vesicle,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044431~Golgi apparatus part,GO:0070013~intracellular organelle lumen,",None, , , 
TRDN,triadin,0.021954130176285,0.56485013438407,0.724234718801977,333,0.301799987891845,0.340065672890207,1,3.25192852766262E-07,2,,"GO:0003012~muscle system process,GO:0006936~muscle contraction,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0016528~sarcoplasm,GO:0016529~sarcoplasmic reticulum,GO:0031224~intrinsic to membrane,",None, , , 
PPP4R1,"protein phosphatase 4, regulatory subunit 1",0.022022969053013,0.565841869245156,0.718711721737855,343,0.177214745363094,1,1,1,2,,"GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0019208~phosphatase regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0030362~protein phosphatase type 4 regulator activity,",None, , , 
EPG5,Ectopic P-Granules Autophagy Protein 5 Homolog (C. Elegans),0.022602890341181,0.574638994586616,0.579181643336283,566,0.773989645351894,1,0.382789390978339,0.29150618463885,2,,None,None, , , 
EPHA5,EPH receptor A5,0.022700416752993,0.574638994586616,0.327362129931994,852,0.925081197895635,1,0.07009405772913,1,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016310~phosphorylation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04360:Axon guidance,", , , 
ABCA5,"ATP-binding cassette, sub-family A (ABC1), member 5",0.022708500997588,0.574638994586616,0.202069278523758,942,0.717294587180583,1,0.503116045574968,1,2,,"GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005768~endosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa02010:ABC transporters,", , , 
RBM47,RNA binding motif protein 47,0.02285714472589,0.574929199988374,0.76169647998159,290,0.64201614354073,1,0.674155105710547,1,2,,"GO:0003723~RNA binding,",None, , , 
KDM3A,lysine (K)-specific demethylase 3A,0.023046601293399,0.577835524240816,0.517787935933983,642,0.305857556518427,1,1,1,2,,"GO:0006081~cellular aldehyde metabolic process,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006482~protein amino acid demethylation,GO:0006730~one-carbon metabolic process,GO:0007242~intracellular signaling cascade,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0008214~protein amino acid dealkylation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016577~histone demethylation,GO:0019953~sexual reproduction,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032504~multicellular organism reproduction,GO:0032870~cellular response to hormone stimulus,GO:0033169~histone H3-K9 demethylation,GO:0045449~regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0046184~aldehyde biosynthetic process,GO:0046292~formaldehyde metabolic process,GO:0046293~formaldehyde biosynthetic process,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0055114~oxidation reduction,GO:0070076~histone lysine demethylation,GO:0005506~iron ion binding,GO:0008270~zinc ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0050681~androgen receptor binding,GO:0051427~hormone receptor binding,",None, , , 
SLTM,"SAFB-like, transcription modulator",0.023159372015171,0.578334104106121,0.67875629282337,398,0.439443576215312,1,1,0.220845608813965,2,,"GO:0006350~transcription,GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0045449~regulation of transcription,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
USP15,ubiquitin specific peptidase 15,0.023699552924233,0.586479774702322,0.665786092599713,420,0.645255451939965,1,0.745415986888831,1,2,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004221~ubiquitin thiolesterase activity,GO:0004843~ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0019783~small conjugating protein-specific protease activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
CPEB4,cytoplasmic polyadenylation element binding protein 4,0.023705349852789,0.586479774702322,0.586367098388988,547,0.305857556518427,1,1,0.036050945147172,2,,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
NLRC5,"NLR family, CARD domain containing 5",0.023830600167841,0.587245093054224,0.43918250535448,745,0.18478618943585,1,1,1,2,,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
ADAMTS20,"ADAM metallopeptidase with thrombospondin type 1 motif, 20",0.02391572538787,0.588566316890678,0.268854651888099,899,0.773989645351894,1,0.505087244311173,1,2,,"GO:0006508~proteolysis,GO:0009967~positive regulation of signal transduction,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0030198~extracellular matrix organization,GO:0042981~regulation of apoptosis,GO:0043062~extracellular structure organization,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045597~positive regulation of cell differentiation,GO:0045634~regulation of melanocyte differentiation,GO:0045636~positive regulation of melanocyte differentiation,GO:0048070~regulation of pigmentation during development,GO:0048087~positive regulation of pigmentation during development,GO:0050932~regulation of pigment cell differentiation,GO:0050942~positive regulation of pigment cell differentiation,GO:0051094~positive regulation of developmental process,GO:0060548~negative regulation of cell death,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
FN1,fibronectin 1,0.024145761779288,0.591888037106716,0.4229906135779,772,0.93497313539866,1,0.116981176010963,1.31890170703944E-41,2,,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0002526~acute inflammatory response,GO:0006928~cell motion,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0008360~regulation of cell shape,GO:0009611~response to wounding,GO:0016477~cell migration,GO:0018149~peptide cross-linking,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0031589~cell-substrate adhesion,GO:0032989~cellular component morphogenesis,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0034446~substrate adhesion-dependent cell spreading,GO:0042060~wound healing,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005793~ER-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0001871~pattern binding,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005518~collagen binding,GO:0005539~glycosaminoglycan binding,GO:0008047~enzyme activator activity,GO:0008201~heparin binding,GO:0016504~peptidase activator activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,", , , 
DCHS1,dachsous 1 (Drosophila),0.024727957703438,0.601423856695984,0.29706196337799,875,0.987332615704823,1,0.03230571218278,1.04703288803852E-27,2,,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0016339~calcium-dependent cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
DOCK11,dedicator of cytokinesis 11,0.024858526615126,0.602246976191884,0.524640746751503,628,0.704316256842655,0.471820800885674,0.775559138960562,2.7404948473988E-15,2,,"GO:0000166~nucleotide binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
POGZ,pogo transposable element with ZNF domain,0.026202748973466,0.621118208217472,0.150175215075081,968,0.812105621027031,1,0.250415274812614,1,2,,"GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
MAP7D1,MAP7 domain containing 1,0.026246314048419,0.621362357554401,0.224069358554646,932,0.503082242153045,1,1,3.57030272484822E-05,2,,"GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",None, , , 
PLCB3,"phospholipase C, beta 3 (phosphatidylinositol-specific)",0.02635500136579,0.621406461934897,0.619916587446865,498,0.640237668049965,1,0.787415323919243,1,2,,"GO:0006644~phospholipid metabolic process,GO:0007242~intracellular signaling cascade,GO:0009395~phospholipid catabolic process,GO:0016042~lipid catabolic process,GO:0019637~organophosphate metabolic process,GO:0044242~cellular lipid catabolic process,GO:0000267~cell fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0019898~extrinsic to membrane,GO:0004435~phosphoinositide phospholipase C activity,GO:0004620~phospholipase activity,GO:0004629~phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016298~lipase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa00562:Inositol phosphate metabolism,hsa04020:Calcium signaling pathway,hsa04062:Chemokine signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04270:Vascular smooth muscle contraction,hsa04310:Wnt signaling pathway,hsa04540:Gap junction,hsa04720:Long-term potentiation,hsa04730:Long-term depression,hsa04912:GnRH signaling pathway,hsa04916:Melanogenesis,hsa05010:Alzheimer's disease,hsa05016:Huntington's disease,", , , 
CTNNA1,"catenin (cadherin-associated protein), alpha 1, 102kDa",0.026446914580444,0.621406461934897,0.59580224164199,530,0.553849849559387,1,1,0.000247357243364,2,,"GO:0007043~cell-cell junction assembly,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0043297~apical junction assembly,GO:0045216~cell-cell junction organization,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0009898~internal side of plasma membrane,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0005198~structural molecule activity,GO:0008092~cytoskeletal protein binding,GO:0017166~vinculin binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,","hsa04520:Adherens junction,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05200:Pathways in cancer,hsa05213:Endometrial cancer,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),", , , 
ACSM3,acyl-CoA synthetase medium-chain family member 3,0.02652338941118,0.621406461934897,0.32305829903956,853,0.387319489330458,1,1,1,2,,"GO:0003013~circulatory system process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0008610~lipid biosynthetic process,GO:0016053~organic acid biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0015645~fatty-acid ligase activity,GO:0016877~ligase activity, forming carbon-sulfur bonds,GO:0016878~acid-thiol ligase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0047760~butyrate-CoA ligase activity,","hsa00650:Butanoate metabolism,", , , 
BRWD1,bromodomain and WD repeat domain containing 1,0.026849967168711,0.626913170930443,0.33201428939396,848,0.659905676010901,1,0.621617423105817,8.17923788948685E-12,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0030528~transcription regulator activity,",None, , , 
ATP8B4,"ATPase, class I, type 8B, member 4",0.026971557840674,0.627399413332442,0.451657117205797,726,0.553849849559387,1,0.904617443377186,1.12326959954561E-13,2,,"GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006869~lipid transport,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010876~lipid localization,GO:0015914~phospholipid transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,",None, , , 
TRAPPC8,Trafficking Protein Particle Complex 8,0.027314709418173,0.633016696305271,0.570578787577006,574,0.434308262356797,1,1,1,2,,"GO:0006888~ER to Golgi vesicle-mediated transport,GO:0016192~vesicle-mediated transport,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0044431~Golgi apparatus part,",None, , , 
QSER1,glutamine and serine rich 1,0.028221234906184,0.647395804906937,0.315803570040772,859,0.322887265574805,1,1,1,2,,None,None, , , 
PCBP2,poly(rC) binding protein 2,0.028271320481361,0.647395804906937,0.71137185744973,355,0.231564826453251,1,1,1,2,,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0030529~ribonucleoprotein complex,GO:0003677~DNA binding,GO:0003723~RNA binding,",None, , , 
ITPR2,"inositol 1,4,5-triphosphate receptor, type 2",0.028437164184977,0.648118238594592,0.126339666791249,980,0.825060998552453,1,0.475808461183278,1,2,,"GO:0001666~response to hypoxia,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,GO:0070482~response to oxygen levels,GO:0000267~cell fraction,GO:0001950~plasma membrane enriched fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005792~microsome,GO:0005938~cell cortex,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0016528~sarcoplasm,GO:0016529~sarcoplasmic reticulum,GO:0030424~axon,GO:0031090~organelle membrane,GO:0031094~platelet dense tubular network,GO:0031095~platelet dense tubular network membrane,GO:0031224~intrinsic to membrane,GO:0033017~sarcoplasmic reticulum membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042598~vesicular fraction,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043209~myelin sheath,GO:0044432~endoplasmic reticulum part,GO:0005216~ion channel activity,GO:0005217~intracellular ligand-gated ion channel activity,GO:0005220~inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005543~phospholipid binding,GO:0008095~inositol-1,4,5-trisphosphate receptor activity,GO:0008289~lipid binding,GO:0015082~di-, tri-valent inorganic cation transmembrane transporter activity,GO:0015085~calcium ion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0035091~phosphoinositide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,","hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04114:Oocyte meiosis,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04720:Long-term potentiation,hsa04730:Long-term depression,hsa04912:GnRH signaling pathway,hsa05010:Alzheimer's disease,", , , 
RGS22,regulator of G-protein signaling 22,0.028705782108425,0.651513127586001,0.29589263036349,877,0.867953372377229,1,0.262029463501847,1,2,,"GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,",None, , , 
NTRK2,"neurotrophic tyrosine kinase, receptor, type 2",0.028800955243224,0.652088536955373,0.630843698580058,483,0.805056991232344,1,0.505087244311173,1,2,,"GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001654~eye development,GO:0001754~eye photoreceptor cell differentiation,GO:0001944~vasculature development,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006140~regulation of nucleotide metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007267~cell-cell signaling,GO:0007423~sensory organ development,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0010647~positive regulation of cell communication,GO:0010975~regulation of neuron projection development,GO:0014047~glutamate secretion,GO:0016310~phosphorylation,GO:0030182~neuron differentiation,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0031344~regulation of cell projection organization,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0032940~secretion by cell,GO:0042461~photoreceptor cell development,GO:0042462~eye photoreceptor cell development,GO:0042490~mechanoreceptor differentiation,GO:0043085~positive regulation of catalytic activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045664~regulation of neuron differentiation,GO:0045761~regulation of adenylate cyclase activity,GO:0045762~positive regulation of adenylate cyclase activity,GO:0046530~photoreceptor cell differentiation,GO:0046548~retinal rod cell development,GO:0046777~protein amino acid autophosphorylation,GO:0046903~secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0048514~blood vessel morphogenesis,GO:0048592~eye morphogenesis,GO:0048666~neuron development,GO:0050767~regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0051046~regulation of secretion,GO:0051240~positive regulation of multicellular organismal process,GO:0051339~regulation of lyase activity,GO:0051349~positive regulation of lyase activity,GO:0051588~regulation of neurotransmitter transport,GO:0051960~regulation of nervous system development,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060284~regulation of cell development,GO:0060341~regulation of cellular localization,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0033267~axon part,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043195~terminal button,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043679~nerve terminal,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0060076~excitatory synapse,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005030~neurotrophin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043121~neurotrophin binding,GO:0048403~brain-derived neurotrophic factor binding,","hsa04010:MAPK signaling pathway,hsa04722:Neurotrophin signaling pathway,", , , 
DST,dystonin,0.028871943013992,0.652904386874524,0.717543426212325,345,0.72206733532029,1,0.693453523010957,3.71487585156351E-05,2,,"GO:0000226~microtubule cytoskeleton organization,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0007409~axonogenesis,GO:0008088~axon cargo transport,GO:0008090~retrograde axon cargo transport,GO:0010970~microtubule-based transport,GO:0022402~cell cycle process,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0030182~neuron differentiation,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031122~cytoplasmic microtubule organization,GO:0031175~neuron projection development,GO:0032886~regulation of microtubule-based process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033043~regulation of organelle organization,GO:0045103~intermediate filament-based process,GO:0045104~intermediate filament cytoskeleton organization,GO:0046907~intracellular transport,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051493~regulation of cytoskeleton organization,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009925~basal plasma membrane,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0030056~hemidesmosome,GO:0031012~extracellular matrix,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0045111~intermediate filament cytoskeleton,GO:0045178~basal part of cell,GO:0060053~neurofilament cytoskeleton,GO:0003779~actin binding,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0008017~microtubule binding,GO:0008022~protein C-terminus binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,GO:0032403~protein complex binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,",None, , , 
ZMYM6,"hypothetical LOC100130633; zinc finger, MYM-type 6",0.029457369600719,0.658963121882435,0.511861338085931,650,0.34248742497799,1,1,0.00113602942403,2,,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
PHEX,"phosphate regulating endopeptidase homolog, X-linked",0.030010795658253,0.667039645519082,0.394689908124237,798,0.724261534730691,1,0.771592454005998,1,2,,"GO:0001501~skeletal system development,GO:0006508~proteolysis,GO:0007267~cell-cell signaling,GO:0031214~biomineral formation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0004175~endopeptidase activity,GO:0004177~aminopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
TAB3,mitogen-activated protein kinase kinase kinase 7 interacting protein 3,0.03023892701519,0.669233314830261,0.148726051837778,969,0.668072799753708,1,0.707289184858051,8.35390332151722E-36,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04621:NOD-like receptor signaling pathway,", , , 
NUP205,nucleoporin 205kDa,0.030364175087419,0.669625060753138,0.241634040945206,918,0.913440815223349,0.817879873922511,0.342096927505986,3.28918057563909E-06,2,,"GO:0000059~protein import into nucleus, docking,GO:0006403~RNA localization,GO:0006461~protein complex assembly,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051236~establishment of RNA localization,GO:0055085~transmembrane transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070727~cellular macromolecule localization,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0046930~pore complex,",None, , , 
ARAP3,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3",0.031191059186508,0.676678436753783,0.240642024012068,919,0.800711049723453,1,0.505087244311173,0.000665765007521,2,,"GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0016192~vesicle-mediated transport,GO:0022604~regulation of cell morphogenesis,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0032012~regulation of ARF protein signal transduction,GO:0032312~regulation of ARF GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0035020~regulation of Rac protein signal transduction,GO:0035021~negative regulation of Rac protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0035024~negative regulation of Rho protein signal transduction,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046580~negative regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051058~negative regulation of small GTPase mediated signal transduction,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051336~regulation of hydrolase activity,GO:0001726~ruffle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0005543~phospholipid binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008047~enzyme activator activity,GO:0008060~ARF GTPase activator activity,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0030675~Rac GTPase activator activity,GO:0030695~GTPase regulator activity,GO:0035091~phosphoinositide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04144:Endocytosis,", , , 
SMG1,"SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans)",0.031191184434124,0.676678436753783,0.39238637933297,801,0.613651676282584,1,0.9488160022319,1,2,,"GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006403~RNA localization,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006468~protein amino acid phosphorylation,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006913~nucleocytoplasmic transport,GO:0006974~response to DNA damage stimulus,GO:0009057~macromolecule catabolic process,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016071~mRNA metabolic process,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0019637~organophosphate metabolic process,GO:0030258~lipid modification,GO:0030384~phosphoinositide metabolic process,GO:0033554~cellular response to stress,GO:0044265~cellular macromolecule catabolic process,GO:0046486~glycerolipid metabolic process,GO:0046777~protein amino acid autophosphorylation,GO:0046834~lipid phosphorylation,GO:0046854~phosphoinositide phosphorylation,GO:0046907~intracellular transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051236~establishment of RNA localization,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ANKRD44,ankyrin repeat domain 44,0.03165217159441,0.684295038439801,0.776474707515669,262,0.747635690748199,1,0.776777111998648,1,2,,None,None, , , 
ZNF451,zinc finger protein 451,0.03177936210501,0.685699252322757,0.65715832967397,436,0.511236250678775,1,1,1,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
AP4E1,"adaptor-related protein complex 4, epsilon 1 subunit",0.031937737317732,0.686495967040185,0.436928008029789,747,0.661956177628766,1,0.886481428527679,1.94942029390074E-08,2,,"GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030117~membrane coat,GO:0030120~vesicle coat,GO:0030126~COPI vesicle coat,GO:0030135~coated vesicle,GO:0030137~COPI-coated vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030663~COPI coated vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0048475~coated membrane,GO:0005198~structural molecule activity,","hsa04142:Lysosome,", , , 
ACSS3,acyl-CoA synthetase short-chain family member 3,0.032224229472247,0.690271080633147,0.314323125071878,860,0.852571337595903,0.638569690742653,0.574713924958474,1,2,,"GO:0005739~mitochondrion,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003987~acetate-CoA ligase activity,GO:0005524~ATP binding,GO:0016405~CoA-ligase activity,GO:0016877~ligase activity, forming carbon-sulfur bonds,GO:0016878~acid-thiol ligase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa00640:Propanoate metabolism,", , , 
KAT6A,K(Lysine) Acetyltransferase 6A,0.03297206410786,0.69660983434747,0.142100736062798,975,0.953835196888601,1,0.196420711694315,1,2,,"GO:0002520~immune system development,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0006350~transcription,GO:0006473~protein amino acid acetylation,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0019827~stem cell maintenance,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031497~chromatin assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0035019~somatic stem cell maintenance,GO:0035162~embryonic hemopoiesis,GO:0043543~protein amino acid acylation,GO:0043933~macromolecular complex subunit organization,GO:0043966~histone H3 acetylation,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048534~hemopoietic or lymphoid organ development,GO:0048568~embryonic organ development,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0000123~histone acetyltransferase complex,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070775~H3 histone acetyltransferase complex,GO:0070776~MOZ/MORF histone acetyltransferase complex,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ARHGEF6,Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6,0.033059062866796,0.69660983434747,0.538474990391338,610,0.83315188957937,1,0.503116045574968,1,2,,"GO:0000165~MAPKKK cascade,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,GO:0035023~regulation of Rho protein signal transduction,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0005829~cytosol,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04810:Regulation of actin cytoskeleton,hsa05212:Pancreatic cancer,", , , 
DDX5,DEAD (Asp-Glu-Ala-Asp) box polypeptide 5,0.033214483500106,0.697093637414028,0.59977852270787,523,0.366184669242657,0.194276866008828,1,1,2,,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008361~regulation of cell size,GO:0008380~RNA splicing,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0016071~mRNA metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032535~regulation of cellular component size,GO:0040007~growth,GO:0045449~regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0005681~spliceosome,GO:0005730~nucleolus,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003712~transcription cofactor activity,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008134~transcription factor binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,","hsa03040:Spliceosome,", , , 
MARK2,MAP/microtubule affinity-regulating kinase 2,0.033456288371879,0.699251880652713,0.147699625234372,970,0.83315188957937,1,0.590876702908044,1,2,,"GO:0000902~cell morphogenesis,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007163~establishment or maintenance of cell polarity,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0016310~phosphorylation,GO:0032989~cellular component morphogenesis,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0019898~extrinsic to membrane,GO:0044448~cell cortex part,GO:0045178~basal part of cell,GO:0045180~basal cortex,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
TIGD4,tigger transposable element derived 4,0.033937020451612,0.705127480551353,0.750324318696393,304,0.361916757647146,1,1,2.36369544885464E-13,2,,"GO:0045449~regulation of transcription,GO:0000775~chromosome, centromeric region,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,",None, , , 
ARAP2,"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2",0.03414664334253,0.705748193120797,0.58616870409474,548,0.686437752031373,1,0.933741165756504,1,2,,"GO:0032012~regulation of ARF protein signal transduction,GO:0032312~regulation of ARF GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005543~phospholipid binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008047~enzyme activator activity,GO:0008060~ARF GTPase activator activity,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0030695~GTPase regulator activity,GO:0035091~phosphoinositide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04144:Endocytosis,", , , 
SLC7A13,"solute carrier family 7, (cationic amino acid transporter, y+ system) member 13",0.034236104527323,0.705748193120797,0.210435511183544,940,0.59520939701259,1,1,1,2,,"GO:0006865~amino acid transport,GO:0015837~amine transport,GO:0015849~organic acid transport,GO:0046942~carboxylic acid transport,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005275~amine transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,",None, , , 
USP6,ubiquitin specific peptidase 6 (Tre-2 oncogene),0.034306941450489,0.705748193120797,0.597500594485377,527,0.350868870921428,1,1,1,2,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032313~regulation of Rab GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032483~regulation of Rab protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004221~ubiquitin thiolesterase activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005097~Rab GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
UBN2,ubinuclein 2,0.034621251251848,0.710648738607987,0.214178351662392,938,0.918170374333687,1,0.299170350544336,6.05135384245156E-07,2,,None,None, , , 
ADNP2,ADNP homeobox 2,0.035054845348842,0.717184508511526,0.484756477345232,687,0.712352917796103,1,0.86861908420637,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
E2F8,E2F transcription factor 8,0.035230323013904,0.719199129592036,0.525000289432719,627,0.829258565672741,1,0.574713924958474,0.116866215169025,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,",None, , , 
SYCP2,synaptonemal complex protein 2,0.03543043285615,0.720920539564295,0.41370231795108,776,0.391188549851751,1,1,1,2,,"GO:0000279~M phase,GO:0003006~reproductive developmental process,GO:0006915~apoptosis,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007128~meiotic prophase I,GO:0007129~synapsis,GO:0007130~synaptonemal complex assembly,GO:0007140~male meiosis,GO:0007143~female meiosis,GO:0007548~sex differentiation,GO:0008219~cell death,GO:0009566~fertilization,GO:0012501~programmed cell death,GO:0016265~death,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030539~male genitalia development,GO:0035112~genitalia morphogenesis,GO:0045137~development of primary sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048806~genitalia development,GO:0048808~male genitalia morphogenesis,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051324~prophase,GO:0051327~M phase of meiotic cell cycle,GO:0070192~chromosome organization involved in meiosis,GO:0070193~synaptonemal complex organization,GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,",None, , , 
HAS2,hyaluronan synthase 2,0.035592213986611,0.723424336295873,0.130814521367939,979,0.36533006107785,1,1,1,2,,"GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0050501~hyaluronan synthase activity,",None, , , 
STK19,serine/threonine kinase 19,0.03570245090701,0.724876174447859,0.616585511788611,503,0.21192215077881,1,1,1,2,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
PTPN12,"protein tyrosine phosphatase, non-receptor type 12",0.035749446734699,0.725042253591136,0.343037467915051,843,0.793406891251112,1,0.745415986888831,1,2,,"GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016311~dephosphorylation,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005829~cytosol,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016791~phosphatase activity,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,",None, , , 
PPP1R13B,"protein phosphatase 1, regulatory (inhibitor) subunit 13B",0.035873188142357,0.725210873848007,0.461846598850551,719,0.724261534730691,1,0.858711823250435,4.05677707516993E-06,2,,"GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045786~negative regulation of cell cycle,GO:0051726~regulation of cell cycle,",None, , , 
SELP,"selectin P (granule membrane protein 140kDa, antigen CD62)",0.035874235635503,0.725210873848007,0.22729916152273,927,0.846120936133285,1,0.367053233444936,1,2,,"GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0002237~response to molecule of bacterial origin,GO:0002685~regulation of leukocyte migration,GO:0002691~regulation of cellular extravasation,GO:0006928~cell motion,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell adhesion,GO:0007159~leukocyte adhesion,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0010033~response to organic substance,GO:0010543~regulation of platelet activation,GO:0010572~positive regulation of platelet activation,GO:0016337~cell-cell adhesion,GO:0016477~cell migration,GO:0022610~biological adhesion,GO:0030193~regulation of blood coagulation,GO:0030334~regulation of cell migration,GO:0032101~regulation of response to external stimulus,GO:0032496~response to lipopolysaccharide,GO:0040012~regulation of locomotion,GO:0042742~defense response to bacterium,GO:0045123~cellular extravasation,GO:0048514~blood vessel morphogenesis,GO:0048870~cell motility,GO:0050818~regulation of coagulation,GO:0050829~defense response to Gram-negative bacterium,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050900~leukocyte migration,GO:0050901~leukocyte tethering or rolling,GO:0051270~regulation of cell motion,GO:0051674~localization of cell,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0030659~cytoplasmic vesicle membrane,GO:0030667~secretory granule membrane,GO:0031090~organelle membrane,GO:0031091~platelet alpha granule,GO:0031092~platelet alpha granule membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0001530~lipopolysaccharide binding,GO:0001871~pattern binding,GO:0001948~glycoprotein binding,GO:0005529~sugar binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008289~lipid binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0033691~sialic acid binding,GO:0042806~fucose binding,GO:0043208~glycosphingolipid binding,GO:0043498~cell surface binding,GO:0043499~eukaryotic cell surface binding,GO:0046625~sphingolipid binding,GO:0048029~monosaccharide binding,GO:0048306~calcium-dependent protein binding,GO:0051861~glycolipid binding,GO:0070492~oligosaccharide binding,","hsa04514:Cell adhesion molecules (CAMs),", , , 
ANKIB1,ankyrin repeat and IBR domain containing 1,0.036065483417505,0.726667971087474,0.261716456341232,905,0.776961865429334,1,0.745415986888831,1,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ZNF568,zinc finger protein 568,0.036101926075763,0.726667971087474,0.48090836477169,690,0.702212537889192,1,0.749774076913278,1,2,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
LONRF2,LON peptidase N-terminal domain and ring finger 2,0.037450240235486,0.736996441984855,0.371756187541372,822,0.763490431730908,1,0.6394955370665,1,2,,"GO:0006508~proteolysis,GO:0004176~ATP-dependent peptidase activity,GO:0008233~peptidase activity,GO:0008270~zinc ion binding,GO:0016887~ATPase activity,GO:0042623~ATPase activity, coupled,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
FAM160A2,"family with sequence similarity 160, member A2",0.037533502173065,0.736996441984855,0.36244722857682,832,0.508922118773424,1,1,4.62576572070301E-31,2,,"GO:0007032~endosome organization,GO:0007033~vacuole organization,GO:0007034~vacuolar transport,GO:0007040~lysosome organization,GO:0007041~lysosomal transport,GO:0008104~protein localization,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0045022~early endosome to late endosome transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070695~FHF complex,",None, , , 
ZNF687,zinc finger protein 687,0.037975824713814,0.740020289911421,0.237574131996163,922,0.779492667418478,1,0.621617423105817,1,2,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CCDC39,coiled-coil domain containing 39,0.03800524700967,0.740020289911421,0.185264696806734,955,0.951986838911172,1,0.342096927505986,1,2,,None,None, , , 
TMTC3,transmembrane and tetratricopeptide repeat containing 3,0.038304012722865,0.741430729171391,0.632819569951144,479,0.793406891251112,1,0.801858501175754,0.483903809882605,2,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
FAM135A,"family with sequence similarity 135, member A",0.038762556027542,0.746438952616971,0.276269033717469,893,0.844100812748515,1,0.660096042000246,0.822563136527392,2,,None,None, , , 
WWC1,WW and C2 domain containing 1,0.039131730780554,0.75092612734635,0.490978210367775,680,0.406297742708815,1,1,0.093061797686661,2,,None,None, , , 
STAU2,"staufen, RNA binding protein, homolog 2 (Drosophila)",0.039156381392759,0.75092612734635,0.673144007617531,408,0.5915085264975,1,1,1,2,,"GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,",None, , , 
SULT1C3,"sulfotransferase family, cytosolic, 1C, member 3",0.039413186680986,0.752442921255091,0.735166151340003,315,0.520082635375384,1,1,1,2,,"GO:0004027~alcohol sulfotransferase activity,GO:0004062~aryl sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016782~transferase activity, transferring sulfur-containing groups,",None, , , 
HSP90AB1,"heat shock protein 90kDa alpha (cytosolic), class B member 1",0.039715263402406,0.754101732935675,0.3930496571151,800,0.801947294685316,1,0.745415986888831,1,2,,"GO:0001959~regulation of cytokine-mediated signaling pathway,GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0009891~positive regulation of biosynthetic process,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0010033~response to organic substance,GO:0010605~negative regulation of macromolecule metabolic process,GO:0030162~regulation of proteolysis,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031329~regulation of cellular catabolic process,GO:0031330~negative regulation of cellular catabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042176~regulation of protein catabolic process,GO:0042177~negative regulation of protein catabolic process,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045861~negative regulation of proteolysis,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051789~response to protein stimulus,GO:0060334~regulation of interferon-gamma-mediated signaling pathway,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0048770~pigment granule,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019904~protein domain specific binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0030554~adenyl nucleotide binding,GO:0030911~TPR domain binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0051082~unfolded protein binding,","hsa04612:Antigen processing and presentation,hsa04621:NOD-like receptor signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa05200:Pathways in cancer,hsa05215:Prostate cancer,", , , 
NRIP1,nuclear receptor interacting protein 1,0.039806510633627,0.754384273018159,0.497764958175984,667,0.782595818014484,1,0.627935987141512,7.27482878468936E-05,2,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001542~ovulation from ovarian follicle,GO:0001543~ovarian follicle rupture,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007242~intracellular signaling cascade,GO:0007276~gamete generation,GO:0007292~female gamete generation,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008585~female gonad development,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010876~lipid localization,GO:0016481~negative regulation of transcription,GO:0019915~lipid storage,GO:0019953~sexual reproduction,GO:0022602~ovulation cycle process,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0030728~ovulation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032504~multicellular organism reproduction,GO:0042698~ovulation cycle,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046545~development of primary female sexual characteristics,GO:0046660~female sex differentiation,GO:0048511~rhythmic process,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0019899~enzyme binding,GO:0030331~estrogen receptor binding,GO:0030528~transcription regulator activity,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0035259~glucocorticoid receptor binding,GO:0042826~histone deacetylase binding,GO:0042974~retinoic acid receptor binding,GO:0046965~retinoid X receptor binding,GO:0050681~androgen receptor binding,GO:0051427~hormone receptor binding,",None, , , 
CD300A,CD300a molecule,0.040066882187909,0.755856071396749,0.436168110643852,749,0.353868644463714,1,1,1,2,,"GO:0006955~immune response,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
PKP4,plakophilin 4,0.040171426239532,0.755856071396749,0.553750571484343,591,0.930322865903579,1,0.475808461183278,1,2,,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0030057~desmosome,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,",None, , , 
PARD3B,par-3 partitioning defective 3 homolog B (C. elegans),0.040175616012689,0.755856071396749,0.54816372660624,602,0.755879225589523,1,0.848879761867496,8.51544414141366E-20,2,,"GO:0007049~cell cycle,GO:0051301~cell division,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0012505~endomembrane system,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,",None, , , 
KIAA1009,KIAA1009,0.040255895652128,0.755856071396749,0.601968981519548,520,0.914645707022236,1,0.424567095942059,3.94900173377079E-11,2,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0051301~cell division,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",None, , , 
RPS6KA3,"ribosomal protein S6 kinase, 90kDa, polypeptide 3",0.040263225603071,0.755856071396749,0.505618203470422,656,0.546401870287078,1,1,1,2,,"GO:0001501~skeletal system development,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0016310~phosphorylation,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04010:MAPK signaling pathway,hsa04114:Oocyte meiosis,hsa04150:mTOR signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,", , , 
CDH24,cadherin-like 24,0.040549074566797,0.759265758361747,0.409850945059076,781,0.57814800177321,1,1,0.261471254029216,2,,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,GO:0005509~calcium ion binding,GO:0008013~beta-catenin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0045294~alpha-catenin binding,GO:0046872~metal ion binding,GO:0070097~delta-catenin binding,",None, , , 
NRP2,neuropilin 2,0.040566798374914,0.759265758361747,0.338515048097486,844,0.814038956401093,1,0.576592883353912,7.44416642194286E-17,2,,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001667~ameboidal cell migration,GO:0001755~neural crest cell migration,GO:0001944~vasculature development,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007507~heart development,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0014031~mesenchymal cell development,GO:0014032~neural crest cell development,GO:0014033~neural crest cell differentiation,GO:0016477~cell migration,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0042330~taxis,GO:0048514~blood vessel morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048762~mesenchymal cell differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0050919~negative chemotaxis,GO:0051674~localization of cell,GO:0060485~mesenchyme development,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0030424~axon,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005021~vascular endothelial growth factor receptor activity,",None, , , 
SENP7,SUMO1/sentrin specific peptidase 7,0.040988116489386,0.761099633644786,0.375642139123545,816,0.776961865429334,0.687243881946198,0.959957487005618,1,2,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0016925~protein sumoylation,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
SPTAN1,"spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)",0.041199184520893,0.761099633644786,0.369582098467854,824,0.966465111347681,1,0.270953647047025,1,2,,"GO:0008064~regulation of actin polymerization or depolymerization,GO:0010639~negative regulation of organelle organization,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0030834~regulation of actin filament depolymerization,GO:0030835~negative regulation of actin filament depolymerization,GO:0030837~negative regulation of actin filament polymerization,GO:0031333~negative regulation of protein complex assembly,GO:0032271~regulation of protein polymerization,GO:0032272~negative regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0043242~negative regulation of protein complex disassembly,GO:0043244~regulation of protein complex disassembly,GO:0043254~regulation of protein complex assembly,GO:0044087~regulation of cellular component biogenesis,GO:0051129~negative regulation of cellular component organization,GO:0051493~regulation of cytoskeleton organization,GO:0051494~negative regulation of cytoskeleton organization,GO:0051693~actin filament capping,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005916~fascia adherens,GO:0005938~cell cortex,GO:0008091~spectrin,GO:0014704~intercalated disc,GO:0015629~actin cytoskeleton,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030863~cortical cytoskeleton,GO:0030864~cortical actin cytoskeleton,GO:0031674~I band,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043292~contractile fiber,GO:0044430~cytoskeletal part,GO:0044448~cell cortex part,GO:0044449~contractile fiber part,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005509~calcium ion binding,GO:0005516~calmodulin binding,GO:0008092~cytoskeletal protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04530:Tight junction,", , , 
RAVER1,"ribonucleoprotein, PTB-binding 1",0.041331858244304,0.761099633644786,0.272444580076922,897,0.361916757647146,1,1,0.168914279633556,2,,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
TPX2,"TPX2, microtubule-associated, homolog (Xenopus laevis)",0.041424055888064,0.761099633644786,0.263247370751281,902,0.53868513039209,1,1,1,2,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0008283~cell proliferation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0000922~spindle pole,GO:0005730~nucleolus,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",None, , , 
PPP6R1,"Protein Phosphatase 6, Regulatory Subunit 1",0.041471090009331,0.761099633644786,0.549216235616657,600,0.24798849320664,1,1,2.9030959685963E-17,2,,None,None, , , 
MAGEE2,"melanoma antigen family E, 2",0.041482437337778,0.761099633644786,0.402464132411685,788,0.74735679281311,1,0.749774076913278,1,2,,None,None, , , 
BMP5,bone morphogenetic protein 5,0.041683437294214,0.761099633644786,0.686271780465536,385,0.930617886567813,1,0.505087244311173,1,2,,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007389~pattern specification process,GO:0040007~growth,GO:0051216~cartilage development,GO:0060348~bone development,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0005125~cytokine activity,GO:0008083~growth factor activity,","hsa04340:Hedgehog signaling pathway,hsa04350:TGF-beta signaling pathway,", , , 
CNGA2,cyclic nucleotide gated channel alpha 2,0.041790247908979,0.762265164206125,0.387323715260172,806,0.86268246596117,1,0.452024338427969,1,2,,"GO:0006811~ion transport,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0055085~transmembrane transport,GO:0016021~integral to membrane,GO:0017071~intracellular cyclic nucleotide activated cation channel complex,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005216~ion channel activity,GO:0005217~intracellular ligand-gated ion channel activity,GO:0005221~intracellular cyclic nucleotide activated cation channel activity,GO:0005222~intracellular cAMP activated cation channel activity,GO:0005261~cation channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016208~AMP binding,GO:0017076~purine nucleotide binding,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030551~cyclic nucleotide binding,GO:0030552~cAMP binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043855~cyclic nucleotide-gated ion channel activity,GO:0046873~metal ion transmembrane transporter activity,",None, , , 
RNF219,ring finger protein 219,0.041932674162263,0.76266837456369,0.561885135596405,585,0.331603804711821,1,1,1.72168701999889E-08,2,,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
TSGA10,"testis specific, 10",0.042081066930812,0.763572041486951,0.545684193317926,605,0.793725342439585,1,0.787415323919243,1,2,,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0005635~nuclear envelope,GO:0009434~microtubule-based flagellum,GO:0012505~endomembrane system,GO:0019861~flagellum,GO:0031090~organelle membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0005198~structural molecule activity,",None, , , 
NECAB1,N-terminal EF-hand calcium binding protein 1,0.042499740249211,0.767007389483106,0.448930709514837,730,0.368191685376496,1,1,1,2,,"GO:0016999~antibiotic metabolic process,GO:0017000~antibiotic biosynthetic process,GO:0017144~drug metabolic process,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",2.59137661888054E-06,0.000543868807461,0.803650795212626,221,4.15075241972329E-05,NA,1,1,1,Known TSG,"GO:0000050~urea cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001889~liver development,GO:0001890~placenta development,GO:0001892~embryonic placenta development,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0006091~generation of precursor metabolites and energy,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0008285~negative regulation of cell proliferation,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0019221~cytokine-mediated signaling pathway,GO:0019627~urea metabolic process,GO:0021700~developmental maturation,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030225~macrophage differentiation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0032774~RNA biosynthetic process,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0043193~positive regulation of gene-specific transcription,GO:0043603~cellular amide metabolic process,GO:0043604~amide biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0045444~fat cell differentiation,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048568~embryonic organ development,GO:0050873~brown fat cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060541~respiratory system development,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003704~specific RNA polymerase II transcription factor activity,GO:0003705~RNA polymerase II transcription factor activity, enhancer binding,GO:0008134~transcription factor binding,GO:0010843~promoter binding,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,","hsa05200:Pathways in cancer,hsa05221:Acute myeloid leukemia,","Dysregulated in almost half of AML patients by transcriptional downregulation, hypermethylation, truncating dominant negative mutations, or LOF mutations (11242107, 22150310), Downregulated in HNSCC (17510391), Overexpressed by translocation in 6 AML patients (16873674, 14603446)",Reviewed (22150310), 
HS6ST1,heparan sulfate 6-O-sulfotransferase 1,2.49309335304689E-05,0.004304062697487,0.538346676503921,611,0.018757245058112,1,0.012691434779526,1,1,Novel/Unclear,"GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001890~placenta development,GO:0001944~vasculature development,GO:0006029~proteoglycan metabolic process,GO:0006790~sulfur metabolic process,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0015015~heparan sulfate proteoglycan biosynthetic process, enzymatic modification,GO:0030166~proteoglycan biosynthetic process,GO:0030201~heparan sulfate proteoglycan metabolic process,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0035295~tube development,GO:0044272~sulfur compound biosynthetic process,GO:0048286~lung alveolus development,GO:0048514~blood vessel morphogenesis,GO:0060541~respiratory system development,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0008146~sulfotransferase activity,GO:0016782~transferase activity, transferring sulfur-containing groups,","hsa00534:Heparan sulfate biosynthesis,","Expressed by tumor cells and endothelial cells (17437011), Expression significantly increases during chondrosarcoma progression (22903264)",Attach sulfate groups heparan sulfate that are critical for FGF2 activation (17437011), 
EMG1,EMG1 nucleolar protein homolog (S. cerevisiae),7.05482726280178E-05,0.010458501463641,0.892802957029934,121,0.019495703672979,3.65604275570964E-13,0.73524777513296,1,1,,"GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0016072~rRNA metabolic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0042254~ribosome biogenesis,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,",None, , , 
MTFR1L,Mitochondrial Fission Regulator 1-Like,7.30227481995287E-05,0.010740093808024,0.964320503427443,54,0.015672478957051,1,0.382789390978339,3.06413295715618E-86,1,Novel,None,None,None,Unknown, 
SOX21,SRY (sex determining region Y)-box 21,8.95624411802024E-05,0.012770510219886,0.562882916198661,583,0.014130727959334,1,0.271476723733921,1,1,,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
CSNK2A1,"casein kinase 2, alpha 1 polypeptide pseudogene; casein kinase 2, alpha 1 polypeptide",0.000109460204917,0.015033876232642,0.772698924388132,271,0.076696962874354,1,0.018953072340703,1,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway,GO:0016310~phosphorylation,GO:0046777~protein amino acid autophosphorylation,GO:0000118~histone deacetylase complex,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005886~plasma membrane,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0070822~Sin3-type complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008013~beta-catenin binding,GO:0017076~purine nucleotide binding,GO:0019208~phosphatase regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0047485~protein N-terminus binding,","hsa04310:Wnt signaling pathway,hsa04520:Adherens junction,hsa04530:Tight junction,", , , 
EXO5,Exonuclease 5,0.000153301247483,0.019479687086613,0.769158352483034,280,0.014592319458862,1,0.503116045574968,1,1,Novel,None,None,None ,A sliding exonuclease required for genome stability - depletion leads to spontaneous and damage-induced chromosome abnormalities (23095756), 
PLAC4,placenta-specific 4,0.000172939513167,0.021392104832144,0.958333029755928,59,0.002389080687938,1,1,1.02163431011217E-11,1,Novel,"GO:0019012~virion,GO:0019028~viral capsid,GO:0044423~virion part,GO:0005198~structural molecule activity,",None,None,"Unknown, upregulated in severe early onset preeclampsia (23522856)", 
DENND6A,DENN/MADD Domain Containing 6A,0.000193000625462,0.02340947196751,0.85572734069265,161,0.072640338203082,0.194276866008828,0.161539563209108,1.01471676738534E-47,1,,None,None, , , 
GGCT,gamma-glutamyl cyclotransferase,0.000270978558416,0.031635053079109,0.852929440486571,165,0.020731291482554,1,0.600158415358331,0.000362325743529,1,Putative OG,"GO:0001836~release of cytochrome c from mitochondria,GO:0006915~apoptosis,GO:0007005~mitochondrion organization,GO:0008219~cell death,GO:0008637~apoptotic mitochondrial changes,GO:0012501~programmed cell death,GO:0016265~death,GO:0005829~cytosol,GO:0003839~gamma-glutamylcyclotransferase activity,GO:0016755~transferase activity, transferring amino-acyl groups,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,","hsa00480:Glutathione metabolism,","Overexpressed in 58% of cervical, 38% of lung, 72% of colon, and 46% of breast cancers (20527979), Expression increased lung, esophagus, stomach, bile duct, and uterine cervix cancer, and decreased in renal and urothelial tumors (22205682), Overexpression has no effect on soft agar colony formation (21475839), Overexpressed in lung tumors (21475839), Transcriptionally derepressed in cancer cells by histone modifications and promoter methylation (23853312), Knockdown of C7orf24 causes significant antiproliferative effects, and overexpression increases proliferation but not transformation of NIH3T3 cells (21136669), Anti-C7orf24 siRNA administered by needle-free jet injection has an antitumor effect in lung cancer-bearing mice (22653386), Upregulated in osteosarcoma (21508379), Downregulation by siRNA inhibits growth of osteosarcoma cell lines (21508379), Potential epithelial cancer biomarker, since it can be detected in serum (20527979)","Regulates glutathione metabolism (18515354),  Negatively regulates cell clustering, promotes invasion and motility (21508379)", 
HDAC2,histone deacetylase 2,0.000326142445978,0.036921301505564,0.94624241326294,66,0.138165643374203,1,0.032909800411802,4.91597818098275E-22,1,Putative OG,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006342~chromatin silencing,GO:0006344~maintenance of chromatin silencing,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006476~protein amino acid deacetylation,GO:0008284~positive regulation of cell proliferation,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0009628~response to abiotic stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010712~regulation of collagen metabolic process,GO:0010714~positive regulation of collagen metabolic process,GO:0010869~regulation of receptor biosynthetic process,GO:0010870~positive regulation of receptor biosynthetic process,GO:0014070~response to organic cyclic substance,GO:0014073~response to tropane,GO:0016458~gene silencing,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016575~histone deacetylation,GO:0030162~regulation of proteolysis,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0032965~regulation of collagen biosynthetic process,GO:0032967~positive regulation of collagen biosynthetic process,GO:0033554~cellular response to stress,GO:0034605~cellular response to heat,GO:0040029~regulation of gene expression, epigenetic,GO:0042127~regulation of cell proliferation,GO:0042220~response to cocaine,GO:0042493~response to drug,GO:0043193~positive regulation of gene-specific transcription,GO:0043279~response to alkaloid,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of transcription factor activity,GO:0044092~negative regulation of molecular function,GO:0044246~regulation of multicellular organismal metabolic process,GO:0044253~positive regulation of multicellular organismal metabolic process,GO:0045346~regulation of MHC class II biosynthetic process,GO:0045347~negative regulation of MHC class II biosynthetic process,GO:0045449~regulation of transcription,GO:0045786~negative regulation of cell cycle,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051090~regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051101~regulation of DNA binding,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0000118~histone deacetylase complex,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005694~chromosome,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0070822~Sin3-type complex,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0004407~histone deacetylase activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0031072~heat shock protein binding,GO:0033558~protein deacetylase activity,GO:0043565~sequence-specific DNA binding,","hsa04110:Cell cycle,hsa04330:Notch signaling pathway,hsa05016:Huntington's disease,hsa05200:Pathways in cancer,hsa05220:Chronic myeloid leukemia,",Reviewed (21725353),Reviewed (21725353), 
STX7,syntaxin 7,0.00034121214886,0.038093650295626,0.825696987934043,196,0.159260725863413,0.039276671482174,0.066343878305903,3.39509953513262E-10,1,Novel,"GO:0006886~intracellular protein transport,GO:0006892~post-Golgi vesicle-mediated transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0070727~cellular macromolecule localization,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005768~endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031201~SNARE complex,GO:0031224~intrinsic to membrane,GO:0044437~vacuolar part,GO:0005484~SNAP receptor activity,","hsa04130:SNARE interactions in vesicular transport,","Expressed in malignant melanoma and lymphoma, decreased expression correlated with tumor stage (19714869)",Unknown, 
CPEB2,cytoplasmic polyadenylation element binding protein 2,0.000353252609439,0.039043819477599,0.74947790978854,305,0.208663559462666,0.720097705280436,0.009571189190129,1,1,,"GO:0006417~regulation of translation,GO:0010608~posttranscriptional regulation of gene expression,GO:0032268~regulation of cellular protein metabolic process,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0008187~poly-pyrimidine tract binding,",None, , , 
HMCN1,hemicentin 1,0.000371651965822,0.040360971334841,0.299578596401016,871,0.314586261877537,1,0.000514146219554,1,1,,"GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0008218~bioluminescence,GO:0009611~response to wounding,GO:0018298~protein-chromophore linkage,GO:0042060~wound healing,GO:0050817~coagulation,GO:0050877~neurological system process,GO:0050878~regulation of body fluid levels,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
SPATA6,spermatogenesis associated 6,0.000409048607074,0.043412607565558,0.730135989328749,321,0.071653253124773,1,0.329352821947289,1,1,,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0005576~extracellular region,",None, , , 
IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.000433790794263,0.045521226101296,0.394360685580134,799,0.331603804711821,1,0.000535822381496,1,1,,"GO:0006081~cellular aldehyde metabolic process,GO:0006084~acetyl-CoA metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006732~coenzyme metabolic process,GO:0009060~aerobic respiration,GO:0009109~coenzyme catabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0045333~cellular respiration,GO:0046356~acetyl-CoA catabolic process,GO:0046487~glyoxylate metabolic process,GO:0051186~cofactor metabolic process,GO:0051187~cofactor catabolic process,GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004448~isocitrate dehydrogenase activity,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,GO:0051287~NAD or NADH binding,","hsa00020:Citrate cycle (TCA cycle),hsa00480:Glutathione metabolism,", , , 
ANKRD46,ankyrin repeat domain 46,0.000446616230932,0.046346358764374,0.646185815874446,453,0.13793999673794,0.817879873922511,0.105361464946347,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
BAX,BCL2-associated X protein,0.000473449993134,0.047803094171586,0.86196213951247,154,0.014892262989791,1,1,1.78475353645231E-22,1,,"GO:0000266~mitochondrial fission,GO:0000737~DNA catabolic process, endonucleolytic,GO:0001101~response to acid,GO:0001541~ovarian follicle development,GO:0001568~blood vessel development,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001764~neuron migration,GO:0001775~cell activation,GO:0001776~leukocyte homeostasis,GO:0001777~T cell homeostatic proliferation,GO:0001782~B cell homeostasis,GO:0001783~B cell apoptosis,GO:0001822~kidney development,GO:0001836~release of cytochrome c from mitochondria,GO:0001844~protein insertion into mitochondrial membrane during induction of apoptosis,GO:0001894~tissue homeostasis,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0001944~vasculature development,GO:0001974~blood vessel remodeling,GO:0002260~lymphocyte homeostasis,GO:0002262~myeloid cell homeostasis,GO:0002339~B cell selection,GO:0002352~B cell negative selection,GO:0002358~B cell homeostatic proliferation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002902~regulation of B cell apoptosis,GO:0002904~positive regulation of B cell apoptosis,GO:0003006~reproductive developmental process,GO:0006259~DNA metabolic process,GO:0006308~DNA catabolic process,GO:0006309~DNA fragmentation involved in apoptosis,GO:0006461~protein complex assembly,GO:0006643~membrane lipid metabolic process,GO:0006664~glycolipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0006808~regulation of nitrogen utilization,GO:0006839~mitochondrial transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0006917~induction of apoptosis,GO:0006919~activation of caspase activity,GO:0006921~cell structure disassembly during apoptosis,GO:0006922~cleavage of lamin,GO:0006923~cleavage of cytoskeletal proteins during apoptosis,GO:0006927~transformed cell apoptosis,GO:0006928~cell motion,GO:0006944~membrane fusion,GO:0006970~response to osmotic stress,GO:0006974~response to DNA damage stimulus,GO:0006997~nucleus organization,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007423~sensory organ development,GO:0007548~sex differentiation,GO:0008053~mitochondrial fusion,GO:0008104~protein localization,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008354~germ cell migration,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0008624~induction of apoptosis by extracellular signals,GO:0008629~induction of apoptosis by intracellular signals,GO:0008634~negative regulation of survival gene product expression,GO:0008635~activation of caspase activity by cytochrome c,GO:0008637~apoptotic mitochondrial changes,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009566~fertilization,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009636~response to toxin,GO:0009651~response to salt stress,GO:0009791~post-embryonic development,GO:0009886~post-embryonic morphogenesis,GO:0010212~response to ionizing radiation,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0010332~response to gamma radiation,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010524~positive regulation of calcium ion transport into cytosol,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010623~developmental programmed cell death,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0010959~regulation of metal ion transport,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016044~membrane organization,GO:0016265~death,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0019953~sexual reproduction,GO:0019987~negative regulation of anti-apoptosis,GO:0021536~diencephalon development,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021761~limbic system development,GO:0021854~hypothalamus development,GO:0021987~cerebral cortex development,GO:0022411~cellular component disassembly,GO:0022602~ovulation cycle process,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030183~B cell differentiation,GO:0030262~apoptotic nuclear changes,GO:0030264~nuclear fragmentation during apoptosis,GO:0030900~forebrain development,GO:0031077~post-embryonic camera-type eye development,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031557~induction of programmed cell death in response to chemical stimulus,GO:0031558~induction of apoptosis in response to chemical stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032471~reduction of endoplasmic reticulum calcium ion concentration,GO:0032504~multicellular organism reproduction,GO:0032844~regulation of homeostatic process,GO:0032846~positive regulation of homeostatic process,GO:0032943~mononuclear cell proliferation,GO:0032976~release of matrix enzymes from mitochondria,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0033554~cellular response to stress,GO:0033599~regulation of mammary gland epithelial cell proliferation,GO:0034103~regulation of tissue remodeling,GO:0034105~positive regulation of tissue remodeling,GO:0034613~cellular protein localization,GO:0034644~cellular response to UV,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035234~germ cell programmed cell death,GO:0042098~T cell proliferation,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042475~odontogenesis of dentine-containing tooth,GO:0042476~odontogenesis,GO:0042592~homeostatic process,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptosis,GO:0043010~camera-type eye development,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043269~regulation of ion transport,GO:0043270~positive regulation of ion transport,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043393~regulation of protein binding,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0043653~mitochondrial fragmentation during apoptosis,GO:0043933~macromolecular complex subunit organization,GO:0044093~positive regulation of molecular function,GO:0044265~cellular macromolecule catabolic process,GO:0045136~development of secondary sexual characteristics,GO:0045137~development of primary sexual characteristics,GO:0045321~leukocyte activation,GO:0045767~regulation of anti-apoptosis,GO:0045884~regulation of survival gene product expression,GO:0045936~negative regulation of phosphate metabolic process,GO:0046545~development of primary female sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046660~female sex differentiation,GO:0046661~male sex differentiation,GO:0046666~retinal cell programmed cell death,GO:0046668~regulation of retinal cell programmed cell death,GO:0046670~positive regulation of retinal cell programmed cell death,GO:0046674~induction of retinal programmed cell death,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046907~intracellular transport,GO:0048050~post-embryonic eye morphogenesis,GO:0048070~regulation of pigmentation during development,GO:0048087~positive regulation of pigmentation during development,GO:0048145~regulation of fibroblast proliferation,GO:0048147~negative regulation of fibroblast proliferation,GO:0048232~male gamete generation,GO:0048284~organelle fusion,GO:0048285~organelle fission,GO:0048511~rhythmic process,GO:0048514~blood vessel morphogenesis,GO:0048515~spermatid differentiation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048563~post-embryonic organ morphogenesis,GO:0048569~post-embryonic organ development,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048597~post-embryonic camera-type eye morphogenesis,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048678~response to axon injury,GO:0048736~appendage development,GO:0048771~tissue remodeling,GO:0048870~cell motility,GO:0048871~multicellular organismal homeostasis,GO:0048872~homeostasis of number of cells,GO:0048873~homeostasis of number of cells within a tissue,GO:0048878~chemical homeostasis,GO:0050678~regulation of epithelial cell proliferation,GO:0050801~ion homeostasis,GO:0051050~positive regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051174~regulation of phosphorus metabolic process,GO:0051204~protein insertion into mitochondrial membrane,GO:0051205~protein insertion into membrane,GO:0051240~positive regulation of multicellular organismal process,GO:0051248~negative regulation of protein metabolic process,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051402~neuron apoptosis,GO:0051668~localization within membrane,GO:0051674~localization of cell,GO:0051726~regulation of cell cycle,GO:0051881~regulation of mitochondrial membrane potential,GO:0051924~regulation of calcium ion transport,GO:0051928~positive regulation of calcium ion transport,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060011~Sertoli cell proliferation,GO:0060041~retina development in camera-type eye,GO:0060058~positive regulation of apoptosis involved in mammary gland involution,GO:0060068~vagina development,GO:0060173~limb development,GO:0060249~anatomical structure homeostasis,GO:0060284~regulation of cell development,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070059~apoptosis in response to endoplasmic reticulum stress,GO:0070227~lymphocyte apoptosis,GO:0070228~regulation of lymphocyte apoptosis,GO:0070230~positive regulation of lymphocyte apoptosis,GO:0070271~protein complex biogenesis,GO:0070584~mitochondrion morphogenesis,GO:0070661~leukocyte proliferation,GO:0070727~cellular macromolecule localization,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005757~mitochondrial permeability transition pore complex,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044429~mitochondrial part,GO:0044432~endoplasmic reticulum part,GO:0044445~cytosolic part,GO:0046930~pore complex,GO:0008289~lipid binding,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051400~BH domain binding,GO:0051434~BH3 domain binding,GO:0070513~death domain binding,","hsa04115:p53 signaling pathway,hsa04210:Apoptosis,hsa04722:Neurotrophin signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05020:Prion diseases,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,", , , 
RIMS2,regulating synaptic membrane exocytosis 2,0.000528179026589,0.051653696532198,0.266174149587473,901,0.358434391640513,1,0.000187607570559,1,1,,"GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0005083~small GTPase regulator activity,GO:0008270~zinc ion binding,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
ATG5,ATG5 autophagy related 5 homolog (S. cerevisiae),0.000576130200784,0.055187364207424,0.771711269267075,272,0.015231708283159,1,1,2.3568794373493E-15,1,,"GO:0000045~autophagic vacuole formation,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0001974~blood vessel remodeling,GO:0003013~circulatory system process,GO:0003015~heart process,GO:0003018~vascular process in circulatory system,GO:0006914~autophagy,GO:0006915~apoptosis,GO:0007033~vacuole organization,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008015~blood circulation,GO:0008219~cell death,GO:0009267~cellular response to starvation,GO:0009991~response to extracellular stimulus,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0014706~striated muscle tissue development,GO:0016236~macroautophagy,GO:0016265~death,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0035051~cardiac cell differentiation,GO:0035150~regulation of tube size,GO:0042311~vasodilation,GO:0042493~response to drug,GO:0042594~response to starvation,GO:0042692~muscle cell differentiation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0048514~blood vessel morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0048771~tissue remodeling,GO:0050880~regulation of blood vessel size,GO:0051146~striated muscle cell differentiation,GO:0051248~negative regulation of protein metabolic process,GO:0055001~muscle cell development,GO:0055006~cardiac cell development,GO:0055007~cardiac muscle cell differentiation,GO:0055012~ventricular cardiac muscle cell differentiation,GO:0055013~cardiac muscle cell development,GO:0055015~ventricular cardiac muscle cell development,GO:0060047~heart contraction,GO:0060537~muscle tissue development,GO:0060548~negative regulation of cell death,GO:0000407~pre-autophagosomal structure,GO:0005773~vacuole,GO:0005776~autophagic vacuole,GO:0034045~pre-autophagosomal structure membrane,","hsa04140:Regulation of autophagy,hsa04622:RIG-I-like receptor signaling pathway,", , , 
SFPQ,splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated),0.000591507075072,0.05599730708968,0.630463842735492,485,0.058452416220687,1,0.416621938814839,0.000624134489206,1,,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006350~transcription,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006974~response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0033554~cellular response to stress,GO:0045449~regulation of transcription,GO:0016363~nuclear matrix,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,",None, , , 
SEC22A,SEC22 vesicle trafficking protein homolog A (S. cerevisiae),0.000591743975242,0.05599730708968,0.712667451405894,351,0.055849194112973,1,0.428948972702908,1,1,,"GO:0006888~ER to Golgi vesicle-mediated transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,",None, , , 
CD58,CD58 molecule,0.000635597066103,0.058773849493792,0.95960000782316,57,0.022318292355759,1,1,4.24612171085665E-34,1,Putative/Known TSG,"GO:0007155~cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,","hsa04514:Cell adhesion molecules (CAMs),","Mutated or deleted in 21% DLBCL patient samples (22137796), Expressed by malignant plasma cells (1490146), Expression increased on circulating monocytes from patients with cervical cancer (22965188)",Downregulation allows evasion of T-cell and NK-cell mediated immune responses (22137796), 
BRE,brain and reproductive organ-expressed (TNFRSF1A modulator),0.000732854333384,0.065812433140726,0.841870889154268,179,0.099280992173055,0.319328035851206,0.505087244311173,1,1,,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006302~double-strand break repair,GO:0006325~chromatin organization,GO:0006915~apoptosis,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0008219~cell death,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0010212~response to ionizing radiation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0012501~programmed cell death,GO:0016265~death,GO:0016568~chromatin modification,GO:0031570~DNA integrity checkpoint,GO:0031572~G2/M transition DNA damage checkpoint,GO:0031576~G2/M transition checkpoint,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0045739~positive regulation of DNA repair,GO:0045767~regulation of anti-apoptosis,GO:0045768~positive regulation of anti-apoptosis,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048584~positive regulation of response to stimulus,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0080135~regulation of cellular response to stress,GO:0000151~ubiquitin ligase complex,GO:0000152~nuclear ubiquitin ligase complex,GO:0070531~BRCA1-A complex,GO:0070552~BRISC complex,GO:0000268~peroxisome targeting sequence binding,GO:0005048~signal sequence binding,GO:0005164~tumor necrosis factor receptor binding,GO:0031593~polyubiquitin binding,GO:0032182~small conjugating protein binding,GO:0032813~tumor necrosis factor receptor superfamily binding,GO:0042277~peptide binding,GO:0043130~ubiquitin binding,",None, , , 
SPCS1,signal peptidase complex subunit 1 homolog (S. cerevisiae),0.000736976475775,0.06586595019617,0.817126792639029,204,0.111315737256526,NA,0.271476723733921,2.51340545465E-51,1,,"GO:0006465~signal peptide processing,GO:0006508~proteolysis,GO:0006518~peptide metabolic process,GO:0016485~protein processing,GO:0051604~protein maturation,GO:0051605~protein maturation by peptide bond cleavage,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005787~signal peptidase complex,GO:0005789~endoplasmic reticulum membrane,GO:0005792~microsome,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0030176~integral to endoplasmic reticulum membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031227~intrinsic to endoplasmic reticulum membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042598~vesicular fraction,GO:0044432~endoplasmic reticulum part,GO:0008233~peptidase activity,GO:0043021~ribonucleoprotein binding,GO:0043022~ribosome binding,",None, , , 
SPSB2,splA/ryanodine receptor domain and SOCS box containing 2,0.000743946263968,0.066172248879325,0.85174926912622,167,0.02985470286766,1,0.886481428527679,1,1,,"GO:0006508~proteolysis,GO:0007242~intracellular signaling cascade,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",None, , , 
RXRB,"retinoid X receptor, beta",0.000784134808483,0.067809509665087,0.663707957125986,426,0.074533638406406,1,0.416621938814839,1,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008283~cell proliferation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0014706~striated muscle tissue development,GO:0014855~striated muscle cell proliferation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0033002~muscle cell proliferation,GO:0035051~cardiac cell differentiation,GO:0035265~organ growth,GO:0040007~growth,GO:0042692~muscle cell differentiation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048738~cardiac muscle tissue development,GO:0051146~striated muscle cell differentiation,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0055007~cardiac muscle cell differentiation,GO:0055012~ventricular cardiac muscle cell differentiation,GO:0055017~cardiac muscle tissue growth,GO:0060038~cardiac muscle cell proliferation,GO:0060419~heart growth,GO:0060537~muscle tissue development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003704~specific RNA polymerase II transcription factor activity,GO:0003707~steroid hormone receptor activity,GO:0003708~retinoic acid receptor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004879~ligand-dependent nuclear receptor activity,GO:0004886~retinoid-X receptor activity,GO:0005496~steroid binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa03320:PPAR signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,", , , 
BRWD3,bromodomain and WD repeat domain containing 3,0.000796739843727,0.068582043967661,0.442228924610374,741,0.383839991399908,1,0.001681203562019,1,1,,None,None, , , 
SRSF11,Serine/Arginine-Rich Splicing Factor 11,0.001013766681307,0.081621326897104,0.87095334213602,146,0.265927402644698,0.086614584322411,0.104977053308268,4.3087996384307E-05,1,,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
DAAM1,dishevelled associated activator of morphogenesis 1,0.001223648084486,0.096035809118131,0.38576188953211,808,0.58944092900803,1,9.38751417225737E-05,1,1,,"GO:0007010~cytoskeleton organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0017016~Ras GTPase binding,GO:0017048~Rho GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,","hsa04310:Wnt signaling pathway,", , , 
BTG3,"BTG family, member 3",0.001270638783246,0.098892757634397,0.517980218482827,640,0.081936187064114,1,0.621617423105817,0.004659215620548,1,,"GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,GO:0045786~negative regulation of cell cycle,GO:0045930~negative regulation of mitotic cell cycle,GO:0051726~regulation of cell cycle,",None, , , 
MOAP1,modulator of apoptosis 1,0.001340812288334,0.101809076153605,0.667784273854056,415,0.11319698274812,1,0.420265180899895,0.000125233714641,1,,"GO:0006915~apoptosis,GO:0006919~activation of caspase activity,GO:0006921~cell structure disassembly during apoptosis,GO:0006997~nucleus organization,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0016265~death,GO:0022411~cellular component disassembly,GO:0030262~apoptotic nuclear changes,GO:0042981~regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0044093~positive regulation of molecular function,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,",None, , , 
SCRN3,secernin 3,0.001425140886414,0.106480826469328,0.837531953399711,188,0.102125317317536,1,0.505087244311173,1,1,,None,None, , , 
UBR5,"similar to E3 ubiquitin protein ligase, HECT domain containing, 1; ubiquitin protein ligase E3 component n-recognin 5",0.001464532029597,0.108988023031266,0.384036203188168,810,0.36533006107785,1,0.023483600277954,1,1,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0008283~cell proliferation,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0030518~steroid hormone receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0033554~cellular response to stress,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0050847~progesterone receptor signaling pathway,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04120:Ubiquitin mediated proteolysis,", , , 
WBP1,similar to WW domain binding protein 1; WW domain binding protein 1,0.001694384921717,0.124115356677493,0.674314889473841,406,0.083196403290283,1,0.745415986888831,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0019904~protein domain specific binding,GO:0050699~WW domain binding,",None, , , 
FAM58A,"family with sequence similarity 58, member A; hypothetical gene supported by NM_152274",0.001792146947254,0.128751972414439,0.713011314373263,350,0.02327437466064,0.638569690742653,1,1,1,,None,None, , , 
PPP3CC,"protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform",0.001859349293384,0.132056218445317,0.867493194596127,151,0.076696962874354,1,0.86861908420637,5.72828971175892E-81,1,,"GO:0006915~apoptosis,GO:0008219~cell death,GO:0008633~activation of pro-apoptotic gene products,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0005829~cytosol,GO:0004721~phosphoprotein phosphatase activity,GO:0005506~iron ion binding,GO:0005516~calmodulin binding,GO:0008270~zinc ion binding,GO:0016791~phosphatase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04114:Oocyte meiosis,hsa04210:Apoptosis,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04720:Long-term potentiation,hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),", , , 
HNRNPD,"heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)",0.001928090151808,0.135382667099199,0.895510830898572,114,0.083196403290283,1,1,0.476220519075704,1,,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0008380~RNA splicing,GO:0009057~macromolecule catabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0016071~mRNA metabolic process,GO:0043487~regulation of RNA stability,GO:0043488~regulation of mRNA stability,GO:0043489~RNA stabilization,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0048255~mRNA stabilization,GO:0051252~regulation of RNA metabolic process,GO:0005694~chromosome,GO:0005829~cytosol,GO:0030529~ribonucleoprotein complex,GO:0030530~heterogeneous nuclear ribonucleoprotein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042162~telomeric DNA binding,GO:0043565~sequence-specific DNA binding,",None, , , 
PEX2,"peroxisomal membrane protein 3, 35kDa",0.001935177049922,0.135382667099199,0.595289635743158,532,0.22109450152272,1,0.161539563209108,1,1,,"GO:0001764~neuron migration,GO:0006928~cell motion,GO:0007031~peroxisome organization,GO:0016477~cell migration,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005779~integral to peroxisomal membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031231~intrinsic to peroxisomal membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0031903~microbody membrane,GO:0042579~microbody,GO:0044438~microbody part,GO:0044439~peroxisomal part,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
LDB1,LIM domain binding 1,0.001945217226984,0.135577285756825,0.748378566392569,306,0.184593999214395,1,0.420265180899895,1.15856024002312E-19,1,,"GO:0001702~gastrulation with mouth forming second,GO:0003002~regionalization,GO:0006355~regulation of transcription, DNA-dependent,GO:0007166~cell surface receptor linked signal transduction,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0009798~axis specification,GO:0009890~negative regulation of biosynthetic process,GO:0009948~anterior/posterior axis specification,GO:0009952~anterior/posterior pattern formation,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016055~Wnt receptor signaling pathway,GO:0016481~negative regulation of transcription,GO:0021533~cell differentiation in hindbrain,GO:0021549~cerebellum development,GO:0021575~hindbrain morphogenesis,GO:0021587~cerebellum morphogenesis,GO:0021680~cerebellar Purkinje cell layer development,GO:0021692~cerebellar Purkinje cell layer morphogenesis,GO:0021694~cerebellar Purkinje cell layer formation,GO:0021695~cerebellar cortex development,GO:0021696~cerebellar cortex morphogenesis,GO:0021697~cerebellar cortex formation,GO:0021702~cerebellar Purkinje cell differentiation,GO:0022037~metencephalon development,GO:0030182~neuron differentiation,GO:0030902~hindbrain development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032844~regulation of homeostatic process,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045646~regulation of erythrocyte differentiation,GO:0045647~negative regulation of erythrocyte differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048598~embryonic morphogenesis,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0019904~protein domain specific binding,GO:0030274~LIM domain binding,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,",None, , , 
HGF,hepatocyte growth factor (hepapoietin A; scatter factor),0.001994685134186,0.137603332669328,0.633204086539445,478,0.583809760116692,1,0.001112456468077,1,1,,"GO:0000087~M phase of mitotic cell cycle,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0006468~protein amino acid phosphorylation,GO:0006508~proteolysis,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006916~anti-apoptosis,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007267~cell-cell signaling,GO:0008283~cell proliferation,GO:0010941~regulation of cell death,GO:0014031~mesenchymal cell development,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0032989~cellular component morphogenesis,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0048285~organelle fission,GO:0048762~mesenchymal cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051450~myoblast proliferation,GO:0060485~mesenchyme development,GO:0060548~negative regulation of cell death,GO:0060638~mesenchymal-epithelial cell signaling,GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,GO:0060688~regulation of morphogenesis of a branching structure,GO:0060693~regulation of branching involved in salivary gland morphogenesis,GO:0005576~extracellular region,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044433~cytoplasmic vesicle part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008083~growth factor activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04060:Cytokine-cytokine receptor interaction,hsa04510:Focal adhesion,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05218:Melanoma,", , , 
COQ9,coenzyme Q9 homolog (S. cerevisiae),0.001996386485004,0.137603332669328,0.853727616567732,164,0.198680930057808,1,0.227591325759547,1,1,,"GO:0006732~coenzyme metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006743~ubiquinone metabolic process,GO:0006744~ubiquinone biosynthetic process,GO:0009108~coenzyme biosynthetic process,GO:0042375~quinone cofactor metabolic process,GO:0045426~quinone cofactor biosynthetic process,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,GO:0005739~mitochondrion,",None, , , 
LEMD2,LEM domain containing 2,0.002113161387054,0.14405745090799,0.635816983784932,472,0.163905003841198,1,0.399243341661191,1,1,,"GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005639~integral to nuclear inner membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031229~intrinsic to nuclear inner membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044453~nuclear membrane part,",None, , , 
CCDC120,coiled-coil domain containing 120,0.002429710510233,0.159971745809814,0.331564870886429,849,0.314586261877537,1,0.074231066734267,1,1,,None,None, , , 
B3GNT5,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5",0.002440174245228,0.159971745809814,0.520512349485256,636,0.083169590603919,1,0.943222637657724,1,1,,"GO:0006486~protein amino acid glycosylation,GO:0006643~membrane lipid metabolic process,GO:0006664~glycolipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009247~glycolipid biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0046467~membrane lipid biosynthetic process,GO:0070085~glycosylation,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008375~acetylglucosaminyltransferase activity,GO:0008378~galactosyltransferase activity,GO:0008457~beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,GO:0008917~lipopolysaccharide N-acetylglucosaminyltransferase activity,","hsa00601:Glycosphingolipid biosynthesis,", , , 
COL8A2,"collagen, type VIII, alpha 2",0.002440813081846,0.159971745809814,0.579378179654206,564,0.21192215077881,1,0.271476723733921,0.231643499680476,1,,"GO:0001654~eye development,GO:0007155~cell adhesion,GO:0007423~sensory organ development,GO:0008283~cell proliferation,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0030198~extracellular matrix organization,GO:0043010~camera-type eye development,GO:0043062~extracellular structure organization,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0050673~epithelial cell proliferation,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0030674~protein binding, bridging,",None, , , 
UGT2A2,"UDP Glucuronosyltransferase 2 Family, Polypeptide A2",0.002488753882079,0.161977121126678,0.637446857247394,467,0.13793999673794,NA,0.783151176270031,1,1,,"GO:0007608~sensory perception of smell, GO:0008152~metabolic process, GO:0009593~detection of chemical stimulus, GO:0052695~cellular glucuronidation,","hsa00040:Pentose and glucuronate interconversions,hsa00053:Ascorbate and aldarate metabolism,hsa00140:Steroid hormone biosynthesis,hsa00500:Starch and sucrose metabolism,hsa00514:Other types of O-glycan biosynthesis,hsa00830:Retinol metabolism,hsa00860:Porphyrin and chlorophyll metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa00983:Drug metabolism - other enzymes,hsa01100:Metabolic pathways", , , 
DPY19L4,dpy-19-like 4 (C. elegans),0.002695791221654,0.170117176450282,0.182194901224775,956,0.46255728259106,0.453288759514313,0.065992974236892,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
CACUL1,"CDK2-Associated, Cullin Domain 1",0.002727561281713,0.170966836178252,0.779537379327169,258,0.102434384678779,1,0.886481428527679,2.3441019082171E-12,1,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000151~ubiquitin ligase complex,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,",None, , , 
APPBP2,amyloid beta precursor protein (cytoplasmic tail) binding protein 2,0.00279274991966,0.173308225080804,0.426255868453308,762,0.172564653284421,1,0.73524777513296,1,1,,"GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0003774~motor activity,GO:0003777~microtubule motor activity,",None, , , 
IL25,interleukin 25,0.002967711317912,0.181750425269765,0.892495393132147,122,0.056177889092091,1,1,0.086973105709634,1,,"GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0009611~response to wounding,GO:0009620~response to fungus,GO:0009624~response to nematode,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030222~eosinophil differentiation,GO:0030851~granulocyte differentiation,GO:0048534~hemopoietic or lymphoid organ development,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0005125~cytokine activity,GO:0030380~interleukin-17E receptor binding,","hsa04060:Cytokine-cytokine receptor interaction,", , , 
CCND3,cyclin D3,0.002996062478137,0.182887094866379,0.524218943276243,630,0.08890512090745,1,1,1,1,,"GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0001775~cell activation,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032943~mononuclear cell proliferation,GO:0033674~positive regulation of kinase activity,GO:0042098~T cell proliferation,GO:0042110~T cell activation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045321~leukocyte activation,GO:0045737~positive regulation of cyclin-dependent protein kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045937~positive regulation of phosphate metabolic process,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051301~cell division,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0070661~leukocyte proliferation,GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein kinase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,","hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04310:Wnt signaling pathway,hsa04510:Focal adhesion,hsa04630:Jak-STAT signaling pathway,", , , 
LEPREL2,leprecan-like 2,0.003017978544925,0.183385954975843,0.814308935491438,211,0.091966882656785,1,1,0.004906780896001,1,,"GO:0055114~oxidation reduction,GO:0005783~endoplasmic reticulum,GO:0005506~iron ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0019797~procollagen-proline 3-dioxygenase activity,GO:0019798~procollagen-proline dioxygenase activity,GO:0019842~vitamin binding,GO:0031406~carboxylic acid binding,GO:0031418~L-ascorbic acid binding,GO:0031543~peptidyl-proline dioxygenase activity,GO:0031544~peptidyl-proline 3-dioxygenase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
MARCKSL1,MARCKS-like 1,0.003051898091524,0.183891627263178,0.581535097026704,558,0.136807194758688,1,0.745415986888831,2.27135907005541E-18,1,,"GO:0008284~positive regulation of cell proliferation,GO:0016192~vesicle-mediated transport,GO:0042127~regulation of cell proliferation,GO:0005886~plasma membrane,GO:0005516~calmodulin binding,","hsa04666:Fc gamma R-mediated phagocytosis,", , , 
PAWR,"PRKC, apoptosis, WT1, regulator",0.003091928097943,0.185704581805373,0.753674277122001,301,0.198680930057808,1,0.428948972702908,1,1,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001816~cytokine production,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0008219~cell death,GO:0008285~negative regulation of cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0030888~regulation of B cell proliferation,GO:0030889~negative regulation of B cell proliferation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032623~interleukin-2 production,GO:0032944~regulation of mononuclear cell proliferation,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0042089~cytokine biosynthetic process,GO:0042094~interleukin-2 biosynthetic process,GO:0042107~cytokine metabolic process,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042981~regulation of apoptosis,GO:0042984~regulation of amyloid precursor protein biosynthetic process,GO:0042986~positive regulation of amyloid precursor protein biosynthetic process,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0050670~regulation of lymphocyte proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050854~regulation of antigen receptor-mediated signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050858~negative regulation of antigen receptor-mediated signaling pathway,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0050863~regulation of T cell activation,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050869~negative regulation of B cell activation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0070663~regulation of leukocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,GO:0005886~plasma membrane,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0030275~LRR domain binding,GO:0030528~transcription regulator activity,GO:0043522~leucine zipper domain binding,",None, , , 
TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",0.003154629364836,0.187660260846385,0.775244618096024,263,0.183395805588652,1,0.505087244311173,0.111740280606482,1,,"GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
BTBD11,BTB (POZ) domain containing 11,0.003213200836404,0.189934741845531,0.243170555358429,917,0.846120936133285,0.64404871523565,0.000146926531583,0.092560882692664,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0003677~DNA binding,",None, , , 
RNF217,ring finger protein 217,0.003303904801566,0.19297086451594,0.548419232309499,601,0.107155541229646,1,0.943222637657724,1.83399818464588E-07,1,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0042787~protein ubiquitination during ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
BAZ2B,"bromodomain adjacent to zinc finger domain, 2B",0.003437311031531,0.198778739188731,0.476813208588629,695,0.572493114338362,1,0.007370682982779,1,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
KBTBD4,kelch repeat and BTB (POZ) domain containing 4,0.003534962363572,0.202251355983671,0.721863748758052,338,0.198807994652244,1,0.505087244311173,1,1,,None,None, , , 
ZFY,"zinc finger protein, Y-linked",0.003559338365912,0.202251355983671,0.648937619854955,448,0.319958097012796,1,0.175460844584417,1,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
NFE2,"nuclear factor (erythroid-derived 2), 45kDa",0.003585218441902,0.202251355983671,0.580173792231098,562,0.20017567600316,1,0.505087244311173,1,1,,"GO:0003013~circulatory system process,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006337~nucleosome disassembly,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007599~hemostasis,GO:0008015~blood circulation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0022411~cellular component disassembly,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031498~chromatin disassembly,GO:0032984~macromolecular complex disassembly,GO:0032986~protein-DNA complex disassembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034623~cellular macromolecular complex disassembly,GO:0034728~nucleosome organization,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0050878~regulation of body fluid levels,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0005730~nucleolus,GO:0005856~cytoskeleton,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,GO:0050699~WW domain binding,",None, , , 
OR2T35,"olfactory receptor, family 2, subfamily T, member 35",0.003599768004682,0.202251355983671,0.647314832588883,450,0.048245469751525,1,1,1,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,",None, , , 
API5,API5-like 1; apoptosis inhibitor 5,0.003599942195599,0.202251355983671,0.817017552467742,205,0.486796451653496,1,0.066343878305903,1,1,,"GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0060548~negative regulation of cell death,GO:0005681~spliceosome,GO:0030529~ribonucleoprotein complex,GO:0017134~fibroblast growth factor binding,GO:0019838~growth factor binding,",None, , , 
CSMD3,CUB and Sushi multiple domains 3,0.003650676979288,0.202949390762259,0.227134007891652,928,0.776961865429334,1,0.000949654177846,1,1,,"GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
ZNF222,zinc finger protein 222,0.003770524229086,0.208371662944059,0.794719811936217,231,0.391188549851751,1,0.086210192121299,1.399718022337E-09,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
SEC63,SEC63 homolog (S. cerevisiae),0.003874500277539,0.212233990276109,0.856915334617235,158,0.406297742708815,1,0.173043279027597,5.24568410871499E-21,1,,"GO:0006457~protein folding,GO:0006605~protein targeting,GO:0006612~protein targeting to membrane,GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,",None, , , 
BRSK1,BR serine/threonine kinase 1,0.003937844209732,0.213822651144164,0.517917945015105,641,0.543165387911942,1,0.02903220135353,1.51742100276345E-16,1,,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000902~cell morphogenesis,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006974~response to DNA damage stimulus,GO:0007163~establishment or maintenance of cell polarity,GO:0007242~intracellular signaling cascade,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0010212~response to ionizing radiation,GO:0016310~phosphorylation,GO:0030010~establishment of cell polarity,GO:0030182~neuron differentiation,GO:0031570~DNA integrity checkpoint,GO:0031572~G2/M transition DNA damage checkpoint,GO:0031576~G2/M transition checkpoint,GO:0032989~cellular component morphogenesis,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0051726~regulation of cell cycle,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044459~plasma membrane part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
UTY,"ubiquitously transcribed tetratricopeptide repeat gene, Y-linked",0.004045688987692,0.217779321616975,0.631912877072856,480,0.305857556518427,1,0.26518730604534,1,1,,"GO:0006325~chromatin organization,GO:0016568~chromatin modification,GO:0051276~chromosome organization,GO:0055114~oxidation reduction,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0005506~iron ion binding,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
SBNO1,strawberry notch homolog 1 (Drosophila),0.004061778557567,0.218017131255141,0.466605155739695,713,0.508762855496194,1,0.067877849760584,0.000709260574667,1,,None,None, , , 
ACOT4,acyl-CoA thioesterase 4; similar to peroxisomal long-chain acyl-coA thioesterase,0.00407947373725,0.218339512716581,0.662091470040031,431,0.126229438078052,1,0.964584671744861,4.31360491166856E-08,1,,"GO:0000038~very-long-chain fatty acid metabolic process,GO:0001676~long-chain fatty acid metabolic process,GO:0006104~succinyl-CoA metabolic process,GO:0006631~fatty acid metabolic process,GO:0006637~acyl-CoA metabolic process,GO:0006732~coenzyme metabolic process,GO:0032788~saturated monocarboxylic acid metabolic process,GO:0032789~unsaturated monocarboxylic acid metabolic process,GO:0043437~butanoic acid metabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0046459~short-chain fatty acid metabolic process,GO:0051186~cofactor metabolic process,GO:0005777~peroxisome,GO:0042579~microbody,GO:0004091~carboxylesterase activity,GO:0016289~CoA hydrolase activity,GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016291~acyl-CoA thioesterase activity,GO:0016790~thiolester hydrolase activity,","hsa01040:Biosynthesis of unsaturated fatty acids,", , , 
ZNF146,zinc finger protein 146,0.004200757098221,0.223072029017029,0.217208566668972,935,0.383384775341622,1,0.12337077733248,2.92673387794025E-20,1,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0001871~pattern binding,GO:0003677~DNA binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008270~zinc ion binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
MAZ,MYC-associated zinc finger protein (purine-binding transcription factor),0.004203723658333,0.223072029017029,0.728517837618769,325,0.271854202334698,1,0.38222470049003,1,1,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006353~transcription termination,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006369~termination of RNA polymerase II transcription,GO:0006461~protein complex assembly,GO:0022411~cellular component disassembly,GO:0032774~RNA biosynthetic process,GO:0032984~macromolecular complex disassembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034623~cellular macromolecular complex disassembly,GO:0043241~protein complex disassembly,GO:0043624~cellular protein complex disassembly,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
C10orf88,chromosome 10 open reading frame 88,0.004597794720061,0.239476844746496,0.729320053199279,324,0.186986691120856,1,0.745415986888831,2.91766868211915E-10,1,,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,",None, , , 
SENP8,SUMO/sentrin specific peptidase family member 8,0.004614110079636,0.239476844746496,0.804369034133806,220,0.089770423061966,1,1,1,1,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
LMBRD2,LMBR1 domain containing 2,0.004615432523622,0.239476844746496,0.468994188538603,711,0.46255728259106,1,0.138864686954504,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
RIMS1,regulating synaptic membrane exocytosis 1,0.00468931052467,0.2426360977571,0.60695628088636,511,0.497620079827641,1,0.094818560173703,0.771320364316132,1,,"GO:0001505~regulation of neurotransmitter levels,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006461~protein complex assembly,GO:0006836~neurotransmitter transport,GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0006944~membrane fusion,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016079~synaptic vesicle exocytosis,GO:0016192~vesicle-mediated transport,GO:0017156~calcium ion-dependent exocytosis,GO:0019226~transmission of nerve impulse,GO:0032940~secretion by cell,GO:0034613~cellular protein localization,GO:0043933~macromolecular complex subunit organization,GO:0045055~regulated secretory pathway,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048489~synaptic vesicle transport,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070727~cellular macromolecule localization,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0042734~presynaptic membrane,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0005083~small GTPase regulator activity,GO:0008270~zinc ion binding,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
IRF2BP2,interferon regulatory factor 2 binding protein 2,0.004777416456575,0.246512049702683,0.527464218761827,622,0.120469886612124,1,1,0.878166106618939,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,",None, , , 
GUSB,"glucuronidase, beta",0.004979614834202,0.252756047521885,0.551819147830326,594,0.29192584281685,1,0.420265180899895,1,1,,"GO:0000272~polysaccharide catabolic process,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006026~aminoglycan catabolic process,GO:0006027~glycosaminoglycan catabolic process,GO:0009057~macromolecule catabolic process,GO:0016052~carbohydrate catabolic process,GO:0030203~glycosaminoglycan metabolic process,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0004566~beta-glucuronidase activity,GO:0043167~ion binding,GO:0043169~cation binding,","hsa00040:Pentose and glucuronate interconversions,hsa00500:Starch and sucrose metabolism,hsa00531:Glycosaminoglycan degradation,hsa00860:Porphyrin and chlorophyll metabolism,hsa00983:Drug metabolism,hsa04142:Lysosome,", , , 
MGAT5,"mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase; hypothetical LOC151162",0.005083688203286,0.254916232891559,0.684997759716413,386,0.477664462193511,1,0.142038435823367,0.069244444803012,1,,"GO:0006486~protein amino acid glycosylation,GO:0006487~protein amino acid N-linked glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0044431~Golgi apparatus part,GO:0008375~acetylglucosaminyltransferase activity,GO:0030144~alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase activity,","hsa00510:N-Glycan biosynthesis,", , , 
TFAM,"transcription factor A, mitochondrial",0.005141184435489,0.256770545643032,0.905801807387894,104,0.076696962874354,1,1,1,1,,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006356~regulation of transcription from RNA polymerase I promoter,GO:0006390~transcription from mitochondrial promoter,GO:0006461~protein complex assembly,GO:0007005~mitochondrion organization,GO:0032774~RNA biosynthetic process,GO:0033108~mitochondrial respiratory chain complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0009295~nucleoid,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0042645~mitochondrial nucleoid,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,","hsa05016:Huntington's disease,", , , 
VAMP1,vesicle-associated membrane protein 1 (synaptobrevin 1),0.005193769330791,0.257332671962444,0.670827668516162,411,0.16541944102598,0.817879873922511,1,1,1,,"GO:0016192~vesicle-mediated transport,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0019717~synaptosome,GO:0019867~outer membrane,GO:0030054~cell junction,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0031982~vesicle,GO:0044429~mitochondrial part,GO:0044459~plasma membrane part,GO:0045202~synapse,","hsa04130:SNARE interactions in vesicular transport,", , , 
PADI2,"peptidyl arginine deiminase, type II",0.005362321084444,0.263586304042965,0.701806211572721,361,0.466526838719756,1,0.180765780910828,3.92079364930318E-112,1,,"GO:0000052~citrulline metabolic process,GO:0006575~cellular amino acid derivative metabolic process,GO:0018101~peptidyl-citrulline biosynthetic process from peptidyl-arginine,GO:0018195~peptidyl-arginine modification,GO:0019240~citrulline biosynthetic process,GO:0042398~cellular amino acid derivative biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,GO:0016813~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
CTH,cystathionase (cystathionine gamma-lyase),0.005461652989784,0.266366099728939,0.596549838702958,529,0.193851849485289,1,0.812549668064137,3.28098871608731E-60,1,,"GO:0000096~sulfur amino acid metabolic process,GO:0000097~sulfur amino acid biosynthetic process,GO:0001558~regulation of cell growth,GO:0006461~protein complex assembly,GO:0006518~peptide metabolic process,GO:0006534~cysteine metabolic process,GO:0006575~cellular amino acid derivative metabolic process,GO:0006732~coenzyme metabolic process,GO:0006749~glutathione metabolic process,GO:0006790~sulfur metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008652~cellular amino acid biosynthetic process,GO:0009069~serine family amino acid metabolic process,GO:0009070~serine family amino acid biosynthetic process,GO:0009309~amine biosynthetic process,GO:0016053~organic acid biosynthetic process,GO:0018065~protein-cofactor linkage,GO:0018205~peptidyl-lysine modification,GO:0018272~protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,GO:0019344~cysteine biosynthetic process,GO:0030308~negative regulation of cell growth,GO:0032535~regulation of cellular component size,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0043933~macromolecular complex subunit organization,GO:0044271~nitrogen compound biosynthetic process,GO:0044272~sulfur compound biosynthetic process,GO:0045792~negative regulation of cell size,GO:0045926~negative regulation of growth,GO:0046394~carboxylic acid biosynthetic process,GO:0050667~homocysteine metabolic process,GO:0051186~cofactor metabolic process,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051262~protein tetramerization,GO:0051289~protein homotetramerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070813~hydrogen sulfide metabolic process,GO:0070814~hydrogen sulfide biosynthetic process,GO:0004121~cystathionine beta-lyase activity,GO:0004123~cystathionine gamma-lyase activity,GO:0016846~carbon-sulfur lyase activity,GO:0019842~vitamin binding,GO:0030170~pyridoxal phosphate binding,GO:0048037~cofactor binding,GO:0070279~vitamin B6 binding,","hsa00260:Glycine, serine and threonine metabolism,hsa00270:Cysteine and methionine metabolism,hsa00450:Selenoamino acid metabolism,hsa00910:Nitrogen metabolism,", , , 
IRF2,interferon regulatory factor 2,0.005571221936489,0.269598068786708,0.499096784120137,666,0.476172239693238,0.578493354020391,0.271476723733921,2.28176271186679E-111,1,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008283~cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
TNRC6A,trinucleotide repeat containing 6A,0.005618968123283,0.27050697313092,0.189388666263574,953,0.512599563854318,1,0.061200479048279,1,1,,"GO:0006417~regulation of translation,GO:0009267~cellular response to starvation,GO:0009890~negative regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016441~posttranscriptional gene silencing,GO:0016458~gene silencing,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035195~gene silencing by miRNA,GO:0035278~gene silencing by miRNA, negative regulation of translation,GO:0040029~regulation of gene expression, epigenetic,GO:0040033~negative regulation of translation, ncRNA-mediated,GO:0042594~response to starvation,GO:0045974~regulation of translation, ncRNA-mediated,GO:0051248~negative regulation of protein metabolic process,GO:0000932~cytoplasmic mRNA processing body,GO:0030529~ribonucleoprotein complex,GO:0035068~micro-ribonucleoprotein complex,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
STIP1,stress-induced-phosphoprotein 1,0.005645231697258,0.270672258614058,0.883180360514881,131,0.511236250678775,0.117527903718632,0.271476723733921,1,1,,"GO:0005794~Golgi apparatus,","hsa05020:Prion diseases,", , , 
MMP10,matrix metallopeptidase 10 (stromelysin 2),0.005700925424457,0.272346767272213,0.697380065649388,368,0.451763036267207,1,0.264844060836597,9.00490612139863E-29,1,,"GO:0006508~proteolysis,GO:0030574~collagen catabolic process,GO:0032963~collagen metabolic process,GO:0044236~multicellular organismal metabolic process,GO:0044243~multicellular organismal catabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
UBE2T,ubiquitin-conjugating enzyme E2T (putative),0.005734378527424,0.272943377041617,0.840759805757381,185,0.120469886612124,1,1,3.34102450722109E-05,1,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004842~ubiquitin-protein ligase activity,GO:0005524~ATP binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0017076~purine nucleotide binding,GO:0019787~small conjugating protein ligase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
SF1,splicing factor 1,0.005805767200589,0.275243465837043,0.383225737399447,811,0.434004138197617,1,0.271476723733921,1,1,,"GO:0000245~spliceosome assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000389~nuclear mRNA 3'-splice site recognition,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006376~mRNA splice site selection,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0007530~sex determination,GO:0007548~sex differentiation,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0016071~mRNA metabolic process,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0022402~cell cycle process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0030238~male sex determination,GO:0033327~Leydig cell differentiation,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042127~regulation of cell proliferation,GO:0043933~macromolecular complex subunit organization,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0046890~regulation of lipid biosynthetic process,GO:0048608~reproductive structure development,GO:0048610~reproductive cellular process,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050810~regulation of steroid biosynthetic process,GO:0065003~macromolecular complex assembly,GO:0005681~spliceosome,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
FIP1L1,FIP1 like 1 (S. cerevisiae),0.005940264550484,0.280197478632572,0.702339405590567,360,0.231402678858472,1,0.898692767374997,1,1,,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0016071~mRNA metabolic process,GO:0003723~RNA binding,",None, , , 
BRMS1,breast cancer metastasis suppressor 1,0.006032939838815,0.283852098864555,0.833197238299148,191,0.389159908706071,1,0.475808461183278,1,1,,None,None, , , 
DNM1L,dynamin 1-like,0.006078909327739,0.284581321636196,0.201917377719774,943,0.326944366796859,1,0.621617423105817,1,1,,"GO:0000266~mitochondrial fission,GO:0006915~apoptosis,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0008219~cell death,GO:0008637~apoptotic mitochondrial changes,GO:0012501~programmed cell death,GO:0016044~membrane organization,GO:0016265~death,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0043653~mitochondrial fragmentation during apoptosis,GO:0048285~organelle fission,GO:0070584~mitochondrion morphogenesis,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0019867~outer membrane,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044431~Golgi apparatus part,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,","hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,", , , 
KRTAP19-2,keratin associated protein 19-2,0.006116396433369,0.28562042244726,0.578037218444241,569,0.239690810977654,1,0.73524777513296,1,1,,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,",None, , , 
C15orf39,chromosome 15 open reading frame 39,0.006276814155707,0.290929557355978,0.412524369848723,778,0.291082237681593,1,0.595630786429956,1,1,,None,None, , , 
TCEB3CL,transcription elongation factor B polypeptide 3C-like; transcription elongation factor B polypeptide 3C-like 2; transcription elongation factor B polypeptide 3C (elongin A3),0.006356048965577,0.293872867891119,0.238627619443882,920,0.144879892976475,NA,NA,8.32733792548441E-05,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0003677~DNA binding,GO:0030528~transcription regulator activity,",None, , , 
KRTAP9-8,keratin associated protein 9-8,0.006446051301017,0.295163246703645,0.27101905917838,898,0.312009080922827,1,0.505087244311173,0.343689474762237,1,,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,",None, , , 
YBX2,Y box binding protein 2,0.006472179102294,0.295163246703645,0.32143869391188,855,0.212267760113638,1,0.858711823250435,0.000779658212707,1,,"GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006417~regulation of translation,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007292~female gamete generation,GO:0009386~translational attenuation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0016071~mRNA metabolic process,GO:0017148~negative regulation of translation,GO:0019953~sexual reproduction,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032504~multicellular organism reproduction,GO:0032774~RNA biosynthetic process,GO:0043487~regulation of RNA stability,GO:0043488~regulation of mRNA stability,GO:0043489~RNA stabilization,GO:0044092~negative regulation of molecular function,GO:0045449~regulation of transcription,GO:0048232~male gamete generation,GO:0048255~mRNA stabilization,GO:0048477~oogenesis,GO:0048515~spermatid differentiation,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0005844~polysome,GO:0030529~ribonucleoprotein complex,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008289~lipid binding,GO:0043021~ribonucleoprotein binding,GO:0045182~translation regulator activity,",None, , , 
KLRG1,"killer cell lectin-like receptor subfamily G, member 1",0.006478769267546,0.295163246703645,0.68217684369365,393,0.355755799249576,1,0.38222470049003,6.54202222832374E-70,1,,"GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006968~cellular defense response,GO:0007166~cell surface receptor linked signal transduction,GO:0009611~response to wounding,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005529~sugar binding,GO:0030246~carbohydrate binding,",None, , , 
SLC35B2,"solute carrier family 35, member B2",0.006533044477233,0.296911770779149,0.533550793164273,616,0.235078335807854,1,0.932145335372239,1,1,,"GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0015858~nucleoside transport,GO:0015860~purine nucleoside transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0046963~3'-phosphoadenosine 5'-phosphosulfate transport,GO:0055085~transmembrane transport,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005337~nucleoside transmembrane transporter activity,GO:0015211~purine nucleoside transmembrane transporter activity,GO:0015932~nucleobase, nucleoside, nucleotide and nucleic acid transmembrane transporter activity,GO:0046964~3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,",None, , , 
TFDP2,transcription factor Dp-2 (E2F dimerization partner 2),0.006692672131955,0.302308148442391,0.735209209141275,314,0.213952254817297,1,1,1,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007049~cell cycle,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,","hsa04110:Cell cycle,", , , 
BRCC3,"BRCA1/BRCA2-containing complex, subunit 3",0.00670033585605,0.302308148442391,0.434047552744313,753,0.259950044030954,0.404324546597738,1,1,1,,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006302~double-strand break repair,GO:0006325~chromatin organization,GO:0006508~proteolysis,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016578~histone deubiquitination,GO:0016579~protein deubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0031570~DNA integrity checkpoint,GO:0031572~G2/M transition DNA damage checkpoint,GO:0031576~G2/M transition checkpoint,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045739~positive regulation of DNA repair,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048584~positive regulation of response to stimulus,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051726~regulation of cell cycle,GO:0070536~protein K63-linked deubiquitination,GO:0070537~histone H2A K63-linked deubiquitination,GO:0070646~protein modification by small protein removal,GO:0070647~protein modification by small protein conjugation or removal,GO:0080135~regulation of cellular response to stress,GO:0000151~ubiquitin ligase complex,GO:0000152~nuclear ubiquitin ligase complex,GO:0070531~BRCA1-A complex,GO:0070552~BRISC complex,GO:0004221~ubiquitin thiolesterase activity,GO:0004843~ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016790~thiolester hydrolase activity,GO:0019783~small conjugating protein-specific protease activity,GO:0031593~polyubiquitin binding,GO:0032182~small conjugating protein binding,GO:0043130~ubiquitin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
NDUFC2,"NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa",0.006772672196447,0.303847066467257,0.31354672653468,861,0.330555287689256,NA,0.621617423105817,1,1,,"GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016310~phosphorylation,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0042773~ATP synthesis coupled electron transport,GO:0042775~mitochondrial ATP synthesis coupled electron transport,GO:0045333~cellular respiration,GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0030964~NADH dehydrogenase complex,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,GO:0045271~respiratory chain complex I,GO:0070469~respiratory chain,GO:0003954~NADH dehydrogenase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016651~oxidoreductase activity, acting on NADH or NADPH,GO:0016655~oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor,GO:0050136~NADH dehydrogenase (quinone) activity,","hsa00190:Oxidative phosphorylation,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,", , , 
COL11A1,"collagen, type XI, alpha 1",0.006808227220281,0.303847066467257,0.595779044680893,531,0.930929953899773,0.044071283408722,0.002295967200538,7.12142214537066E-18,1,,"GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0002062~chondrocyte differentiation,GO:0002063~chondrocyte development,GO:0003007~heart morphogenesis,GO:0006029~proteoglycan metabolic process,GO:0007155~cell adhesion,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0009100~glycoprotein metabolic process,GO:0009581~detection of external stimulus,GO:0009582~detection of abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014706~striated muscle tissue development,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043009~chordate embryonic development,GO:0043062~extracellular structure organization,GO:0043583~ear development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048729~tissue morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0048839~inner ear development,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050906~detection of stimulus involved in sensory perception,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0050953~sensory perception of light stimulus,GO:0050954~sensory perception of mechanical stimulus,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0050982~detection of mechanical stimulus,GO:0051216~cartilage development,GO:0051606~detection of stimulus,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055010~ventricular cardiac muscle morphogenesis,GO:0060415~muscle tissue morphogenesis,GO:0060537~muscle tissue development,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0005592~collagen type XI,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0030674~protein binding, bridging,GO:0050840~extracellular matrix binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,", , , 
CXorf58,chromosome X open reading frame 58,0.006812285637336,0.303847066467257,0.572663969839477,573,0.156168010678539,1,1,1,1,,None,None, , , 
TRIM59,tripartite motif-containing 59,0.006855236441945,0.303847066467257,0.456289023379123,724,0.172643867784091,1,1,0.73241782574022,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ATRNL1,attractin-like 1,0.006861664232539,0.303847066467257,0.73321662205184,316,0.907099150328727,1,0.001112456468077,1.07296514043875E-13,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005529~sugar binding,GO:0030246~carbohydrate binding,",None, , , 
SRSF1,Serine/Arginine-Rich Splicing Factor 1,0.006881002980411,0.303847066467257,0.645014530666917,454,0.389159908706071,1,0.505087244311173,1,1,,"GO:0000245~spliceosome assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006376~mRNA splice site selection,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
FBXL17,F-box and leucine-rich repeat protein 17,0.006897112060716,0.303847066467257,0.655432899055519,441,0.542306306097763,1,0.077326271444392,9.10452931292253E-43,1,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",None, , , 
PAFAH1B2,"platelet-activating factor acetylhydrolase, isoform Ib, subunit 2 (30kDa)",0.00700782582118,0.307459261645681,0.75941675629471,295,0.423593134230533,1,0.26518730604534,6.25700456164364E-83,1,,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0016042~lipid catabolic process,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0003847~1-alkyl-2-acetylglycerophosphocholine esterase activity,GO:0004091~carboxylesterase activity,","hsa00565:Ether lipid metabolism,", , , 
PKD2,polycystic kidney disease 2 (autosomal dominant),0.007056203322495,0.308354916518043,0.877242526778255,136,0.570180224973718,1,0.176972040767524,0.162799036572564,1,,"GO:0001655~urogenital system development,GO:0001701~in utero embryonic development,GO:0001822~kidney development,GO:0001890~placenta development,GO:0001892~embryonic placenta development,GO:0006140~regulation of nucleotide metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007259~JAK-STAT cascade,GO:0007368~determination of left/right symmetry,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0009581~detection of external stimulus,GO:0009582~detection of abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009799~determination of symmetry,GO:0009855~determination of bilateral symmetry,GO:0010959~regulation of metal ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019725~cellular homeostasis,GO:0022402~cell cycle process,GO:0022610~biological adhesion,GO:0022898~regulation of transmembrane transporter activity,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030814~regulation of cAMP metabolic process,GO:0031589~cell-substrate adhesion,GO:0032409~regulation of transporter activity,GO:0032410~negative regulation of transporter activity,GO:0032412~regulation of ion transmembrane transporter activity,GO:0032413~negative regulation of ion transmembrane transporter activity,GO:0032844~regulation of homeostatic process,GO:0034762~regulation of transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0042592~homeostatic process,GO:0043009~chordate embryonic development,GO:0043269~regulation of ion transport,GO:0044092~negative regulation of molecular function,GO:0048568~embryonic organ development,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050982~detection of mechanical stimulus,GO:0051051~negative regulation of transport,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051282~regulation of sequestering of calcium ion,GO:0051283~negative regulation of sequestering of calcium ion,GO:0051480~cytosolic calcium ion homeostasis,GO:0051606~detection of stimulus,GO:0051924~regulation of calcium ion transport,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity,GO:0060315~negative regulation of ryanodine-sensitive calcium-release channel activity,GO:0060401~cytosolic calcium ion transport,GO:0060402~calcium ion transport into cytosol,GO:0002133~polycystin complex,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005929~cilium,GO:0005932~microtubule basal body,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031512~motile primary cilium,GO:0031513~nonmotile primary cilium,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044463~cell projection part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005247~voltage-gated chloride channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0005272~sodium channel activity,GO:0005509~calcium ion binding,GO:0008022~protein C-terminus binding,GO:0008092~cytoskeletal protein binding,GO:0008308~voltage-gated anion channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0019899~enzyme binding,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0051117~ATPase binding,",None, , , 
SNAPC1,"small nuclear RNA activating complex, polypeptide 1, 43kDa",0.007132419157495,0.309540216112558,0.824255697868412,199,0.325131236668642,1,0.745415986888831,0.02388713929752,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,",None, , , 
RSRC1,arginine/serine-rich coiled-coil 1,0.007392460797885,0.317433966077452,0.568548230269722,577,0.623604738532564,1,0.104977053308268,1,1,,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000380~alternative nuclear mRNA splicing, via spliceosome,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006913~nucleocytoplasmic transport,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0016310~phosphorylation,GO:0046677~response to antibiotic,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None, , , 
MEDAG,Mesenteric Estrogen-Dependent Adipogenesis,0.007434626358593,0.31851235264257,0.411562618753158,779,0.06648584888074,1,1,9.15147918422904E-23,1,,None,None, , , 
PSCA,prostate stem cell antigen,0.007547740412628,0.32261840541757,0.193016239237572,949,0.080598851231264,1,1,1,1,,"GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,",None, , , 
CDKN2C,"cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)",0.007594677657212,0.323220617193737,0.815159098968096,209,0.091364132135546,1,1,1.16020538272497E-08,1,,"GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001558~regulation of cell growth,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0010001~glial cell differentiation,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030308~negative regulation of cell growth,GO:0032535~regulation of cellular component size,GO:0040008~regulation of growth,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043549~regulation of kinase activity,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045926~negative regulation of growth,GO:0045936~negative regulation of phosphate metabolic process,GO:0048709~oligodendrocyte differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0004857~enzyme inhibitor activity,GO:0004860~protein kinase inhibitor activity,GO:0004861~cyclin-dependent protein kinase inhibitor activity,GO:0016538~cyclin-dependent protein kinase regulator activity,GO:0019207~kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019887~protein kinase regulator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,","hsa04110:Cell cycle,",Cancer gene census (14993899),0, 
OCIAD2,OCIA domain containing 2,0.007626137102004,0.323220617193737,0.766883492840997,285,0.305857556518427,1,0.886481428527679,1,1,,"GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005768~endosome,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,",None, , , 
FEZ2,fasciculation and elongation protein zeta 2 (zygin II),0.007631045140663,0.323220617193737,0.744385214894562,309,0.334440434895357,1,0.524342468927875,1,1,,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,",None, , , 
FAM175A,"family with sequence similarity 175, member A",0.007662836442254,0.323545983502304,0.686479656114779,383,0.314586261877537,1,0.621617423105817,1,1,,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006302~double-strand break repair,GO:0006325~chromatin organization,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0010212~response to ionizing radiation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0016568~chromatin modification,GO:0031570~DNA integrity checkpoint,GO:0031572~G2/M transition DNA damage checkpoint,GO:0031576~G2/M transition checkpoint,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0045739~positive regulation of DNA repair,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048584~positive regulation of response to stimulus,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0080135~regulation of cellular response to stress,GO:0070531~BRCA1-A complex,GO:0031593~polyubiquitin binding,GO:0032182~small conjugating protein binding,GO:0043130~ubiquitin binding,",None, , , 
CEP128,Centrosomal Protein 128kDa,0.00767336959642,0.323545983502304,0.638324743768452,466,0.399767929243017,1,0.365094295850086,0.000457446265886,1,,None,None, , , 
AAMP,"angio-associated, migratory cell protein",0.007737776397875,0.324795337833506,0.87712012328717,137,0.069787748618718,1,1,1.0063889207804E-46,1,,"GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0006928~cell motion,GO:0010594~regulation of endothelial cell migration,GO:0010595~positive regulation of endothelial cell migration,GO:0014812~muscle cell migration,GO:0014909~smooth muscle cell migration,GO:0016477~cell migration,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0048514~blood vessel morphogenesis,GO:0048870~cell motility,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051674~localization of cell,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0001871~pattern binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,",None, , , 
SPAG11A,sperm associated antigen 11A; sperm associated antigen 11B,0.007757009654839,0.324872608391777,0.617152918970372,500,0.481385016335298,NA,0.329257659327926,4.20961728160807E-73,1,,"GO:0006952~defense response,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0009617~response to bacterium,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0042742~defense response to bacterium,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0005576~extracellular region,",None, , , 
MCRS1,microspherule protein 1,0.007807490696159,0.326255299135463,0.79217833140357,235,0.691746328946334,1,0.066343878305903,1,1,,"GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,",None, , , 
MXRA8,matrix-remodelling associated 8,0.007852242745883,0.326983014590682,0.382634591606391,813,0.161034363867777,1,1,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
ETV3,ets variant 3,0.007859916138509,0.326983014590682,0.473902555629846,701,0.268015562321378,1,0.990178279265157,1,1,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
WNT16,"wingless-type MMTV integration site family, member 16",0.007890036174472,0.327305104023908,0.862331300023598,153,0.184593999214395,1,1,0.047048487205659,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway,GO:0007267~cell-cell signaling,GO:0016055~Wnt receptor signaling pathway,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,","hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,", , , 
SENP3,SUMO1/sentrin/SMT3 specific peptidase 3,0.008056951034111,0.331488520630317,0.871595670903959,144,0.382078818022627,0.571473810679365,0.745415986888831,2.08457486387571E-05,1,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0004843~ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0019783~small conjugating protein-specific protease activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
LUC7L2,LUC7-like 2 (S. cerevisiae),0.008128302044272,0.332228783118063,0.875265444667077,141,0.389159908706071,1,0.420265180899895,3.00924212541704E-07,1,,"GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
COPG2,"coatomer protein complex, subunit gamma 2",0.008274469640311,0.336729451876641,0.186544903809283,954,0.304867780901408,0.720097705280436,0.990178279265157,0.000124581599749,1,,"GO:0006886~intracellular protein transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0070727~cellular macromolecule localization,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030117~membrane coat,GO:0030120~vesicle coat,GO:0030126~COPI vesicle coat,GO:0030135~coated vesicle,GO:0030137~COPI-coated vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030663~COPI coated vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0048475~coated membrane,GO:0005198~structural molecule activity,",None, , , 
KRT222,keratin 222 pseudogene,0.008314384839193,0.337618248720167,0.723525015525342,335,0.486796451653496,1,0.416621938814839,0.192554266809709,1,,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,GO:0005198~structural molecule activity,",None, , , 
MPZ,myelin protein zero,0.008415023694417,0.340225600839864,0.337998577720325,845,0.361916757647146,1,0.745415986888831,1,1,,"GO:0001508~regulation of action potential,GO:0006873~cellular ion homeostasis,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007272~ensheathment of neurons,GO:0008366~axon ensheathment,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019725~cellular homeostasis,GO:0034330~cell junction organization,GO:0034331~cell junction maintenance,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0043954~cellular component maintenance,GO:0045216~cell-cell junction organization,GO:0045217~cell-cell junction maintenance,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0055082~cellular chemical homeostasis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0005198~structural molecule activity,","hsa04514:Cell adhesion molecules (CAMs),", , , 
ZNF768,zinc finger protein 768,0.008493329373671,0.341911421057768,0.476912384891326,693,0.339662096545566,1,0.613513232463045,1,1,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0000428~DNA-directed RNA polymerase complex,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0030880~RNA polymerase complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
PAN3,PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae),0.008574248239069,0.344405790176185,0.742086518830515,310,0.551173273446675,1,0.271476723733921,2.69486732144076E-22,1,,"GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0009057~macromolecule catabolic process,GO:0016071~mRNA metabolic process,GO:0016310~phosphorylation,GO:0044265~cellular macromolecule catabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
TEX26,Testis Expressed 26,0.00873056838186,0.347714897238287,0.785660020897477,246,0.506121295789211,1,0.227591325759547,6.49363208218125E-23,1,,None,None, , , 
SMAD7,SMAD family member 7,0.008848279375901,0.349422855100313,0.63375669892516,476,0.423593134230533,1,0.399243341661191,0.00072588848035,1,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0001944~vasculature development,GO:0003007~heart morphogenesis,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006873~cellular ion homeostasis,GO:0006937~regulation of muscle contraction,GO:0006942~regulation of striated muscle contraction,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008016~regulation of heart contraction,GO:0009890~negative regulation of biosynthetic process,GO:0009894~regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0009968~negative regulation of signal transduction,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0010721~negative regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010771~negative regulation of cell morphogenesis involved in differentiation,GO:0010799~regulation of peptidyl-threonine phosphorylation,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0014706~striated muscle tissue development,GO:0016310~phosphorylation,GO:0016481~negative regulation of transcription,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0022407~regulation of cell-cell adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022604~regulation of cell morphogenesis,GO:0030155~regulation of cell adhesion,GO:0030162~regulation of proteolysis,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030509~BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031329~regulation of cellular catabolic process,GO:0031331~positive regulation of cellular catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031503~protein complex localization,GO:0031647~regulation of protein stability,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0032844~regulation of homeostatic process,GO:0032925~regulation of activin receptor signaling pathway,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0034332~adherens junction organization,GO:0034333~adherens junction assembly,GO:0034405~response to fluid shear stress,GO:0034616~response to laminar fluid shear stress,GO:0034629~cellular protein complex localization,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042176~regulation of protein catabolic process,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0043086~negative regulation of catalytic activity,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of transcription factor activity,GO:0044057~regulation of system process,GO:0044092~negative regulation of molecular function,GO:0045216~cell-cell junction organization,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045767~regulation of anti-apoptosis,GO:0045768~positive regulation of anti-apoptosis,GO:0045785~positive regulation of cell adhesion,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0048514~blood vessel morphogenesis,GO:0048729~tissue morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0048844~artery morphogenesis,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050821~protein stabilization,GO:0051090~regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051101~regulation of DNA binding,GO:0051129~negative regulation of cellular component organization,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051340~regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051899~membrane depolarization,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055010~ventricular cardiac muscle morphogenesis,GO:0055082~cellular chemical homeostasis,GO:0055117~regulation of cardiac muscle contraction,GO:0060284~regulation of cell development,GO:0060373~regulation of ventricular cardiomyocyte membrane depolarization,GO:0060389~pathway-restricted SMAD protein phosphorylation,GO:0060393~regulation of pathway-restricted SMAD protein phosphorylation,GO:0060394~negative regulation of pathway-restricted SMAD protein phosphorylation,GO:0060411~heart septum morphogenesis,GO:0060412~ventricular septum morphogenesis,GO:0060415~muscle tissue morphogenesis,GO:0060537~muscle tissue development,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0016342~catenin complex,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0044459~plasma membrane part,GO:0070013~intracellular organelle lumen,GO:0070161~anchoring junction,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0005072~transforming growth factor beta receptor, cytoplasmic mediator activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005518~collagen binding,GO:0008013~beta-catenin binding,GO:0010843~promoter binding,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0030617~transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0034713~type I transforming growth factor beta receptor binding,GO:0043565~sequence-specific DNA binding,GO:0046332~SMAD binding,GO:0048185~activin binding,GO:0070411~I-SMAD binding,","hsa04350:TGF-beta signaling pathway,", , , 
GNB4,"guanine nucleotide binding protein (G protein), beta polypeptide 4",0.008883382372734,0.349952082556059,0.201045128322398,944,0.512402317662506,1,0.210323522573515,1,1,,"GO:0007242~intracellular signaling cascade,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0010033~response to organic substance,GO:0032870~cellular response to hormone stimulus,","hsa04062:Chemokine signaling pathway,", , , 
NIT1,nitrilase 1,0.008899629057078,0.349952082556059,0.424312715345039,770,0.180232923212735,1,1,1,1,,"GO:0000257~nitrilase activity,GO:0016815~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,",None, , , 
PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)",0.008917885930547,0.349952082556059,0.85612303723812,160,0.451033625559685,1,0.505087244311173,1,1,,"GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0001932~regulation of protein amino acid phosphorylation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007242~intracellular signaling cascade,GO:0007369~gastrulation,GO:0007498~mesoderm development,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0010033~response to organic substance,GO:0019220~regulation of phosphate metabolic process,GO:0031399~regulation of protein modification process,GO:0032147~activation of protein kinase activity,GO:0032268~regulation of cellular protein metabolic process,GO:0032870~cellular response to hormone stimulus,GO:0033674~positive regulation of kinase activity,GO:0034199~activation of protein kinase A activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048332~mesoderm morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0005829~cytosol,GO:0005952~cAMP-dependent protein kinase complex,GO:0031594~neuromuscular junction,GO:0045202~synapse,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0016208~AMP binding,GO:0017076~purine nucleotide binding,GO:0019207~kinase regulator activity,GO:0019887~protein kinase regulator activity,GO:0030551~cyclic nucleotide binding,GO:0030552~cAMP binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04210:Apoptosis,hsa04910:Insulin signaling pathway,", , , 
CYBRD1,cytochrome b reductase 1,0.009629857980374,0.371756882785259,0.515429144529935,644,0.320807184082685,1,0.745415986888831,1,1,,"GO:0006091~generation of precursor metabolites and energy,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010039~response to iron ion,GO:0022900~electron transport chain,GO:0055114~oxidation reduction,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0000293~ferric-chelate reductase activity,GO:0005506~iron ion binding,GO:0016722~oxidoreductase activity, oxidizing metal ions,GO:0016723~oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
KIRREL,kin of IRRE like (Drosophila),0.009632760386962,0.371756882785259,0.281779676762244,888,0.867953372377229,0.687243881946198,0.01808787213127,1,1,,"GO:0007588~excretion,GO:0046903~secretion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
SMURF2,SMAD specific E3 ubiquitin protein ligase 2,0.009899038121539,0.378888222485882,0.666644946628625,418,0.646696693936275,1,0.173043279027597,1,1,,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0009057~macromolecule catabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0030509~BMP signaling pathway,GO:0030579~ubiquitin-dependent SMAD protein catabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000151~ubiquitin ligase complex,GO:0005886~plasma membrane,GO:0045121~membrane raft,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0042802~identical protein binding,","hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa04350:TGF-beta signaling pathway,", , , 
PLCL1,phospholipase C-like 1,0.009940149242728,0.378888222485882,0.312051381454555,863,0.865384930113013,1,0.005629812000978,0.839846608345287,1,,"GO:0007242~intracellular signaling cascade,GO:0007610~behavior,GO:0004435~phosphoinositide phospholipase C activity,GO:0004620~phospholipase activity,GO:0004629~phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016298~lipase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
EIF3J,"eukaryotic translation initiation factor 3, subunit J",0.009953810347844,0.378888222485882,0.900086715179938,110,0.185388102014922,1,1,2.46134032411981E-41,1,,"GO:0006412~translation,GO:0006413~translational initiation,GO:0005829~cytosol,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0003743~translation initiation factor activity,GO:0008135~translation factor activity, nucleic acid binding,",None, , , 
C11orf94,Chromosome 11 Open Reading Frame 94,0.009959533017858,0.378888222485882,0.756299631368137,299,0.326944366796859,1,0.745415986888831,1,1,,"GO:0005576~extracellular region,",None, , , 
CCBE1,collagen and calcium binding EGF domains 1,0.010130634725047,0.381512350865222,0.456753187359899,722,0.570089238309989,1,0.271476723733921,8.19902118302638E-27,1,,"GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0001945~lymph vessel development,GO:0001946~lymphangiogenesis,GO:0002040~sprouting angiogenesis,GO:0048514~blood vessel morphogenesis,GO:0048845~venous blood vessel morphogenesis,GO:0005576~extracellular region,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
TBC1D19,"TBC1 domain family, member 19",0.010229956711191,0.382968403595269,0.813829169640753,213,0.248203727921346,1,1,1,1,,"GO:0032313~regulation of Rab GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032483~regulation of Rab protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005097~Rab GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
GNA13,"guanine nucleotide binding protein (G protein), alpha 13",0.010264204521798,0.382968403595269,0.276839990600316,891,0.915564401306741,1,0.001227926277335,1,1,,"GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001701~in utero embryonic development,GO:0001763~morphogenesis of a branching structure,GO:0001775~cell activation,GO:0001944~vasculature development,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0007389~pattern specification process,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008360~regulation of cell shape,GO:0009611~response to wounding,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0019725~cellular homeostasis,GO:0022604~regulation of cell morphogenesis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030168~platelet activation,GO:0030334~regulation of cell migration,GO:0031584~activation of phospholipase D activity,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040012~regulation of locomotion,GO:0042060~wound healing,GO:0042592~homeostatic process,GO:0043009~chordate embryonic development,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0048514~blood vessel morphogenesis,GO:0048754~branching morphogenesis of a tube,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051270~regulation of cell motion,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031253~cell projection membrane,GO:0031410~cytoplasmic vesicle,GO:0031526~brush border membrane,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0048770~pigment granule,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0031701~angiotensin receptor binding,GO:0031702~type 1 angiotensin receptor binding,GO:0031752~D5 dopamine receptor binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0050780~dopamine receptor binding,","hsa04270:Vascular smooth muscle contraction,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,", , , 
MCM7,minichromosome maintenance complex component 7,0.010271811670926,0.382968403595269,0.651405722335551,445,0.546771303462305,1,0.337793531458596,1,1,,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006268~DNA unwinding during replication,GO:0006270~DNA replication initiation,GO:0006350~transcription,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0019220~regulation of phosphate metabolic process,GO:0032392~DNA geometric change,GO:0032508~DNA duplex unwinding,GO:0033554~cellular response to stress,GO:0042325~regulation of phosphorylation,GO:0045449~regulation of transcription,GO:0051174~regulation of phosphorus metabolic process,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0042555~MCM complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043566~structure-specific DNA binding,","hsa03030:DNA replication,hsa04110:Cell cycle,", , , 
INPP4A,"inositol polyphosphate-4-phosphatase, type I, 107kDa",0.01032358583973,0.383693458870761,0.526742737817347,623,0.845564975663217,0.17048923469897,0.049992677538067,1,1,,"GO:0004437~inositol or phosphatidylinositol phosphatase activity,GO:0016316~phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,GO:0016791~phosphatase activity,GO:0034593~phosphatidylinositol bisphosphate phosphatase activity,GO:0034596~phosphoinositide 4-phosphatase activity,GO:0034597~phosphatidyl-inositol-4,5-bisphosphate 4-phosphatase activity,GO:0042577~lipid phosphatase activity,","hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,", , , 
ERO1LB,ERO1-like beta (S. cerevisiae),0.010346833421357,0.383693458870761,0.16883238010424,962,0.489340439045559,1,0.337244195918755,1,1,,"GO:0006091~generation of precursor metabolites and energy,GO:0006457~protein folding,GO:0006467~protein thiol-disulfide exchange,GO:0022900~electron transport chain,GO:0055114~oxidation reduction,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0031090~organelle membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0009055~electron carrier activity,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0016671~oxidoreductase activity, acting on sulfur group of donors, disulfide as acceptor,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050662~coenzyme binding,GO:0051082~unfolded protein binding,",None, , , 
PXK,PX domain containing serine/threonine kinase,0.010385902302117,0.383963854200602,0.84230713635123,178,0.307346459704176,1,1,7.48156177898649E-45,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0009611~response to wounding,GO:0016310~phosphorylation,GO:0031644~regulation of neurological system process,GO:0032780~negative regulation of ATPase activity,GO:0043086~negative regulation of catalytic activity,GO:0043269~regulation of ion transport,GO:0043271~negative regulation of ion transport,GO:0043462~regulation of ATPase activity,GO:0044057~regulation of system process,GO:0044092~negative regulation of molecular function,GO:0050804~regulation of synaptic transmission,GO:0051051~negative regulation of transport,GO:0051336~regulation of hydrolase activity,GO:0051346~negative regulation of hydrolase activity,GO:0051969~regulation of transmission of nerve impulse,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0008022~protein C-terminus binding,GO:0008092~cytoskeletal protein binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035091~phosphoinositide binding,",None, , , 
LETM2,leucine zipper-EF-hand containing transmembrane protein 2,0.010407305793716,0.383963854200602,0.825257601782551,197,0.213952254817297,1,1,1,1,,"GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,",None, , , 
SUFU,suppressor of fused homolog (Drosophila),0.010442402587607,0.383963854200602,0.895247107179518,115,0.423593134230533,0.319328035851206,0.858711823250435,1.14850960362387E-20,1,,"GO:0001501~skeletal system development,GO:0006355~regulation of transcription, DNA-dependent,GO:0006508~proteolysis,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,","hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,",Cancer gene census (14993899),0, 
GRPEL2,"GrpE-like 2, mitochondrial (E. coli)",0.010603535676516,0.389122677606367,0.72548442304611,331,0.295055376807704,1,0.886481428527679,4.7416119863883E-37,1,,"GO:0006457~protein folding,GO:0006605~protein targeting,GO:0006626~protein targeting to mitochondrion,GO:0006839~mitochondrial transport,GO:0006886~intracellular protein transport,GO:0007005~mitochondrion organization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0017038~protein import,GO:0030150~protein import into mitochondrial matrix,GO:0033365~protein localization in organelle,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0055085~transmembrane transport,GO:0065002~intracellular protein transmembrane transport,GO:0070585~protein localization in mitochondrion,GO:0070727~cellular macromolecule localization,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000774~adenyl-nucleotide exchange factor activity,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0060590~ATPase regulator activity,",None, , , 
MIB1,mindbomb homolog 1 (Drosophila),0.010626091085329,0.389185794868366,0.529749012548457,621,0.818380727334137,1,0.030324001619147,1,1,,"GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001756~somitogenesis,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001944~vasculature development,GO:0001947~heart looping,GO:0002009~morphogenesis of an epithelium,GO:0003002~regionalization,GO:0003007~heart morphogenesis,GO:0006508~proteolysis,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009952~anterior/posterior pattern formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0021915~neural tube development,GO:0030100~regulation of endocytosis,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035282~segmentation,GO:0035295~tube development,GO:0043009~chordate embryonic development,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045807~positive regulation of endocytosis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0050767~regulation of neurogenesis,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060627~regulation of vesicle-mediated transport,GO:0070647~protein modification by small protein conjugation or removal,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
NCAPH2,"non-SMC condensin II complex, subunit H2",0.010649342573113,0.389274109438701,0.643100853153298,458,0.675823878784828,0.007552523311108,0.342096927505986,1,1,,"GO:0006323~DNA packaging,GO:0030261~chromosome condensation,GO:0051276~chromosome organization,",None, , , 
PIGB,"phosphatidylinositol glycan anchor biosynthesis, class B",0.010770400251987,0.392164339779465,0.55788072323614,590,0.269194387967839,1,0.971784231743341,0.000526386835044,1,,"GO:0006497~protein amino acid lipidation,GO:0006505~GPI anchor metabolic process,GO:0006506~GPI anchor biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0016254~preassembly of GPI anchor in ER membrane,GO:0019637~organophosphate metabolic process,GO:0030384~phosphoinositide metabolic process,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0045017~glycerolipid biosynthetic process,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046489~phosphoinositide biosynthetic process,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031227~intrinsic to endoplasmic reticulum membrane,GO:0031300~intrinsic to organelle membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0000030~mannosyltransferase activity,GO:0004376~glycolipid mannosyltransferase activity,","hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,", , , 
IGSF1,"immunoglobulin superfamily, member 1",0.0109113749877,0.396524461858441,0.276658853589221,892,0.508762855496194,1,0.420265180899895,1,1,,"GO:0045449~regulation of transcription,GO:0005576~extracellular region,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0015026~coreceptor activity,GO:0034711~inhibin binding,GO:0048186~inhibin beta-A binding,GO:0048187~inhibin beta-B binding,",None, , , 
AKIP1,A Kinase (PRKA) Interacting Protein 1,0.010993808605213,0.398744370751016,0.591868615406077,535,0.174737163665832,1,1,3.5293610510554E-24,1,,None,None, , , 
MALT1,mucosa associated lymphoid tissue lymphoma translocation gene 1,0.011103666017217,0.399625004885544,0.894960707141965,116,0.509049012414356,1,0.595630786429956,9.56801680710772E-30,1,,"GO:0001775~cell activation,GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0001923~B-1 B cell differentiation,GO:0002237~response to molecule of bacterial origin,GO:0002253~activation of immune response,GO:0002335~mature B cell differentiation,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002700~regulation of production of molecular mediator of immune response,GO:0002702~positive regulation of production of molecular mediator of immune response,GO:0002703~regulation of leukocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002709~regulation of T cell mediated immunity,GO:0002711~positive regulation of T cell mediated immunity,GO:0002718~regulation of cytokine production during immune response,GO:0002720~positive regulation of cytokine production during immune response,GO:0002724~regulation of T cell cytokine production,GO:0002726~positive regulation of T cell cytokine production,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signal transduction,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002819~regulation of adaptive immune response,GO:0002821~positive regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002824~positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0006461~protein complex assembly,GO:0006508~proteolysis,GO:0006913~nucleocytoplasmic transport,GO:0006916~anti-apoptosis,GO:0006952~defense response,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007249~I-kappaB kinase/NF-kappaB cascade,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0008283~cell proliferation,GO:0009057~macromolecule catabolic process,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0019220~regulation of phosphate metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030163~protein catabolic process,GO:0030183~B cell differentiation,GO:0032147~activation of protein kinase activity,GO:0032663~regulation of interleukin-2 production,GO:0032743~positive regulation of interleukin-2 production,GO:0032943~mononuclear cell proliferation,GO:0033674~positive regulation of kinase activity,GO:0042098~T cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042325~regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043388~positive regulation of DNA binding,GO:0043549~regulation of kinase activity,GO:0043632~modification-dependent macromolecule catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045087~innate immune response,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046907~intracellular transport,GO:0048534~hemopoietic or lymphoid organ development,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0050854~regulation of antigen receptor-mediated signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050870~positive regulation of T cell activation,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051259~protein oligomerization,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070661~leukocyte proliferation,GO:0005829~cytosol,GO:0032449~CBM complex,GO:0048471~perinuclear region of cytoplasm,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004842~ubiquitin-protein ligase activity,GO:0008047~enzyme activator activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0019787~small conjugating protein ligase activity,GO:0043621~protein self-association,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,", , , 
SMARCD2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2",0.011241843155665,0.403361741905996,0.668079837752618,414,0.526163475775603,1,0.505087244311173,1,1,,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0016514~SWI/SNF complex,GO:0016585~chromatin remodeling complex,GO:0070603~SWI/SNF-type complex,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None, , , 
SAMD4A,sterile alpha motif domain containing 4A,0.011252653343819,0.403361741905996,0.244714452984746,915,0.55657847925564,1,0.227591325759547,1,1,,"GO:0006417~regulation of translation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0045727~positive regulation of translation,GO:0051247~positive regulation of protein metabolic process,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0019717~synaptosome,GO:0030054~cell junction,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0030371~translation repressor activity,GO:0045182~translation regulator activity,",None, , , 
RABL6,"RAB, Member RAS Oncogene Family-Like 6",0.011276182875446,0.403361741905996,0.42373685240035,771,0.523859259797601,1,0.298771804543033,1,1,,"GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0000166~nucleotide binding,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",None, , , 
FAM222B,"Family With Sequence Similarity 222, Member B",0.011315464037622,0.403361741905996,0.547758323823173,603,0.231533422790292,1,1,1,1,,None,None, , , 
C1orf53,chromosome 1 open reading frame 53,0.011399304964478,0.404256274984353,0.507334855612049,654,0.458702687494425,NA,0.621617423105817,1,1,,None,None, , , 
EOMES,eomesodermin homolog (Xenopus laevis),0.011448769712871,0.404256274984353,0.69078608420614,378,0.514287835235824,1,0.505087244311173,3.19842549978488E-29,1,,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001701~in utero embryonic development,GO:0001704~formation of primary germ layer,GO:0001706~endoderm formation,GO:0001707~mesoderm formation,GO:0001775~cell activation,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0001837~epithelial to mesenchymal transition,GO:0001890~placenta development,GO:0001892~embryonic placenta development,GO:0002263~cell activation during immune response,GO:0002285~lymphocyte activation during immune response,GO:0002286~T cell activation during immune response,GO:0002287~alpha-beta T cell activation during immune response,GO:0002292~T cell differentiation during immune response,GO:0002293~alpha-beta T cell differentiation during immune response,GO:0002302~CD8-positive, alpha-beta T cell differentiation during immune response,GO:0002366~leukocyte activation during immune response,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006955~immune response,GO:0007369~gastrulation,GO:0007492~endoderm development,GO:0007498~mesoderm development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014031~mesenchymal cell development,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030217~T cell differentiation,GO:0032989~cellular component morphogenesis,GO:0042110~T cell activation,GO:0043009~chordate embryonic development,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0046631~alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046649~lymphocyte activation,GO:0048332~mesoderm morphogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048762~mesenchymal cell differentiation,GO:0051094~positive regulation of developmental process,GO:0051252~regulation of RNA metabolic process,GO:0060485~mesenchyme development,GO:0060706~cell differentiation involved in embryonic placenta development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None, , , 
IAH1,isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae),0.011474786843311,0.404410459332476,0.62403864319189,495,0.17969514678406,1,1,1,1,,"GO:0016042~lipid catabolic process,",None, , , 
MEF2B,LOC729991-MEF2B readthrough transcript; myocyte enhancer factor 2B,0.011543241574239,0.406056891459892,0.147294034755861,971,0.840187572303684,1,0.038129880226435,1,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007517~muscle organ development,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,",None, , , 
AMY2A,"amylase, alpha 2A (pancreatic)",0.011694882345283,0.409079976268785,0.720702283758265,340,0.406297742708815,1,0.621617423105817,2.90169067379638E-22,1,,"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0004556~alpha-amylase activity,GO:0005509~calcium ion binding,GO:0016160~amylase activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa00500:Starch and sucrose metabolism,", , , 
MSX1,msh homeobox 1,0.011717723461457,0.409112815956181,0.642717944991239,459,0.407193326215162,1,0.621617423105817,1,1,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001701~in utero embryonic development,GO:0003007~heart morphogenesis,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008285~negative regulation of cell proliferation,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0016481~negative regulation of transcription,GO:0030326~embryonic limb morphogenesis,GO:0030509~BMP signaling pathway,GO:0030900~forebrain development,GO:0030901~midbrain development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051789~response to protein stimulus,GO:0060173~limb development,GO:0060548~negative regulation of cell death,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
RIC3,resistance to inhibitors of cholinesterase 3 homolog (C. elegans),0.011777614061287,0.409897409894367,0.881531180861048,132,0.703117634977137,0.720097705280436,0.239978199885825,7.88522490934517E-24,1,,"GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
ARFGAP3,ADP-ribosylation factor GTPase activating protein 3,0.011919122465213,0.410769905032683,0.582777334425162,555,0.313628434207815,0.893571396845862,1,4.99451081335922E-12,1,,"GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0009306~protein secretion,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032012~regulation of ARF protein signal transduction,GO:0032312~regulation of ARF GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032940~secretion by cell,GO:0034613~cellular protein localization,GO:0043087~regulation of GTPase activity,GO:0045184~establishment of protein localization,GO:0046578~regulation of Ras protein signal transduction,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0070727~cellular macromolecule localization,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008060~ARF GTPase activator activity,GO:0008270~zinc ion binding,GO:0008565~protein transporter activity,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04144:Endocytosis,", , , 
ANAPC4,anaphase promoting complex subunit 4,0.011977605750953,0.412025226191615,0.729912594554662,322,0.542185978129246,0.468960239540674,0.621617423105817,1,1,,"GO:0000086~G2/M transition of mitotic cell cycle,GO:0000087~M phase of mitotic cell cycle,GO:0000090~mitotic anaphase,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0009057~macromolecule catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048285~organelle fission,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051301~cell division,GO:0051322~anaphase,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000151~ubiquitin ligase complex,GO:0000152~nuclear ubiquitin ligase complex,GO:0005654~nucleoplasm,GO:0005680~anaphase-promoting complex,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04914:Progesterone-mediated oocyte maturation,", , , 
BMF,Bcl2 modifying factor,0.012101869177719,0.412620634646191,0.839823727832845,186,0.128919884318848,1,1,2.1684775746575E-58,1,,"GO:0006915~apoptosis,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",None, , , 
RTF1,"Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)",0.012105364729703,0.412620634646191,0.89666391920651,112,0.529634809694765,1,0.505087244311173,2.83064314968523E-61,1,,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006461~protein complex assembly,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,",None, , , 
CUL1,cullin 1,0.012260211577951,0.416282541113007,0.311412337833662,864,0.830672778498767,1,0.053125090503257,4.71802813147305E-17,1,,"GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008629~induction of apoptosis by intracellular signals,GO:0009057~macromolecule catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000151~ubiquitin ligase complex,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,", , , 
POGLUT1,Protein O-Glucosyltransferase 1,0.012277205126124,0.416282541113007,0.677304709539275,402,0.705849725300684,0.813942632239755,0.255152378265114,1,1,,"GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0031974~membrane-enclosed lumen,GO:0043233~organelle lumen,GO:0044432~endoplasmic reticulum part,GO:0070013~intracellular organelle lumen,",None, , , 
TM9SF3,transmembrane 9 superfamily member 3,0.012279655236001,0.416282541113007,0.520634078584227,635,0.506121295789211,1,0.621617423105817,4.28474300151639E-22,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
ATG14,Autophagy Related 14,0.012395990838011,0.418706533206518,0.906287084361663,102,0.146709612482053,1,1,1,1,,None,None, , , 
C7orf50,chromosome 7 open reading frame 50,0.012485530371825,0.41986238230345,0.714320312148436,348,0.32956975240756,1,0.886481428527679,2.52624044323983E-11,1,,None,None, , , 
FGFBP1,fibroblast growth factor binding protein 1,0.012497643586954,0.41986238230345,0.73014994482328,320,0.271054068171744,1,1,1,1,,"GO:0007267~cell-cell signaling,GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0044421~extracellular region part,GO:0001871~pattern binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0019838~growth factor binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,",None, , , 
NUCKS1,nuclear casein kinase and cyclin-dependent kinase substrate 1,0.012641244781175,0.423164536321818,0.346195071272883,839,0.382078818022627,1,0.745415986888831,1,1,,None,None, , , 
C8orf37,chromosome 8 open reading frame 37,0.012721568821763,0.425091563545085,0.306678851332286,865,0.739216506533635,1,0.066343878305903,1,1,,None,None, , , 
SGMS2,sphingomyelin synthase 2,0.012846793892298,0.427702144814018,0.434395233851286,751,0.553849849559387,1,0.505087244311173,0.003744670794437,1,,"GO:0006643~membrane lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006672~ceramide metabolic process,GO:0006684~sphingomyelin metabolic process,GO:0006686~sphingomyelin biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0019637~organophosphate metabolic process,GO:0030148~sphingolipid biosynthetic process,GO:0046467~membrane lipid biosynthetic process,GO:0046513~ceramide biosynthetic process,GO:0046519~sphingoid metabolic process,GO:0046520~sphingoid biosynthetic process,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0030173~integral to Golgi membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031228~intrinsic to Golgi membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0044431~Golgi apparatus part,GO:0044459~plasma membrane part,GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0033188~sphingomyelin synthase activity,GO:0047493~ceramide cholinephosphotransferase activity,","hsa00600:Sphingolipid metabolism,", , , 
PRDX3,peroxiredoxin 3,0.012891284733138,0.427702144814018,0.502507185419801,659,0.217045309078003,1,1,3.94710499479286E-12,1,,"GO:0000302~response to reactive oxygen species,GO:0001890~placenta development,GO:0001893~maternal placenta development,GO:0002237~response to molecule of bacterial origin,GO:0002520~immune system development,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006873~cellular ion homeostasis,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0008284~positive regulation of cell proliferation,GO:0009617~response to bacterium,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010941~regulation of cell death,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0032496~response to lipopolysaccharide,GO:0033554~cellular response to stress,GO:0033673~negative regulation of kinase activity,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043388~positive regulation of DNA binding,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043549~regulation of kinase activity,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0045454~cell redox homeostasis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051881~regulation of mitochondrial membrane potential,GO:0055082~cellular chemical homeostasis,GO:0055114~oxidation reduction,GO:0060548~negative regulation of cell death,GO:0070301~cellular response to hydrogen peroxide,GO:0005739~mitochondrion,GO:0005768~endosome,GO:0005769~early endosome,GO:0005829~cytosol,GO:0008385~IkappaB kinase complex,GO:0044445~cytosolic part,GO:0004601~peroxidase activity,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0008022~protein C-terminus binding,GO:0008785~alkyl hydroperoxide reductase activity,GO:0016209~antioxidant activity,GO:0016651~oxidoreductase activity, acting on NADH or NADPH,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0016668~oxidoreductase activity, acting on sulfur group of donors, NAD or NADP as acceptor,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030414~peptidase inhibitor activity,GO:0042802~identical protein binding,GO:0043027~caspase inhibitor activity,GO:0043028~caspase regulator activity,GO:0051920~peroxiredoxin activity,",None, , , 
NKAIN4,Na+/K+ transporting ATPase interacting 4,0.012920940857323,0.427925982755198,0.146774081595477,972,0.58147419783392,1,0.26518730604534,1,1,,"GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
IK,"similar to CG18005; IK cytokine, down-regulator of HLA II",0.013238284057916,0.433062474847693,0.886657720059007,129,0.44336934738674,0.368547672816551,0.922946820691503,0.001399031529193,1,,"GO:0006955~immune response,GO:0007267~cell-cell signaling,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005625~soluble fraction,GO:0044421~extracellular region part,",None, , , 
COPS4,COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis),0.013238325024789,0.433062474847693,0.785463639959974,247,0.425620619628491,1,0.876560862545503,0.746387077320418,1,,"GO:0008180~signalosome,",None, , , 
PPP1R3D,"protein phosphatase 1, regulatory (inhibitor) subunit 3D",0.01334598763659,0.435821159202543,0.298056467449748,872,0.537782963618956,1,0.38222470049003,1,1,,"GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0019318~hexose metabolic process,GO:0044042~glucan metabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,","hsa04910:Insulin signaling pathway,", , , 
MSL3,male-specific lethal 3 homolog (Drosophila),0.013477449152266,0.438041577911792,0.84906501267648,171,0.663177623498086,0.368547672816551,0.420265180899895,1,1,,"GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0016568~chromatin modification,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
R3HCC1L,R3H Domain And Coiled-Coil Containing 1-Like,0.013528824513504,0.438041577911792,0.665047206245077,423,0.366184669242657,1,0.84978015877207,1.31441624773137E-26,1,,None,None, , , 
HOXD9,homeobox D9,0.013531237777992,0.438041577911792,0.47598068195845,697,0.508922118773424,1,0.475808461183278,1,1,,"GO:0001501~skeletal system development,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007389~pattern specification process,GO:0007422~peripheral nervous system development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008344~adult locomotory behavior,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0009954~proximal/distal pattern formation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0014706~striated muscle tissue development,GO:0030182~neuron differentiation,GO:0030326~embryonic limb morphogenesis,GO:0030534~adult behavior,GO:0030879~mammary gland development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048666~neuron development,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048732~gland development,GO:0048736~appendage development,GO:0048934~peripheral nervous system neuron differentiation,GO:0048935~peripheral nervous system neuron development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060173~limb development,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
MTO1,mitochondrial translation optimization 1 homolog (S. cerevisiae),0.013645035484329,0.440961276490984,0.589006477550323,541,0.73282572254473,0.453288759514313,0.271476723733921,0.223373528094244,1,,"GO:0006396~RNA processing,GO:0006399~tRNA metabolic process,GO:0008033~tRNA processing,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0005739~mitochondrion,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0009055~electron carrier activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050662~coenzyme binding,",None, , , 
PLK2,polo-like kinase 2 (Drosophila),0.013729438795755,0.441758011053217,0.73182105145901,319,0.523859259797601,1,0.420265180899895,4.56464508671178E-75,1,,"GO:0000278~mitotic cell cycle,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0016310~phosphorylation,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042801~polo kinase kinase activity,",None, , , 
DALRD3,DALR anticodon binding domain containing 3,0.013769449214076,0.441923611460004,0.816415661890917,206,0.211040000460127,1,1,4.51660408268768E-74,1,,"GO:0006399~tRNA metabolic process,GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006420~arginyl-tRNA aminoacylation,GO:0034660~ncRNA metabolic process,GO:0043038~amino acid activation,GO:0043039~tRNA aminoacylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004814~arginine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016875~ligase activity, forming carbon-oxygen bonds,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
KHSRP,KH-type splicing regulatory protein,0.013818127470863,0.442725219602482,0.5266769392092,624,0.645255451939965,0.002671906700031,0.621617423105817,1.29164823545486E-25,1,,"GO:0006350~transcription,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006403~RNA localization,GO:0008380~RNA splicing,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016071~mRNA metabolic process,GO:0045449~regulation of transcription,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051236~establishment of RNA localization,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0031202~RNA splicing factor activity, transesterification mechanism,",None, , , 
MAST2,microtubule associated serine/threonine kinase 2,0.013875813666005,0.443372288691371,0.40151899040597,789,0.879361433879004,1,0.038129880226435,1,1,,"GO:0001817~regulation of cytokine production,GO:0003006~reproductive developmental process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0016310~phosphorylation,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0032655~regulation of interleukin-12 production,GO:0042035~regulation of cytokine biosynthetic process,GO:0045075~regulation of interleukin-12 biosynthetic process,GO:0048232~male gamete generation,GO:0048515~spermatid differentiation,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
COL9A2,"collagen, type IX, alpha 2",0.013885796289119,0.443372288691371,0.343795271258362,842,0.578752769466742,0.319328035851206,0.634855678262747,1,1,,"GO:0001501~skeletal system development,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005593~FACIT collagen,GO:0005594~collagen type IX,GO:0030934~anchoring collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0030020~extracellular matrix structural constituent conferring tensile strength,",None, , , 
C6orf203,chromosome 6 open reading frame 203,0.01429637523845,0.454926734376512,0.77461207299972,265,0.413194126803811,1,0.745415986888831,1.44163570455806E-16,1,,None,None, , , 
ZNF12,postmeiotic segregation increased 2-like 3; zinc finger protein 12,0.014523903812944,0.458748050711736,0.635404424735577,474,0.776961865429334,1,0.142038435823367,6.70967828051664E-29,1,,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030983~mismatched DNA binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
AQP2,aquaporin 2 (collecting duct),0.014589971207275,0.458748050711736,0.02380942612524,1000,0.662854231918872,0.893571396845862,0.420265180899895,1,1,,"GO:0001977~renal system process involved in regulation of blood volume,GO:0003013~circulatory system process,GO:0003014~renal system process,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003073~regulation of systemic arterial blood pressure,GO:0003097~renal water transport,GO:0006833~water transport,GO:0006970~response to osmotic stress,GO:0007588~excretion,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0009414~response to water deprivation,GO:0009415~response to water,GO:0009628~response to abiotic stimulus,GO:0009651~response to salt stress,GO:0009991~response to extracellular stimulus,GO:0031668~cellular response to extracellular stimulus,GO:0033554~cellular response to stress,GO:0042044~fluid transport,GO:0042631~cellular response to water deprivation,GO:0046903~secretion,GO:0050878~regulation of body fluid levels,GO:0055085~transmembrane transport,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0055037~recycling endosome,GO:0003779~actin binding,GO:0005372~water transporter activity,GO:0008092~cytoskeletal protein binding,GO:0015250~water channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,",None, , , 
YWHAE,"similar to 14-3-3 protein epsilon (14-3-3E) (Mitochondrial import stimulation factor L subunit) (MSF L); tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide",0.014614252717289,0.458748050711736,0.200747631188384,945,0.509049012414356,1,0.505087244311173,0.066683144612993,1,,"GO:0001764~neuron migration,GO:0006605~protein targeting,GO:0006886~intracellular protein transport,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006928~cell motion,GO:0007242~intracellular signaling cascade,GO:0008104~protein localization,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0015031~protein transport,GO:0016265~death,GO:0016477~cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021761~limbic system development,GO:0021766~hippocampus development,GO:0021987~cerebral cortex development,GO:0030900~forebrain development,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0034613~cellular protein localization,GO:0035303~regulation of dephosphorylation,GO:0035304~regulation of protein amino acid dephosphorylation,GO:0035305~negative regulation of dephosphorylation,GO:0035308~negative regulation of protein amino acid dephosphorylation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045184~establishment of protein localization,GO:0045936~negative regulation of phosphate metabolic process,GO:0046907~intracellular transport,GO:0048870~cell motility,GO:0051174~regulation of phosphorus metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051674~localization of cell,GO:0070727~cellular macromolecule localization,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0048770~pigment granule,GO:0016597~amino acid binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0031406~carboxylic acid binding,GO:0042826~histone deacetylase binding,GO:0043176~amine binding,GO:0045309~protein phosphorylated amino acid binding,GO:0050815~phosphoserine binding,GO:0051219~phosphoprotein binding,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04722:Neurotrophin signaling pathway,", , , 
LIN28B,lin-28 homolog B (C. elegans),0.014634197481654,0.458748050711736,0.715632908082136,346,0.756775526873616,1,0.086210192121299,2.96352488326057E-16,1,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0006396~RNA processing,GO:0006401~RNA catabolic process,GO:0009057~macromolecule catabolic process,GO:0010033~response to organic substance,GO:0010586~miRNA metabolic process,GO:0010587~miRNA catabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016441~posttranscriptional gene silencing,GO:0016458~gene silencing,GO:0031047~gene silencing by RNA,GO:0031050~dsRNA fragmentation,GO:0031054~pre-microRNA processing,GO:0031123~RNA 3'-end processing,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0034661~ncRNA catabolic process,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035195~gene silencing by miRNA,GO:0035196~gene silencing by miRNA, production of miRNAs,GO:0040029~regulation of gene expression, epigenetic,GO:0043331~response to dsRNA,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
GRXCR1,"glutaredoxin, cysteine rich 1",0.014651753517913,0.458748050711736,0.174560951211714,960,0.877681070295713,0.846204308491937,0.066428757066903,6.16802749182684E-56,1,,"GO:0006457~protein folding,GO:0019725~cellular homeostasis,GO:0042592~homeostatic process,GO:0045454~cell redox homeostasis,GO:0009055~electron carrier activity,GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,",None, , , 
CASC3,cancer susceptibility candidate 3,0.014677213324172,0.458748050711736,0.11805896003127,984,0.578752769466742,1,0.342096927505986,1,1,,"GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006403~RNA localization,GO:0006417~regulation of translation,GO:0008298~intracellular mRNA localization,GO:0008380~RNA splicing,GO:0009057~macromolecule catabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016071~mRNA metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051236~establishment of RNA localization,GO:0070727~cellular macromolecule localization,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0048471~perinuclear region of cytoplasm,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,GO:0042802~identical protein binding,",None, , , 
ZNF717,zinc finger protein 717,0.014681058784904,0.458748050711736,0.89372283652759,119,0.169281950799227,1,1,2.83878613813882E-28,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
TIGD7,tigger transposable element derived 7,0.014690355954651,0.458748050711736,0.545289198541806,606,0.465749926734155,1,0.621617423105817,0.063916050525852,1,,"GO:0045449~regulation of transcription,GO:0000775~chromosome, centromeric region,GO:0005694~chromosome,GO:0030529~ribonucleoprotein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,",None, , , 
KRTAP4-6,keratin associated protein 4-6; keratin associated protein 4-7; keratin associated protein 4-8; keratin associated protein 4-11,0.014711457617733,0.458748050711736,0.134889668284418,978,0.288004147586643,NA,NA,0.618188697727811,1,,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,",None, , , 
SLC25A51,"Solute Carrier Family 25, Member 51",0.01473573694668,0.458748050711736,0.689777764394234,379,0.512535884928564,1,0.505087244311173,0.005471192556005,1,,"GO:0055085~transmembrane transport,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,",None, , , 
SEL1L,sel-1 suppressor of lin-12-like (C. elegans),0.014927681560154,0.462411548693388,0.72420958607881,334,0.900580773373732,0.319328035851206,0.071749565120695,0.001296428564603,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
ZNF654,zinc finger protein 654,0.015249583223758,0.470094017426411,0.485937514013775,686,0.48295260543433,1,0.621617423105817,1.28716865411395E-11,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ARHGAP27,Rho GTPase activating protein 27,0.015295948687024,0.470696911902665,0.628675718059477,487,0.314586261877537,1,1,0.024742866793065,1,,"GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0032318~regulation of Ras GTPase activity,GO:0032319~regulation of Rho GTPase activity,GO:0032320~positive regulation of Ras GTPase activity,GO:0032321~positive regulation of Rho GTPase activity,GO:0032489~regulation of Cdc42 protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043088~regulation of Cdc42 GTPase activity,GO:0043089~positive regulation of Cdc42 GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0044093~positive regulation of molecular function,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0019898~extrinsic to membrane,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0030675~Rac GTPase activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
PYGO2,pygopus homolog 2 (Drosophila),0.015344639827582,0.471418630492443,0.598053307975072,526,0.305857556518427,1,1,1,1,,"GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001701~in utero embryonic development,GO:0001822~kidney development,GO:0002088~lens development in camera-type eye,GO:0007166~cell surface receptor linked signal transduction,GO:0007423~sensory organ development,GO:0009791~post-embryonic development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0016055~Wnt receptor signaling pathway,GO:0040007~growth,GO:0043009~chordate embryonic development,GO:0043010~camera-type eye development,GO:0048589~developmental growth,GO:0060021~palate development,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CHRDL1,chordin-like 1,0.015386252682442,0.471920876609736,0.668143458715165,413,0.530780095629375,0.24557763453244,0.858711823250435,0.11236595067017,1,,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0030509~BMP signaling pathway,GO:0060348~bone development,GO:0005576~extracellular region,",None, , , 
PSTPIP1,proline-serine-threonine phosphatase interacting protein 1,0.015417610730102,0.472107460373081,0.335094926257488,846,0.74735679281311,1,0.259421173804159,3.45696240982597E-09,1,,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0001725~stress fiber,GO:0005826~contractile ring,GO:0005856~cytoskeleton,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0032153~cell division site,GO:0032155~cell division site part,GO:0032432~actin filament bundle,GO:0042641~actomyosin,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044448~cell cortex part,GO:0048471~perinuclear region of cytoplasm,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,","hsa04621:NOD-like receptor signaling pathway,", , , 
MED6,mediator complex subunit 6,0.015510392292899,0.473661857402489,0.762054447296575,289,0.314968726838903,1,1,2.06408876780354E-08,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0016592~Srb-mediator complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016251~general RNA polymerase II transcription factor activity,GO:0016455~RNA polymerase II transcription mediator activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None, , , 
FAM53C,"family with sequence similarity 53, member C",0.015520653499278,0.473661857402489,0.405840331385146,785,0.488584022864902,1,0.621617423105817,0.00415044016635,1,,None,None, , , 
CBLN3,cerebellin 3 precursor,0.015588111978142,0.473661857402489,0.610342634541342,508,0.291082237681593,1,1,0.019858224704703,1,,"GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,",None, , , 
YPEL2,yippee-like 2 (Drosophila),0.015627316787624,0.473661857402489,0.434326698789668,752,0.301799987891845,1,1,1,1,,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,",None, , , 
OR7C1,"olfactory receptor, family 7, subfamily C, member 1",0.015637686805252,0.473661857402489,0.471923460668146,706,0.523859259797601,1,0.505087244311173,1,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,","hsa04740:Olfactory transduction,", , , 
TOP1,topoisomerase (DNA) I,0.015645878581152,0.473661857402489,0.42519612997534,767,0.663379188157386,0.631768750281355,0.505087244311173,1,1,,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006265~DNA topological change,GO:0006268~DNA unwinding during replication,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0032392~DNA geometric change,GO:0032508~DNA duplex unwinding,GO:0040016~embryonic cleavage,GO:0042493~response to drug,GO:0051301~cell division,GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043025~cell soma,GO:0043204~perikaryon,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003916~DNA topoisomerase activity,GO:0003917~DNA topoisomerase type I activity,GO:0003918~DNA topoisomerase (ATP-hydrolyzing) activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
MARCH8,"Membrane-Associated Ring Finger (C3HC4) 8, E3 Ubiquitin Protein Ligase",0.015760166409793,0.475580207380498,0.774375322096094,267,0.434004138197617,1,0.745415986888831,1,1,,"GO:0006508~proteolysis,GO:0006955~immune response,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CACNA1H,"calcium channel, voltage-dependent, T type, alpha 1H subunit",0.016070728823113,0.483215103435816,0.260104940509938,906,0.846120936133285,1,0.064071265741545,0.386189389821531,1,,"GO:0000768~syncytium formation by plasma membrane fusion,GO:0003012~muscle system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006936~muscle contraction,GO:0006949~syncytium formation,GO:0007517~muscle organ development,GO:0007520~myoblast fusion,GO:0008016~regulation of heart contraction,GO:0014902~myotube differentiation,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0042692~muscle cell differentiation,GO:0044057~regulation of system process,GO:0051146~striated muscle cell differentiation,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016021~integral to membrane,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043204~perikaryon,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0008332~low voltage-gated calcium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,","hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,", , , 
ENO2,"enolase 2 (gamma, neuronal)",0.016212704084875,0.485315864745807,0.033072882461392,999,0.73282572254473,1,0.142038435823367,1,1,,"GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006090~pyruvate metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006094~gluconeogenesis,GO:0006096~glycolysis,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0014070~response to organic cyclic substance,GO:0016051~carbohydrate biosynthetic process,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019319~hexose biosynthetic process,GO:0019320~hexose catabolic process,GO:0032355~response to estradiol stimulus,GO:0034637~cellular carbohydrate biosynthetic process,GO:0042493~response to drug,GO:0043627~response to estrogen stimulus,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046165~alcohol biosynthetic process,GO:0046364~monosaccharide biosynthetic process,GO:0046365~monosaccharide catabolic process,GO:0048545~response to steroid hormone stimulus,GO:0000015~phosphopyruvate hydratase complex,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019717~synaptosome,GO:0043025~cell soma,GO:0043204~perikaryon,GO:0044445~cytosolic part,GO:0000287~magnesium ion binding,GO:0004634~phosphopyruvate hydratase activity,GO:0016836~hydro-lyase activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa00010:Glycolysis / Gluconeogenesis,hsa03018:RNA degradation,", , , 
C16orf70,chromosome 16 open reading frame 70,0.016410116640171,0.489286990790518,0.550839941124232,597,0.58944092900803,0.237550355203275,0.745415986888831,1.95371985173217E-08,1,,"GO:0006886~intracellular protein transport,GO:0006892~post-Golgi vesicle-mediated transport,GO:0006893~Golgi to plasma membrane transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0043001~Golgi to plasma membrane protein transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0070727~cellular macromolecule localization,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0008021~synaptic vesicle,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030425~dendrite,GO:0030659~cytoplasmic vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0044456~synapse part,GO:0045202~synapse,",None, , , 
GLT8D1,glycosyltransferase 8 domain containing 1,0.016488691689766,0.490433554256602,0.601293901639318,521,0.363386439426116,1,0.964584671744861,8.87562126120836E-76,1,,"GO:0005739~mitochondrion,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
PIK3R3,"phosphoinositide-3-kinase, regulatory subunit 3 (gamma)",0.016654799193317,0.494526998542039,0.565810750612005,579,0.318663881456849,1,1,0.022639163680911,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008286~insulin receptor signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0043434~response to peptide hormone stimulus,GO:0005829~cytosol,GO:0005942~phosphoinositide 3-kinase complex,GO:0044445~cytosolic part,GO:0001727~lipid kinase activity,GO:0004428~inositol or phosphatidylinositol kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0019207~kinase regulator activity,GO:0035004~phosphoinositide 3-kinase activity,GO:0035014~phosphoinositide 3-kinase regulator activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,","hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04150:mTOR signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,", , , 
RHOXF2,"Rhox homeobox family, member 2",0.016857208568002,0.498923241409998,0.500728794127479,663,0.508922118773424,1,0.621617423105817,1,1,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
PRIM1,"primase, DNA, polypeptide 1 (49kDa)",0.016937302038115,0.499009250425798,0.726303901373873,330,0.259950044030954,1,1,1,1,,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006350~transcription,GO:0032774~RNA biosynthetic process,GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005658~alpha DNA polymerase:primase complex,GO:0005694~chromosome,GO:0030894~replisome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0043596~nuclear replication fork,GO:0043601~nuclear replisome,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0003896~DNA primase activity,GO:0003899~DNA-directed RNA polymerase activity,GO:0008270~zinc ion binding,GO:0016779~nucleotidyltransferase activity,GO:0034062~RNA polymerase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03030:DNA replication,", , , 
IRF2BP1,interferon regulatory factor 2 binding protein 1,0.016972564933548,0.499076869494517,0.768146347909517,283,0.332850778320811,1,1,8.49376245968666E-18,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,",None, , , 
TMEM165,transmembrane protein 165,0.016993034370069,0.499076869494517,0.144448829016421,973,0.726869353530654,1,0.175460844584417,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
FAM153A,"family with sequence similarity 153, member A",0.017185066002254,0.500458477384162,0.471442994566175,707,0.840581144328319,0.039276671482174,0.26518730604534,0.316820356335507,1,,None,None, , , 
SDC4,syndecan 4,0.017197806432817,0.500458477384162,0.512662232052342,648,0.197993647751347,1,1,1,1,,"GO:0006937~regulation of muscle contraction,GO:0019220~regulation of phosphate metabolic process,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0030016~myofibril,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043034~costamere,GO:0043292~contractile fiber,GO:0044449~contractile fiber part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0070161~anchoring junction,GO:0008092~cytoskeletal protein binding,GO:0042805~actinin binding,GO:0051018~protein kinase A binding,GO:0051393~alpha-actinin binding,GO:0070053~thrombospondin receptor activity,","hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),", , , 
HNRPDL,heterogeneous nuclear ribonucleoprotein D-like,0.017200832083122,0.500458477384162,0.624083088740383,494,0.357595035632042,1,1,0.577592873438012,1,,"GO:0006350~transcription,GO:0006396~RNA processing,GO:0045449~regulation of transcription,GO:0030529~ribonucleoprotein complex,GO:0030530~heterogeneous nuclear ribonucleoprotein complex,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0008143~poly(A) RNA binding,GO:0043566~structure-specific DNA binding,GO:0070717~poly-purine tract binding,",None, , , 
CDH7,"cadherin 7, type 2",0.017461090840987,0.505082086961644,0.403156914902269,787,0.978888608669698,1,0.013926318684271,6.71982755834415E-42,1,,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
LRFN4,leucine rich repeat and fibronectin type III domain containing 4,0.017602668594927,0.507407788093568,0.425259859612766,766,0.232970444914403,1,1,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
SLC6A14,"solute carrier family 6 (amino acid transporter), member 14",0.01763630638937,0.507594094063241,0.375245599402197,817,0.542185978129246,1,0.806613549597766,1,1,,"GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0009636~response to toxin,GO:0015837~amine transport,GO:0015849~organic acid transport,GO:0046942~carboxylic acid transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005903~brush border,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0005275~amine transmembrane transporter activity,GO:0005326~neurotransmitter transporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015370~solute:sodium symporter activity,",None, , , 
KLRC2,"killer cell lectin-like receptor subfamily C, member 2",0.017742061793036,0.509323817647268,0.618715414990556,499,0.469828181510526,1,0.745415986888831,5.86090463065432E-08,1,,"GO:0006952~defense response,GO:0006968~cellular defense response,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0005529~sugar binding,GO:0030246~carbohydrate binding,","hsa04612:Antigen processing and presentation,hsa04650:Natural killer cell mediated cytotoxicity,", , , 
TRIM72,tripartite motif-containing 72,0.017751074529529,0.509323817647268,0.465267379718628,715,0.511236250678775,0.978493926431691,0.898692767374997,1,1,,"GO:0001778~plasma membrane repair,GO:0003012~muscle system process,GO:0006461~protein complex assembly,GO:0006887~exocytosis,GO:0007009~plasma membrane organization,GO:0007517~muscle organ development,GO:0009611~response to wounding,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0032940~secretion by cell,GO:0042060~wound healing,GO:0043933~macromolecular complex subunit organization,GO:0046903~secretion,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042383~sarcolemma,GO:0044433~cytoplasmic vesicle part,GO:0001786~phosphatidylserine binding,GO:0005543~phospholipid binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ODF1,outer dense fiber of sperm tails 1,0.017924580782115,0.512560763710357,0.12505021748379,982,0.458702687494425,1,0.793026157219052,1,1,,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0001520~outer dense fiber,GO:0005930~axoneme,GO:0042995~cell projection,GO:0044447~axoneme part,GO:0044463~cell projection part,GO:0005198~structural molecule activity,",None, , , 
ZDHHC13,"zinc finger, DHHC-type containing 13",0.018031603414942,0.513652406603922,0.507454262592489,653,0.476383100868938,1,0.745415986888831,0.419714566591294,1,,"GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
CTSK,cathepsin K,0.018302291617951,0.520347800809282,0.578555075483506,568,0.183395805588652,1,1,1,1,,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001894~tissue homeostasis,GO:0001957~intramembranous ossification,GO:0006508~proteolysis,GO:0042592~homeostatic process,GO:0045453~bone resorption,GO:0046849~bone remodeling,GO:0048771~tissue remodeling,GO:0048871~multicellular organismal homeostasis,GO:0060249~anatomical structure homeostasis,GO:0060348~bone development,GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005773~vacuole,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04142:Lysosome,", , , 
TTYH1,tweety homolog 1 (Drosophila),0.01847236714909,0.522916794460867,0.700549290549205,363,0.879361433879004,1,0.122408621449127,1.30822981209501E-17,1,,"GO:0000041~transition metal ion transport,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006826~iron ion transport,GO:0007155~cell adhesion,GO:0015674~di-, tri-valent inorganic cation transport,GO:0022610~biological adhesion,GO:0030001~metal ion transport,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0005216~ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0005381~iron ion transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0015082~di-, tri-valent inorganic cation transmembrane transporter activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046915~transition metal ion transmembrane transporter activity,",None, , , 
RASSF7,Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,0.018476636026777,0.522916794460867,0.739491032723122,313,0.366184669242657,1,1,1.50465044036339E-21,1,,"GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,",None, , , 
MYCN,"v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)",0.018578702709894,0.524573966661322,0.372147987271313,821,0.74735679281311,1,0.180765780910828,1,1,,"GO:0001763~morphogenesis of a branching structure,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0048754~branching morphogenesis of a tube,GO:0051252~regulation of RNA metabolic process,GO:0060541~respiratory system development,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
E2F5,"E2F transcription factor 5, p130-binding",0.018708070792183,0.527070971835878,0.663278091589976,428,0.425422271462593,1,1,1,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008134~transcription factor binding,GO:0030528~transcription regulator activity,","hsa04110:Cell cycle,hsa04350:TGF-beta signaling pathway,", , , 
SPATA17,spermatogenesis associated 17,0.019173067004021,0.532227764784555,0.522850486669077,632,0.512094081736782,1,0.910322520092466,1,1,,"GO:0005516~calmodulin binding,",None, , , 
GSK3B,glycogen synthase kinase 3 beta,0.019261521976249,0.532227764784555,0.425317334950648,765,0.508762855496194,1,0.971784231743341,1,1,,"GO:0000320~re-entry into mitotic cell cycle,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006605~protein targeting,GO:0006611~protein export from nucleus,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006916~anti-apoptosis,GO:0006983~ER overload response,GO:0006984~ER-nuclear signaling pathway,GO:0007049~cell cycle,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0008104~protein localization,GO:0010941~regulation of cell death,GO:0015031~protein transport,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016055~Wnt receptor signaling pathway,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0019318~hexose metabolic process,GO:0022402~cell cycle process,GO:0031334~positive regulation of protein complex assembly,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032880~regulation of protein localization,GO:0033157~regulation of intracellular protein transport,GO:0033554~cellular response to stress,GO:0034613~cellular protein localization,GO:0034976~response to endoplasmic reticulum stress,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043254~regulation of protein complex assembly,GO:0044042~glucan metabolic process,GO:0044087~regulation of cellular component biogenesis,GO:0044264~cellular polysaccharide metabolic process,GO:0045184~establishment of protein localization,GO:0045444~fat cell differentiation,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0046825~regulation of protein export from nucleus,GO:0046827~positive regulation of protein export from nucleus,GO:0046907~intracellular transport,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0060341~regulation of cellular localization,GO:0060548~negative regulation of cell death,GO:0070201~regulation of establishment of protein localization,GO:0070727~cellular macromolecule localization,GO:0005829~cytosol,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0030877~beta-catenin destruction complex,GO:0034747~Axin-APC-beta-catenin-GSK3B complex,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043198~dendritic shaft,GO:0044463~cell projection part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0002039~p53 binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0034236~protein kinase A catalytic subunit binding,GO:0050321~tau-protein kinase activity,GO:0051018~protein kinase A binding,GO:0051059~NF-kappaB binding,","hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04360:Axon guidance,hsa04510:Focal adhesion,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04916:Melanogenesis,hsa05010:Alzheimer's disease,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05217:Basal cell carcinoma,", , , 
OR4F5,"olfactory receptor, family 4, subfamily F, member 5",0.019407865341751,0.533866892964951,0.142321063882628,974,0.382078818022627,NA,1,1,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,","hsa04740:Olfactory transduction,", , , 
SUCNR1,succinate receptor 1,0.019456353696064,0.533866892964951,0.386122169011988,807,0.291082237681593,1,1,1,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0001608~nucleotide receptor activity, G-protein coupled,GO:0001614~purinergic nucleotide receptor activity,GO:0016502~nucleotide receptor activity,GO:0045028~purinergic nucleotide receptor activity, G-protein coupled,",None, , , 
TNFRSF18,"tumor necrosis factor receptor superfamily, member 18",0.019504830284969,0.533866892964951,0.673680977776414,407,0.383384775341622,NA,1,1,1,,"GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0060548~negative regulation of cell death,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005031~tumor necrosis factor receptor activity,GO:0019955~cytokine binding,GO:0043120~tumor necrosis factor binding,","hsa04060:Cytokine-cytokine receptor interaction,", , , 
TMEM55A,transmembrane protein 55A,0.019528567131687,0.533866892964951,0.478325530866699,692,0.672861049619117,0.813942632239755,0.621617423105817,1,1,,"GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005768~endosome,GO:0005773~vacuole,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
RTN4IP1,reticulon 4 interacting protein 1,0.019574801994812,0.533866892964951,0.551602515069583,595,0.511236250678775,1,0.745415986888831,4.65756191212114E-19,1,,"GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
JUN,jun oncogene,0.019590744366036,0.533866892964951,0.471314995372551,709,0.54645863555447,1,0.621617423105817,0.733612736542142,1,,"GO:0000060~protein import into nucleus, translocation,GO:0000302~response to reactive oxygen species,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001836~release of cytochrome c from mitochondria,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0001944~vasculature development,GO:0002237~response to molecule of bacterial origin,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0006275~regulation of DNA replication,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006873~cellular ion homeostasis,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptosis,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007184~SMAD protein nuclear translocation,GO:0007568~aging,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007623~circadian rhythm,GO:0008104~protein localization,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0009267~cellular response to starvation,GO:0009612~response to mechanical stimulus,GO:0009617~response to bacterium,GO:0009628~response to abiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0014070~response to organic cyclic substance,GO:0015031~protein transport,GO:0016265~death,GO:0017038~protein import,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0030855~epithelial cell differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0031952~regulation of protein amino acid autophosphorylation,GO:0031953~negative regulation of protein amino acid autophosphorylation,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032496~response to lipopolysaccharide,GO:0033365~protein localization in organelle,GO:0033554~cellular response to stress,GO:0034097~response to cytokine stimulus,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0035026~leading edge cell differentiation,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0042594~response to starvation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045655~regulation of monocyte differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045740~positive regulation of DNA replication,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046907~intracellular transport,GO:0048511~rhythmic process,GO:0048514~blood vessel morphogenesis,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051094~positive regulation of developmental process,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051365~cellular response to potassium ion starvation,GO:0051591~response to cAMP,GO:0051726~regulation of cell cycle,GO:0051899~membrane depolarization,GO:0055082~cellular chemical homeostasis,GO:0060395~SMAD protein signal transduction,GO:0060429~epithelium development,GO:0070727~cellular macromolecule localization,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008134~transcription factor binding,GO:0010843~promoter binding,GO:0030528~transcription regulator activity,GO:0030695~GTPase regulator activity,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046332~SMAD binding,GO:0046983~protein dimerization activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0070412~R-SMAD binding,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04310:Wnt signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,", , , 
NR3C1,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",0.019618376349649,0.533866892964951,0.35982457523042,836,0.863871072183607,1,0.058690670133948,0.000702056362782,1,,"GO:0006109~regulation of carbohydrate metabolic process,GO:0006111~regulation of gluconeogenesis,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007242~intracellular signaling cascade,GO:0008202~steroid metabolic process,GO:0008211~glucocorticoid metabolic process,GO:0010033~response to organic substance,GO:0010565~regulation of cellular ketone metabolic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010817~regulation of hormone levels,GO:0010906~regulation of glucose metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0016568~chromatin modification,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0030325~adrenal gland development,GO:0030518~steroid hormone receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031943~regulation of glucocorticoid metabolic process,GO:0031946~regulation of glucocorticoid biosynthetic process,GO:0031958~corticosteroid receptor signaling pathway,GO:0032350~regulation of hormone metabolic process,GO:0032774~RNA biosynthetic process,GO:0034754~cellular hormone metabolic process,GO:0035270~endocrine system development,GO:0042445~hormone metabolic process,GO:0042921~glucocorticoid receptor signaling pathway,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0045449~regulation of transcription,GO:0046885~regulation of hormone biosynthetic process,GO:0046890~regulation of lipid biosynthetic process,GO:0048732~gland development,GO:0050810~regulation of steroid biosynthetic process,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051789~response to protein stimulus,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003707~steroid hormone receptor activity,GO:0004879~ligand-dependent nuclear receptor activity,GO:0004883~glucocorticoid receptor activity,GO:0005496~steroid binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04080:Neuroactive ligand-receptor interaction,", , , 
FN3KRP,fructosamine 3 kinase related protein,0.01970512243884,0.534988345981229,0.412955494891645,777,0.645595720645646,1,0.621617423105817,0.021131847428238,1,,None,None, , , 
MICU3,"mitochondrial calcium uptake family, member 3",0.019792203292105,0.535945865467253,0.497722569703365,668,0.74735679281311,1,0.420265180899895,2.85459007396697E-50,1,,"GO:0005509~calcium ion binding,GO:0016021~integral to membrane,GO:0005739~mitochondrion",None, , , 
HECA,headcase homolog (Drosophila),0.019849526629818,0.536146468970301,0.564721460293163,581,0.530358103091292,1,0.693453523010957,1.05748366790265E-15,1,,"GO:0030323~respiratory tube development,GO:0035295~tube development,",None, , , 
CCDC171,coiled-coil domain containing 171,0.01994296420129,0.53682607239966,0.591984254563704,534,0.753093108138707,1,0.342096927505986,1.128374789639E-39,1,,None,None, , , 
NDUFA8,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa",0.019969811387879,0.53682607239966,0.657847451569124,434,0.617460903123271,1,0.475808461183278,1,1,,"GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016310~phosphorylation,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0042773~ATP synthesis coupled electron transport,GO:0042775~mitochondrial ATP synthesis coupled electron transport,GO:0045333~cellular respiration,GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005747~mitochondrial respiratory chain complex I,GO:0019866~organelle inner membrane,GO:0030964~NADH dehydrogenase complex,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,GO:0045271~respiratory chain complex I,GO:0070469~respiratory chain,GO:0003954~NADH dehydrogenase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016651~oxidoreductase activity, acting on NADH or NADPH,GO:0016655~oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor,GO:0050136~NADH dehydrogenase (quinone) activity,","hsa00190:Oxidative phosphorylation,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,", , , 
RMDN3,Regulator Of Microtubule Dynamics 3,0.020212925760495,0.539783246282068,0.706801784570201,359,0.382078818022627,1,1,4.83259711143823E-57,1,,"GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0005739~mitochondrion,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",None, , , 
TBKBP1,TBK1 binding protein 1,0.020228506472373,0.539783246282068,0.641854468764038,461,0.552342143717882,1,0.621617423105817,1,1,,"GO:0006952~defense response,GO:0006955~immune response,GO:0045087~innate immune response,","hsa04622:RIG-I-like receptor signaling pathway,", , , 
FBXL19,F-box and leucine-rich repeat protein 19,0.02027398140989,0.540224962561096,0.436432918683331,748,0.42400322205366,1,0.953842715951356,1,1,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
AKR1C2,"aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)",0.020569524607812,0.544218342987716,0.475079076116278,700,0.312009080922827,1,1,0.49062949462597,1,,"GO:0006631~fatty acid metabolic process,GO:0006690~icosanoid metabolic process,GO:0006692~prostanoid metabolic process,GO:0006693~prostaglandin metabolic process,GO:0007586~digestion,GO:0008202~steroid metabolic process,GO:0033559~unsaturated fatty acid metabolic process,GO:0055114~oxidation reduction,GO:0005496~steroid binding,GO:0008289~lipid binding,GO:0016229~steroid dehydrogenase activity,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0031406~carboxylic acid binding,GO:0032052~bile acid binding,GO:0033293~monocarboxylic acid binding,GO:0033764~steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0047026~3-alpha-hydroxysteroid dehydrogenase (A-specific) activity,GO:0047115~trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,","hsa00140:Steroid hormone biosynthesis,hsa00980:Metabolism of xenobiotics by cytochrome P450,", , , 
ISY1,ISY1 splicing factor homolog (S. cerevisiae),0.020686660370444,0.545771368728147,0.689604414278653,380,0.578769496777565,0.817879873922511,0.876560862545503,1,1,,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0005681~spliceosome,GO:0005730~nucleolus,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,","hsa03040:Spliceosome,", , , 
TFG,TRK-fused gene,0.020812879822892,0.548326914262063,0.426430787980869,760,0.301799987891845,1,1,1,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0016310~phosphorylation,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,","hsa05200:Pathways in cancer,hsa05216:Thyroid cancer,", , , 
FUT11,"fucosyltransferase 11 (alpha (1,3) fucosyltransferase)",0.020909765240841,0.550103528075577,0.217597846757328,934,0.563010620780794,1,0.621617423105817,1.37731345437034E-06,1,,"GO:0006486~protein amino acid glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0044431~Golgi apparatus part,GO:0008417~fucosyltransferase activity,GO:0046920~alpha(1,3)-fucosyltransferase activity,",None, , , 
GPM6A,glycoprotein M6A,0.021017900569778,0.551175521925926,0.592834681899127,533,0.718478090855294,1,0.463044273101743,4.29306175564389E-63,1,,"GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0046873~metal ion transmembrane transporter activity,",None, , , 
GPR137B,G protein-coupled receptor 137B,0.021039035662144,0.551175521925926,0.206669144178999,941,0.612505797432436,1,0.745415986888831,2.46976061552169E-21,1,,"GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,",None, , , 
DDX4,DEAD (Asp-Glu-Ala-Asp) box polypeptide 4,0.021276358373948,0.555833703590167,0.470648124501956,710,0.776961865429334,1,0.342096927505986,6.80882968450513E-62,1,,"GO:0032880~regulation of protein localization,GO:0030529~ribonucleoprotein complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,",None, , , 
PAX2,paired box 2,0.021384539225117,0.55615369033203,0.687293359059946,381,0.741265918434039,1,0.271476723733921,1.03531923689058E-18,1,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001709~cell fate determination,GO:0001763~morphogenesis of a branching structure,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0002009~morphogenesis of an epithelium,GO:0002064~epithelial cell development,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007409~axonogenesis,GO:0007423~sensory organ development,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0016481~negative regulation of transcription,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030855~epithelial cell differentiation,GO:0031175~neuron projection development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043010~camera-type eye development,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043583~ear development,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048729~tissue morphogenesis,GO:0048754~branching morphogenesis of a tube,GO:0048812~neuron projection morphogenesis,GO:0048839~inner ear development,GO:0048858~cell projection morphogenesis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060231~mesenchymal to epithelial transition,GO:0060429~epithelium development,GO:0060548~negative regulation of cell death,GO:0060562~epithelial tube morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0034451~centriolar satellite,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044450~microtubule organizing center part,GO:0003677~DNA binding,",None, , , 
DYNC1LI2,"dynein, cytoplasmic 1, light intermediate chain 2",0.021387361863714,0.55615369033203,0.760110892286503,293,0.818900729050157,0.846204308491937,0.337244195918755,0.0081301087702,1,,"GO:0005856~cytoskeleton,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0030286~dynein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
GPR88,G protein-coupled receptor 88,0.021407704017813,0.55615369033203,0.40803629475909,784,0.540577603798751,1,0.73524777513296,3.34795327564208E-19,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
EIF4ENIF1,eukaryotic translation initiation factor 4E nuclear import factor 1,0.021547814178408,0.558240805878618,0.191996316969607,950,0.911377635387788,1,0.04453187072788,1,1,,"GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,GO:0005829~cytosol,GO:0003743~translation initiation factor activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0008565~protein transporter activity,",None, , , 
STIL,SCL/TAL1 interrupting locus,0.021617741445105,0.558503170751193,0.545085336026015,607,0.616319820598673,1,0.525159447973644,1,1,,"GO:0008283~cell proliferation,GO:0005829~cytosol,",None, , , 
MRPS31,mitochondrial ribosomal protein S31,0.021758554191046,0.560642659467292,0.788281227611089,241,0.521035267765579,1,0.964584671744861,3.51475654293279E-70,1,,"GO:0005739~mitochondrion,GO:0005840~ribosome,GO:0030529~ribonucleoprotein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0019904~protein domain specific binding,",None, , , 
SCHIP1,schwannomin interacting protein 1,0.022053970515063,0.56586004842151,0.230065136584823,926,0.785635162861288,0.978493926431691,0.420265180899895,1,1,,"GO:0042802~identical protein binding,",None, , , 
ACY1,aminoacylase 1,0.022166234611437,0.567414674440251,0.794055296780126,232,0.326944366796859,1,1,1.60358800804741E-74,1,,"GO:0006508~proteolysis,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005829~cytosol,GO:0004046~aminoacylase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa00330:Arginine and proline metabolism,", , , 
FIBP,fibroblast growth factor (acidic) intracellular binding protein,0.022175315185041,0.567414674440251,0.501359297713784,661,0.358071238463377,1,1,1,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0019898~extrinsic to membrane,GO:0017134~fibroblast growth factor binding,GO:0019838~growth factor binding,",None, , , 
DMWD,"dystrophia myotonica, WD repeat containing",0.022265083152911,0.568932268417536,0.322231051167577,854,0.717810333170055,1,0.342096927505986,2.10576272219031E-08,1,,"GO:0000279~M phase,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,",None, , , 
MDFIC,MyoD family inhibitor domain containing,0.022365997474687,0.570730145942172,0.256526538279641,910,0.586327207823529,1,0.621617423105817,1,1,,"GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0001932~regulation of protein amino acid phosphorylation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0007257~activation of JUN kinase activity,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010628~positive regulation of gene expression,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0031098~stress-activated protein kinase signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043506~regulation of JUN kinase activity,GO:0043507~positive regulation of JUN kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0046328~regulation of JNK cascade,GO:0046782~regulation of viral transcription,GO:0048524~positive regulation of viral reproduction,GO:0050434~positive regulation of viral transcription,GO:0050792~regulation of viral reproduction,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0008134~transcription factor binding,GO:0030332~cyclin binding,GO:0030957~Tat protein binding,",None, , , 
NR6A1,"nuclear receptor subfamily 6, group A, member 1",0.022601472912426,0.574638994586616,0.680749694310573,394,0.841035390395841,1,0.264844060836597,1,1,,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0019953~sexual reproduction,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032504~multicellular organism reproduction,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003707~steroid hormone receptor activity,GO:0004879~ligand-dependent nuclear receptor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,",None, , , 
FOXQ1,forkhead box Q1,0.022622767100804,0.574638994586616,0.048948736867096,998,0.540323431128064,1,0.745415986888831,1.72080744889898E-07,1,,"GO:0001942~hair follicle development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007398~ectoderm development,GO:0008544~epidermis development,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0031069~hair follicle morphogenesis,GO:0042303~molting cycle,GO:0042633~hair cycle,GO:0045449~regulation of transcription,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
CLASP2,cytoplasmic linker associated protein 2,0.022806986494692,0.574914575889802,0.779613800916819,257,0.942669762591106,0.468960239540674,0.142038435823367,1.06318198320748E-27,1,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000902~cell morphogenesis,GO:0006928~cell motion,GO:0007026~negative regulation of microtubule depolymerization,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007163~establishment or maintenance of cell polarity,GO:0010639~negative regulation of organelle organization,GO:0016477~cell migration,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031110~regulation of microtubule polymerization or depolymerization,GO:0031111~negative regulation of microtubule polymerization or depolymerization,GO:0031114~regulation of microtubule depolymerization,GO:0032886~regulation of microtubule-based process,GO:0032989~cellular component morphogenesis,GO:0033043~regulation of organelle organization,GO:0043242~negative regulation of protein complex disassembly,GO:0043244~regulation of protein complex disassembly,GO:0048285~organelle fission,GO:0048870~cell motility,GO:0051129~negative regulation of cellular component organization,GO:0051301~cell division,GO:0051493~regulation of cytoskeleton organization,GO:0051494~negative regulation of cytoskeleton organization,GO:0051674~localization of cell,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005694~chromosome,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005828~kinetochore microtubule,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0005938~cell cortex,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044430~cytoskeletal part,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0008107~galactoside 2-alpha-L-fucosyltransferase activity,GO:0008417~fucosyltransferase activity,GO:0015631~tubulin binding,GO:0031127~alpha(1,2)-fucosyltransferase activity,GO:0051010~microtubule plus-end binding,",None, , , 
FGB,fibrinogen beta chain,0.022869125520176,0.574929199988374,0.66672710811191,417,0.928567400858825,1,0.041319498656893,4.20628458495197E-14,1,,"GO:0001775~cell activation,GO:0006461~protein complex assembly,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0009611~response to wounding,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0030168~platelet activation,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042060~wound healing,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051258~protein polymerization,GO:0051592~response to calcium ion,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005615~extracellular space,GO:0005625~soluble fraction,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0030674~protein binding, bridging,GO:0043498~cell surface binding,GO:0043499~eukaryotic cell surface binding,","hsa04610:Complement and coagulation cascades,", , , 
SLC30A1,"solute carrier family 30 (zinc transporter), member 1",0.022986518808092,0.577103743032736,0.291608498500528,881,0.646696693936275,1,0.505087244311173,1,1,,"GO:0000041~transition metal ion transport,GO:0001701~in utero embryonic development,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006829~zinc ion transport,GO:0006873~cellular ion homeostasis,GO:0006882~cellular zinc ion homeostasis,GO:0009792~embryonic development ending in birth or egg hatching,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042592~homeostatic process,GO:0043009~chordate embryonic development,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055069~zinc ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005385~zinc ion transmembrane transporter activity,GO:0008270~zinc ion binding,GO:0015082~di-, tri-valent inorganic cation transmembrane transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046914~transition metal ion binding,GO:0046915~transition metal ion transmembrane transporter activity,",None, , , 
CACNB4,"calcium channel, voltage-dependent, beta 4 subunit",0.023138281541689,0.578334104106121,0.122427854862397,983,0.731858278692504,1,0.505087244311173,1,1,,"GO:0002253~activation of immune response,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002520~immune system development,GO:0002684~positive regulation of immune system process,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signal transduction,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006163~purine nucleotide metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006865~amino acid transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007270~nerve-nerve synaptic transmission,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007528~neuromuscular junction development,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0007628~adult walking behavior,GO:0008344~adult locomotory behavior,GO:0009123~nucleoside monophosphate metabolic process,GO:0009187~cyclic nucleotide metabolic process,GO:0010959~regulation of metal ion transport,GO:0014051~gamma-aminobutyric acid secretion,GO:0014706~striated muscle tissue development,GO:0015674~di-, tri-valent inorganic cation transport,GO:0015807~L-amino acid transport,GO:0015812~gamma-aminobutyric acid transport,GO:0015837~amine transport,GO:0015849~organic acid transport,GO:0019226~transmission of nerve impulse,GO:0019227~neuronal action potential propagation,GO:0019725~cellular homeostasis,GO:0022898~regulation of transmembrane transporter activity,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030534~adult behavior,GO:0032409~regulation of transporter activity,GO:0032412~regulation of ion transmembrane transporter activity,GO:0034762~regulation of transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0035249~synaptic transmission, glutamatergic,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0042692~muscle cell differentiation,GO:0043062~extracellular structure organization,GO:0043269~regulation of ion transport,GO:0046058~cAMP metabolic process,GO:0046903~secretion,GO:0046942~carboxylic acid transport,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048537~mucosal-associated lymphoid tissue development,GO:0048538~thymus development,GO:0048541~Peyer's patch development,GO:0048584~positive regulation of response to stimulus,GO:0048741~skeletal muscle fiber development,GO:0048747~muscle fiber development,GO:0048878~chemical homeostasis,GO:0050778~positive regulation of immune response,GO:0050801~ion homeostasis,GO:0050808~synapse organization,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0050877~neurological system process,GO:0051146~striated muscle cell differentiation,GO:0051924~regulation of calcium ion transport,GO:0051925~regulation of calcium ion transport via voltage-gated calcium channel activity,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0009898~internal side of plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,","hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,", , , 
KLHDC8B,kelch domain containing 8B,0.023148731220842,0.578334104106121,0.78172390207893,252,0.703336197876626,1,0.621617423105817,2.50068726337867E-81,1,,None,None, , , 
GJB1,"gap junction protein, beta 1, 32kDa",0.023227868517252,0.579270168269368,0.541551407753596,609,0.489340439045559,1,0.886481428527679,1,1,,"GO:0006461~protein complex assembly,GO:0006862~nucleotide transport,GO:0007267~cell-cell signaling,GO:0015865~purine nucleotide transport,GO:0015868~purine ribonucleotide transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005921~gap junction,GO:0005922~connexon complex,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0044459~plasma membrane part,GO:0005243~gap junction channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022829~wide pore channel activity,",None, , , 
RNASEH2B,"ribonuclease H2, subunit B",0.023279732226391,0.579445225105943,0.550185293576844,599,0.759326049645545,1,0.524342468927875,3.94414982601069E-95,1,,None,"hsa03030:DNA replication,", , , 
SRPX2,"sushi-repeat-containing protein, X-linked 2",0.023296930459584,0.579445225105943,0.625508314920179,493,0.60360720344515,1,0.621617423105817,1,1,,"GO:0005576~extracellular region,",None, , , 
FAM57B,"family with sequence similarity 57, member B",0.02333224615234,0.579551896116443,0.430649372258739,757,0.511236250678775,1,0.86861908420637,1,1,,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
DDO,D-aspartate oxidase,0.023516845915442,0.583361440709889,0.674581222751804,405,0.407193326215162,1,1,3.97584738655388E-19,1,,"GO:0006531~aspartate metabolic process,GO:0006533~aspartate catabolic process,GO:0007320~insemination,GO:0007610~behavior,GO:0007618~mating,GO:0007620~copulation,GO:0007625~grooming behavior,GO:0009063~cellular amino acid catabolic process,GO:0009066~aspartate family amino acid metabolic process,GO:0009068~aspartate family amino acid catabolic process,GO:0009310~amine catabolic process,GO:0010817~regulation of hormone levels,GO:0016054~organic acid catabolic process,GO:0032504~multicellular organism reproduction,GO:0042445~hormone metabolic process,GO:0046395~carboxylic acid catabolic process,GO:0048609~reproductive process in a multicellular organism,GO:0055114~oxidation reduction,GO:0005777~peroxisome,GO:0042579~microbody,GO:0003884~D-amino-acid oxidase activity,GO:0008445~D-aspartate oxidase activity,GO:0015922~aspartate oxidase activity,GO:0016638~oxidoreductase activity, acting on the CH-NH2 group of donors,GO:0016641~oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,","hsa00250:Alanine, aspartate and glutamate metabolism,", , , 
MGAT4C,"mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)",0.023775422930565,0.587245093054224,0.584927694629998,552,0.907099150328727,1,0.068723807073135,0.097726893683951,1,,"GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008375~acetylglucosaminyltransferase activity,GO:0008454~alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
CMAS,cytidine monophosphate N-acetylneuraminic acid synthetase,0.023808932755152,0.587245093054224,0.508739257812457,652,0.813306303463948,0.846204308491937,0.420265180899895,1,1,,"GO:0000271~polysaccharide biosynthetic process,GO:0005976~polysaccharide metabolic process,GO:0008610~lipid biosynthetic process,GO:0008653~lipopolysaccharide metabolic process,GO:0009103~lipopolysaccharide biosynthetic process,GO:0016051~carbohydrate biosynthetic process,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0044264~cellular polysaccharide metabolic process,GO:0008781~N-acylneuraminate cytidylyltransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0070567~cytidylyltransferase activity,","hsa00520:Amino sugar and nucleotide sugar metabolism,", , , 
FBXL3,F-box and leucine-rich repeat protein 3,0.024024072225128,0.590454796175215,0.403242635334087,786,0.55657847925564,1,0.745415986888831,7.6705011166821E-12,1,,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,GO:0000151~ubiquitin ligase complex,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,",None, , , 
TINAG,tubulointerstitial nephritis antigen,0.024131700586719,0.591888037106716,0.583575843102777,554,0.616319820598673,1,0.886481428527679,0.229655812978395,1,,"GO:0006508~proteolysis,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007439~ectodermal gut development,GO:0007442~hindgut morphogenesis,GO:0007443~Malpighian tubule morphogenesis,GO:0022610~biological adhesion,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0048546~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048565~gut development,GO:0048567~ectodermal gut morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048619~embryonic hindgut morphogenesis,GO:0055123~digestive system development,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0000166~nucleotide binding,GO:0001871~pattern binding,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
CDC25A,cell division cycle 25 homolog A (S. pombe),0.024244167063225,0.593521358550428,0.586426735793548,546,0.523859259797601,1,0.858711823250435,4.48633894860254E-67,1,,"GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0008283~cell proliferation,GO:0016311~dephosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0042325~regulation of phosphorylation,GO:0043549~regulation of kinase activity,GO:0045859~regulation of protein kinase activity,GO:0048285~organelle fission,GO:0051174~regulation of phosphorus metabolic process,GO:0051301~cell division,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016791~phosphatase activity,","hsa04110:Cell cycle,hsa04914:Progesterone-mediated oocyte maturation,", , , 
NKX6-1,NK6 homeobox 1,0.024292261324963,0.593920352472493,0.365600341451408,829,0.230055597680821,1,1,0.636907129095587,1,,"GO:0001708~cell fate specification,GO:0002791~regulation of peptide secretion,GO:0002793~positive regulation of peptide secretion,GO:0003002~regionalization,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0007224~smoothened signaling pathway,GO:0007389~pattern specification process,GO:0009953~dorsal/ventral pattern formation,GO:0010001~glial cell differentiation,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010720~positive regulation of cell development,GO:0010721~negative regulation of cell development,GO:0014013~regulation of gliogenesis,GO:0014014~negative regulation of gliogenesis,GO:0014015~positive regulation of gliogenesis,GO:0021510~spinal cord development,GO:0021511~spinal cord patterning,GO:0021513~spinal cord dorsal/ventral patterning,GO:0021514~ventral spinal cord interneuron differentiation,GO:0021515~cell differentiation in spinal cord,GO:0021517~ventral spinal cord development,GO:0021520~spinal cord motor neuron cell fate specification,GO:0021521~ventral spinal cord interneuron specification,GO:0021522~spinal cord motor neuron differentiation,GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,GO:0030182~neuron differentiation,GO:0031016~pancreas development,GO:0031018~endocrine pancreas development,GO:0032024~positive regulation of insulin secretion,GO:0032583~regulation of gene-specific transcription,GO:0035270~endocrine system development,GO:0042063~gliogenesis,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045685~regulation of glial cell differentiation,GO:0045686~negative regulation of glial cell differentiation,GO:0045687~positive regulation of glial cell differentiation,GO:0046883~regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,GO:0048663~neuron fate commitment,GO:0048665~neuron fate specification,GO:0048709~oligodendrocyte differentiation,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050796~regulation of insulin secretion,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051252~regulation of RNA metabolic process,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060341~regulation of cellular localization,GO:0060579~ventral spinal cord interneuron fate commitment,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,","hsa04950:Maturity onset diabetes of the young,", , , 
LPAR3,lysophosphatidic acid receptor 3,0.024416540838561,0.595721039600953,0.486200551726557,684,0.547627637128814,1,0.787415323919243,1.63329773540236E-08,1,,"GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0009967~positive regulation of signal transduction,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010863~positive regulation of phospholipase C activity,GO:0010959~regulation of metal ion transport,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019226~transmission of nerve impulse,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0032060~bleb formation,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043269~regulation of ion transport,GO:0043270~positive regulation of ion transport,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048015~phosphoinositide-mediated signaling,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0051050~positive regulation of transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051347~positive regulation of transferase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0051482~elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating),GO:0051924~regulation of calcium ion transport,GO:0051928~positive regulation of calcium ion transport,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0001619~lysosphingolipid and lysophosphatidic acid receptor activity,GO:0001965~G-protein alpha-subunit binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,","hsa04080:Neuroactive ligand-receptor interaction,", , , 
ADPGK,ADP-dependent glucokinase,0.024453695951315,0.595721039600953,0.588682683253538,542,0.515042765958543,1,0.876560862545503,1,1,,"GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006096~glycolysis,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0005576~extracellular region,GO:0000287~magnesium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043843~ADP-specific glucokinase activity,GO:0046872~metal ion binding,",None, , , 
DEFB113,"defensin, beta 113",0.02446158988029,0.595721039600953,0.398907889484969,791,0.288473701051681,1,1,0.57289651784207,1,,"GO:0006952~defense response,GO:0009617~response to bacterium,GO:0042742~defense response to bacterium,GO:0005576~extracellular region,",None, , , 
TOB1,"transducer of ERBB2, 1",0.024801429869731,0.601977639637365,0.51528050363328,645,0.425422271462593,1,1,1,1,,"GO:0000060~protein import into nucleus, translocation,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007184~SMAD protein nuclear translocation,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0015031~protein transport,GO:0017038~protein import,GO:0030278~regulation of ossification,GO:0030510~regulation of BMP signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0042127~regulation of cell proliferation,GO:0045184~establishment of protein localization,GO:0045596~negative regulation of cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0070727~cellular macromolecule localization,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0005070~SH3/SH2 adaptor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0030674~protein binding, bridging,GO:0046332~SMAD binding,GO:0060090~molecular adaptor activity,",None, , , 
GDPD3,glycerophosphodiester phosphodiesterase domain containing 3,0.024815181889864,0.601977639637365,0.379979661442695,814,0.537782963618956,1,0.84978015877207,1,1,,"GO:0006071~glycerol metabolic process,GO:0019400~alditol metabolic process,GO:0019751~polyol metabolic process,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008081~phosphoric diester hydrolase activity,GO:0008889~glycerophosphodiester phosphodiesterase activity,",None, , , 
RBM5,RNA binding motif protein 5,0.025001303842639,0.604218069977026,0.87278403160595,143,0.60360720344515,1,0.886481428527679,8.3445008719062E-78,1,,"GO:0000245~spliceosome assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000381~regulation of alternative nuclear mRNA splicing, via spliceosome,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006915~apoptosis,GO:0008219~cell death,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0016071~mRNA metabolic process,GO:0016265~death,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043484~regulation of RNA splicing,GO:0043933~macromolecular complex subunit organization,GO:0048024~regulation of nuclear mRNA splicing, via spliceosome,GO:0050684~regulation of mRNA processing,GO:0051252~regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0005681~spliceosome,GO:0005730~nucleolus,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
STK38,serine/threonine kinase 38,0.025004580978224,0.604218069977026,0.10538187313525,989,0.850052657095054,1,0.271476723733921,1,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0016310~phosphorylation,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070688~MLL5-L complex,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
PPP1R1B,"protein phosphatase 1, regulatory (inhibitor) subunit 1B",0.025095460612115,0.605630631490556,0.372942203117631,820,0.793725342439585,1,0.475808461183278,1,1,,"GO:0006350~transcription,GO:0007610~behavior,GO:0007617~mating behavior,GO:0007618~mating,GO:0007621~negative regulation of female receptivity,GO:0019098~reproductive behavior,GO:0032504~multicellular organism reproduction,GO:0033057~reproductive behavior in a multicellular organism,GO:0045924~regulation of female receptivity,GO:0048609~reproductive process in a multicellular organism,GO:0051705~behavioral interaction between organisms,GO:0060180~female mating behavior,GO:0005829~cytosol,GO:0004857~enzyme inhibitor activity,GO:0004860~protein kinase inhibitor activity,GO:0004864~phosphoprotein phosphatase inhibitor activity,GO:0019207~kinase regulator activity,GO:0019208~phosphatase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019212~phosphatase inhibitor activity,GO:0019887~protein kinase regulator activity,GO:0019888~protein phosphatase regulator activity,",None, , , 
ACADVL,"acyl-Coenzyme A dehydrogenase, very long chain",0.025180474644427,0.606898175333232,0.292041266702863,880,0.529634809694765,1,1,5.9330194540327E-05,1,,"GO:0006091~generation of precursor metabolites and energy,GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0009062~fatty acid catabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016042~lipid catabolic process,GO:0016054~organic acid catabolic process,GO:0019395~fatty acid oxidation,GO:0030258~lipid modification,GO:0034440~lipid oxidation,GO:0044242~cellular lipid catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0009295~nucleoid,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031980~mitochondrial lumen,GO:0042645~mitochondrial nucleoid,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0004466~long-chain-acyl-CoA dehydrogenase activity,GO:0009055~electron carrier activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050662~coenzyme binding,","hsa00071:Fatty acid metabolism,", , , 
RTN3,reticulon 3,0.025268504283922,0.608235040617743,0.258948403746034,908,0.383839991399908,1,1,1,1,,"GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044421~extracellular region part,GO:0070013~intracellular organelle lumen,",None, , , 
ARL6IP4,ADP-ribosylation-like factor 6 interacting protein 4,0.025326989140016,0.608858211256567,0.431816525092218,754,0.458702687494425,NA,1,6.22288245650337E-06,1,,"GO:0006396~RNA processing,GO:0008380~RNA splicing,",None, , , 
LAMTOR4,"Late Endosomal/Lysosomal Adaptor, MAPK And MTOR Activator 4",0.02539460040297,0.609698895793152,0.760247525338375,292,0.305857556518427,1,1,1,1,,None,None, , , 
TTPAL,tocopherol (alpha) transfer protein-like,0.025443969779529,0.610100014777698,0.222778357112423,933,0.642513180390068,1,0.812549668064137,1,1,,None,None, , , 
CABYR,calcium binding tyrosine-(Y)-phosphorylation regulated,0.025534851986986,0.611494231108857,0.651317964468362,446,0.46255728259106,0.893571396845862,1,1,1,,"GO:0005856~cytoskeleton,GO:0005929~cilium,GO:0009434~microtubule-based flagellum,GO:0019861~flagellum,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044442~microtubule-based flagellum part,GO:0044460~flagellum part,GO:0044463~cell projection part,GO:0005509~calcium ion binding,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0019207~kinase regulator activity,GO:0019887~protein kinase regulator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
ITFG1,integrin alpha FG-GAP repeat containing 1,0.02580878822648,0.616699515411057,0.225248872570561,930,0.563010620780794,1,0.953842715951356,1,1,,"GO:0005576~extracellular region,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
CRISPLD1,cysteine-rich secretory protein LCCL domain containing 1,0.025818246215078,0.616699515411057,0.162221351163757,965,0.640237668049965,1,0.783828753636386,1,1,,"GO:0005576~extracellular region,",None, , , 
ZNF763,zinc finger protein 763,0.025959615252715,0.619284359266224,0.639493551571573,464,0.46255728259106,1,1,0.529574404718248,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
RUNDC1,RUN domain containing 1,0.02601841642095,0.619895408580269,0.666274623097514,419,0.548354130259599,1,0.84978015877207,0.014021486064974,1,,None,None, , , 
LNX2,ligand of numb-protein X 2,0.026084677593822,0.620276831447565,0.488552237206887,683,0.793406891251112,1,0.271476723733921,2.88875711908826E-17,1,,"GO:0006461~protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0008270~zinc ion binding,GO:0019904~protein domain specific binding,GO:0030165~PDZ domain binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
MYEF2,myelin expression factor 2,0.026116457776227,0.620276831447565,0.6788280948451,397,0.870073081188473,1,0.136598382188982,4.07621357958909E-22,1,,"GO:0001709~cell fate determination,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007518~myoblast cell fate determination,GO:0032774~RNA biosynthetic process,GO:0042692~muscle cell differentiation,GO:0045165~cell fate commitment,GO:0045445~myoblast differentiation,GO:0048625~myoblast cell fate commitment,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003705~RNA polymerase II transcription factor activity, enhancer binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
TMEM70,transmembrane protein 70,0.026134047130426,0.620276831447565,0.330124750840392,850,0.686437752031373,1,0.524342468927875,1,1,,"GO:0006461~protein complex assembly,GO:0007005~mitochondrion organization,GO:0033615~mitochondrial proton-transporting ATP synthase complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043461~proton-transporting ATP synthase complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0070071~proton-transporting two-sector ATPase complex assembly,GO:0070271~protein complex biogenesis,GO:0070272~proton-transporting ATP synthase complex biogenesis,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0032592~integral to mitochondrial membrane,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,",None, , , 
CECR6,"cat eye syndrome chromosome region, candidate 6",0.026297907198581,0.621406461934897,0.1250922601306,981,0.406297742708815,1,1,0.429956555383685,1,,None,None, , , 
PSKH1,protein serine kinase H1,0.026520306312812,0.621406461934897,0.721407135629868,339,0.354827597063225,1,1,3.34906810820064E-07,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
HIGD2A,"HIG1 hypoxia inducible domain family, member 2A",0.026524030437988,0.621406461934897,0.069775122572889,996,0.429933700635118,NA,NA,0.409443283838216,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
HEPACAM,hepatocyte cell adhesion molecule; HEPACAM opposite strand 1,0.026547585878476,0.621406461934897,0.437526476520131,746,0.508922118773424,1,0.953842715951356,2.22794664784684E-81,1,,"GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007155~cell adhesion,GO:0022402~cell cycle process,GO:0022610~biological adhesion,GO:0040008~regulation of growth,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,",None, , , 
STEAP1B,STEAP Family Member 1B,0.026836196219462,0.626913170930443,0.61431106977218,506,0.476186226665411,NA,1,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050662~coenzyme binding,",None, , , 
RASA2,RAS p21 protein activator 2,0.026954318500665,0.627399413332442,0.491197412067837,679,0.823566393006951,0.371170788696107,0.540324378122553,1,1,,"GO:0007242~intracellular signaling cascade,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0048471~perinuclear region of cytoplasm,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,", , , 
NFKB2,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100),0.026969166233613,0.627399413332442,0.626016724635527,490,0.81208552813464,1,0.420265180899895,1.100997879366E-20,1,,"GO:0001775~cell activation,GO:0002250~adaptive immune response,GO:0002266~follicular dendritic cell activation,GO:0002268~follicular dendritic cell differentiation,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002467~germinal center formation,GO:0002520~immune system development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006955~immune response,GO:0030198~extracellular matrix organization,GO:0043062~extracellular structure organization,GO:0045449~regulation of transcription,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0033256~I-kappaB/NF-kappaB complex,GO:0033257~Bcl3/NF-kappaB2 complex,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,","hsa04010:MAPK signaling pathway,hsa05200:Pathways in cancer,", , , 
TAF1B,"TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa",0.027092893030411,0.629437996162989,0.394928988123677,797,0.522944142624094,1,0.910322520092466,1,1,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
EEF1A1,eukaryotic translation elongation factor 1 alpha-like 7; eukaryotic translation elongation factor 1 alpha-like 3; similar to eukaryotic translation elongation factor 1 alpha 1; eukaryotic translation elongation factor 1 alpha 1,0.027233621424169,0.631921508797585,0.461996793273587,718,0.661022274637861,1,0.621617423105817,0.279428970316535,1,,"GO:0006412~translation,GO:0006414~translational elongation,GO:0005829~cytosol,GO:0005853~eukaryotic translation elongation factor 1 complex,GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008135~translation factor activity, nucleic acid binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",None, , , 
TSG101,tumor susceptibility gene 101,0.027585839200867,0.638507918752149,0.519008382423135,638,0.447167313338233,0.631768750281355,1,1,1,,"GO:0001558~regulation of cell growth,GO:0006355~regulation of transcription, DNA-dependent,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006513~protein monoubiquitination,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007398~ectoderm development,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0008544~epidermis development,GO:0009057~macromolecule catabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009913~epidermal cell differentiation,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0015031~protein transport,GO:0016032~viral reproduction,GO:0016481~negative regulation of transcription,GO:0016567~protein ubiquitination,GO:0019058~viral infectious cycle,GO:0019067~viral assembly, maturation, egress, and release,GO:0019076~release of virus from host,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022415~viral reproductive process,GO:0030163~protein catabolic process,GO:0030216~keratinocyte differentiation,GO:0030855~epithelial cell differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032446~protein modification by small protein conjugation,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046753~non-lytic viral release,GO:0046755~non-lytic virus budding,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051301~cell division,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060429~epithelium development,GO:0070647~protein modification by small protein conjugation or removal,GO:0005730~nucleolus,GO:0005768~endosome,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0030528~transcription regulator activity,GO:0032182~small conjugating protein binding,GO:0043130~ubiquitin binding,GO:0048306~calcium-dependent protein binding,","hsa04144:Endocytosis,", , , 
EML4,echinoderm microtubule associated protein like 4,0.027855905040985,0.643375565344966,0.56627223723387,578,0.731375465016592,1,0.73524777513296,1,1,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",None, , , 
CTSF,cathepsin F,0.027865026626911,0.643375565344966,0.661219226626796,432,0.511236250678775,1,1,1,1,,"GO:0006508~proteolysis,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04142:Lysosome,", , , 
NEUROD2,neurogenic differentiation 2,0.027992211878473,0.645514229232102,0.409090204670578,783,0.724261534730691,1,0.503116045574968,1,1,,"GO:0001662~behavioral fear response,GO:0002209~behavioral defense response,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0008306~associative learning,GO:0030182~neuron differentiation,GO:0033555~multicellular organismal response to stress,GO:0042596~fear response,GO:0045449~regulation of transcription,GO:0048666~neuron development,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
NME5,"non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)",0.02809003595781,0.646971370722479,0.699038211710048,366,0.314856113903218,1,1,0.002600932710747,1,,"GO:0003006~reproductive developmental process,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006183~GTP biosynthetic process,GO:0006213~pyrimidine nucleoside metabolic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0006228~UTP biosynthetic process,GO:0006241~CTP biosynthetic process,GO:0006916~anti-apoptosis,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0009116~nucleoside metabolic process,GO:0009119~ribonucleoside metabolic process,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009147~pyrimidine nucleoside triphosphate metabolic process,GO:0009148~pyrimidine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009208~pyrimidine ribonucleoside triphosphate metabolic process,GO:0009209~pyrimidine ribonucleoside triphosphate biosynthetic process,GO:0009218~pyrimidine ribonucleotide metabolic process,GO:0009220~pyrimidine ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010941~regulation of cell death,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0044271~nitrogen compound biosynthetic process,GO:0046036~CTP metabolic process,GO:0046039~GTP metabolic process,GO:0046051~UTP metabolic process,GO:0046131~pyrimidine ribonucleoside metabolic process,GO:0048232~male gamete generation,GO:0048515~spermatid differentiation,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0060548~negative regulation of cell death,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004550~nucleoside diphosphate kinase activity,GO:0005524~ATP binding,GO:0016776~phosphotransferase activity, phosphate group as acceptor,GO:0017076~purine nucleotide binding,GO:0019205~nucleobase, nucleoside, nucleotide kinase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,", , , 
PXMP2,"hypothetical LOC100129532; peroxisomal membrane protein 2, 22kDa",0.02813643134356,0.647241873234428,0.580591050988784,560,0.495589060497094,1,1,1,1,,"GO:0005777~peroxisome,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0042579~microbody,",None, , , 
RHBDL3,"rhomboid, veinlet-like 3 (Drosophila)",0.028279214303803,0.647395804906937,0.580011585863445,563,0.885042912582466,1,0.271476723733921,6.21760934045622E-33,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
ABHD16A,HLA-B associated transcript 5,0.02828175902372,0.647395804906937,0.39539958390543,796,0.617460903123271,1,0.745415986888831,1,1,,"GO:0006952~defense response,GO:0006986~response to unfolded protein,GO:0007584~response to nutrient,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0031667~response to nutrient levels,GO:0051789~response to protein stimulus,GO:0005829~cytosol,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008134~transcription factor binding,GO:0051059~NF-kappaB binding,",None, , , 
DEFB115,"defensin, beta 115",0.028402174883677,0.648118238594592,0.382698500687304,812,0.72206733532029,1,0.745415986888831,1,1,,"GO:0006952~defense response,GO:0009617~response to bacterium,GO:0042742~defense response to bacterium,GO:0005576~extracellular region,",None, , , 
MFAP1,microfibrillar-associated protein 1,0.028431951236163,0.648118238594592,0.522130439001749,633,0.841004279486211,1,0.239978199885825,1.08617370083211E-40,1,,"GO:0001527~microfibril,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0043205~fibril,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,",None, , , 
CDC73,"cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)",0.028452109622976,0.648118238594592,0.369648008483404,823,0.951632204089476,1,0.142038435823367,1,1,,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006513~protein monoubiquitination,GO:0007049~cell cycle,GO:0010390~histone monoubiquitination,GO:0016567~protein ubiquitination,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016574~histone ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0033523~histone H2B ubiquitination,GO:0051276~chromosome organization,GO:0070647~protein modification by small protein conjugation or removal,GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0016593~Cdc73/Paf1 complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",None, , , 
PHC3,polyhomeotic homolog 3 (Drosophila),0.028540619885068,0.649049655739751,0.088317949647639,994,0.845564975663217,1,0.227591325759547,1,1,,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
HPS1,Hermansky-Pudlak syndrome 1,0.028562493549873,0.649049655739751,0.44090962778999,744,0.793406891251112,1,0.342096927505986,2.14609219248115E-29,1,,"GO:0007033~vacuole organization,GO:0007040~lysosome organization,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0000267~cell fraction,GO:0000323~lytic vacuole,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044459~plasma membrane part,GO:0046983~protein dimerization activity,",None, , , 
ING5,"inhibitor of growth family, member 5",0.028757945874078,0.651904940512018,0.77147705044061,273,0.584070218538396,0.194276866008828,1,1,1,,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006473~protein amino acid acetylation,GO:0008285~negative regulation of cell proliferation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0043543~protein amino acid acylation,GO:0043966~histone H3 acetylation,GO:0045449~regulation of transcription,GO:0045926~negative regulation of growth,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0000123~histone acetyltransferase complex,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070775~H3 histone acetyltransferase complex,GO:0070776~MOZ/MORF histone acetyltransferase complex,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
TREH,trehalase (brush-border membrane glycoprotein),0.029053718147235,0.656220557765658,0.670515402895232,412,0.60360720344515,1,0.990178279265157,3.61470913646442E-68,1,,"GO:0005984~disaccharide metabolic process,GO:0005991~trehalose metabolic process,GO:0005993~trehalose catabolic process,GO:0009311~oligosaccharide metabolic process,GO:0009313~oligosaccharide catabolic process,GO:0016052~carbohydrate catabolic process,GO:0016137~glycoside metabolic process,GO:0016139~glycoside catabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046352~disaccharide catabolic process,GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0046658~anchored to plasma membrane,GO:0004555~alpha,alpha-trehalase activity,GO:0015927~trehalase activity,","hsa00500:Starch and sucrose metabolism,", , , 
LCE5A,late cornified envelope 5A,0.029095702547619,0.656375154452875,0.397222560561602,793,0.403811859612114,1,1,1,1,,"GO:0007398~ectoderm development,GO:0008544~epidermis development,GO:0009913~epidermal cell differentiation,GO:0030216~keratinocyte differentiation,GO:0030855~epithelial cell differentiation,GO:0031424~keratinization,GO:0060429~epithelium development,",None, , , 
PRDX1,peroxiredoxin 1,0.029134270838897,0.656452406513583,0.198573220363438,946,0.686437752031373,1,0.621617423105817,1,1,,"GO:0000302~response to reactive oxygen species,GO:0000303~response to superoxide,GO:0000305~response to oxygen radical,GO:0001501~skeletal system development,GO:0001906~cell killing,GO:0001909~leukocyte mediated cytotoxicity,GO:0002228~natural killer cell mediated immunity,GO:0002252~immune effector process,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006801~superoxide metabolic process,GO:0006917~induction of apoptosis,GO:0006952~defense response,GO:0006955~immune response,GO:0006979~response to oxidative stress,GO:0008283~cell proliferation,GO:0010035~response to inorganic substance,GO:0010627~regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0019430~removal of superoxide radicals,GO:0019725~cellular homeostasis,GO:0032386~regulation of intracellular transport,GO:0032872~regulation of stress-activated MAPK cascade,GO:0032880~regulation of protein localization,GO:0033157~regulation of intracellular protein transport,GO:0033554~cellular response to stress,GO:0034101~erythrocyte homeostasis,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042306~regulation of protein import into nucleus,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0042981~regulation of apoptosis,GO:0042990~regulation of transcription factor import into nucleus,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043408~regulation of MAPKKK cascade,GO:0045087~innate immune response,GO:0045454~cell redox homeostasis,GO:0046822~regulation of nucleocytoplasmic transport,GO:0048872~homeostasis of number of cells,GO:0051223~regulation of protein transport,GO:0055114~oxidation reduction,GO:0060341~regulation of cellular localization,GO:0070201~regulation of establishment of protein localization,GO:0070301~cellular response to hydrogen peroxide,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0005739~mitochondrion,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0048770~pigment granule,GO:0004601~peroxidase activity,GO:0008379~thioredoxin peroxidase activity,GO:0016209~antioxidant activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0051920~peroxiredoxin activity,",None, , , 
INO80E,INO80 complex subunit E,0.029177762915211,0.656640281317146,0.783782120957575,250,0.851767097941501,1,0.227591325759547,1,1,,None,None, , , 
KIAA1967,KIAA1967,0.029257817647127,0.657649549736073,0.442647074665293,740,0.987684930790552,1,0.086227261596822,1.37017880094851E-82,1,,"GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,",None, , , 
SLC16A10,"solute carrier family 16, member 10 (aromatic amino acid transporter)",0.029317887131497,0.658207708809183,0.74134817891231,312,0.686437752031373,1,0.621617423105817,1.20796490933152E-20,1,,"GO:0006865~amino acid transport,GO:0015801~aromatic amino acid transport,GO:0015837~amine transport,GO:0015849~organic acid transport,GO:0046942~carboxylic acid transport,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,",None, , , 
ARHGAP12,Rho GTPase activating protein 12,0.029363144669854,0.658432388101088,0.64762159175737,449,0.74735679281311,1,0.649072210399093,1,1,,"GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
POLA2,"polymerase (DNA directed), alpha 2 (70kD subunit)",0.029422547682446,0.658963121882435,0.108730710591376,988,0.269194387967839,1,1,1,1,,"GO:0000060~protein import into nucleus, translocation,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0070727~cellular macromolecule localization,GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005658~alpha DNA polymerase:primase complex,GO:0005694~chromosome,GO:0030894~replisome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0043596~nuclear replication fork,GO:0043601~nuclear replisome,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016779~nucleotidyltransferase activity,GO:0034061~DNA polymerase activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03030:DNA replication,", , , 
WNT1,"wingless-type MMTV integration site family, member 1",0.029527796221264,0.659748451694958,0.652511790086612,443,0.629585581895529,1,0.745415986888831,1,1,,"GO:0000902~cell morphogenesis,GO:0001708~cell fate specification,GO:0001709~cell fate determination,GO:0003002~regionalization,GO:0006355~regulation of transcription, DNA-dependent,GO:0006928~cell motion,GO:0007163~establishment or maintenance of cell polarity,GO:0007166~cell surface receptor linked signal transduction,GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway,GO:0007389~pattern specification process,GO:0007423~sensory organ development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt receptor signaling pathway,GO:0016477~cell migration,GO:0021532~neural tube patterning,GO:0021536~diencephalon development,GO:0021700~developmental maturation,GO:0021732~midbrain-hindbrain boundary maturation,GO:0021797~forebrain anterior/posterior pattern formation,GO:0021871~forebrain regionalization,GO:0021903~rostrocaudal neural tube patterning,GO:0021915~neural tube development,GO:0022004~midbrain-hindbrain boundary maturation during brain development,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0030917~midbrain-hindbrain boundary development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032989~cellular component morphogenesis,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043009~chordate embryonic development,GO:0043583~ear development,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048663~neuron fate commitment,GO:0048664~neuron fate determination,GO:0048839~inner ear development,GO:0048870~cell motility,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051674~localization of cell,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,","hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,", , , 
DLG1,"discs, large homolog 1 (Drosophila)",0.02995238274632,0.667039645519082,0.2381544838596,921,0.951632204089476,0.439018548965955,0.271476723733921,0.089681391735999,1,,"GO:0000075~cell cycle checkpoint,GO:0000902~cell morphogenesis,GO:0001935~endothelial cell proliferation,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007093~mitotic cell cycle checkpoint,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007346~regulation of mitotic cell cycle,GO:0008283~cell proliferation,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030865~cortical cytoskeleton organization,GO:0030866~cortical actin cytoskeleton organization,GO:0031575~G1/S transition checkpoint,GO:0032989~cellular component morphogenesis,GO:0045786~negative regulation of cell cycle,GO:0045930~negative regulation of mitotic cell cycle,GO:0051726~regulation of cell cycle,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0012505~endomembrane system,GO:0014069~postsynaptic density,GO:0016323~basolateral plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0031090~organelle membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042383~sarcolemma,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044432~endoplasmic reticulum part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0004385~guanylate kinase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0008022~protein C-terminus binding,GO:0008092~cytoskeletal protein binding,GO:0015459~potassium channel regulator activity,GO:0016247~channel regulator activity,GO:0016776~phosphotransferase activity, phosphate group as acceptor,GO:0016791~phosphatase activity,GO:0019201~nucleotide kinase activity,GO:0019205~nucleobase, nucleoside, nucleotide kinase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,","hsa04660:T cell receptor signaling pathway,", , , 
KLHL8,kelch-like 8 (Drosophila),0.029990964085415,0.667039645519082,0.446278378396916,736,0.60360720344515,1,0.970645685897825,1.16913772061003E-06,1,,None,None, , , 
PDE6A,"phosphodiesterase 6A, cGMP-specific, rod, alpha",0.030068385969649,0.667039645519082,0.599362251745704,524,0.964151244138997,1,0.180765780910828,0.001076254258334,1,,"GO:0007600~sensory perception,GO:0007601~visual perception,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,","hsa00230:Purine metabolism,", , , 
ARAF,v-raf murine sarcoma 3611 viral oncogene homolog,0.030224397609318,0.669233314830261,0.608844312706961,509,0.893491414921308,0.404324546597738,0.420265180899895,1,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0016310~phosphorylation,GO:0000267~cell fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0019992~diacylglycerol binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04012:ErbB signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04650:Natural killer cell mediated cytotoxicity,hsa04720:Long-term potentiation,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,", , , 
RBM15B,RNA binding motif protein 15B,0.030299354858455,0.669522583783186,0.652139464340145,444,0.777171109936601,1,0.420265180899895,1.05108116737727E-77,1,,"GO:0000381~regulation of alternative nuclear mRNA splicing, via spliceosome,GO:0006350~transcription,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006913~nucleocytoplasmic transport,GO:0008380~RNA splicing,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016071~mRNA metabolic process,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0043484~regulation of RNA splicing,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046907~intracellular transport,GO:0048024~regulation of nuclear mRNA splicing, via spliceosome,GO:0050684~regulation of mRNA processing,GO:0051169~nuclear transport,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
NELL1,NEL-like 1 (chicken),0.030323684666234,0.669522583783186,0.424563283737847,769,0.943765117387339,1,0.240904027396112,0.834175856943646,1,,"GO:0006917~induction of apoptosis,GO:0007155~cell adhesion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0022610~biological adhesion,GO:0030278~regulation of ossification,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045667~regulation of osteoblast differentiation,GO:0055114~oxidation reduction,GO:0005576~extracellular region,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005080~protein kinase C binding,GO:0005198~structural molecule activity,GO:0005509~calcium ion binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,GO:0051287~NAD or NADH binding,",None, , , 
PYCARD,PYD and CARD domain containing,0.030460819830187,0.670590172852134,0.518618969897215,639,0.73282572254473,1,0.524342468927875,1,1,,"GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0006508~proteolysis,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006919~activation of caspase activity,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0019221~cytokine-mediated signaling pathway,GO:0032651~regulation of interleukin-1 beta production,GO:0032652~regulation of interleukin-1 production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032732~positive regulation of interleukin-1 production,GO:0032880~regulation of protein localization,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043388~positive regulation of DNA binding,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0050704~regulation of interleukin-1 secretion,GO:0050706~regulation of interleukin-1 beta secretion,GO:0050707~regulation of cytokine secretion,GO:0050708~regulation of protein secretion,GO:0050714~positive regulation of protein secretion,GO:0050715~positive regulation of cytokine secretion,GO:0050716~positive regulation of interleukin-1 secretion,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051240~positive regulation of multicellular organismal process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0060341~regulation of cellular localization,GO:0070201~regulation of establishment of protein localization,GO:0005829~cytosol,GO:0008385~IkappaB kinase complex,GO:0044445~cytosolic part,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0008047~enzyme activator activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008656~caspase activator activity,GO:0016504~peptidase activator activity,GO:0019904~protein domain specific binding,GO:0032090~Pyrin domain binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043028~caspase regulator activity,GO:0046983~protein dimerization activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,", , , 
RTFDC1,Replication Termination Factor 2 Domain Containing 1,0.030508491918677,0.670590172852134,0.318031569703168,856,0.943747496116349,1,0.227591325759547,1,1,,None,None, , , 
EME1,essential meiotic endonuclease 1 homolog 1 (S. pombe),0.030515640394256,0.670590172852134,0.365202574656113,831,0.361916757647146,1,1,1,1,,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa03440:Homologous recombination,", , , 
ZBTB11,zinc finger and BTB domain containing 11,0.030770690983648,0.674963981528789,0.410516395607006,780,0.872771370894906,1,0.337793531458596,1,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
RPS6KB1,"ribosomal protein S6 kinase, 70kDa, polypeptide 1",0.03095248521935,0.676211526924467,0.426221699348197,763,0.36533006107785,1,1,1,1,,"GO:0001101~response to acid,GO:0002237~response to molecule of bacterial origin,GO:0003006~reproductive developmental process,GO:0003009~skeletal muscle contraction,GO:0003012~muscle system process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0006936~muscle contraction,GO:0006941~striated muscle contraction,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007568~aging,GO:0007584~response to nutrient,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007613~memory,GO:0007616~long-term memory,GO:0008284~positive regulation of cell proliferation,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0009611~response to wounding,GO:0009612~response to mechanical stimulus,GO:0009617~response to bacterium,GO:0009628~response to abiotic stimulus,GO:0009636~response to toxin,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009743~response to carbohydrate stimulus,GO:0009746~response to hexose stimulus,GO:0009749~response to glucose stimulus,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0014070~response to organic cyclic substance,GO:0014075~response to amine stimulus,GO:0014732~skeletal muscle atrophy,GO:0014874~response to stimulus involved in regulation of muscle adaptation,GO:0014878~response to electrical stimulus involved in regulation of muscle adaptation,GO:0014888~striated muscle adaptation,GO:0014889~muscle atrophy,GO:0014891~striated muscle atrophy,GO:0014910~regulation of smooth muscle cell migration,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016202~regulation of striated muscle tissue development,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0019953~sexual reproduction,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031667~response to nutrient levels,GO:0031960~response to corticosteroid stimulus,GO:0032496~response to lipopolysaccharide,GO:0032504~multicellular organism reproduction,GO:0032868~response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0033574~response to testosterone stimulus,GO:0033762~response to glucagon stimulus,GO:0034284~response to monosaccharide stimulus,GO:0040008~regulation of growth,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043200~response to amino acid stimulus,GO:0043201~response to leucine,GO:0043434~response to peptide hormone stimulus,GO:0043491~protein kinase B signaling cascade,GO:0043500~muscle adaptation,GO:0043501~skeletal muscle adaptation,GO:0043502~regulation of muscle adaptation,GO:0044057~regulation of system process,GO:0045471~response to ethanol,GO:0045844~positive regulation of striated muscle development,GO:0045927~positive regulation of growth,GO:0048545~response to steroid hormone stimulus,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048631~regulation of skeletal muscle growth,GO:0048633~positive regulation of skeletal muscle growth,GO:0048634~regulation of muscle development,GO:0048636~positive regulation of muscle development,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048641~regulation of skeletal muscle tissue development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048870~cell motility,GO:0050877~neurological system process,GO:0050879~multicellular organismal movement,GO:0050881~musculoskeletal movement,GO:0050890~cognition,GO:0051094~positive regulation of developmental process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051384~response to glucocorticoid stimulus,GO:0051602~response to electrical stimulus,GO:0051674~localization of cell,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0019717~synaptosome,GO:0030054~cell junction,GO:0030529~ribonucleoprotein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004711~ribosomal protein S6 kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042277~peptide binding,","hsa04012:ErbB signaling pathway,hsa04150:mTOR signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04910:Insulin signaling pathway,hsa05221:Acute myeloid leukemia,", , , 
SNAP29,"synaptosomal-associated protein, 29kDa",0.030964262744722,0.676211526924467,0.7325834802428,318,0.583809760116692,1,0.886481428527679,1,1,,"GO:0006887~exocytosis,GO:0006903~vesicle targeting,GO:0006944~membrane fusion,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0032940~secretion by cell,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0051640~organelle localization,GO:0051648~vesicle localization,GO:0051650~establishment of vesicle localization,GO:0051656~establishment of organelle localization,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0019717~synaptosome,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0005484~SNAP receptor activity,","hsa04130:SNARE interactions in vesicular transport,", , , 
NUDT19,nudix (nucleoside diphosphate linked moiety X)-type motif 19,0.030988653945465,0.676211526924467,0.158162852264982,967,0.434004138197617,1,1,8.23840750871366E-13,1,,"GO:0005739~mitochondrion,GO:0005777~peroxisome,GO:0042579~microbody,GO:0000287~magnesium ion binding,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
ARRDC3,arrestin domain containing 3,0.031081411568541,0.676678436753783,0.841686355223255,180,0.971774166496375,1,0.177218244215795,6.13877486750509E-68,1,,None,None, , , 
HNRNPUL2,heterogeneous nuclear ribonucleoprotein U-like 2,0.031558836927973,0.683538690736053,0.277574770517198,889,0.820592272584007,1,0.342096927505986,1,1,,None,None, , , 
STX5,syntaxin 5,0.031580592649779,0.683538690736053,0.365532067261483,830,0.467795527264049,1,1,1,1,,"GO:0006886~intracellular protein transport,GO:0006903~vesicle targeting,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0034613~cellular protein localization,GO:0042147~retrograde transport, endosome to Golgi,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051640~organelle localization,GO:0051648~vesicle localization,GO:0051650~establishment of vesicle localization,GO:0051656~establishment of organelle localization,GO:0070727~cellular macromolecule localization,GO:0000139~Golgi membrane,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031201~SNARE complex,GO:0031224~intrinsic to membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044431~Golgi apparatus part,GO:0070013~intracellular organelle lumen,GO:0005484~SNAP receptor activity,GO:0047485~protein N-terminus binding,","hsa04130:SNARE interactions in vesicular transport,", , , 
CNIH,cornichon homolog (Drosophila),0.031790542990069,0.685699252322757,0.499933320789141,664,0.852571337595903,0.371170788696107,0.600158415358331,1,1,,"GO:0006955~immune response,GO:0007242~intracellular signaling cascade,GO:0016192~vesicle-mediated transport,GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0044431~Golgi apparatus part,",None, , , 
C10orf25,chromosome 10 open reading frame 25,0.031866010691487,0.686425209344161,0.568671874294648,576,0.186986691120856,1,1,0.107099812899016,1,,"GO:0005576~extracellular region,",None, , , 
CNOT6,"CCR4-NOT transcription complex, subunit 6",0.031897696970434,0.686425209344161,0.530494128537768,620,0.857751487667913,1,0.420265180899895,0.428682811931051,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa03018:RNA degradation,", , , 
DEFB123,"defensin, beta 123",0.032063999692909,0.688417758923967,0.491880179639687,678,0.508922118773424,1,1,1,1,,"GO:0006952~defense response,GO:0009617~response to bacterium,GO:0042742~defense response to bacterium,GO:0005576~extracellular region,",None, , , 
DCT,"dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2)",0.032156793115393,0.689617380714614,0.115927384862815,986,0.70019662646369,1,0.678621428843043,1.81398945716261E-06,1,,"GO:0006570~tyrosine metabolic process,GO:0006582~melanin metabolic process,GO:0006583~melanin biosynthetic process from tyrosine,GO:0007398~ectoderm development,GO:0008544~epidermis development,GO:0009072~aromatic amino acid family metabolic process,GO:0019748~secondary metabolic process,GO:0042438~melanin biosynthetic process,GO:0042440~pigment metabolic process,GO:0043473~pigmentation,GO:0046148~pigment biosynthetic process,GO:0048066~pigmentation during development,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005792~microsome,GO:0005829~cytosol,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0042598~vesicular fraction,GO:0048770~pigment granule,GO:0004167~dopachrome isomerase activity,GO:0005507~copper ion binding,GO:0008270~zinc ion binding,GO:0016860~intramolecular oxidoreductase activity,GO:0016863~intramolecular oxidoreductase activity, transposing C=C bonds,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00350:Tyrosine metabolism,hsa04916:Melanogenesis,", , , 
C1orf68,chromosome 1 open reading frame 68,0.032395056774864,0.692342409036257,0.360670923121644,835,0.190872141803601,1,1,1,1,,"GO:0007398~ectoderm development,GO:0008544~epidermis development,",None, , , 
FUNDC1,FUN14 domain containing 1,0.032475853573077,0.693275964447434,0.741693588343457,311,0.757923084700634,1,0.524342468927875,1,1,,None,None, , , 
UNCX,UNC homeobox,0.032608644273628,0.693947177149008,0.316112665485728,858,0.590895929441894,1,0.886481428527679,2.08608138131261E-09,1,,"GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007155~cell adhesion,GO:0007389~pattern specification process,GO:0016337~cell-cell adhesion,GO:0021510~spinal cord development,GO:0021516~dorsal spinal cord development,GO:0022610~biological adhesion,GO:0045449~regulation of transcription,GO:0048705~skeletal system morphogenesis,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
SAMHD1,SAM domain and HD domain 1,0.032631708337211,0.693947177149008,0.064174765421474,997,0.72206733532029,1,0.806613549597766,1,1,,"GO:0002252~immune effector process,GO:0006952~defense response,GO:0006955~immune response,GO:0009615~response to virus,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0051607~defense response to virus,",None, , , 
SAV1,salvador homolog 1 (Drosophila),0.032658503252367,0.693947177149008,0.791942883849251,236,0.511236250678775,1,1,1,1,,"GO:0042802~identical protein binding,",None, , , 
GNG2,"guanine nucleotide binding protein (G protein), gamma 2",0.032724891703914,0.693947177149008,0.451676270968387,725,0.782595818014484,1,0.475808461183278,1,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0008283~cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0010033~response to organic substance,GO:0032870~cellular response to hormone stimulus,GO:0005794~Golgi apparatus,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0044459~plasma membrane part,","hsa04062:Chemokine signaling pathway,", , , 
PLA2G15,"phospholipase A2, group XV",0.032735990398951,0.693947177149008,0.635466066927506,473,0.305857556518427,1,1,8.79545172914065E-07,1,,"GO:0006575~cellular amino acid derivative metabolic process,GO:0006576~biogenic amine metabolic process,GO:0006631~fatty acid metabolic process,GO:0006643~membrane lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006672~ceramide metabolic process,GO:0009062~fatty acid catabolic process,GO:0016042~lipid catabolic process,GO:0016054~organic acid catabolic process,GO:0019637~organophosphate metabolic process,GO:0042439~ethanolamine and derivative metabolic process,GO:0044242~cellular lipid catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0046470~phosphatidylcholine metabolic process,GO:0046486~glycerolipid metabolic process,GO:0046519~sphingoid metabolic process,GO:0000267~cell fraction,GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005625~soluble fraction,GO:0005764~lysosome,GO:0005773~vacuole,GO:0004091~carboxylesterase activity,GO:0004607~phosphatidylcholine-sterol O-acyltransferase activity,GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0008374~O-acyltransferase activity,GO:0016298~lipase activity,GO:0047499~calcium-independent phospholipase A2 activity,","hsa00564:Glycerophospholipid metabolism,hsa04142:Lysosome,", , , 
SPAG4,sperm associated antigen 4,0.03278599623616,0.693947177149008,0.396581906863461,795,0.488584022864902,1,1,1,1,,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0009434~microtubule-based flagellum,GO:0015630~microtubule cytoskeleton,GO:0016021~integral to membrane,GO:0019861~flagellum,GO:0031224~intrinsic to membrane,GO:0035086~flagellar axoneme,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044442~microtubule-based flagellum part,GO:0044460~flagellum part,GO:0044463~cell projection part,GO:0005198~structural molecule activity,GO:0042802~identical protein binding,",None, , , 
YEATS4,YEATS domain containing 4,0.032804505456533,0.693947177149008,0.665434707813975,422,0.645255451939965,1,1,1,1,,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006473~protein amino acid acetylation,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031328~positive regulation of cellular biosynthetic process,GO:0040008~regulation of growth,GO:0043543~protein amino acid acylation,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048285~organelle fission,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0000123~histone acetyltransferase complex,GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0035267~NuA4 histone acetyltransferase complex,GO:0043189~H4/H2A histone acetyltransferase complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0008022~protein C-terminus binding,GO:0030528~transcription regulator activity,",None, , , 
APEX1,APEX nuclease (multifunctional DNA repair enzyme) 1,0.033048593734557,0.69660983434747,0.46225079862779,717,0.488584022864902,1,1,0.066666361037053,1,,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006974~response to DNA damage stimulus,GO:0019725~cellular homeostasis,GO:0032774~RNA biosynthetic process,GO:0033554~cellular response to stress,GO:0042592~homeostatic process,GO:0045454~cell redox homeostasis,GO:0051098~regulation of binding,GO:0051101~regulation of DNA binding,GO:0005654~nucleoplasm,GO:0005783~endoplasmic reticulum,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005840~ribosome,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0048471~perinuclear region of cytoplasm,GO:0070013~intracellular organelle lumen,GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0004521~endoribonuclease activity,GO:0004523~ribonuclease H activity,GO:0004527~exonuclease activity,GO:0004528~phosphodiesterase I activity,GO:0004536~deoxyribonuclease activity,GO:0004540~ribonuclease activity,GO:0004844~uracil DNA N-glycosylase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008134~transcription factor binding,GO:0008408~3'-5' exonuclease activity,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0016799~hydrolase activity, hydrolyzing N-glycosyl compounds,GO:0016891~endoribonuclease activity, producing 5'-phosphomonoesters,GO:0016893~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,GO:0019104~DNA N-glycosylase activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa03410:Base excision repair,", , , 
TEAD1,TEA domain family member 1 (SV40 transcriptional enhancer factor),0.033202571256315,0.697093637414028,0.565131582251406,580,0.981178928621531,1,0.177218244215795,8.07500964746125E-08,1,,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None, , , 
CDK17,PCTAIRE protein kinase 2,0.033263213707834,0.697332849437301,0.501420080894371,660,0.979722688956875,0.007552523311108,0.342096927505986,0.556225916026461,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
SWAP70,SWAP switching B-cell complex 70kDa subunit,0.033329929031007,0.697948143912762,0.887249636346569,127,0.522944142624094,1,1,8.20435038862537E-26,1,,"GO:0001775~cell activation,GO:0002200~somatic diversification of immune receptors,GO:0002204~somatic recombination of immunoglobulin genes during immune response,GO:0002208~somatic diversification of immunoglobulins during immune response,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002377~immunoglobulin production,GO:0002381~immunoglobulin production during immune response,GO:0002440~production of molecular mediator of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002520~immune system development,GO:0002562~somatic diversification of immune receptors via germline recombination within a single locus,GO:0006259~DNA metabolic process,GO:0006310~DNA recombination,GO:0006955~immune response,GO:0016064~immunoglobulin mediated immune response,GO:0016444~somatic cell DNA recombination,GO:0016445~somatic diversification of immunoglobulins,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0042113~B cell activation,GO:0045190~isotype switching,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",None, , , 
ACBD4,acyl-Coenzyme A binding domain containing 4,0.033467058263479,0.699251880652713,0.821168928497703,203,0.434004138197617,1,1,0.001929100696359,1,,"GO:0000062~acyl-CoA binding,GO:0005504~fatty acid binding,GO:0008289~lipid binding,GO:0031406~carboxylic acid binding,GO:0033293~monocarboxylic acid binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,",None, , , 
GPSM2,"G-protein signaling modulator 2 (AGS3-like, C. elegans)",0.033766419487889,0.704223450257412,0.793554369108338,233,0.515042765958543,1,1,2.74292963436322E-22,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0005938~cell cortex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0042802~identical protein binding,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
BLMH,bleomycin hydrolase,0.03380413655111,0.704223450257412,0.798850961844453,228,0.458702687494425,1,1,1,1,,"GO:0006508~proteolysis,GO:0009636~response to toxin,GO:0042493~response to drug,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0004175~endopeptidase activity,GO:0004177~aminopeptidase activity,GO:0004180~carboxypeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008238~exopeptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
METTL1,methyltransferase like 1,0.033818107761706,0.704223450257412,0.473287677159998,704,0.60360720344515,1,0.886481428527679,1,1,,"GO:0006396~RNA processing,GO:0006399~tRNA metabolic process,GO:0006400~tRNA modification,GO:0008033~tRNA processing,GO:0009451~RNA modification,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008173~RNA methyltransferase activity,GO:0008175~tRNA methyltransferase activity,GO:0008176~tRNA (guanine-N7-)-methyltransferase activity,GO:0016423~tRNA (guanine) methyltransferase activity,",None, , , 
KCNJ9,"potassium inwardly-rectifying channel, subfamily J, member 9",0.033923731338243,0.705127480551353,0.367578656908482,825,0.776961865429334,1,0.505087244311173,1,1,,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005216~ion channel activity,GO:0005242~inward rectifier potassium channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015467~G-protein activated inward rectifier potassium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",None, , , 
DAZAP1,DAZ associated protein 1,0.033983036832389,0.705299049991316,0.695715814843967,371,0.44336934738674,1,1,1.58019884801215E-226,1,,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
CMPK1,"cytidine monophosphate (UMP-CMP) kinase 1, cytosolic",0.034099027526981,0.705748193120797,0.482931905888284,688,0.522944142624094,1,1,1,1,,"GO:0006220~pyrimidine nucleotide metabolic process,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009218~pyrimidine ribonucleotide metabolic process,GO:0009220~pyrimidine ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004127~cytidylate kinase activity,GO:0004849~uridine kinase activity,GO:0005524~ATP binding,GO:0016776~phosphotransferase activity, phosphate group as acceptor,GO:0017076~purine nucleotide binding,GO:0019201~nucleotide kinase activity,GO:0019205~nucleobase, nucleoside, nucleotide kinase activity,GO:0019206~nucleoside kinase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa00240:Pyrimidine metabolism,", , , 
CFI,complement factor I,0.034176382797939,0.705748193120797,0.286027044903757,885,0.776961865429334,1,0.724507651291874,0.025159844636243,1,,"GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002526~acute inflammatory response,GO:0002541~activation of plasma proteins involved in acute inflammatory response,GO:0002684~positive regulation of immune system process,GO:0006508~proteolysis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0006959~humoral immune response,GO:0009611~response to wounding,GO:0016064~immunoglobulin mediated immune response,GO:0016485~protein processing,GO:0019724~B cell mediated immunity,GO:0045087~innate immune response,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0051604~protein maturation,GO:0051605~protein maturation by peptide bond cleavage,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04610:Complement and coagulation cascades,", , , 
ALPL,"alkaline phosphatase, liver/bone/kidney",0.034218690736988,0.705748193120797,0.641787796748575,462,0.877681070295713,1,0.420265180899895,1.49814701255805E-133,1,,"GO:0001501~skeletal system development,GO:0007584~response to nutrient,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0031214~biomineral formation,GO:0031667~response to nutrient levels,GO:0031960~response to corticosteroid stimulus,GO:0033273~response to vitamin,GO:0033280~response to vitamin D,GO:0046677~response to antibiotic,GO:0048545~response to steroid hormone stimulus,GO:0051384~response to glucocorticoid stimulus,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0000287~magnesium ion binding,GO:0004035~alkaline phosphatase activity,GO:0008270~zinc ion binding,GO:0016791~phosphatase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00790:Folate biosynthesis,", , , 
ARHGAP26,Rho GTPase activating protein 26,0.034275927928664,0.705748193120797,0.434414863180597,750,0.845564975663217,1,0.342096927505986,0.002340018962866,1,,"GO:0007010~cytoskeleton organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
STK4,serine/threonine kinase 4,0.034605674873993,0.710648738607987,0.671763633915411,410,0.846120936133285,1,0.342096927505986,1,1,,"GO:0000902~cell morphogenesis,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0032989~cellular component morphogenesis,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0046777~protein amino acid autophosphorylation,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,","hsa04010:MAPK signaling pathway,hsa05200:Pathways in cancer,hsa05223:Non-small cell lung cancer,", , , 
RCOR1,REST corepressor 1,0.034892611709984,0.71464812952937,0.752219647774366,303,0.856775619556526,1,0.505087244311173,1.48150830119797E-05,1,,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0003677~DNA binding,","hsa05016:Huntington's disease,", , , 
LANCL3,LanC lantibiotic synthetase component C-like 3 (bacterial),0.035149544636892,0.718335168788308,0.492638930885675,675,0.784036226874366,1,0.745415986888831,1.32087983205474E-43,1,,None,None, , , 
MTX1,metaxin 1,0.035308284046342,0.720003752949363,0.714493679655886,347,0.695625735116895,1,0.745415986888831,1,1,,"GO:0006605~protein targeting,GO:0006626~protein targeting to mitochondrion,GO:0006839~mitochondrial transport,GO:0006886~intracellular protein transport,GO:0007005~mitochondrion organization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070585~protein localization in mitochondrion,GO:0070727~cellular macromolecule localization,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0044429~mitochondrial part,",None, , , 
KCNIP4,Kv channel interacting protein 4,0.035847661414109,0.725210873848007,0.801865048124837,224,0.508762855496194,1,1,0.011520972895132,1,,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",None, , , 
NIPA2,non imprinted in Prader-Willi/Angelman syndrome 2,0.035917772505005,0.725306024455121,0.451178119758063,727,0.724261534730691,1,0.724507651291874,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
KDELR3,KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3,0.035966606704853,0.725507825745094,0.683745393979926,388,0.325638335415723,1,1,1,1,,"GO:0006621~protein retention in ER lumen,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032507~maintenance of protein location in cell,GO:0045184~establishment of protein localization,GO:0045185~maintenance of protein location,GO:0051235~maintenance of location,GO:0051651~maintenance of location in cell,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005048~signal sequence binding,GO:0042277~peptide binding,GO:0046923~ER retention sequence binding,","hsa05110:Vibrio cholerae infection,", , , 
RIC8B,resistance to inhibitors of cholinesterase 8 homolog B (C. elegans),0.036234369918631,0.727518183808422,0.449705936458503,729,0.8643690811695,1,0.337244195918755,0.021402207518226,1,,"GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0001965~G-protein alpha-subunit binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",None, , , 
IGFN1,immunoglobulin-like and fibronectin type III domain containing 1,0.036249676390493,0.727518183808422,0.211254644641951,939,0.83315188957937,1,0.420265180899895,1,1,,None,None, , , 
PPP1R3C,"protein phosphatase 1, regulatory (inhibitor) subunit 3C",0.036265093338059,0.727518183808422,0.531824567125124,619,0.322887265574805,1,1,2.00457663961402E-24,1,,"GO:0000271~polysaccharide biosynthetic process,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005981~regulation of glycogen catabolic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006109~regulation of carbohydrate metabolic process,GO:0006112~energy reserve metabolic process,GO:0009250~glucan biosynthetic process,GO:0009894~regulation of catabolic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010906~regulation of glucose metabolic process,GO:0010962~regulation of glucan biosynthetic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016051~carbohydrate biosynthetic process,GO:0019318~hexose metabolic process,GO:0031329~regulation of cellular catabolic process,GO:0032881~regulation of polysaccharide metabolic process,GO:0032885~regulation of polysaccharide biosynthetic process,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043470~regulation of carbohydrate catabolic process,GO:0043471~regulation of cellular carbohydrate catabolic process,GO:0044042~glucan metabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005792~microsome,GO:0042587~glycogen granule,GO:0042598~vesicular fraction,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0019899~enzyme binding,","hsa04910:Insulin signaling pathway,", , , 
CCL8,chemokine (C-C motif) ligand 8,0.036299959703916,0.727518183808422,0.550977060396128,596,0.70664763202471,1,0.745415986888831,0.000229005580925,1,,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007267~cell-cell signaling,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009611~response to wounding,GO:0009615~response to virus,GO:0015674~di-, tri-valent inorganic cation transport,GO:0016192~vesicle-mediated transport,GO:0030001~metal ion transport,GO:0032940~secretion by cell,GO:0042330~taxis,GO:0046903~secretion,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0001871~pattern binding,GO:0005125~cytokine activity,GO:0005539~glycosaminoglycan binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0042379~chemokine receptor binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,", , , 
PAQR3,progestin and adipoQ receptor family member III,0.036652453694104,0.732225863692159,0.780155174545431,254,0.414150439101681,1,1,0.300276673663008,1,,"GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
POLD3,"polymerase (DNA-directed), delta 3, accessory subunit",0.03686970479484,0.73374519497817,0.5595330080589,586,0.675306423974206,1,0.84978015877207,1,1,,"GO:0000731~DNA synthesis during DNA repair,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006298~mismatch repair,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,GO:0000228~nuclear chromosome,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005694~chromosome,GO:0030894~replisome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032993~protein-DNA complex,GO:0042575~DNA polymerase complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0043596~nuclear replication fork,GO:0043601~nuclear replisome,GO:0043625~delta DNA polymerase complex,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016779~nucleotidyltransferase activity,GO:0034061~DNA polymerase activity,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,hsa03430:Mismatch repair,hsa03440:Homologous recombination,", , , 
CPB1,carboxypeptidase B1 (tissue),0.036879577659221,0.73374519497817,0.30162610241426,869,0.987332615704823,1,0.227591325759547,1,1,,"GO:0006508~proteolysis,GO:0005576~extracellular region,GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
MKL1,megakaryoblastic leukemia (translocation) 1,0.036902640984132,0.73374519497817,0.39217196716068,802,0.978888608669698,1,0.113648128859315,1,1,,"GO:0006350~transcription,GO:0006916~anti-apoptosis,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0031328~positive regulation of cellular biosynthetic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0060548~negative regulation of cell death,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003779~actin binding,GO:0003785~actin monomer binding,GO:0008092~cytoskeletal protein binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",None, , , 
SLC9A9,"solute carrier family 9 (sodium/hydrogen exchanger), member 9",0.036972740096626,0.73374519497817,0.276912142111889,890,0.830672778498767,1,0.660096042000246,1,1,,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006885~regulation of pH,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055085~transmembrane transport,GO:0005768~endosome,GO:0005770~late endosome,GO:0010008~endosome membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031902~late endosome membrane,GO:0044440~endosomal part,GO:0055037~recycling endosome,GO:0005451~monovalent cation:hydrogen antiporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015297~antiporter activity,GO:0015298~solute:cation antiporter activity,GO:0015299~solute:hydrogen antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015385~sodium:hydrogen antiporter activity,GO:0015491~cation:cation antiporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
AP4M1,"adaptor-related protein complex 4, mu 1 subunit",0.036987968582825,0.73374519497817,0.421826053994658,773,0.640237668049965,1,0.886481428527679,1,1,,"GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0000138~Golgi trans cisterna,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005905~coated pit,GO:0012505~endomembrane system,GO:0030117~membrane coat,GO:0030118~clathrin coat,GO:0030119~AP-type membrane coat adaptor complex,GO:0030131~clathrin adaptor complex,GO:0031984~organelle subcompartment,GO:0031985~Golgi cisterna,GO:0044431~Golgi apparatus part,GO:0048475~coated membrane,","hsa04142:Lysosome,", , , 
CHPF2,chondroitin sulfate glucuronyltransferase,0.03700347843404,0.73374519497817,0.194922143555699,948,0.593487475771254,1,0.991617699290978,4.19911413962474E-51,1,,"GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031984~organelle subcompartment,GO:0031985~Golgi cisterna,GO:0032580~Golgi cisterna membrane,GO:0044431~Golgi apparatus part,GO:0015020~glucuronosyltransferase activity,GO:0050510~N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,","hsa00532:Chondroitin sulfate biosynthesis,", , , 
PTN,pleiotrophin,0.037070624032974,0.734297122282001,0.426743712685417,759,0.97944659264195,1,0.227591325759547,3.24972957488838E-05,1,,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0008284~positive regulation of cell proliferation,GO:0030282~bone mineralization,GO:0031214~biomineral formation,GO:0042127~regulation of cell proliferation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051302~regulation of cell division,GO:0051781~positive regulation of cell division,GO:0060348~bone development,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0044421~extracellular region part,GO:0001871~pattern binding,GO:0004857~enzyme inhibitor activity,GO:0004864~phosphoprotein phosphatase inhibitor activity,GO:0005539~glycosaminoglycan binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0019208~phosphatase regulator activity,GO:0019212~phosphatase inhibitor activity,GO:0019888~protein phosphatase regulator activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,",None, , , 
PIGH,"phosphatidylinositol glycan anchor biosynthesis, class H",0.037306975152551,0.736996441984855,0.581120809601365,559,0.650749984632027,1,1,3.2184953699955E-07,1,,"GO:0006497~protein amino acid lipidation,GO:0006505~GPI anchor metabolic process,GO:0006506~GPI anchor biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0016254~preassembly of GPI anchor in ER membrane,GO:0019637~organophosphate metabolic process,GO:0030384~phosphoinositide metabolic process,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0045017~glycerolipid biosynthetic process,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046489~phosphoinositide biosynthetic process,GO:0005783~endoplasmic reticulum,GO:0008375~acetylglucosaminyltransferase activity,GO:0017176~phosphatidylinositol N-acetylglucosaminyltransferase activity,","hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,", , , 
NOTCH2NL,Notch homolog 2 (Drosophila) N-terminal like,0.037429326617863,0.736996441984855,0.472098628184464,705,0.773989645351894,1,0.787415323919243,1.09941515636655E-12,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0005576~extracellular region,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
GBE1,"glucan (1,4-alpha-), branching enzyme 1",0.037453791562329,0.736996441984855,0.305470246931811,866,0.529634809694765,1,1,9.78883509003912E-27,1,,"GO:0000271~polysaccharide biosynthetic process,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0009250~glucan biosynthetic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016051~carbohydrate biosynthetic process,GO:0019318~hexose metabolic process,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0044042~glucan metabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0005829~cytosol,GO:0003844~1,4-alpha-glucan branching enzyme activity,GO:0043167~ion binding,GO:0043169~cation binding,","hsa00500:Starch and sucrose metabolism,", , , 
PARP2,poly (ADP-ribose) polymerase 2,0.037465022336805,0.736996441984855,0.586102680358462,549,0.805056991232344,1,0.742087095988098,0.099491498087386,1,,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006471~protein amino acid ADP-ribosylation,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0016763~transferase activity, transferring pentosyl groups,","hsa03410:Base excision repair,", , , 
RNMT,RNA (guanine-7-) methyltransferase,0.037485338064858,0.736996441984855,0.78832726197225,240,0.594123174532628,1,1,0.000219026779463,1,,"GO:0006370~mRNA capping,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0009452~RNA capping,GO:0016071~mRNA metabolic process,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,GO:0004482~mRNA (guanine-N7-)-methyltransferase activity,GO:0008170~N-methyltransferase activity,GO:0008173~RNA methyltransferase activity,GO:0008174~mRNA methyltransferase activity,",None, , , 
TLR9,toll-like receptor 9,0.037562000790705,0.736996441984855,0.262442794696381,903,0.865129179476974,1,0.35533311031061,6.42860152311051E-76,1,,"GO:0001817~regulation of cytokine production,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007249~I-kappaB kinase/NF-kappaB cascade,GO:0009611~response to wounding,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032479~regulation of type I interferon production,GO:0032647~regulation of interferon-alpha production,GO:0032648~regulation of interferon-beta production,GO:0032649~regulation of interferon-gamma production,GO:0042035~regulation of cytokine biosynthetic process,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042742~defense response to bacterium,GO:0045072~regulation of interferon-gamma biosynthetic process,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045087~innate immune response,GO:0045354~regulation of interferon-alpha biosynthetic process,GO:0045356~positive regulation of interferon-alpha biosynthetic process,GO:0045357~regulation of interferon-beta biosynthetic process,GO:0045359~positive regulation of interferon-beta biosynthetic process,GO:0005576~extracellular region,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0044440~endosomal part,GO:0003723~RNA binding,GO:0005149~interleukin-1 receptor binding,GO:0035197~siRNA binding,","hsa04620:Toll-like receptor signaling pathway,", , , 
EIF5A2,eukaryotic translation initiation factor 5A2,0.037694002721075,0.738810363931744,0.409158163041214,782,0.763490431730908,1,0.886481428527679,2.33560702319951E-07,1,,"GO:0006403~RNA localization,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006448~regulation of translational elongation,GO:0006449~regulation of translational termination,GO:0006452~translational frameshifting,GO:0006575~cellular amino acid derivative metabolic process,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0008104~protein localization,GO:0008284~positive regulation of cell proliferation,GO:0008612~peptidyl-lysine modification to hypusine,GO:0009891~positive regulation of biosynthetic process,GO:0010509~polyamine homeostasis,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0015031~protein transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0018205~peptidyl-lysine modification,GO:0019953~sexual reproduction,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032504~multicellular organism reproduction,GO:0042127~regulation of cell proliferation,GO:0042592~homeostatic process,GO:0043243~positive regulation of protein complex disassembly,GO:0043244~regulation of protein complex disassembly,GO:0045184~establishment of protein localization,GO:0045727~positive regulation of translation,GO:0045901~positive regulation of translational elongation,GO:0045905~positive regulation of translational termination,GO:0046516~hypusine metabolic process,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0048878~chemical homeostasis,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051130~positive regulation of cellular component organization,GO:0051236~establishment of RNA localization,GO:0051247~positive regulation of protein metabolic process,GO:0055085~transmembrane transport,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044459~plasma membrane part,GO:0046930~pore complex,GO:0003723~RNA binding,GO:0003746~translation elongation factor activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0043021~ribonucleoprotein binding,GO:0043022~ribosome binding,",None, , , 
CAMTA2,calmodulin binding transcription activator 2,0.037830212643537,0.739927269077089,0.297358493993362,874,0.940242529846683,1,0.365094295850086,1,1,,"GO:0003012~muscle system process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0014887~cardiac muscle adaptation,GO:0014888~striated muscle adaptation,GO:0014896~muscle hypertrophy,GO:0014897~striated muscle hypertrophy,GO:0014898~cardiac muscle hypertrophy,GO:0031328~positive regulation of cellular biosynthetic process,GO:0043500~muscle adaptation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0003682~chromatin binding,GO:0005516~calmodulin binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0042826~histone deacetylase binding,",None, , , 
SH3PXD2A,SH3 and PX domains 2A,0.038031964615013,0.740020289911421,0.562431531399331,584,0.854865758791796,1,0.395685362190299,3.62133618652013E-26,1,,"GO:0002102~podosome,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0035091~phosphoinositide binding,",None, , , 
DNAJB13,"DnaJ (Hsp40) related, subfamily B, member 13",0.038059438200553,0.740020289911421,0.447131532101687,733,0.891829337459174,1,0.298771804543033,1,1,,"GO:0006457~protein folding,GO:0006915~apoptosis,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,",None, , , 
SETDB2,"SET domain, bifurcated 2",0.038098847805251,0.740020289911421,0.643710223934658,456,0.660630962226537,1,0.886481428527679,1.02613637435126E-95,1,,"GO:0006325~chromatin organization,GO:0016568~chromatin modification,GO:0051276~chromosome organization,GO:0003677~DNA binding,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00310:Lysine degradation,", , , 
JOSD1,Josephin domain containing 1,0.038112292890133,0.740020289911421,0.816003732190765,207,0.431023515766244,1,1,1,1,,None,None, , , 
FOXE3,forkhead box E3,0.038176724439406,0.740501594811693,0.327878753060927,851,0.870073081188473,1,0.344697204816764,1,1,,"GO:0001654~eye development,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007423~sensory organ development,GO:0008284~positive regulation of cell proliferation,GO:0032774~RNA biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",None, , , 
CCRL1,chemokine (C-C motif) receptor-like 1,0.03823820283769,0.740924679258508,0.302858778915528,867,0.531489495394206,1,1,1,1,,"GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0042330~taxis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0001653~peptide receptor activity,GO:0004950~chemokine receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0016493~C-C chemokine receptor activity,GO:0019955~cytokine binding,GO:0019956~chemokine binding,GO:0019957~C-C chemokine binding,GO:0042277~peptide binding,",None, , , 
GTF3C6,"general transcription factor IIIC, polypeptide 6, alpha 35kDa",0.038350698895776,0.741565946867694,0.631849172721882,481,0.86268246596117,1,0.382789390978339,1.22604593856418E-21,1,,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006383~transcription from RNA polymerase III promoter,GO:0009303~rRNA transcription,GO:0009304~tRNA transcription,GO:0032774~RNA biosynthetic process,GO:0042791~5S class rRNA transcription,GO:0042797~tRNA transcription from RNA polymerase III promoter,GO:0000127~transcription factor TFIIIC complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003709~RNA polymerase III transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
UBXN2B,UBX domain protein 2B,0.038394770686878,0.741650384343532,0.159868175624458,966,0.813743945110058,1,0.505087244311173,1,1,,"GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,",None, , , 
TOR1AIP1,torsin A interacting protein 1,0.038611374672601,0.745063912716441,0.178939801010933,957,0.672422429417368,1,0.876560862545503,1,1,,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
RANBP3L,RAN binding protein 3-like,0.038747017174386,0.746438952616971,0.683753373744877,387,0.741586034308808,1,0.953842715951356,1,1,,"GO:0046907~intracellular transport,",None, , , 
VEGFB,vascular endothelial growth factor B,0.039098704956321,0.75092612734635,0.646344184841916,452,0.305751326641053,1,1,1,1,,"GO:0001558~regulation of cell growth,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,GO:0051302~regulation of cell division,GO:0051781~positive regulation of cell division,GO:0005576~extracellular region,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044433~cytoplasmic vesicle part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0001871~pattern binding,GO:0005172~vascular endothelial growth factor receptor binding,GO:0005539~glycosaminoglycan binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04150:mTOR signaling pathway,hsa04510:Focal adhesion,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05219:Bladder cancer,", , , 
NRBP2,nuclear receptor binding protein 2,0.039196918988901,0.750932563890956,0.447349899150907,732,0.770875014268066,1,0.886481428527679,1,1,,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,",None, , , 
C16orf86,chromosome 16 open reading frame 86,0.039278501736284,0.751654546381388,0.584494979268408,553,0.663177623498086,1,0.886481428527679,7.68797947157074E-07,1,,None,None, , , 
BCL7C,B-cell CLL/lymphoma 7C,0.039477170235558,0.752442921255091,0.366546794875688,826,0.387319489330458,1,1,1,1,,"GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,",None, , , 
PHGDH,phosphoglycerate dehydrogenase,0.03959503667146,0.753152433794511,0.116108766841511,985,0.921761785676266,0.978493926431691,0.505087244311173,1.78533841579963E-15,1,,"GO:0006541~glutamine metabolic process,GO:0006544~glycine metabolic process,GO:0006563~L-serine metabolic process,GO:0006564~L-serine biosynthetic process,GO:0006566~threonine metabolic process,GO:0006575~cellular amino acid derivative metabolic process,GO:0006790~sulfur metabolic process,GO:0007049~cell cycle,GO:0008652~cellular amino acid biosynthetic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009066~aspartate family amino acid metabolic process,GO:0009069~serine family amino acid metabolic process,GO:0009070~serine family amino acid biosynthetic process,GO:0009309~amine biosynthetic process,GO:0009448~gamma-aminobutyric acid metabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010001~glial cell differentiation,GO:0016053~organic acid biosynthetic process,GO:0019530~taurine metabolic process,GO:0021510~spinal cord development,GO:0021782~glial cell development,GO:0021915~neural tube development,GO:0022402~cell cycle process,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0042063~gliogenesis,GO:0043009~chordate embryonic development,GO:0044271~nitrogen compound biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0048666~neuron development,GO:0055114~oxidation reduction,GO:0000166~nucleotide binding,GO:0004617~phosphoglycerate dehydrogenase activity,GO:0009055~electron carrier activity,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,GO:0051287~NAD or NADH binding,","hsa00260:Glycine, serine and threonine metabolism,", , , 
MRPL24,mitochondrial ribosomal protein L24,0.039725686878779,0.754101732935675,0.471381281322344,708,0.753093108138707,1,0.73524777513296,1,1,,"GO:0006412~translation,GO:0005739~mitochondrion,GO:0005840~ribosome,GO:0030529~ribonucleoprotein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,",None, , , 
TRIP13,thyroid hormone receptor interactor 13,0.039821624427883,0.754384273018159,0.110471230761209,987,0.54645863555447,1,1,1,1,,"GO:0000239~pachytene,GO:0000279~M phase,GO:0001556~oocyte maturation,GO:0003006~reproductive developmental process,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007128~meiotic prophase I,GO:0007131~reciprocal meiotic recombination,GO:0007140~male meiosis,GO:0007141~male meiosis I,GO:0007143~female meiosis,GO:0007144~female meiosis I,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007292~female gamete generation,GO:0009994~oocyte differentiation,GO:0019953~sexual reproduction,GO:0021700~developmental maturation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0032504~multicellular organism reproduction,GO:0032774~RNA biosynthetic process,GO:0033554~cellular response to stress,GO:0048232~male gamete generation,GO:0048469~cell maturation,GO:0048477~oogenesis,GO:0048515~spermatid differentiation,GO:0048599~oocyte development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0051321~meiotic cell cycle,GO:0051324~prophase,GO:0051327~M phase of meiotic cell cycle,GO:0001673~male germ cell nucleus,GO:0043073~germ cell nucleus,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003712~transcription cofactor activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,",None, , , 
LDOC1L,"leucine zipper, down-regulated in cancer 1-like",0.039879381821299,0.754384273018159,0.53501819482766,614,0.55657847925564,1,1,2.28417316976154E-24,1,,None,None, , , 
C14orf93,chromosome 14 open reading frame 93,0.039902117979653,0.754384273018159,0.334231004897785,847,0.726869353530654,1,0.964584671744861,0.313917492208498,1,,"GO:0005576~extracellular region,",None, , , 
TMED10,transmembrane emp24-like trafficking protein 10 (yeast),0.040071212539678,0.755856071396749,0.377902785675426,815,0.55740994886578,1,1,5.48578444963197E-08,1,,"GO:0006887~exocytosis,GO:0006903~vesicle targeting,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032940~secretion by cell,GO:0045055~regulated secretory pathway,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0048199~vesicle targeting, to, from or within Golgi,GO:0051640~organelle localization,GO:0051648~vesicle localization,GO:0051650~establishment of vesicle localization,GO:0051656~establishment of organelle localization,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005792~microsome,GO:0005793~ER-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0030659~cytoplasmic vesicle membrane,GO:0030667~secretory granule membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0042588~zymogen granule,GO:0042589~zymogen granule membrane,GO:0042598~vesicular fraction,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0048770~pigment granule,",None, , , 
HPR,haptoglobin-related protein; haptoglobin,0.0402504303824,0.755856071396749,0.753585167129883,302,0.651675974250201,1,0.932145335372239,1.57279537027543E-09,1,,"GO:0006508~proteolysis,GO:0006873~cellular ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0006952~defense response,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055072~iron ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0032994~protein-lipid complex,GO:0034358~plasma lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0034366~spherical high-density lipoprotein particle,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0030492~hemoglobin binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",None, , , 
PLK1,polo-like kinase 1 (Drosophila),0.040452639880137,0.758649458153684,0.268620023485546,900,0.877681070295713,1,0.540324378122553,1,1,,"GO:0000087~M phase of mitotic cell cycle,GO:0000236~mitotic prometaphase,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000910~cytokinesis,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007126~meiosis,GO:0007143~female meiosis,GO:0008283~cell proliferation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0016310~phosphorylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0033205~cytokinesis during cell cycle,GO:0033206~cytokinesis after meiosis,GO:0040038~polar body extrusion after meiotic divisions,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0046677~response to antibiotic,GO:0048285~organelle fission,GO:0051247~positive regulation of protein metabolic process,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0000922~spindle pole,GO:0005654~nucleoplasm,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0051233~spindle midzone,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042801~polo kinase kinase activity,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04914:Progesterone-mediated oocyte maturation,", , , 
GPR141,G protein-coupled receptor 141,0.040666919123229,0.759939094130659,0.101318523129276,992,0.968471023165246,1,0.180765780910828,1.90509125027056E-17,1,,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",None, , , 
MKL2,MKL/myocardin-like 2,0.040688381616131,0.759939094130659,0.189667898576675,951,0.994716145054135,1,0.271476723733921,1,1,,"GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001889~liver development,GO:0001944~vasculature development,GO:0003007~heart morphogenesis,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0014706~striated muscle tissue development,GO:0016202~regulation of striated muscle tissue development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0042692~muscle cell differentiation,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0045844~positive regulation of striated muscle development,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048514~blood vessel morphogenesis,GO:0048568~embryonic organ development,GO:0048634~regulation of muscle development,GO:0048636~positive regulation of muscle development,GO:0048738~cardiac muscle tissue development,GO:0051094~positive regulation of developmental process,GO:0051145~smooth muscle cell differentiation,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060537~muscle tissue development,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,",None, , , 
TBR1,"T-box, brain, 1",0.040927584511909,0.761099633644786,0.450660593691975,728,0.846120936133285,1,0.475808461183278,1,1,,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030902~hindbrain development,GO:0031175~neuron projection development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",None, , , 
ESRP1,epithelial splicing regulatory protein 1,0.041103830294178,0.761099633644786,0.176041198289091,959,0.935730958504963,1,0.389201770142258,1,1,,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0043484~regulation of RNA splicing,GO:0051252~regulation of RNA metabolic process,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,",None, , , 
CUL2,cullin 2,0.0411204174851,0.761099633644786,0.564615126349295,582,0.978888608669698,1,0.342096927505986,1,1,,"GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0008629~induction of apoptosis by intracellular signals,GO:0009057~macromolecule catabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000151~ubiquitin ligase complex,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,","hsa04120:Ubiquitin mediated proteolysis,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,", , , 
ZBTB44,zinc finger and BTB domain containing 44,0.041169588238231,0.761099633644786,0.49611896248738,670,0.83315188957937,1,0.505087244311173,3.20789680575873E-82,1,,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",None, , , 
RAD9B,RAD9 homolog B (S. pombe),0.041267862913031,0.761099633644786,0.47596257292552,698,0.90803971761104,0.638569690742653,0.621617423105817,0.013773421013165,1,,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,",None, , , 
CYP8B1,"cytochrome P450, family 8, subfamily B, polypeptide 1",0.041445696726756,0.761099633644786,0.282278537404874,887,0.823566393006951,1,0.571300529550603,2.64835121914691E-49,1,,"GO:0055114~oxidation reduction,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005792~microsome,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042598~vesicular fraction,GO:0044432~endoplasmic reticulum part,GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0008397~sterol 12-alpha-hydroxylase activity,GO:0009055~electron carrier activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0033778~7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,","hsa00120:Primary bile acid biosynthesis,hsa03320:PPAR signaling pathway,", , , 
FAM19A1,"family with sequence similarity 19 (chemokine (C-C motif)-like), member A1",0.041491017308646,0.761099633644786,0.397089390802186,794,0.987332615704823,1,0.298771804543033,1.19017570425364E-23,1,,"GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,",None, , , 
MFSD8,major facilitator superfamily domain containing 8,0.041609345037631,0.761099633644786,0.473340987042372,702,0.964151244138997,1,0.342096927505986,0.00863137815292,1,,"GO:0008219~cell death,GO:0016265~death,GO:0055085~transmembrane transport,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,","hsa04142:Lysosome,", , , 
ANXA7,annexin A7,0.041622114698336,0.761099633644786,0.299683508741497,870,0.942271873396842,1,0.420265180899895,1,1,,"GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006884~cell volume homeostasis,GO:0006970~response to osmotic stress,GO:0007599~hemostasis,GO:0008283~cell proliferation,GO:0008360~regulation of cell shape,GO:0009628~response to abiotic stimulus,GO:0009651~response to salt stress,GO:0009992~cellular water homeostasis,GO:0019725~cellular homeostasis,GO:0022604~regulation of cell morphogenesis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030104~water homeostasis,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050878~regulation of body fluid levels,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005635~nuclear envelope,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0031982~vesicle,GO:0005509~calcium ion binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008289~lipid binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0048306~calcium-dependent protein binding,",None, , , 
KCNIP2,Kv channel interacting protein 2,0.041661165729094,0.761099633644786,0.552249729620249,593,0.846120936133285,1,0.503116045574968,1.81925065482824E-20,1,,"GO:0003012~muscle system process,GO:0005513~detection of calcium ion,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006936~muscle contraction,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0008016~regulation of heart contraction,GO:0009593~detection of chemical stimulus,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0015672~monovalent inorganic cation transport,GO:0016044~membrane organization,GO:0019226~transmission of nerve impulse,GO:0021700~developmental maturation,GO:0030001~metal ion transport,GO:0030182~neuron differentiation,GO:0042551~neuron maturation,GO:0044057~regulation of system process,GO:0045161~neuronal ion channel clustering,GO:0045163~clustering of voltage-gated potassium channels,GO:0048469~cell maturation,GO:0048666~neuron development,GO:0050877~neurological system process,GO:0051592~response to calcium ion,GO:0051606~detection of stimulus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005048~signal sequence binding,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005250~A-type (transient outward) potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0015271~outward rectifier potassium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0042277~peptide binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046923~ER retention sequence binding,GO:0047485~protein N-terminus binding,",None, , , 
SLC10A3,"solute carrier family 10 (sodium/bile acid cotransporter family), member 3",0.041828887698018,0.762265164206125,0.101697887338046,991,0.671217436249012,1,0.922946820691503,1,1,,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006820~anion transport,GO:0007584~response to nutrient,GO:0009991~response to extracellular stimulus,GO:0015672~monovalent inorganic cation transport,GO:0015711~organic anion transport,GO:0030001~metal ion transport,GO:0031667~response to nutrient levels,GO:0032526~response to retinoic acid,GO:0033189~response to vitamin A,GO:0033273~response to vitamin,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005343~organic acid:sodium symporter activity,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0008508~bile acid:sodium symporter activity,GO:0015125~bile acid transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015370~solute:sodium symporter activity,",None, , , 
FBXO34,F-box protein 34,0.041911319402728,0.76266837456369,0.197591658864277,947,0.721992153837658,1,0.858711823250435,1,1,,"GO:0006508~proteolysis,GO:0008104~protein localization,GO:0009057~macromolecule catabolic process,GO:0015031~protein transport,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045184~establishment of protein localization,GO:0051603~proteolysis involved in cellular protein catabolic process,",None, , , 
C1QA,"complement component 1, q subcomponent, A chain",0.042011967131376,0.763367251018453,0.918165691121036,90,0.32956975240756,1,1,4.09733284702981E-119,1,,"GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002526~acute inflammatory response,GO:0002541~activation of plasma proteins involved in acute inflammatory response,GO:0002684~positive regulation of immune system process,GO:0006508~proteolysis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0006959~humoral immune response,GO:0007267~cell-cell signaling,GO:0009611~response to wounding,GO:0016064~immunoglobulin mediated immune response,GO:0016485~protein processing,GO:0019724~B cell mediated immunity,GO:0045087~innate immune response,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0051604~protein maturation,GO:0051605~protein maturation by peptide bond cleavage,GO:0005576~extracellular region,GO:0005602~complement component C1 complex,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0044421~extracellular region part,","hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05322:Systemic lupus erythematosus,", , , 
C12orf10,chromosome 12 open reading frame 10,0.042127495545473,0.763572041486951,0.494006574377644,673,0.703117634977137,1,1,1,1,,"GO:0043473~pigmentation,GO:0005739~mitochondrion,",None, , , 
EGFL6,"EGF-like-domain, multiple 6",0.042145873696292,0.763572041486951,0.615562406938557,504,0.65716934113113,1,1,1,1,,"GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005178~integrin binding,GO:0005509~calcium ion binding,GO:0032403~protein complex binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",None, , , 
RBFOX2,"RNA Binding Protein, Fox-1 Homolog (C. Elegans) 2",0.042272418110316,0.765122575467624,0.515649004347578,643,0.846120936133285,1,0.505087244311173,1,1,,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007242~intracellular signaling cascade,GO:0008380~RNA splicing,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016071~mRNA metabolic process,GO:0016481~negative regulation of transcription,GO:0030518~steroid hormone receptor signaling pathway,GO:0030520~estrogen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031327~negative regulation of cellular biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0000166~nucleotide binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,",None, , , 
NAMPT,nicotinamide phosphoribosyltransferase,0.042367041870882,0.766092909105723,0.524305590309004,629,0.724261534730691,1,1,0.000178978578878,1,,"GO:0006732~coenzyme metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006766~vitamin metabolic process,GO:0006767~water-soluble vitamin metabolic process,GO:0006769~nicotinamide metabolic process,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0009108~coenzyme biosynthetic process,GO:0009110~vitamin biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009435~NAD biosynthetic process,GO:0009820~alkaloid metabolic process,GO:0019359~nicotinamide nucleotide biosynthetic process,GO:0019362~pyridine nucleotide metabolic process,GO:0019363~pyridine nucleotide biosynthetic process,GO:0019674~NAD metabolic process,GO:0019748~secondary metabolic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0042364~water-soluble vitamin biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046496~nicotinamide nucleotide metabolic process,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,GO:0005829~cytosol,GO:0005125~cytokine activity,GO:0016763~transferase activity, transferring pentosyl groups,GO:0047280~nicotinamide phosphoribosyltransferase activity,","hsa00760:Nicotinate and nicotinamide metabolism,", , , 
GALR3,galanin receptor 3,0.042474130884079,0.767007389483106,0.246412980837737,913,0.692086688644406,1,0.886481428527679,1,1,,"GO:0006140~regulation of nucleotide metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007631~feeding behavior,GO:0019226~transmission of nerve impulse,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031280~negative regulation of cyclase activity,GO:0043086~negative regulation of catalytic activity,GO:0044092~negative regulation of molecular function,GO:0045761~regulation of adenylate cyclase activity,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051339~regulation of lyase activity,GO:0051350~negative regulation of lyase activity,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0001653~peptide receptor activity,GO:0004966~galanin receptor activity,GO:0008188~neuropeptide receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,GO:0042277~peptide binding,GO:0042923~neuropeptide binding,","hsa04080:Neuroactive ligand-receptor interaction,", , , 
VSTM2A,V-set and transmembrane domain containing 2A,0.042609908673298,0.768253363039129,0.288756524312817,883,0.778885220183975,1,0.886481428527679,1,1,,"GO:0005576~extracellular region,",None, , , 
PTPN3,"protein tyrosine phosphatase, non-receptor type 3",0.042738813243708,0.768831040964209,0.520794908059286,634,0.865384930113013,1,0.656276216627911,1,1,,"GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016311~dephosphorylation,GO:0030162~regulation of proteolysis,GO:0031329~regulation of cellular catabolic process,GO:0031330~negative regulation of cellular catabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0042176~regulation of protein catabolic process,GO:0042177~negative regulation of protein catabolic process,GO:0045861~negative regulation of proteolysis,GO:0051043~regulation of membrane protein ectodomain proteolysis,GO:0051045~negative regulation of membrane protein ectodomain proteolysis,GO:0051248~negative regulation of protein metabolic process,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008092~cytoskeletal protein binding,GO:0016791~phosphatase activity,",None, , , 
STXBP2,syntaxin binding protein 2,0.042771570497716,0.768831040964209,0.502936142532349,658,0.830672778498767,0.453429867731963,0.886481428527679,4.55881257423084E-49,1,,"GO:0001775~cell activation,GO:0002252~immune effector process,GO:0002263~cell activation during immune response,GO:0002274~myeloid leukocyte activation,GO:0002275~myeloid cell activation during immune response,GO:0002366~leukocyte activation during immune response,GO:0002443~leukocyte mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002446~neutrophil mediated immunity,GO:0002694~regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002703~regulation of leukocyte mediated immunity,GO:0002886~regulation of myeloid leukocyte mediated immunity,GO:0006887~exocytosis,GO:0006904~vesicle docking during exocytosis,GO:0006955~immune response,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0017157~regulation of exocytosis,GO:0022406~membrane docking,GO:0032940~secretion by cell,GO:0033003~regulation of mast cell activation,GO:0042119~neutrophil activation,GO:0043299~leukocyte degranulation,GO:0043300~regulation of leukocyte degranulation,GO:0043304~regulation of mast cell degranulation,GO:0043312~neutrophil degranulation,GO:0045055~regulated secretory pathway,GO:0045184~establishment of protein localization,GO:0045321~leukocyte activation,GO:0046903~secretion,GO:0048278~vesicle docking,GO:0050865~regulation of cell activation,GO:0051046~regulation of secretion,GO:0060341~regulation of cellular localization,GO:0060627~regulation of vesicle-mediated transport,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005766~primary lysosome,GO:0005773~vacuole,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031201~SNARE complex,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042581~specific granule,GO:0042582~azurophil granule,GO:0070820~tertiary granule,GO:0000149~SNARE binding,GO:0019905~syntaxin binding,GO:0030348~syntaxin-3 binding,",None, , , 
PIM2,pim-2 oncogene,0.042852744697542,0.768831040964209,0.189460614228523,952,0.425620619628491,1,1,1,1,,"GO:0000279~M phase,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0007005~mitochondrion organization,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0007140~male meiosis,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0009894~regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0009967~positive regulation of signal transduction,GO:0010506~regulation of autophagy,GO:0010508~positive regulation of autophagy,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031329~regulation of cellular catabolic process,GO:0031331~positive regulation of cellular catabolic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0060548~negative regulation of cell death,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa05221:Acute myeloid leukemia,", , , 
POLDIP3,"polymerase (DNA-directed), delta interacting protein 3",0.042884088232297,0.768831040964209,0.623145283213595,496,0.914645707022236,1,0.342096927505986,1.02677355161318E-09,1,,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,",None, , , 
